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Abstract
This thesis covers the development of a theoretical model of macroscopic vascular-
ized tumor growth, the analysis of morphological characteristics, blood flow and tissue
oxygenation in dependence on the vascular network in which the tumor grows, as well as
an analysis of potential barriers to drug delivery caused by the transport characteristics
of tumor blood vessel networks and tissue. An extended model is developed, incorporat-
ing processes of angiogenesis, vaso-dilation, vessel regression and collapse, for tumors
embedded in artificial arterio-venous networks. It is predicted that substances dissolved
in blood are rapidly conducted in maximal concentrations through most parts of the tumor
network. Simulations of interstitial fluid flow and spatio-temporally variable drug concen-
trations showed that the local tumor vascular density predominantly determines the dose
delivered and that non-diffusive substances may not reach all areas of tumors due to the
heterogeneity of interstitial fluid flow. Moreover a new computational model to determine
coupled intravascular and tissue oxygen concentrations was conceived which is applied to
simulated tumor blood vessel networks guided by optical mammography data. Random
differences of initial vessel layouts can accordingly explain the blood oxygen saturation
fluctuations observed in tumors of a cohort of patients, to some degree. However other
factors such as vessel compression need to be taken into account.
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Zusammenfassung
Diese Arbeit umfasst die Entwicklung eines theoretischen Models fu¨r makroskopis-
ches vaskularisiertes Tumorwachstum, Untersuchung von morphologischen Kenngro¨ßen,
Blutfluss und Sauerstoffversorgung in Abha¨ngigkeit des Gefa¨ßnetzes in dem der Tu-
mor wa¨chst, sowie auch die Analyse von mo¨glichen, durch Transporteigenschaften des
Tumorblutgefa¨ßnetzes und Gewebes verursachten Barrieren zur Medikamentablieferung.
Ein erweitertes, die Prozesse Angiogenesis, Vasodilatation, Gefa¨ßru¨ckentwicklung, und
Kollaps umfassendes Model wird fu¨r Tumore erarbeitet, die in ku¨nstlichen arterio-veno¨sen
Netzwerken wachsen. Es werden Modellvorhersagen getroffen, dass in Blut gelo¨ste Sub-
stanzen schnell in maximaler Konzentration durch gro¨ßte Teile des Tumornetzwerkes
geleitet werden. Simulationen des Flusses von Gewebeflu¨ssigkeit und raum-zeitlich ver-
a¨nderlichen Medikamentkonzentrationen zeigten, dass die abgelieferte Dosis maßgeblich
von der lokalen Gefa¨ßdichte bestimmt ist und dass nicht-diffundierende Substanzen auf-
grund des interstitiellen Flu¨ssigkeitsflusses i.A. nicht alle Bereiche eines Tumors erreichen
ko¨nnen. Weiterhin wurde ein neues Rechenmodel zur Bestimmung von gekoppelten in-
travaskula¨ren-und Gewebesauerstoffkonzentrationen entwickelt, welches gefu¨hrt von op-
tischen Mammographiedaten, auf simulierte Tumorblutgefa¨ßnetzwerke angewand wird.
Demzufolge ko¨nnen zufa¨llige Unterschiede in der Anordnung der Anfangsvaskulatur die
beobachteten Blutsauerstoffsa¨ttigungen in einer Schar von Patienten zu gewissem Grad
erkla¨ren. Jedoch mu¨ssen andere Faktoren wie Gefa¨ßkompression in Betracht gezogen
werden.
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Part I
Thesis
1 Introduction
1.1 Physics of cancer
”Physics of Cancer” has recently become a major interdisciplinary research field [see Ins08].
The reason is, even after decades of research, since the declaration of the “war against can-
cer” in 1971 in the US, cancer is a leading cause of death worldwide and is an ever-growing
problem in the aging population. Altogether, average patient survival times have improved
only little. However, some cancers have very high cure rates, when detected at an early
stage, notably testicular cancer. In contrast, great progress has been made in the treat-
ment of conditions of the heart and the circulatory system. At the surface, cancer is simple.
Cells of the body mutate and start to proliferate uncontrolled. Eventually they migrate to
distant parts of the body where they form secondary tumors. Tumors must have deep evo-
lutionary roots since they occur naturally even in ancient, primitive, multi-cellular organisms
[Dom+14]. Today, drug resistance and obstacles to delivery are still major challenges to
overcome. Moreover there is no general theory of cancer with predictive power.
A growing tumor is in reality a complex entity which comprises many phenomena on dif-
ferent scales from biochemistry to the mechanics of macroscopic tissues. It is not merely a
blob of cloned cells, but rather resembles a growing organ, for instance in its composition
into different cell lines and in the interaction with its environment [ENW10]. There are other
types of cancer than these so-called solid tumors, for example leukemia. But the latter is not
the topic of this thesis. There are several hallmarks of cancer, one of them is Angiogenesis,
the formation of new blood vessels, which helps to fuel tumor growth with additional nutri-
ents [HW11]. As we will see, angiogenesis, and other processes, give rise to tumor blood
vessel networks which are abnormally chaotic and spatially heterogeneous, and therefore
inadequate to supply the entire tumor, leading to the emergence of hypoxia (lack of oxy-
gen) and necrosis. Unfortunately, drugs are normally supplied through these networks, too.
Moreover, hypoxia is detrimental for several reasons. It impedes the efficacy of radiation
therapy and drugs, and promotes tumor invasiveness, to name a few issues encountered in
clinical treatment.
Physics comes into play where transport and growth processes are considered. For ex-
ample a growing tumor spheroid can be described by partial differential equations or particle
models for tumor cell population distributions and for various other components which evolve
in time according to forces and growth terms present in the system. Blood vessel networks
are commonly represented by one-dimensional network models and often include compu-
tation of blood flow according to the analogy of Kirchhoff’s laws. They are essential building
blocks of mathematical models, acting as sources and drains of substances. Transport
through tissue, can be described by diffusion-advection-reaction equations for concentra-
tion distributions of drugs, oxygen or other substances. Hence, many phenomena relevant
to tumor growth are physical in nature and can be analyzed with mathematical theoretical
models. See also the Refs. [Tra09; Low+10; SBP13; RW15] for reviews of recent work.
1.2 Anatomy of cancer
A solid tumor typically starts off as an avascular multicellular spheroid, i.e. it is a blob of
tumor cells with no blood vessels in it. Its growth starts, when cells undergo mutations dis-
abling their regulatory circuits for proliferation and apoptosis (programmed cell death). Such
cells are in principle able to divide infinite number of times. After an initial phase of expo-
nential growth, the radius of the spheroid continues to grow linearly [Bru+03; DH05] since
proliferation of tumor cells (TCs) is restricted to a few cell layers behind the tumor-tissue
interface. Also vascularized tumors show this linear growth regime [Do¨m+02; Hol+99]. TCs
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Figure 1. Illustration of a capillary and the oxygen concentration distribution inside
and around it: Extravasation of oxygen and other solutes is driven by radial concentration
gradients. The left hand side shows a schematic cross section of a capillary lumen extend-
ing to the right into a section of surrounding tissue. Blood flow develops a core rich of red
blood cells (RBCs) where most of the oxygen is carried. The boundary layer between core
and vessel wall is free of RBCs. In our model, the vessel wall is treated as part of the tissue,
i.e. it is not explicitly represented. However the rate of oxygen consumption in arterial walls
has been subject of controversy [Pit11]. Oxygen diffuses through those compartment in-
cluding RBCs where it is also bound to hemoglobin. In tissue, oxygen is consumed with rate
M(P ), where P is its partial pressure (PO2). Near isolated vessels, oxygen consumption
leads to an approximately exponential decay of the concentration curve cO2(r). In tumors,
the distance, where cO2 reaches practically zero, denoted diffusion distance, is ca. 100µm
[CJ00]. Beyond this, tissue becomes necrotic due to hypoxia. Under physiological condi-
tions, the spacing between blood vessels is less than the (tissue specific) diffusion distance
such that a sufficiently high oxygen concentration is present everywhere. The depicted oxy-
gen concentration curve cO2(r) was drawn for illustration, following theoretical calculations
[MEG11]. The rather weak intravascular concentration gradient justifies the approximation
that intravascular oxygen concentration is assumed constant in the radial direction, and
therefore only depending on the longitudinal position on the vessel axis.
Figure 2. Experimentally measured oxygen partial pressures and pH: Partial pressure
(pO2; blue curve) and pH (red) were measured in human tumor xenografts and plotted
versus distance to the nearest blood vessels [Hel+97]. Tumor cells further away than the
diffusion distance of oxygen of ca. 100 µm become hypoxic. Tumor cells survive under such
low oxygen conditions by switching to glycolytic metabolism, the byproducts of which lower
the pH to acidic levels [HW11]. (Reprinted from [CJ00] with permission. Copyright 2000
Macmillan Magazines Ltd.)
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within the tumor interior either enter a quiescent state due to nutrient and space restrictions
or die off (necrosis). Thus a necrotic core develops, and an equilibrium between prolifera-
tion and death is established, limiting the size of the spheroid to approximately 1 mm3. In
the following we consider only oxygen as representative of nutrients although it is not the
only one. For instance, TCs need glucose as well, but the limitation to oxygen-only is a
common approximation for theoretical models. Not all tumors start as avascular spheres
though. Some types, e.g. glioma brain tumors and breast tumors, incorporate (coopt) the
blood vessel network of the host at the beginning of growth [HWY99; RCR09]. It was indeed
shown that TCs preferably proliferate around blood vessels, apparently while displacing or
destroying normal tissue [Do¨m+07]. The ability to metastasize may develop at a later point
in time.
Normally, maintenance of the vasculature depends on a balance of pro-and antiangio-
genic factors such as blood flow and metabolic demand, mediated by complex biochemical
signaling networks not yet fully understood. This system adapts the microvascular density
(MVD) to the nutrient demand of tissue and regulates development of blood vessels into
arteries, capillaries and veins for an efficient blood flow. The walls of capillaries consist
of endothelial cells (ECs). Arterioles that connect capillaries to arteries, get progressively
thicker with additional cell layers composed of pericytes, smooth muscle cells and other
components. Venules also exhibit supporting cell layers which are however thinner than
on arterioles [MH13]. Capillaries, where most of the substance exchange occurs, must be
homogeneously distributed since the range of diffusion of nutrients is limited. Oxygen for
instance is a very light molecule and thus distributes quickly by diffusion, but it is also bound
and consumed in cells which leads to an approximately exponential decay of the concen-
tration around blood vessels (s. Figs. 1 and 2). The typical diffusion range within tumors is
approximately 100 µm [CJ00] which is also the distance from blood vessels up to which TCs
can remain viable. The diffusion range in normal tissues lies between 50 µm (brain) and
150 µm (breast). In tumors, the angiogenic balance is disrupted, resulting in the transfor-
mation of the original vasculature into a heterogeneous chaotic network (see below). Three
processes which normally act together but are spatially separated in tumors take part in this
transformation: sprouting of new vessels (angiogenesis), circumferential growth and vessel
regression.
In general, tumor growth is hampered by the lack of oxygen, be it due to vessel regres-
sion, increased metabolic demand, or the start as avascular sphere. But eventually TCs
switch to a phenotype that induces angiogenesis. The resulting increase of vascular den-
sity allows further growth. Induction of angiogenesis depends on the release of compounds
known as growthfactors (GFs) which are essential mediator molecules of angiogenic sig-
nals. VEGF is a well-known major player [CJ00; MC03; CJ11; Log+14]. GFs are generally
produced under lack of oxygen (hypoxia) and diffuse through tissue where they are bound
and degraded. This leads to a finite range of the angiogenic signal amounting to several
100 µm [Do¨m+02; Hol+99]. Various GFs have different purposes. In angiogenesis, they
loosen the cell layers of vascular walls, and stimulate ECs to proliferate and to migrate away
from their parent vessel. ECs follow GF gradients to the source of GF (chemotaxis) trailed
by more ECs that form a new sprout [NHH98; Ger+03; SM11]. If the tip encounters another
vessel it will fuse with it and mature into a perfused capillary. Otherwise the sprout retracts
after some time. Neovasculature as well as preexisting vessels are coopted when the tumor
grows past them. Other modes of vascularization such as branch splitting (intussuception)
[BHD04] or assembly of capillaries from free moving ECs (vasculogenesis) [TAP06] play a
lesser role in tumor growth. However, sprouting takes place mostly uncontrolled, resulting
in dense chaotic vascular excrescence, that is often dysfunctional. Some evidence suggest
that it can be even detrimental to growth [SH07].
A few 100 µm into the tumor interior, angiogenesis stops and endothelial cells a switch
to circumferential growth leading to vaso-dilation. Tumor vessels of Melanoma and Glioma
tend to dilate to a maximum of ca. 25 µm radius but no further. Moreover, vessels un-
dergo a period of regression until eventual collapse of the lumen and pinch off of blood flow
[Do¨m+02; HWY99]. Only few dilated vessels survive this thinning process, leading to a very
sparse network of isolated vessels. Viable TCs remain as cuffs around these vessels. Be-
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Figure 3. Depth-coded microscopy images of vascular networks: (A) A normal capillary
network with some supplying and draining arterioles and venules, respectively. Capillaries
appear as thin straight segments, which is typical, for instance, for muscle tissue (Scale
bar = 100 µm). (B) Blood vessel network in a mammary carcinoma bearing mouse (tumor
location indicated by dashed circle). Vascular remodeling is apparent in proximity of the
tumor. Numerous dilated, tortuous vessels proceed from a few parent vessels toward the
tumor (a). The tumor rim is densely and chaotically vascularized due to excessive branching.
The vascular density drops dramatically into the tumor, leaving large regions void of vessels
(c, b; scale bar = 1 mm). (Reprinted from [Bai+11] with permission. Copyright 2011 James
W. Baish et al.)
Figure 4. Histological sections of rat glioma brain tumors: (A-C) depict the progression
of a tumor (viable tumor cells stained red; endothelial cells stained black; scale bar = 1mm).
Small 1-week tumors exhibit normal appearing blood vessels. After two weeks, decreased
density and vaso-dilation are visible. In 4-week tumors, vessels are mostly isolated and have
cuffs of viable tumor cells around them. Distal regions are necrotic. The tumor rim is densely
vascularized. (D-G) depicts regression of a blood vessel with detachment of pericytes and
smooth muscle cells (black) from the vessel wall (brown). (Scale bar = 50 µm; Reprinted
from [HWY99] with permission. Copyright 2005 American Association for the Advancement
of Science)
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Figure 5. Experimental morphological data of human melanoma in mouse models:
The vessel network development was followed during tumor growth from an intradermal in-
oculation of 104 tumor cells until the tumor reached 4− 5 mm in diameter. At day 10, tumor
growth transitions to a linear regime, consistent the confinement of proliferative activity to an
annular shell behind the invasive edge (A). (B-D) display data for different regions: Tumor
center; the tumor periphery - a 100 µm wide band of tumor immediately adjacent to the in-
vasive edge; peritumoral tissue - a 200 µm wide band of host connective tissue immediately
adjacent to the tumor periphery. After 15 days, MVD (B) and Vessel perimeters (C) assume
plateau values. Vessels are generally abnormally dilated, and the MVD is high near the
invasive edge whereas it stays low in the tumor center. The tumor coopts the dense periph-
eral vasculature and subsequently dilutes it. Thus the activity of vascular remodeling moves
with the invasive edge. EC labeling index (D) is essentially the percentage of proliferating
endothelial cells (ECs), i.e. the plot indicates angiogenic activity all across the tumor and
beyond. (Reprinted from [Do¨m+02] with permission. Copyright 2002 John Wiley & Sons,
Ltd)
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yond the diffusion range of oxygen, TCs die of hypoxia, whereupon large necrotic regions
emerge in the tumor interior. The details of the regulatory systems that lead to such malfunc-
tioning are still not well understood. But it is known that GFs are continued to be produced
(expressed) in TCs of the tumor interior, which, as aforementioned, can destabilize vessels,
but also promote ECs survival. The switch from angiogenesis to circumferential growth is
mediated by the ephB4 guidance molecule [Erb+06] and depends on the sensed direction
of the GF concentration gradient [SM11]. Blood flow is crucial for vessel survival and matu-
ration, where Angiopoietins (Ang-1/2) among others act as regulatory molecules [Goe+08;
Buc+14]. They are expressed by ECs which react to the shear stress which is exerted by
the blood flow on the vessel wall [AY13]. Ang-2, a negative regulator, promoting regression,
is frequently overexpressed in tumors [HWY99]. Thus, a normal blood vessel network is
progressively transformed into a tumor specific vasculature by the angiogenic activity at the
tumor edge.
The result is a compartmentalization into a ca. 200 µm wide band around the periphery
where the MVD is elevated. The MVD decreases from there sharply into the tumor interior
where the vasculature is approximately only half as dense than in normal tissue [Hol+99;
Do¨m+02]. Tumor vessels are generally tortuous, chaotically connected and dilated. Images
of experimental tumors are reprinted in Figs. 3 and 4. Quantitative morphological data from
[Do¨m+02] is reprinted in Fig. 5.
Tumor vessels are also leaky, i.e. huge gaps are present in their walls due to missing ECs
[CJ00]. Through these leaks, blood plasma can easily escape into intercellular spaces. The
liquid that normally fills these spaces is called interstitial fluid (s. Figs. 6 and 7). Normally,
only a small amount of blood plasma leaks through nanometer sized gaps between ECs
whereupon it becomes part of the interstitial fluid (IF). IF is absorbed into lymphatic channels
which eventually feed the liquid back into the blood stream. In tumors, the permeability of
the vessel walls is increased by two orders of magnitude [JTM07] since missing ECs leave
holes of the size of micrometers. Moreover, tumors often lack lymphatic vessels, although
they can induce lymphangiogenesis similar to regular angiogenesis and can metastasize
through lymphatics in the tumor periphery [TA10]. The lack of lymphatics and the hyper-
permeability leads to the phenomenon of elevated interstitial fluid pressure (IFP), i.e. the
hydrostatic pressure of the liquid is elevated to the level of vessels [SL12]. The IFP in
the tumor interior is relatively homogeneous at levels between 10 − 40 mmHg . Across the
tumor boundary it drops down to the level in normal tissue where the IFP is zero in good
approximation. The interstitial fluid flows through tissue like water or oil flows through a
porous medium, e.g. through rock. In tissues, cells and ECM assume the role of the medium.
Consequently, IF flows predominantly in the radial direction out of the tumor spheroid, with
measured velocities between 0.1 to 0.2 µm/s near the boundary of a 1 cm sized tumor
[Jai87]. This can drive TCs into the surrounding lymphatics and move drug out of the tumor
(see below).
1.3 The difficulty of cancer treatment
This section reviews biophysically relevant obstacles to treatment, most of which are founded
in the peculiarities of tumor blood vessel networks. In tumors, an efficient delivery of drugs
is not guaranteed, as it is in normal tissue with a normal vasculature. However, current
cancer-killing drugs have poor selectivity, i.e. they are toxic to normal cells, too. Therefore,
it is not possible to simply increase the dose to compensate for inadequacies of the vas-
culature. Traditionally, the efficacy of drugs is analyzed using cell monolayers. Thus their
performance in patients is often overestimated. It is imperative that cancer therapies ideally
kill every single tumor cell because even a few surviving tumor cells can grow a new tumor
or metastases [see the review MT06].
At the time of diagnosis and prognosis, the MVD is used as an indicator of malignancy
and tumor progression. Authoritative for further actions is the local MVD in areas where
the MVD is highest, so called hot spots [Do¨m+02]. This mandates a solid understanding of
tumor vascular network formation.
The reasons for poor drug delivery are severalfold. Since the vasculature in the tumor
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Figure 6. Illustration of interstitial fluid flow: Interstitial fluid (IF) is the liquid in which
tissue cells bath [MH13]. It is derived from blood, i.e. it escapes through gaps in-between
endothelial cells, which line the lumen of blood vessels, into extracellular space (left). IF
contains various signaling substances, nutrients and waste products which are exchanged
with tissue cells. Extracellular spaces are not only filled with IF but also contain adhe-
sion molecules and a network of fibers composed of various proteins such as collagen and
elastin. Together these three components are denoted extracellular matrix. Pores and fibers
pose a resistance to the flow of the IF akin to the flow of water or oil through a porous rock.
IF is absorbed into lymphatic channels (right) from where it is brought back into the blood
stream. In normal tissue, a large resistance to transvascular flow leads to a large drop of
the hydrostatic pressure across the vessel wall, so that the interstitial fluid pressure (IFP)
approximately assumes the reference value of zero purported by the lymphatic system. In
tumors (yellow), the interstitial fluid flow (IFF) is altered dramatically due to extremely large
gaps in vascular walls and lack of functional lymphatics [Hel+04]. Consequently, the IFP is
pulled up to the level of the blood pressure. 0 to 94 mmHg were measured in human tumors
[JTM07]. Concomitantly, IF flows from the tumor center across the tumor interface until it
is completely absorbed by lymphatics in normal tissue. This facilitates metastasation into
lymphatics, and is likely detrimental to drug delivery. [Hel+04].
Figure 7. Electron microscopy image of fibroblasts embedded in the extracellular
matrix: Fibroblasts are responsible for production of extracellular matrix constituents such
as collagen fibers. Empty spaces are filled with the interstitial fluid. Functional tissues (or
tumors) would contain other, specialized, cell lines (or tumor cells) as well. (Scale bar =
10 µm; Reprinted from [Nis+88] with permission. Copyright Association for Research in
Vision and Ophtalmology)
8
center is very sparse, the efficacy of drugs depends on the ability to penetrate tissue well.
However this is often not the case. Instead, strong drug concentration gradients emerge
around blood vessels, and persist over long periods of time [Pri+05] (s. Fig. 8). Most drug
molecules are diffusive but still the flow of the IF might additionally impede their distribution
by washout of drug into the surrounding normal tissue. Washout is likely a bigger issue for
nano-scale particles which have much lower diffusion coefficient due to their mass [BJ89].
Finally low blood flow rates and excessive extravasation might lead to premature release
of all drug before adequate concentrations can reach all parts of a tumor. In particular,
compression of blood vessels can cause impairment of blood flow. This is now regarded
as therapeutic opportunity [Jai14]. Solid components of the tumor push each other due
space limitations and thus give rise to the so-called solid pressure which also acts on blood
vessels. The fibers of the ECM transmit these forces, and it was shown that a reduction
of the amount of fibers can increase blood flow [Cha+13; Sty+12; Cha+14]. There is also
some evidence that elevated IFP aids in the compression of vessels [Gri+99; Del+14]. The
discovery of tumor induced angiogenesis [Fol71], and VEGF, sparked the development of a
new type of treatment in which the vasculature is targeted with angiogenesis suppressing
agents to deprive the tumor of nutrients. This is a so-called anti-angiogenic therapy, today
often used concomitantly to other measures, such as chemotherapy. A recent concept is
“vascular normalization”, where a balance between excessive pruning and a reduction of
angiogenic activity is to be effectuated in order to reduce leakiness and thus improve blood
flow [Jai13]. However the underlying mechanisms are still poorly understood. What works
for one kind of tumor can have an adverse effect in another type of tumor [MT06].
Moreover, the success of ordinary therapeutic strategies is tied to the oxygenation sta-
tus of the tumor. For instance, some chemotherapeutics work poorly in oxygen deprived
environments due the chemical reactions involved. Other drugs can only kill cycling (prolif-
erating) cells and are therefore unefficative against tumor cells (TCs) which are quiescent
which can be caused by hypoxia or high solid pressure. Hypoxic TCs are also resistant to
radiation therapy since oxygen is required so that ionizing radiation can produce DNA dam-
aging compounds [KR15]. Hypoxia also promotes invasive growth, i.e. the tendency and
ability of TCs to migrate increases, which can lead to the penetration of barriers between
different organs and the growth of fingering protrusions of the tumor spheroid [Pen+03].
Hence, hypoxia is generally associated with poor prognosis [BW04; Har02].
It is possible to obtain important tumor characteristic data such as perfusion, blood vol-
ume and hypoxia status from patients using positron emission tomography (PET) and other
imaging methods. However the interpretation of raw sensor data requires theoretical mod-
els. Moreover the resolution of current methods is limited to a voxel size of ca. 1 mm3. On
the other hand, microscopic information are hardly accessible experimentally. Direct mea-
surement of oxygen partial pressure PO2 is performed by invasive probes, making it im-
practical to obtain a large enough sample size for heterogeneous environments like tumors.
Worse, invasive probes can distort the true values [TJI03]. Interstitial fluid flow velocities are
measured by invasive microscopy [Jai99]. Concentration distributions of drugs were mea-
sured by microscopy of dissected tumorous tissue [Pri+05], exploiting auto-fluorescence.
In this regard theoretical models and computer simulation can provide insight into the tu-
mor micro environment in order to foster the understanding of macroscopic phenomena and
therapy failures.
9
Figure 8. Experimental distributions of drug in a histological section: A microscopy
image was taken from a section of tumor tissue of a tumor bearing mouse that received
a dose of Doxorubicin, an ordinary chemotherapeutic, 180 minutes prior to excision. The
color value of blue is proportional to the Doxorubicin concentration. Endothelial cells of
the vessel walls are stained red, viable tumor cells are stained black and necrotic tissue is
green. Concentration gradients changed minimally from 5 minutes up to three hours after
the injection. (Scale bar = 100 µm; reprinted from [Pri+05] with permission. Copyright 2005
American Association for Cancer Research)
Figure 9. Basic components of a theoretical model of vascularized tumor growth: Fol-
lowing [BR06], tumor and vascular network interact via concentration distributions of growth-
factors (GF) and oxygen (O2), where tumor cells are sources of GF and the vascular network
is the source of O2. Blood flow is (re)computed after alterations of the vascular network to
reflect the changes in blood pressure, flow rates and shear stresses. The dynamical interac-
tions used in our model are described in detail in [WR13, Suppl.1, Fig.1] (s. reprint in Sec.
8.1). Briefly, tumor cells can proliferate in response to a sufficient O2 supply, and will die
to O2 deprivation. GF either stimulates growth of new vascular sprouts (angiogenesis) or
causes vascular dilatation, depending on if the vessel is located within the tumor or outside.
Furthermore, low shear stress on vessel walls (low blood flow) leads to regression and col-
lapse. In general, the tumor mass can be represented in various ways, i.e. discrete particles
or continuous density distributions governed by partial differential equations. The vascula-
ture is represented by a graph, or network model. However some other work incorporates
it as continuous vessel density distribution, in which case a model of blood flow has to be
omitted or severely simplified. Interactions, as described, are sufficient to predict realistic
vascular morphologies of melanoma and glioma tumors.
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1.4 Goals of this thesis
While the ultimate goal would be the construction of a predictive patient specific simulation of
tumor growth and treatment, the focus of this work is to elucidate fundamental relationships
between tumor vascular morphology, processes of tumor vascular remodeling, vasculature
of the host, blood flow, adequacy of drug transport and oxygenation. Extending upon the
work of Bartha, Lee, and Rieger [BR06; LRB06] (s. Fig. 9) this thesis covers, over a series
of four papers [WBR08; WBR09; WR10; WR13], the development of a theoretical model of
three-dimensional tumor growth within an artificial arterio-venous network on macroscopic
scales. The focus of [WR13] is interstitial fluid flow and drug delivery, and in a fifth paper we
considered tumor oxygenation exclusively [Wel+15].
We abolished oversimplifications of blood flow and oxygen concentration computations.
Moreover, we analyzed the dependence of MVD and fractal dimension df on parameters
for vessel regression [WBR08]. The restriction to pure capillary networks was a serious
limitation of our work and other theoretical models of tumor growth. Therein, initial capil-
lary segments of the host are laid out in regular square or hexagonal patterns. It is hardly
possible to emulate realistic blood flow conditions on macroscopic scales in such a network.
If, for instance, a homogeneous blood pressure gradient is imposed on the boundary then
artifacts arise where tumor blood vessels clearly follow preferred directions imposed by the
global flow. In reality, the capillary plexus is however supplied and drained by adjacent ar-
terioles and venules. Therefore, we considered a vascular tumor growth model augmented
with an artificial algorithmically constructed arterio-venous initial network of normal tissue in
two dimensions [WBR09]. Original predictions of Refs. [BR06; LRB06] of vascular morphol-
ogy had to be confirmed with this supposedly more faithful model. In [WR10] we laid the
foundation allowing us to simulate macroscopic (ca. 0.5 mm3) systems in three dimensions.
A continuum model of the tumor spheroid [WR13] was implemented which may be used in
future to study morphological growth instabilities which are exhibit by highly invasive tumors.
During this work, we realized that the predicted spatial distribution of tumor vessels de-
pends strongly on the layout of initial (t = 0) vascular trees in which the tumor grows. There-
fore, this thesis also touches the inverse problem, i.e. how initial networks must look like to
obtain agreement with experimental data, such as blood oxygen saturations obtained from
mammography. For this purpose, we generated various initial network configurations and
determined biophysical quantities in dependence thereof [Wel+15]. Moreover we attempted
to develop a means to predict the emergence of cluster of locally increased MVD (vascu-
lar hot-spots) by correlation with blood pressure differences within the initial networks (s.
Appendix A).
In regard of the tortuous and chaotic nature of the tumor vasculature it is questionable
if blood flow can distribute drug sufficiently within a reasonable period of time. Indeed,
extremely low blood flow velocities of 0.1 mm/s were observed in animal models [JS10].
Therefore, we considered the flow of an intravascular tracer substance through final com-
puted tumor vascular networks using a time dependent simulation of concentration distri-
butions [WBR08; WBR09; WR10]. This allows to gauge the performance of conduction of
drugs in vascular networks that are more realistic for actual patients, than in networks con-
sidered previously. The question for barriers to drug delivery is considered further in Ref.
[WR13], where we performed simulations of interstitial fluid flow and spatio-temporal drug
concentration distributions in tissue. It is often assumed that elevated IFP is a barrier to drug
delivery since the extravasated flux density per vessel surface area is proportional to the hy-
drostatic pressure difference across vessel walls. However this cannot be the root cause
of bad drug performance since the system behaves essentially like a series of resistors of
which one resistor (tumor blood vessel walls) has particularly low resistance. Therefore
other possible barriers to drug delivery are considered and targets for therapeutic strategies
are explored.
In previous work, extremely good perfusion of tumor vessels was predicted, guided by
data for Melanoma and Glioma. Under conditions of low blood flow however, consideration
of spatially varying intravascular levels of oxygen and other substances is required because
a substantial fraction may be lost during the transit through the tumor vasculature. This is
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addressed in our fifth paper [Wel+15], using a new computational model of coupled intravas-
cular and tissue oxygen concentrations. It is applied to elucidate the statistical distribution of
average oxygen saturations in simulated tumors, guided by breast cancer. Grosenick et al.
[Gro+05] and others [Spi+05; Tar+05] obtained such data from a cohort of patients using
optical mammography. It exists the prospect of being able to deduce aspects of vascular
morphology and blood flow based on such indirect measurements. However, this requires
adequate predictive models.
2 State of the art research
This section will briefly review the basic theory and modeling approaches of mathematical
models of tumor growth.
2.1 Theoretical models of tissues
There are two approaches to describe tissues. In continuum mechanics conservation equa-
tions are formulated for mass, momentum and sometimes energy, and on the other hand, in
particle methods, particles represent either cells or macroscopic sections of tissue and move
according to Newtons equations of motion. Fluids and deformable bodies are described in
this way, too. But for living tissues, addition and removal of mass and momentum due to
growth and death needs to be taken into account. The simplest form of mass conservation
to satisfy this is the partial differential equation (PDE)
dρ
dt
= −ρ∇u+ α, (1)
where ρ = ρ(x, t) is the density depending on space and time, dρ/dt is total derivative in
time which can be expanded into dρ/dt = ∂ρ/∂t + u∇ρ, ∇ is the Nabla operator, u is the
local velocity, and α embodies local sources and drains. The general form of momentum
equations is
d(ρu)
dt
= ∇ · σ + f , (2)
where σ is the Cauchy stress tensor and f is the total body force, accounting for gravity for
instance. In reality, biological tissues are highly complex materials [Ver+09, see the review].
On short time scales, they show elastic behavior which is usually neglected in models of
tumor growth. On long time scales, i.e. days, residual stresses are relaxed by rearrange-
ment of ECM fibers and cell adhesion molecules, leading to viscous behavior. Moreover,
cells show active responses to stimuli, e.g. migratory behavior. In practice, growing tumors
are therefore modeled like (viscous) liquids, including an isotropic (solid) pressure, friction,
and adhesion forces. Inertial forces are conveniently neglected since biological growth and
migrations happens in a regime of very low Reynolds numbers (Re ≪ 1). Conservation
of energy is in general not considered, assuming a constant temperature and equations of
state oblivious to the inner energy. The growth of multicellular spheroids [AM04; APS06;
Amb+11; Cia+13; Vol06] and tumors in general [ZWC05; Swa+11; PT09] was described
using continuum models of a single homogeneous material.
Current state of the art are multi-phase or mixture models where total mass, momentum
and stress, are given as summations over contributions from cells of different types, ECM
and water. All of these phases are allowed to coexist in space, where their relative amount
within the unit volume is given by respective volume fractions. The motion of the cell pop-
ulation is often modeled analogous to fluid flow through a porous medium, where the ECM
takes the role of the medium. The “flow” thus represents migratory motion in response to
solid pressure. Depending on the choice of components and their stress tensors, mixture
models describe various growth phenomena, and indeed found numerous applications to
study avascular [BP03; ML07; AP09; Wis+08; Cia+13; Sci+13] and vascular tumor growth
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[BBL03; CGP06; Sta+07; Mac+09; HB13]. It is relatively straight forward to implement
cell-cell adhesion, modeled by effective surface tension forces to study growth induced mor-
phological instabilities of the interface between cell populations. Such instabilities can occur
because either protruding perturbations have better access to nutrients than recessions,
facilitating the growth of the perturbation, or as viscous instabilities akin to a less viscous
fluid injected into a more viscous fluid. The result is the growth of finger-like protrusions.
Following [PT09] we implemented a simple mixture model [WR13] with the intent to study
such instabilities. But it is still topic for future work.
Dissolved substances like oxygen, GFs, or drugs are an essential component of many
tumor growth models. In case of drugs or oxygen, their concentration distributions may be
the entire subject of study, for instance in our papers [WR13] and [Wel+15]. The simplest
general equation to describe the transport of the concentration c(x, t) of one species is the
diffusion-advection-reaction equation
∂c
∂t
+∇ · (cu) = ∇ · (D∇c) +R, (3)
where the substance diffuses with diffusion constant D and is carried with the flow of the
solute with velocity u. The reaction term R can comprise sources and drains, e.g. vessels
are sources of oxygen whereas tissue consumption is represented by a homogeneous drain
distribution. In multi-components system, each component i is associated with the concen-
tration ci each of which is governed by an equation of type (3) [PT09]. Then R (or rather Ri)
also comprise transition rates between compartments. This way, drug binding to different
intracellular compartments was described in simulations of drug concentrations in tumors
[Sin+09]. The advection term in calculations of oxygen distributions is usually neglected
since oxygen transport is dominated by diffusion due to its low molecular weight. Moreover,
it is sufficient to consider quasi stationary distributions where ∂c/∂t = 0 since equilibration
times are much shorter than growth processes in tissues [BR06]. Thus we obtain
0 = D∇2c+R, (4)
assuming equal concentration c in all compartments and a constant oxygen diffusion coef-
ficient D. Such partial PDEs can only be solved analytically in special cases. In general,
the equations are solved numerically with the help of finite difference (FD) or finite element
methods (FEM) or some variation thereof. In both methods, space is divided into numerical
cells defined by regular grids or unstructured meshes. In FD methods, the solution is ap-
proximated by function values at discrete grid points and derivative operators of the original
equations are replaced by differences between functions values on neighboring grid points.
In FEM, an approximate solution is computed in a finite dimensional function space over the
considered domain. FEM have the advantage that they can be applied straight forwardly to
unstructured meshes and therefore work well for arbitrary domain shapes. FD methods are
much easier to implement on regular grids and arguably more efficient. We and many other
authors consider tumor growth in square (cubic) domains, hence FD formulations are used.
The application of difference operators leads to systems of linear or non-linear equations in
the solution values at grid points. The core of numerical solutions consists often of routines
for the inversion of sparse matrices. Such routines comprise specialized factorization meth-
ods, multi-grid, or Fourier transformation. See e.g. the nice book [LeV07] for an introduction
to FD methods.
In particle based models matter is described from a frame of reference that moves with
a given initial piece of material. Such a piece of material is represented by a particle with a
given position, velocity and various other associated quantities. The collection of thousands
to millions of particles thus describes the entire body. This is the traditional approach in
fluid dynamics. In biological applications, the particle count is not conserved in general.
Instead particles are allowed to replicate or vanish to reflect growth and regression of real
tissues. In microscopic systems, particles can be conveniently identified with individual
cells. Otherwise particles can represent macroscopic volumes as it is the case in dissipative
particle dynamics. The time dynamics can be described simply by Newtons equation of
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Figure 10. Simulated tumor growth and vascular remodeling: The image sequence
shows the temporal evolution of the vascular network and of the interface between viable
tumor cells and normal or necrotic tissue (yellow blob). It is a three-dimensional system,
computed for [WR13], of which a quadrant is cut out so that the tumor interior can be seen.
The view is zoomed in slightly, whereas the full system can be seen in Fig. 11. For scale: the
tumor radius at t = 500 h is ca. 1.8mm. Vessel segments are color coded by blood pressure
(red is high; approximately 10 kPa, or 75 mmHg). At t = 0 h the simulation is initialized with
a small tumor nucleus in the center and a pre-generated vasculature of the host. The oxygen
consumption of tumor cells is elevated compared to normal tissue, leading to a drop of the
tissue oxygen concentration, secretion of diffusing GF and stimulation of angiogenesis. As a
result, at t = 100, the vascular density (MVD) has increased near the tumor rim. Unperfused
segments, i.e. blind ends, are displayed in dark gray. Some of them are newly extending
angiogenic sprouts. Others pertain to vessel segment chains where one segment has been
removed according to the vascular regression and collapse process, pinching off blood flow.
Angiogenesis, dilation and regression act mostly near the expanding tumor-tissue interface,
transforming the host vasculature into a typical compartmentalized tumor network. Necrotic
regions occur as a result of hypoxia. Since only viable areas are shown, necrotic regions
appear as hollow interior.
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motion for each particle as in molecular dynamics simulations, i.e.
∂mivi
∂t
= Fi(x0, . . . , xN , . . . ),
where mi, vi, xi denote the mass, velocity and position of the i-th particle, and Fi denotes
the force on the particle depending on the current state of the system. These equations
must be solved numerically in a discrete time-stepping scheme. In between time steps, an
extra step can be added to account for proliferation and death of particles. Continuous space
particle models were used to study the growth dynamics of multicellular spheroids [RCM07;
DH05] and of tissues that are in competition with each other [Bas+11]. Alternatively, the
time dynamics can be described by stochastic processes and be simulated by Monte-Carlo
methods (see below).
In cellular automata models, particles are confined to sites on a lattice. Particles may be
able to hop or proliferate to neighboring sites. Due to its simplicity this is a popular approach
to study tumor growth [ABM03; BR06; Bet+06; LRB06; Wei+09; Owe+09; EHH09; End+09]
and angiogenesis [AC98; PVS04; Wei+09; Per+11]. In the latter case, particles represent
pipe segments of a network. It is however more adequate to think of the network as a
dynamically changing graph as in mathematical graph theory. The space-time dynamics
can be determined by deterministic rules which are applied once per discrete time step, or
by stochastic processes, or a mix of both. A stochastic process is formally described by
the Master Equation for the rate of change of the probability Pk to find the system in state
k = 1..n
dPk
dt
=
∑
l
AklPl.
The matrix Akl contains the transition rates according to which the system transitions from
state l to k with probability Akldt.
2.2 Theoretical models of blood vessel networks
Microscopic sections of micro vascular networks can in principle be represented by individ-
ual endothelial cells in particle models or by distributions in continuum mechanics frame-
works. This is well suited for simulation of vasculogenesis [SBP13] or angiogenesis when
the migration of individual cells is considered. However, in models of tumor induced an-
giogenesis and vascular network formation many biological details are omitted in favor of
a simple network representation as collection of pipe segments. This approach was first
applied to tumor angiogenesis by Anderson and Chaplain [AC98] and has since then been
adopted into many other works [SRM+02; SAC06; BR06; LRB06; ABM03; Cai+11; Per+11;
ABM03; BBL03; CGP06; Sta+07; Mac+09]. Mathematically the network is represented as
a graph G(E, V ) with edges E and vertices (or nodes) V . An edge is defined as pair of
vertices e = (i, j) with i, j ∈ V forming a connection between i and j. Thus standard graph
algorithms, such as depth-first-traversal [TS09], can be used as building blocks for model
processes and for analysis. To model biological systems, edges and vertices are associated
with biophysical variables like for instance a radius and a blood flow rate.
2.3 A model of tumor induced angiogenesis and vascular remodeling
Bartha and Rieger [BR06] considered the spatio-temporal evolution of the blood vessel net-
work of a tumor and of the surrounding tissue as stochastic process, where edges (vessel
segments) are added and removed depending on blood flow and on concentration of growth-
factors (s. Fig. 9). Therefore, they associated edges with the vascular tube radius r, blood
flow rate q, and wall shear stress f . In our work [WBR09; WR10; WR13; Wel+15], we also
incorporate variables for the life time of angiogenic sprouts, time since entering the tumor,
and degeneracy state of the vessel wall. Furthermore, Bartha and Rieger [BR06] defined
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Figure 11. Final simulated tumor and tumor blood vessel network: Depicted is a visual-
ization of the final state of the simulation shown in Fig. 10 at t = 700 h, where the simulation
is stopped. The full simulation cube of 8 mm lateral length is shown. As before, a quadrant
is cut out, the interface to viable tumor mass is shown in yellow and the vascular network
is displayed as collection of cylinders, color coded according to blood pressure. The bulk of
volume surrounding the (yellow) tumor spheroid is filled with the initial vascular network. It
appears solid, but actually fills only ca. 10% of the available volume. The tumor vasculature
exhibits the typical compartmentalization found in melanoma and glioma [Hol+99; Do¨m+07]
as briefly described in Fig. 10. Networks such as this are the basis of further studies of
interstitial fluid pressure and drug transport [WR13] and tumor oxygenation [Wel+15].
16
transition probabilities reflecting the processes of sprouting angiognesis, vessel dilation, col-
lapse, and regression. A discrete time stepping scheme was used, where a sweep over all
vessels is performed per step and process, modifying the network accordingly. These pro-
cesses are, in brief, defined as follows:
Angiogenesis: A new straight segment is introduced with non-zero probability, connecting
the current site x and a distant site x′ if both sites are occupied by circulated vessels,
if the GF concentration at x is sufficiently high, but only if there are no other branching
points nearby, the distance |x−x′| is small enough, and no site on the path is occupied
by TCs.
Dilation: There is a non-zero probability that the radius r of of a vessel segment is in-
creased by a magnitude that corresponds to the addition of the diameter of a single
EC to the circumference, if the local GF concentration is sufficiently high, if TCs are
nearby, and if r is smaller than the upper limit rmax.
Collapse: A vessel segment surrounded by TCs has a non-zero probability to be removed
if the wall shear stress f is less than the threshold fcrit.
Regression: An uncirculated vessel segment has a non-zero probability to be removed if
the oxygen concentration is less than a threshold.
The probabilities are simply given as fractions ∆t/τproc of the time step ∆t and process
specific time constants τproc under the precondition that ∆t ≪ τproc. Consequently angio-
genesis occurs near the invasive front where the tumor is not yet grown over the network.
On the other hand, circumferential growth (dilation) occurs only within the tumor. Bartha
and Rieger [BR06] found that this initially leads to decreased flow rates, also decreasing
the shear stress f . This further leads to removal of segments according to the collapse
rule, redirecting blood flow to other vessels. Blood flow in these vessels is thus stabilized.
Remaining unperfused segments are rapidly removed according to the regression rule. Cir-
culated vessel are determined with the help of the biconnected component graph algorithm
[HT73]. A biconnected component is a subset of V such that for a pair of vertices a, b ∈ V ,
there are two disjoint paths from a to b. Hence all tumor vessels that are in the biconnected
component of the remaining regular initial network are circulated [BR06]. Bartha, Lee and
Rieger [BR06; LRB06] furthermore considered individual TCs with the help of a simple par-
ticle model. Therein, lattice sites are identified with the potential location of one and only
one TC, assuming that TCs cannot move but proliferate to neighboring sites. Given a small
initial tumor nucleus, proliferation is consequently confined to the tumor rim, yielding linear
growth dynamics of tumor spheroids. Moreover, TCs can be flagged as dead in case that
the oxygen concentration becomes too low. Dead TC occupy lattice sites, prohibiting pro-
liferation thereto, but are otherwise inert. Thus the size and spatial distribution of necrotic
regions can be analyzed. In our papers [WBR08; WBR09] we followed this approach, but
later adopted a more sophisticated continuum mixture model [PT09] incorporating cell motil-
ity, cell-cell adhesion and homeostatic pressure dependent proliferation. Figs. 10 and 11
illustrate tumor vascular remodeling based on simulation data obtained from our extended
model. As illustrated in Fig. 12, vessel network and the remaining tissue can be defined on
disparate but spatially coexisting domains.
2.4 Computation of blood flow and hematocrit
Depending on the application, blood flow can be considered on various scales, i.e. from
computation of the velocity field on micrometer scale to bulk perfusion measured inml blood
ml tissue−1min−1 as e.g. obtained from positron emission tomography (PET). For pipe
networks of tumors models, blood flow is approximated as ideal laminar flow, where the flow
rates q define the blood volume throughput per time through each pipe. Blood pressure
variables, p, are associated with nodes. Thus, q is determined by Poiseuille’s law
q =
πr4
8η
∆p
l
, (5)
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Figure 12. Representation of tumor blood vessel network and tissue domains: Vas-
culature and tumor may be defined on different spatially overlapping domains as illustrated
in (a). In [WBR08; WBR09], we considered two-dimensional systems where vessel seg-
ments occupy bonds on a triangular lattice L as depicted here. The vascular network is
indicated by solid lines of varying thickness and color, reflecting the hierarchical nature of
arterio-venous networks. The color code reflects the blood pressure drop from arteries (red)
to veins (blue), as displayed in other figures as well. At inlets and outlets of the network, we
use radius dependent boundary conditions of constant blood pressure (analog of constant
voltage sources). Vessel segments can span several bonds in a straight line, and can be
added or removed during the temporal evolution of the network. In three-dimensional sim-
ulations [WR13; Wel+15], vessel segments occupy bonds on a face centered cubic (FCC)
lattice. Such lattices can be represented by flat layers stacked in the vertical as depicted in
(b). The layers are offset from each other in the horizontal which repeats itself after three
layers, denoted by the stacking order ABC as indicated. Triangular (and FCC) lattices have
a high degree of symmetry and allow realistic vascular branching angles (c). In two dimen-
sions [WBR08; WBR09], individual tumor cells can be represented on vertices of L with a
lattice constant hv = 10 µm corresponding to the diameter of a tumor cell. Also, L must
be sufficiently fine to resolve angiogenic sprouts in regions of high vascular density even
though the original vascular network is not as dense. In three-dimensions it is hardly possi-
ble to represent individual cells of a solid mass of a significant size, simply due to the cost
of the sheer number of items to store. Therefore, we switched to a representation by cell
density distributions on a coarser cubic lattice as indicated [WR10; WR13]. The tumor mass
Ωt is indicated as orange blob. Figure (c) illustrates our definition of branching angle, i.e. the
angle between daughter branch and the axis of the parent vessel.
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where r is the vessel radius, η the viscosity, l the length, and ∆p denotes the blood pressure
difference between the ends of the segment. Conservation of mass requires that the flow
into a node equals the flow out of the node, i.e.∑
i
qi = 0, (6)
analogous to Kirchoff’s laws of electricity, where i indexes vessels adjacent to a given node
under consideration. Together with boundary conditions, a system of equations is obtained
which is sparse and can be solved with standard numerical methods, e.g. using a sparse
LU-factorization of the corresponding system matrix. Because of the red blood cell (RBC)
content, blood is a non-Newtonian fluid, i.e. its viscosity η(r,H) depends on the vessel radius
r and on blood hematocrit H. The hematocrit is the blood volume fraction of RBCs. The
viscosity is commonly expressed by the decomposition into the product of the blood plasma
viscosity ηplasma, which is constant, and a correction factor, the relative viscosity ηrel(r,H).
Pries et al. [Pri+94] derived a well-known phenomenological formula for ηrel(r,H) which is
easy to incorporate. As a first approximation, it can be sufficient to consider a constant
prescribed hematocrit as in [BR06; WR10; WR13] since the viscosity varies only by about a
factor of 5 over relevant radii ranges from 4 to 25 µm, whereas the dependence of the flow
rate on r4 plays a much greater role.
In other work [ABM03; Bet+06; Owe+09; Per+11] and our recent paper [Wel+15] a vary-
ing hematocrit distribution was computed in order to capture the oxygen concentration de-
pendence on the number of red blood cells, in which the majority of oxygen is stored. A
low hematocrit can consequently lead to rapid depletion of blood oxygen. The distribution
of hematocrit is sensitive to blood flow rates, i.e., at bifurcations, RBCs tend to flow into
the faster perfused vascular branch which is the well-known phase separation effect. Com-
putational models use a phenomenological formula by Pries et al. [Pri+90], describing the
hematocrit in each down stream branch depending on flow rates q in vessels adjacent to
the bifurcation and upstream hematocrit H. With its help, the hematocrit can be propagated
downstream through the network, given an inlet hematocrit. The computation of the flow
rates and computation of the hematocrit distribution can be performed in alternating order
until convergence to a self-consistent solution, usually in a few iterations [Pri+90]. See also
[BR06; Wel+15].
2.5 Vascular networks of normal tissue
To adequately represent a tumor bearing tissue, a model of tumor growth should incorporate
the vascular network of healthy tissue. The capillary bed, where most of the solute exchange
with blood takes place, is connected to supplying arterioles and draining venules. Arterioles
and venules join into larger arteries and veins which are eventually connected to the heart
[MH13]. An idealized simple model of a vascular tree is a space filling fractal. In order
to supply tissue efficiently, with minimal power dissipation, power law scaling relations for
vascular radii and vessel lengths have to hold true [WBE97]. For instance, the well-known
Murray’s law states that the radius rc of a parent vessel is related to the radii of the child
vessels at a bifurcation, ra and rb, by r
α
c = r
α
a + r
α
b with an exponent α between two and
three.
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Figure 13. Blood vessel network construction by stochastic growth on a lattice: Fol-
lowing [GK01], the algorithm initializes the network by growing random arterial (red) and ve-
nous (blue) trees under exclusion of volume (a). In this initial stage, segments are attached
in random directions to randomly chosen tree tips. Starting (root) nodes, which become the
top level arterial inlets or venous outlets, need to be specified a-priori. For the lack of better
knowledge we consider different hand picked configuration types specifying the number and
locations of such root nodes, see [WBR09, Fig. 5], [Wel+15, Fig. 7], and [WR13, S1] for
an illustration of the algorithm. Characteristics of the emerging tumor network, e.g. tissue
perfusion, depend significantly on the choice of these configurations and some of them may
not be physiologically realistic. Eventually the lattice is filled, the growth stage terminates,
capillary connections are added between tree tips of opposing types (arteries and veins),
and blood flow is computed. The result is depicted in (b) where capillaries are light green
and the arterio-venous trees are color coded by blood pressure (high is red, low is blue).
In a second stage, trees are remodeled, i.e. tree tips exhibiting low shear stress are re-
moved whereas tips exhibiting high shear stress can grow by further random additions of
vascular segments. Capillaries in this stage are temporarily created for the computation of
blood flow and removed again afterwards. This is carried out in sweeps where all current
tree tips are visited, blood flow is computed and the process is repeated. Eventually the
iteration converges to a state with interdigitating trees and homogeneously distributed cap-
illaries. In three dimensions, our construction algorithm of initial arterio-venous networks
[WR13] is able to fill the entire simulation box. In two dimensions [WBR09], volume exclu-
sion frequently causes arterial and venous trees to deny each other access to growth into
the corners of the simulation box.
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In early models of angiogenesis, the initial network consisted only of a single parent
vessel [AC98]. These models adequately describe angiogenesis in the rabbit eye model
[Gim+74]. Essentially, a small tumor on the cornea of the rabbit eye stimulates vascular
sprouting in a few large parent vessels from up to 1mm away. These sprouts branch exces-
sively and form a dense capillary mesh between the tumor and the parent vessels. Similar
configurations were used in later work [SRM+02; SAC06; Wu+08; Wu+09]. However, in
the bulk of tissue, the distance to sites of angiogenic activity is evidently only a few hun-
dred micrometers [Do¨m+02; Hol+99]. Therefore, the capillary plexus of normal tissue is
often represented by vessel segments arranged in regular patterns, e.g. as square grid, or
hexagonal grid, omitting supplying arteries and draining veins [ABM03; Byr+06; Owe+09;
Wei+09; Bet+06; BR06; LRB06; Wu+13; Wu+08]. Blood flow is computed assuming a fixed
blood pressure at boundaries of the simulation box. We used a regular hexagonal pattern
[WBR08], and later considered arterio-venous networks [WBR09; WR13; Wel+15]. Other
authors use random arrangements of lines e.g. [Gev11] or voronoi cells as basis for vascular
networks [Saf12].
Two decades ago, algorithmic construction of arterial trees was already considered by
Schreiner [Sch93]. The basic idea of this algorithm is to grow a tree, branch by branch. At
each step, the existing tree is first geometrically scaled to increase in dimension. This in-
creases the distance between vessels, implying that tissue oxygenation would worsen each
step. However a new segment is added according to some optimality criterion in order to
supply the voxel in space that is most in need of oxygen. Thus, oxygenation stays approxi-
mately constant. This process is repeated until the desired size is reached. Later Go¨dde and
Kurz [GK01] developed a lattice based growth model which represents the entire connected
vessel network including arteries, capillaries and veins so that blood can flow (s. Fig. 13).
We adopted this model in [WBR09; WR13; Wel+15] as replacement for previous capillary
networks that were based on honeycomb lattices. The basic principle is again shear-stress
based vascular remodeling. First, random arterial and venous trees are grown by succes-
sive attachment of new bifurcations at existing tree leafs. Then connections, representing
capillaries, are added between leafs of the arterial and venous trees to allow for computation
of blood flow. In a following iterative process, vessels exhibiting low shear stress are pruned
while leafs exhibiting high shear stress are allowed to grow. This way, interdigitating trees
develop until eventually the vasculature converges to a (mostly) stationary configuration.
Details on our recent implementation are given in Ref. [Wel+15]. Note that our construction
scheme differs from the original by Go¨dde and Kurz [GK01] since not all details are provided
by them.
In future it might be possible to obtain real scanned blood vessel networks of sufficient
accuracy and size. However, current state of the art microscopy methods can only see
through a tissue slab up to a maximal depth of ca. 250 µm [Cas+06]. Recently, data ob-
tained from micro computed tomography (µ-CT) was used by Stamatelos et al. [Sta+14] to
reconstruct large parts of the vascular system of an animal-model breast tumor. However, it
is questionable if all capillaries were captured since the resolution of the scanner was only
8 µm, and many dead ends were in the reconstructed network. Results of these works are
reprinted in Figs. 16 and 17. Similar results were obtained for other cranial [GFP10] and
coronary [Lee+07] blood vessel networks.
2.6 Time dependent intravascular tracer concentration
Rather than computing stationary concentration distributions, we are here interested in fol-
lowing an injected bolus of some substances during the transit through the vascular network.
For this purpose, S.R.McDougall et al. [SRM+02] already adopted a method from petrol en-
gineering, originally developed to predict solute transport through porous rock. It allows the
computation of time dependent concentrations of a tracer c associated with segments of a
vascular networks. The basic idea is to collect amounts of tracer m in nodes of the net-
work and distribute it downstream in proportion to the flow rates q of downstream vessels.
This procedure, akin to the upwind-differencing scheme for advection equations, is applied
repeatedly in time steps of length ∆t. The amounts of substance from upstream vessels,
21
added into downstream nodes, is accordingly ∆m = cq∆t. Thus, given a time dependent
inlet concentration cin(t), the method yields concentrations c(t) of each vessel. Transvascu-
lar loss was not considered although the method would be straight forward to extend to take
this into account.
We applied the method to networks created by our tumor growth simulation for regular
[WBR08; WR10] and arterio-venous initial networks [WBR09]. However, in our network
model, the assumption that network edges are of constant length, and short compared to
their radius is violated, leading to an amplified propagation velocity. Therefore we track the
position of the interface that separates clean blood from tracer “contaminated” blood and
moves with the velocity of blood flow. Similar models were developed for the simulation of
capillary rise in network models of porous materials [Ake+98] and are widely used there
[e.g. RTS15].
2.7 Interstitial fluid pressure
Interstitial fluid flow (IFF) is prevalently modeled as liquid flowing through a porous medium
[JB88; JTM07; Wu+08; Cai+11; Wu+13; ZSS07; Sef+14; Sef+15], where tissue cells and
the fibers of the extracellular matrix assume the role of the medium. Fluid and medium are
described in general within the framework of mixture theory with the help of distributions
of their local volume fraction and their velocity distributions. However, the medium is often
assumed rigid. The volume fraction of the liquid is identified with the porosity ǫ which de-
scribes the amount of space available per unit volume within the medium. This space is
filled by definition with the liquid. Assuming rigidity and (quasi) stationary flow, the system is
characterized by the spatial velocity field of the liquid, v(x), where x is the space coordinate.
The velocity v is determined by the gradient of the hydrostatic pressure p according to the
well-known Darcy’s Law
v = −K∇p, (7)
where the permeability constant K is the product of an intrinsic permeability constant of
the medium, the porosity and the inverse fluid viscosity. Usually, K is obtained directly
from experimental data for a specific tissue type. Assuming incompressibility and constant
permeability, the mass conservation equation obtained is a Poisson equation in p:
∇ · v = −K∇2p = Q, (8)
where Q was added to represent sources (vessels) and drains (vessels, lymphatics). Dis-
cretization leads to a symmetric positive definite system of equations which is straight for-
ward to solve by state of the art methods, e.g. FFT or preconditioned conjugate gradient
[KL00]. We adopted this simple approach to determine IFP and IFF in vascular networks of
simulated tumors [WR13]. Some authors consider IFF within a fully coupled mixture model,
where v is the relative velocity between the IF and a moving cell population [Wis+08]. Other
authors incorporate IFF into models of tumor growth and allow compression of blood vessels
due to elevated IFP [Wu+13].
2.8 Transvascular fluid exchange
Normally only a miniscule amount of blood plasma can leave the blood stream through tiny
gaps between ECs. But in tumor vessels, large quantities escape through gaps where entire
ECs are missing. The net loss of fluid volume per time Jv within a given control volume is
given by the Starling equation
Jv = LpS [pv − pi + σT (πv − πi)] , (9)
where Lp is the hydraulic permeability of the vasculature, S is the vascular surface area
within the control volume, pv is the blood pressure, pi is the interstitial pressure, σT is the
average osmotic reflection coefficient and πv and πi are the osmotic pressures of plasma
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and IF, respectively [JB88]. The osmotic term σT (πv − πi) represents forces generated
by various dissolved substances and can be considered as a constant offset from pv at
an experimentally determined value [JB88]. This form of transvascular coupling is straight
forward to apply in models where the vasculature is considered as a homogeneous phase.
In network models of the vasculature, the flux from each individual segment has to be
taken into account in Eq.(8) as a local source of fluid. A simple means to facilitate this is to
let the vessel network occupy the same lattice used for the numerical discretization of Eq.(8)
which was done in Refs. [Wu+08; Cai+11; Wu+13]. Then each node of the vessel network
j corresponds to a discretization site of Eq.(8), and local transvascular fluxes between them
can be defined according to Eq.(9), where S now stands for the local surface area of the
segments in the vicinity of node j. Using the standard finite difference stencil for the Laplace
operator in (8) one obtains a combined system of equations, equivalent to Kirchhoff’s laws.
It is a common scheme in simulations of tumor growth, not limited to computation of IF, but
also applied in theoretical studies of drug delivery [Sin+09; Sef+15] and oxygation [DTK03;
KB06; Mon+11; Ske+12; EPK13].
More generally, vessels can be considered as line-like sources akin to the Dirac δ dis-
tribution, a concept which has been formulated mathematically rigorously for the solution
of elliptic equations with Dirac terms by finite element methods [DAn12] and applied to IFF
[CZ14]. We can thus replace (9) by the distribution
J(y) =
∫
Γ
Lp2πr(p˜v − pi)δ(x− y)dx (10)
where x, y are spatial coordinates on the network and in tissue space respectively, Γ is
the set of one-dimensional curves (or line segments) that describes the vascular network,
p˜v is the effective blood pressure including the osmosis terms, and r is the vessel radius.
The permeability Lp, blood pressure p˜v and radius r can vary depending on the position on
the network x. In our IFP paper [WR13] we considered the efflux from a vascular network
on a tetrahedral lattice into a tissue domain discretized by a cubic grid. This was done for
a convenient solution of the diffusion-advection equation describing drug transport. Taking
inspiration from immersed boundary methods [Pes02], and following [Bea01], we replaced
the Dirac δ distribution with a smoothed kernel δǫ with finite width of ǫ. Thus the flux J is
distributed from each point on the network to several nearby tissue discretization points. We
use an analog scheme to compute the efflux of drug [WR13].
2.9 Oxygen transport
Oxygenation of tissues has been studied in great detail theoretically [Hel+96; Gol08], begin-
ning with the work of Krogh [Kro19] who conceived a simple model of muscle tissue that is
reduced to a central straight capillary and an outer concentric cylinder representing muscle
fibers. Recent refined versions of such one-capillary models achieve very good agreement
with experimental studies of artificial capillaries [NHO89; Nai+90; Hel+96; MEG11]. The typ-
ical radial distribution of oxygen in such a scenario is illustrated in Fig. 1. The cylinder model
adequately describes muscle fibers where capillaries run mostly in parallel, but many tissues
such as tumors have more complex vasculature. The relevant literature, can be roughly di-
vided into two approaches. Some authors [HS89; GP00; Sec+04; GBE04; GBE06; Tso+07;
SSD11; FGE13; SD13; Wel+15] seek self-consistent solutions of the equations for advection
of oxygen in blood within a realistic blood vessel network and diffusion of oxygen in tissue.
This includes acquisition of networks either by artificial construction or experiments, as well
as computation of blood flow. On the other hand, many authors use simplified models, where
capillaries constitute sources of oxygen of an a-priori determined strength corresponding to
a certain intravascular oxygen concentration. Depending on the application it is adequate
to model the vasculature as disjoint set of points (in 2d) or lines (in 3d) that are placed
in the tissue domain according to some statistical distribution or scanned images [DTK03;
EPK13; KB06; Mon+11; Ske+12]. Thus only a stationary diffusion equation needs to be
solved to determine the tissue oxygen concentration distribution. See [Wel+15] for a more
comprehensive review (reprinted in Sec. 9).
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Figure 14. Oxygen transport and extravasation in a tube: Blood flows with the total
volumetric rate of q volume units per time through the vessel of radius r. The intravascular
oxygen (O2) concentration c(x) is determined by the partial pressure of O2 P (x) depending
on the position x on the vessel axis. The concentration c(P ) is given by the sum of dissolved
O2 αP and hemoglobin-bound O2 c0HS(P ), where c0 is the O2 concentration in RBCs, H
is the hematocrit and S(P ) is the Hill-curve of hemoglobin saturation. The flux density of
oxygen leaving the vessel at each point on the longitudinal axis is 2πr · jtv, where jtv is the
flux density per unit area, modeled using an empirical mass transfer coefficient γ(r), times
the difference to the partial pressure of O2 in the surrounding tissue Pt, hence jtv = γ(r) ·
(P−Pt). This leads to a decay of the intravascular concentration c(x) with a local slope dc/dx
proportional to γ(P −Pt)/q. In most theoretical tumor growth models, including ours, except
[WBR08], these details are omitted and a constant vascular O2 partial pressure is assumed.
Since the concentration of bound O2 is much larger than dissolved O2 c0HS(P ) ≫ αP , a
better approximation is to assume a O2 concentration that is proportional toH, see [WBR08;
Wel+15]. In [Wel+15] we focused on computation of O2 distributions in stationary tumor
networks including a varying vascular O2 concentration.
Figure 15. Coupling of the numerical solution of intravascular oxygen distributions
with tissue oxygen concentration: This figure relates to the computation of (variable)
intravascular and tissue oxygen (O2) concentrations [Wel+15]. Numerical integration of
intravascular O2 partial pressure P (x) uses integration points, denoted xk (a, red dots).
Spatial coordinates, corresponding to a location on the vascular network are denoted as
vector x. Extra-and intravasation are represented by line-like sources and drains, including
Dirac-δ distributions. The tissue O2 partial pressure Pt is approximated as weighted super-
position of basis functions ϕj , defined over the tissue domain Ω, with spatial coordinates y,
and centered at grid points yj (b). Following standard finite element methods (FEM), we
use piecewise tri-linear functions (in three dimensions) that interpolate control values at grid
points. The volumetric transvascular oxygen flux density is given by 2πrjtvδ(y − x), where
δ is the Dirac-δ distribution, and jtv is proportional to P (x) − Pt(x). From the standard
Gallerkin method [KL00] it follows that the transvascular flux of a finite segment of length
∆x given by 2πrjtv∆x at xk is added as source contribution according to the weight ϕj(xk)
to each corner point j of the enclosing grid cell. In our study of interstitial fluid flow [WR13]
we used a slightly different approach in that the δ-distribution was replaced with a smooth
kernel yielding a volumetric interstitial fluid source density that is a smooth function of y.
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For the study of intravascular oxygen transport it is crucial to take into account that oxy-
gen is, for the most part, bound to hemoglobin in red blood cells (RBCs). Each of the four
heme groups of the hemoglobin molecule can bind one oxygen molecule. The steady state
of the binding and unbinding processes is described in good approximation by the Hill-curve
[Gol08]
S(P ) =
Pn
Pn + Pn50
, (11)
where P is the partial pressure of oxygen, S(P ) is the fraction of oxygen bound relative to
the maximal capacity, c0 is the concentration of oxygen in RBCs at full saturation, n is the
Hill exponent and P50 denotes the partial pressure of oxygen where S(P50) = 1/2. Hence,
the total concentration of oxygen c is given by
c = αP +Hc0S(P ), (12)
whereH is the hematocrit and α = αp+Hαrbc is the effective solubility in blood and αp, αrbc
the solubility in plasma and RBCs, respectively. The transvascular flux density jtv of oxygen
leaving blood through the blood-vessel interface is strongly diffusion dominated. It is com-
monly expressed in units ofml O2min
−1 cm−2mmHg−1, and follows Fick’s law jtv = −α∇P
at the interface (s. Fig. 14). In single capillary models, the concentration distribution of oxy-
gen is described by advection-diffusion partial differential equations in three dimensions.
Thus the expression −α∇P yields the oxygen flux at any point in space. However, in large
scale network models it is too expensive to compute all microscopic details of the oxygen
distribution. Therefore an effective mass transfer coefficient (MTC) γ, similar to Lp of Eq.(9),
is used to obtain the transvascular flux density jtv from average tissue and blood oxygen
partial pressures [Gol08] according to
jtv = γ(Pv − Pt), (13)
where Pt is the partial pressure of oxygen at the inner wall of the vessel lumen, and Pv is
the partial pressure at the center of the vessel. Note that γ represents an effective radial
diffusion coefficient of oxygen in blood. Lp of the Starling equation, on the other hand,
represents the permeability of the wall. In small vessels, blood tends to form an RBC-rich
core and a RBC-free boundary layer. For larger vessels (r > 100 µm), the discrete nature of
RBCs plays a lesser role. Therefore the MTC is function of the vessel radius r, hematocrit
H, and blood oxygen saturation S [Hel+96]. The functional dependency γ(r,H, S) can be
obtained from single capillary simulations and experiments. Assuming radial symmetry, and
further assuming that radial variations of the oxygen concentration in blood are negligible,
the change of the oxygen flux along the vessel axis is simply given by the differential equation
q
dc
dx
= −2πrjtv, (14)
where q is the blood flow rate, and x denotes the longitudinal space coordinate on the vessel
axis. In order to determine the oxygen distribution across an entire network, assumptions
must be made on the distribution at vessel junctions, e.g. instant equilibration of the partial
pressure of oxygen flowing into a junction. With the help of mass balance equations, the
concentration of outflowing oxygen can be computed. Thus the solution for the oxygen
concentration can be propagated downstream. We describe this in more detail in [Wel+15].
Furthermore, the tissue oxygen concentration ct = αtPt is determined by the diffusion
equation for the partial pressure Pt
0 = αtD∇
2Pt −M(Pt) + Jtv, (15)
where D is the diffusion coefficient of oxygen, M(P ) is a partial pressure dependent con-
sumption rate, and Jtv is the source and drain strength distribution of vessels. Jtv can be
formulated with the help of the Dirac δ distribution in analogy to (10) (s. Fig. 15). A general
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good approximation to the consumption rate of oxygen M(P ) is the well-known Michaelis-
Menten relation
M(P ) =M0
P
P + P ′50
, (16)
which tends to zero for small P , assumes the value M0/2 for P = P
′
50 and goes asymptoti-
cally to the maximal consumption rate M0. For some problems like tumor oxygenation it is
usually assumed that the oxygen concentration rather low, i.e. Pt < P
′
50. Then it is sufficient
to use a linear approximation M(P ) ≈ −λP for some rate coefficient λ. In physiological
conditions, M(P ) is often approximated by zero order kinetics M(P ) ≈ M0. This is only
applicable in case of good oxygenation since the solution for Pt can otherwise drop below
zero.
The system of combined equations for the concentration of intravascular oxygen and
tissue oxygen is very challenging to solve and it can only be done numerically. David, Hsu,
Safaeian and David [HS89; Sec+04; SD13] used a Green’s function method based on the
Green’s function G of the Laplacian ∇2, where G is the solution to ∇2G(x) = δ(x). The
solution to Eq.(15) is thus formally given by the convolution of G withM(Pt) + Jtv [Sec+04].
Goldman [Gol08] and the authors in the references therein use very fine grid tesselations
of 3 µm, and consider vessels as sources of oxygen with non-zero radius. This facilitates
the numerical treatment of the transvascular flux coupling with help of the gradient boundary
condition −α∇Pt = jtv at vessel surfaces. We further explored the concepts used in our IFF
paper [WR13] and followed [Sec+04; Bea01; CZ14] in the development of a new method
to compute intra-and extravascular oxygen distributions [RW15]. Methods developed for
the study of oxygen distributions can also be employed to consider distribution of other
substances like drugs. Moreover oxygen adds the complication of hemoglobin binding which
leads to nonlinear systems of equations. For other substances this can be omitted and linear
equations are obtained. As aforementioned, in many cases it may be adequate to consider
constant intravascular concentrations.
3 Summary of the publications that are part of this thesis
This section reviews the development of our model of tumor growth and summarizes the
things considered in our publications.
3.1 Emergent vascular network inhomogeneities and resulting blood
flow patterns in a growing tumor
In previous work Lee, Bartha, and Rieger [LRB06; BR06] suggested a theoretical simula-
tion model of tumor growth and vascular remodeling (s. Sec. 2.3) which predicts realistic
vascular density distributions. However this model was quite simplified in several key areas.
First, the supply of oxygen (O2) was modeled using sources of constant O2 extravasation
rate, whereas the net transvascular oxygen flux proper is proportional to the difference of
oxygen partial pressure PO2 between blood and tissue [Gol08]. Hence the attenuation of
the net flux due to back diffusion was neglected, leading to overestimation of the O2 concen-
tration. Secondly, blood is a non-Newtonian fluid, i.e. when blood flows though a capillary,
its viscosity η depends on the tube radius and hematocrit (s. Sec. 2.4). This dependence
was neglected in [BR06; LRB06] by using a constant viscosity, in spite of the variation of
the relative viscosity ηrel by a factor of approximately five for the capillary radii considered
[PS05, Fig. 4] (ηrel(r = 25 µm,H = 0.15) ≈ 1.5, ηrel(r = 5 µm,H = 0.6) = 8). Vascular radii
in tumors are subject to a spatial compartmentalization similar to the MVD (radii are small in
the neovascular plexus and dilated within the tumor). Therefore, the interplay of shear force
correlated vascular collapse with viscosity variations due to radius and hematocrit variation
could affect simulation results unpredictably. Finally, the phase separation effect (segrega-
tion of RBC into the faster perfused branch at bifurcations; s. Sec. 2.4) was neglected. In
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real tumor, this effect could lead to uneven distribution of hematocrit and thus uneven distri-
bution of blood flow and oxygen availability. In the first part of this paper (reprinted in Sec.
5) we present model extensions where these issues are adressed, and we further analyze
these extensions in comparison to before. In the second part we consider the flow of an
intravascular tracer substance in order to gauge the ability of networks generated by our
simulation to deliver drugs into tumors. The vasculature model closely follows the original
work [BR06; LRB06], i.e. the vascular network is formed by segments on a lattice subject to
a time dependent dynamical evolution steered by processes given in [WBR08, Sec 2.] and
illustrated in [WBR08, Fig. 2].
The following enumeration should familiarize the reader with the alterations and exten-
sions made in this paper: in contrast to [BR06; LRB06] we used a triangular lattice instead
of a square lattice since it allows for more realistic branching angles for the arterio-veneous
vasculature model implemented in later work [WBR09]. Moreover, for efficiency, vascular
segments occupy lattice bonds and are allowed to span multiple bonds with which a line
segment is formed between two lattice sites that are the end points [WBR08, Fig. 1]. Pre-
viously the network was represented by sequences of 10 µm wide pieces, representing
endothelial cells, and occupying lattice sites, which was prohibitively expensive for larger
systems. In addition, the previous angiogenesis process was extended with an initial sprout
creation and subsequent grow over an extended period of time where previously a “bridge”
between perfused parallel vessels was created instantly. The new version is useful to em-
ulate tip splitting since sprouting can now be initiated from a sprouting unperfused branch.
It also allows for fusion of sprouting branches. These alterations yielded qualitative model
predictions as before [WBR08, Fig. 12. bottom left], and hardly quantitative differences.
It should be noted here that blood flow in [BR06] was computed using a local relaxation
method, i.e. Gauss-Seidel [KL00], to solve the equivalent of Kirchoff’s laws (6). It is well-
known that local relaxation methods remove high-frequency components of the error, in the
sense of a Fourier decomposition, rapidly, but which then continue to converge orders of
magnitude slower for smooth components of the error [BHM01]. This lead to a premature
halt of the iteration and overestimation of the blood pressure gradient. In this paper this was
fixed by using a direct solver (essentially Gauss elimination) specialized for sparse systems
of equations [Dav04]. As a result tumor vessels bend inwards toward the middle of the tumor
spheroid, an artifact of flow boundary conditions which has not been observed previously
(cf. [BR06, Fig. 3] vs. [WBR08, Fig. 12. ]). Also the critical collapse threshold (here
f (c)), according to which it is determined if vessel segments are prone to collapse, had to
be adjusted to decreased levels of wall shear stress.
In the base case of this paper we also incorporated the aforementioned radius and hema-
tocrit dependent relative viscosity ηrel as well as the phase separation effect. For this pur-
pose, we computed vascular hematocrit distributions [WBR08, Eqs. 2-6] according to the
procedure developed by Pries et al. [Pri+90]. We further abolished constant-rate oxygen
sources by using a source density per unit tissue area of the form α(c
(B)
o −co) that is propor-
tional to the difference between blood oxygen concentration c
(B)
o and tissue oxygen concen-
tration co. The prefactor α is positive for lattice sites that coincide with vessel segments and
zero otherwise. Therefore, co is henceforth computed by solution of the stationary diffusion
equation [WBR08, Eq. 7]. This is less straight forward than previously [BR06] since now the
oxygen source strength depends on the concentration itself. The discretized analog of the
diffusion equation [WBR08, Eq. 7] is a sparse system of linear equations which was also
solved numerically by the routines in [Dav04]. Since RBCs carry the majority of blood oxygen
in hemoglobin bound form, we considered a blood oxygen concentration c
(B)
o proportional
to hematocrit H. We think this is justified as crude approximation to a detailed intravascular
oxygen simulation since the rate of oxygen depletion of blood dc/dx (14) depends on the
hematocrit according to Eqs. (11, 12, 14), i.e. the average oxygen concentration taken over
a given section of the vascular network increases with the hematocrit.
A simulation result is depicted in [WBR08, Fig. 3]. On the left column, the vascular
network, color coded by flow rate q, and tumor cells are shown, The oxygen concentration
co is shown on the right hand side. The visualization of the distribution of oxygen also
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reflects vascular hematocrit levels because the source strength of oxygen is proportional
to hematocrit. Immediately apparent is the preferred direction of tumor vessels which is
imposed by blood pressure boundary conditions generating a homogeneous blood pressure
gradient along the diagonal in the initial (t = 0) capillary network. We recognize that the
hematocrit and tissue oxygen are distributed asymmetrically (there is more on the left hand
side of the tumor) which must be the consequence of the rectangular simulation domain. On
the other hand hematocrit variations within tumor vessels are barely recognizable, and the
average hematocrit equals the inlet hematocrit. However these predictions will not hold true
for simulations using arterio-venous networks in subsequent work [Wel+15]. There, model
predictions show a drastic decrease of hematocrit in the peripheral capillary plexus.
This paper then continues with the analysis of the dependence of the microvascular den-
sity (MVD) and fractal dimension df on the critical collapse wall shear stress f
(c) [WBR08,
Fig. 6] and collapse probability pcoll [WBR08, Fig. 7]. Both variables f
(c) and pcoll are
space dependent, assuming maximal values of f (c,max) and p(c,max) in the tumor periphery
[WBR08, Eq. 12]. In the first case, the collapse probability p(c,max) was held constant and
f (c,max) was varied. In the second case p(c,max) was varied and f (c,max) was set to 10 times
the parameter value of the base case. Vessels are only allowed to collapse according to pcoll
when their wall shear stress f is lower than f (c). Thus the probabilistic nature of collapses is
given more weight. Vascular morphology indeed differs between both cases, where f (c,max)
variation yielded networks with clearly imposed flow direction and p(c,max) variation cases
produced tortuous networks with many loops. Fractal dimension df correlated well with
vascular density (MVD) and f (c,max) or p(c,max) , respectively. Furthermore, although both
cases yielded visually distinct results, the dimension df varied over similar value ranges.
The paper then proceeds with the analysis of cases where the relative viscosity as func-
tion of vessel radius r and hematocrit H is simplified to include only the r dependence or is
simply constant [WBR08, Fig. 9]. We also analyzed different variants of the dependence of
f (c), pcoll on the spatial position in relation to the tumor and on vessel radii [WBR08, Fig. 10].
While these experiments yielded somewhat different networks neither of them changed the
quality of our predictions. Moreover we also considered the neglect of oxygen backflow, i.e.
a model variant where vessels are constant rate producers of oxygen as originally proposed
[BR06]. For realistic parameters, the inclusion of backflow reduced the available tissue oxy-
gen concentration in the tumor periphery significantly [WBR08, Fig. 11]. Therefore tumor
growth , i.e. the net expansion rate of the spheroid, is much more sensitive to the choice of
oxygen concentration thresholds of hypoxia and quiescence.
In the final part of the paper we considered the flow of a tracer through static final
(t = 800 h) simulated tumor vascular networks. The computational model used yields time
dependent vascular concentration distributions given a time dependent concentration at the
inlets (s. Sec. 2.6). The results are quickly summarized, namely that the tracer travels very
fast, within ca. two minutes through the entire network with the exception of insignificantly
small vascular loops where it takes longer. However the neglect of extravasation makes
these results only applicable for cases where the transvascular losses are actually small.
3.2 Vascular remodelling of an arterio-venous blood vessel network
during solid tumour growth
In this paper [WBR09] we considered the augmentation of our model of tumor growth with an
arterio-venous initial network of normal tissue in two dimensions (reprinted in Sec. 6). The
limitation to exclusively capillary networks is a serious limitation shared by previous work by
us and other theoretical models of tumor vascular remodeling [RW15], i.e. initial capillary
segments of the host are laid out in regular square or hexagonal patterns. It is hardly pos-
sible to select realistic blood flow boundary conditions for such networks. As we have seen,
imposing a homogeneous blood pressure gradient yields tumor vascular networks where the
global flow direction is imposed on the direction of tumor blood vessels. In reality, the capil-
lary plexus is however supplied and drained by adjacent arterioles and venules. Therefore
we expect the absence of a global flow direction but rather that local capillary blood flow de-
pends on the geometrical layout of arteriolar and venous vascular trees. We addressed this
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issue as aforementioned by incorporating arterio-venous vascular trees of the initial (t = 0)
host tissue (s. Sec. 2.5). In the first part of this paper, we explore vascular morphologies
obtained by tumor vascular remodeling of different vascular tree configurations [WBR09,
Sec.3] and attempt to correlate the occurrence of locally increased MVD with blood pres-
sure in initial vascular networks. In the second part we show predictions of intravascular
tracer flow.
For this purpose, we retained the foundation of previous work, i.e. vessels are repre-
sented as pipe segments occupying bonds on a triangular lattice, and the tumor spheroid is
represented by cells occupying sites on the lattice. Tumor vascular remodeling processes
are adopted without change except for vascular collapse (see below). We closely follow
the method conceived by Go¨dde and Kurz [GK01] to computer generate vascular trees as
already outlined in Sec. 2.5 and more comprehensively described in [WBR09, Appendix
A]. The principal idea is stochastic growth and remodeling of trees by successive addition
of structural elements under exclusion of volume. Structural elements are single segments
and bifurcations composed of three segments. These elements are added successively to
already existing tree tips in random order and orientation until the latticed is filled up [s.
WBR09, Fig.15, a-c]. The algorithm has a second stage which is similar, but tip segments
can be removed as well, depending on wall shear stress [s. WBR09, Fig.15, d-f]. Con-
nections between arterial and venous trees, representing the capillary bed, are maintained
during growth. Thus blood flow can be determined based on boundary conditions at just a
few in-and outlets for which experimental pressure or flow values can be used [Wel+15, S5
Appendix]. Later we proposed an alteration to produce less tortuous high-caliber vessels
and the extension to three dimensions [WR13, Sec. ’Initial Blood Vessel Network Construc-
tion’].
Previously, initial blood vessel networks consisted exclusively of capillaries of radius 5 µm
but vessels of arterio-venous networks considered in this paper also include arterioles of up
to 100 µm radius. The walls of arterioles exhibit additional layers of pericytes and smooth
muscle cells which is why they are thicker than capillaries. We therefore assumed that arte-
rioles are more resistant to collapse than capillaries which necessitates an alteration of the
previous collapse process. Hence we introduced a wall stability variable w associated with
vessel segments that works like a countdown ticking down as soon as the tumor spheroid
expands over segments and allows collapse only if w = 0 and f < f (c). The initial stability
w(t = 0) depends on the radius r and vessel type [WBR09, Sec. 2.2. and Fig. 2.]. Fur-
thermore, we omitted the computation of hematocrit distributions for simplicity assuming an
average hematocrit of 0.45. We omitted the functional dependence of the critical collapse
shear stress f (c) on the distance from the tumor, i.e. f (c) = f (c,max) according to Sec. 3.1.
Snapshots of simulation states can be viewed in [WBR09, Figs. 3, 4, and 5]. We con-
sidered four different vascular configurations of initial networks (t = 0) which differ in the
location of vascular tree roots [WBR09, Fig. 5]. These tree roots are the starting point of
the aforementioned vascular growth procedure. The selection of their number, type (arterial
or venous), and location was completely arbitrary. But in principle statistical data such as
frequency distributions of vascular radii could help reject configurations that are unrealistic
for a given tissue. In later work [Wel+15] we explored the dependence of other parame-
ters such as regional blood volume rBV , perfusion rBF and blood oxygen saturation Y on
a greater number of root configurations (s. 3.5). Evidently the imposition of a global flow
direction is abolished, but rather vessels emanate from arterioles protruding into the tumor
[WBR09, Fig. 5].
The new model predicts vascular morphologies which obey the same compartmentaliza-
tion of vascular density (MVD) and vascular radii as before on regular initial networks, i.e.
vascularization is high in at the tumor periphery and diluted in the tumor center. Capillaries
in the tumor center are generally dilated, but now the tumor center also exhibits higher-
caliber vessels co-opted from the initial network. Such vessels exhibit a radius r larger than
the maximal dilation threshold rmax and are therefore not subject to dilation. Radially aver-
aged quantities MVD, vessel radius O2 concentration, flow rate q, tumor cell density and wall
shear stress f are in good agreement with earlier work, see [WBR09, Fig. 4] vs. [WBR08,
Fig. 4]. However flow rates q are increased overall by a factor of 10 due to the presence of
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vessels much thicker than capillaries.
Flow rates within the peripheral vascular plexus are predicted to be of the magnitude of
normal capillaries. The model fails to predict severely decreased blood flow velocities found
in animal models [JS10; Yua+94]. On the other hand the model predicts arterio-venous
short-cuts within the tumor, i.e. vaso-dilation gives rise to mostly very well perfused vascular
threads connecting arterioles with venoules [WBR08, Fig. 8]. Such shunts were suggested
in the experimental literature where “flow hotspots” are frequently found in tumors of patients
[Sah+05].
Considering severe heterogeneity of local vascular densities [WBR09, Fig. 5] depending
on initial networks, we attempted to correlate local MVD with differences in blood pressure
between neighboring vessels in initial networks. For this purpose, we computed an auxiliary
“pressure” field p(x) as function of space x at t = 0 that interpolates approximately the blood
pressure pv in spaces between vessels. Hence p is given as the solution of∇
2p+a·(pv−p) =
0, where a is zero in empty space and a ≫ 1 at sites coincident with vessels. Since a is
large, p assumes the value of the blood pressure in good approximation. Then we plotted
the magnitude of the gradient ||∇p|| as local averages taken over small boxes versus the
local MVD at t = 1200 h as shown in [WBR09, Figs. 10 and 11]. This yielded a low
correlation coefficient between 0.2 and 0.4 per simulation run. A much better correlation
(0.9) was obtained for MVD and ||∇p|| when averages were taken over the area of entire
tumors. We obtain similar results from simulated three-dimensional tumors generated for
our recent paper [Wel+15]. See Appendix A.
Finally, we determined frequency distributions of (a) MVD, (b) size of clusters of necrotic
regions and (c) size of clusters of high MVD [WBR09, Fig. 12]. These distributions follow
power laws with a common exponent of −1.4. Such algebraic distributions are commonly
found in systems near a phase transition or in classical percolation at the critical threshold.
The second part of the paper is the straight forward application of intravascular tracer flow
computations following [WBR08]. (s. Sec. 2.6). Qualitatively, predictions agree with earlier
results [WBR08], i.e. blood saturated with tracer flows through, in good approximation, the
entire tumor vasculatures within very short times. In contrast to earlier predictions blood flow
velocities in arterio-venous network are higher (≥ 1 mm/s) which is why the transit times
are now of the order of seconds instead of minutes.
3.3 Physical determinants of vascular network remodeling during tu-
mor growth
Two-dimensional simulations of tumor growth are, without doubt, useful but two-dimensional
geometry does not adequately represent real tumors. Properties like vascular density, ves-
sel radius, blood volume, and so on are subject to a compartmentalization into annular shells
around the center of the tumor spheroid. But nevertheless, the tumor vascular network ex-
hibits no spatial symmetry. This is a difference to the situation in tissue like muscles where
capillaries run in-between muscle fibers mostly in parallel to each other. In such cases the
longitudinal dimension may be integrated out or it may be sufficient to consider a thin slab
under periodic boundary conditions. Two-dimensionality also leads to restrictions for initial
(t = 0) networks because arterial and venous trees cannot cross each other or wind around
each other as they can in three dimensions. Moreover, Lee, Rieger, and Bartha [LRB06]
already performed simulations using initial blood vessels arranged as cubic lattice. Their
results should be confirmed for arterio-venous networks.
These concerns are addressed in this paper [WR10] where we present an extension of
the construction algorithm for artificial three-dimensional arterio-venous networks on cubic
lattices and a new simple continuum model of the tumor spheroid (reprinted in Sec. 7). As
previously, we consider morphological characteristics of the emergent tumor networks. The
final part of our paper continues with simulations of intravascular tracer flow.
For this paper we switched to a cubic lattice for the arrangement of vessel segments,
following Lee, Rieger, and Bartha [LRB06]. This is much simpler than the extension of tri-
angular lattices to three dimensions but excludes realistic 60◦ branching angles between
daughter branches at bifurcations (s. Fig. 12). Later this restriction was removed using
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face centered cubic (FCC) lattices [WR13]. The previous procedure for the construction of
vascular trees (s. 3.2) was altered for three dimensions. Y-shaped bifurcations as structural
elements were replaced by two new elements that can be appended to tree tips. First, a T-
junction consisting of three segments and secondly, a fork-shaped junction (−⊏) consisting
of five segments. The additional space dimension provides additional rotational degrees of
freedom for the orientation of appended elements relative to their parent segment. We sim-
ply handle this analogous as before, by enumeration of all possible configurations and pick-
ing of an admissible configuration which produces no overlap with other vessels, weighted
so that the forward direction relative to the parent segment is ten times more likely than tak-
ing a 90◦ turn [WR10, Sec. 2.7]. Furthermore, it is too computationally costly to represent
each single tumor cell in three dimensions. Therefore we sought an effective description of
tissue on a macroscopic scale, of which a multiplicity exists in the literature (s. Sec 2.1).
We implemented a simple reaction-diffusion model for the density distribution of tumor cells
c(x, t) depending on space x and time t [WR10, Eq. 1]. We assume that c can vary between
0 and the maximal tolerable density c(max) beyond which cells stop proliferating. Moreover
we assume that the extracellular matrix behaves like a porous medium, posing a resistance
to cell migration, and that TCs are driven by a solid pressure P which is assumed as func-
tion of their density, following e.g. [AP09]. This leads to a migration velocity v = −D∇P (c),
where D is a mobility constant. (Note that P is not to be mistaken for the the oxygen partial
pressure elsewhere). Analogous to the previous discrete model, cells of normal tissue are
not explicitly represented. Hence c is computed as solution to the partial differential equation
∂c
∂t
= −D∇ · [c∇P (c)] + kpc
(
1− c/c(max)
)
− knc, (17)
where kp and kn are oxygen dependent rate constants for proliferation and necrosis [s. the
rates WR10, Eqs. 2 and 3]. A solution to this equation, provided sufficient oxygen and
an initial spherical nucleus, is a spherical soliton wave expanding from an initial spheroid.
The actual computed solutions also approximately describe a spherical tumor. We identify
necrotic regions simply as areas where the oxygen concentration o level is below the necro-
sis threshold o
(death)
TC , neglecting the time TCs can survive under hypoxia. This works well
since the local oxygen concentration within the tumor center can only decrease (by vessel
collapse). Otherwise we would have to track the density distribution of necrotic TCs as well.
The solution of (17) is carried out by finite differencing methods on a cubic grid discretization
with a cell width of h = 30 µm. Other parts of our model remained in principle the same, but
with some technical exceptions. First the vascular network of the tumor growth simulation
is maintained at a lattice constant of hv = 10 µm for sufficiently high resolution of the tumor
neovascular plexus. Hence, we cease to assume that vessel lattices and grids for numerical
solution of continuous variables coincide. To conserve memory we only store pointers to
vascular segments in a dictionary (hash table [TS09]) using indices of lattice sites as keys.
In the determination whether a vessel lies within the tumor we check if c(x) < 1/2 · c(max),
where c(x) is obtained by piecewise linear interpolation of control values at grid points.
Moreover the numerical solution of the diffusion equation for the oxygen concentration dis-
tributions is defined on the same numerical grid used to represent c. Therefore oxygen
source flux density contributions of vessels are distributed to nearby grid sites analog to the
source flux density of interstitial fluid according to Sec. 2.8.
The extended model predicts vascular and tumor morphology consistent with earlier pre-
dictions, i.e. a well vascularized rim and a tumor core with few isolated dilated vessels, as
shown in visualizations [WR10, Figs. 3 and 4] and radial distributions [WR10, Fig. 5].
Correction: regardless of what the paper states, the vascular density MVD was actually
calculated as line density LD, i.e. vascular network length per measurement volume, in unit
of 102 µm−2, [Wel+15, s. also Appendix S2, Eq. 1]. Hence the predicted normal tissue line
density LD is actually 150 mm
−2 in fair agreement with the histological MVD of normal skin
amounting to 80mm−2. In the worst case LD overestimates the histological MVD by a factor
of three simply because the cutting-plane of the histological MVD misses vessels in parallel
to the plane. Nevertheless LD was used as representation of the MVD in at least another
publication [Sta+14], and we continued to use it in following work [WR13; Wel+15], correctly
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designated.
Moreover we determined (box-counting) fractal dimensions, [WR10, Sec. 3.3] for which
we obtain df (tumor) = 2.5 ± 0.03 as average and standard deviation taken over entire
tumor networks which is in good agreement with previous df = 2.52 ± 0.05 [LRB06] based
on remodeled capillary networks, and which corresponds to the dimension of the critical
percolation cluster in three dimensions. We also computed fractal dimensions of arterio-
venous trees df (av) = 1.64 which happened to be in good agreement with experimental data
df = 1.65 ± 0.05 [Gaz+95]. However different method were used. We used box-counting in
three-dimensions, whereas Gazit et al. [Gaz+95] considered binary valued images of two-
dimensional projections.
The last part of this section of this paper, [WR10, Sec. 3.4], presents our attempt to
confirm the correlation of local tumor MVD versus local blood pressure differences at t = 0.
We computed ||∇p|| according to the definition in Sec. 3.2, and plotted it versus the local
tumor MVD at t = 800 h. However we failed to reproduce the correlation found in the two-
dimensional case [WBR09]. We suspect an error, because we repeated the calculations for
the tumor vascular networks generated for our recent study of tumor oxygenation [Wel+15],
using new program codes, and obtained a correlation coefficient amounting to 0.41 for local
MVD(t = 800 h) versus ||∇p||(t = 0) taken over (100 µm)3 voxels. For the MVD(t = 800 h)
versus the average of ||∇p||(t = 0) taken over the area of entire tumors at t = 800 h we
obtained a correlation coefficient of 0.93 consistent with previous results (s. Appendix A).
In the second part of this paper we consider again the conduction of a tracer substance
through the tumor vascular network using previous methods (s. Sec. 2.6). Consistent with
predictions based on two-dimensional networks, high tracer concentrations are conducted
within seconds through the entire vascular network.
3.4 Interstitial Fluid Flow and Drug Delivery in Vascularized Tumors:
A Computational Model
Interstitial fluid flow (IFF) in tumorous tissue has been considered theoretically to some ex-
tent but only either using constant capillary density distributions within simple continuum
models, or under unrealistic assumptions for a patients capillary network (s. Sec. 2.7).
Moreover, at the current time, experimental acquisition of detailed maps of IFF of human
tumors appears infeasible since invasive methods are state of the art. However, IFF can,
depending on the type of drug, affect its distribution potentially negatively [JB88]. Also, the
spatial concentration distribution of drugs has rarely been considered in the literature. Pre-
vious theoretical models are limited to regular capillary initial (t = 0) networks, e.g. [Sin+09]
or consider a continuous vascular density [JB88]. Experimentally, penetration experiments
are performed for homogeneous cells layers and genetic causes for drug resistance are ex-
amined but heterogeneity of drug distributions were only considered in few cases [MT06;
Zhe+01; Pri+05]. An example of experimental drug distributions in tissues is reprinted in
Fig. 8.
In this paper [WR13] (reprinted in Sec. 8) we focus on IFF and drug delivery in solid
tumors like melanoma or glioma, using simulated tumor blood vessel networks based on
artificial arterio-venous vasculatures of normal tissue. We also abolished deficiencies of our
previous continuum model of the tumor spheroid [WR10], and switched to face centered
cubic (FCC) lattices for the arrangement of vessels. One such deficiency is that the model
equations would allow solutions where the tumor cell (TC) density c rises sharply at the
invasive edge. For instance, assuming quiescent tumor cells (low oxygen availability), a
stationary solution to the differential equation (17) is c(x) = c0 for x within some arbitrary
region T and c = 0 elsewhere. We can find c0 by definition of P so that P (c0) = 0. Thus,
TCs feel no pressure and therefore stay in place. Another problem with this approach is the
curvature of the interface ∂T which can be arbitrarily high. Therefore the solution c(x) may
not be representable on the numerical grid. Also, in real tumors, cell-cell adhesion causes a
certain degree of smoothness of the tumor interface. In this paper this is corrected by a new
continuum model of the tumor spheroid, closely following [PT09] and the refs. therein. In
principle, a common density distribution φ (actually fractional volume per unit volume) with
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a common migration velocity vφ is defined for TCs and normal tissue cells. The interface
between TCs and normal cells is defined via an auxiliary function, i.e. using the Level Set
method [SS03]. Thus the interface is defined as 0-level of the auxiliary function providing
the closest distance from the interface within some proximity of the interface. We found
that this already works well. For future considerations it is possible to include a surface
tension force, following [BKZ92]. The switch to vascular FCC lattices was undertaken to
revert back to 60◦ branching angles. This may seem overly complicated at first, but FCC
lattices can be represented by layers of two-dimensional triangular lattices which are set off
from each other according to the well known-stacking order ABCABC. . . (s. Fig. 12). We
organize sites logically as sites of a three-dimensional cubic lattice that is spatially distorted
to coincide with the conceptual FCC lattice. Neighbors of a given site must correspond to the
FCC lattice. Therefore, exploiting translational symmetry, we store precomputed neighbor
lists for a minimal number of exemplary sites. Generation of arterio-venous initial networks
was carried out again using Y-junctions as structural elements of growth, true to the original
proposal [GK01] [WR13, see also S1 Fig. 2].
A cohort of initial (t = 0) arterio-venous networks were generated. Subsequently tu-
mor growth and vascular remodeling were simulated using previous methods in conjunction
with the new model of tissue described above [WR13, Fig. 2]. Computed tumor spheroids
and vascular networks exhibit morphological compartmentalization in agreement with pre-
vious predictions [WR13, Fig. 3]. Interstitial fluid flow and drug delivery were considered
for stationary final (t = 800 h) simulated tumors, i.e. although we determined concentration
distributions depending on time, we still kept the tissue and network configuration frozen in
time. Interstitial fluid pressure p(x) and its velocity field vl(x) were determined according to
Sec. 2.7, i.e. by finite difference solution of (8). Note that p is not to be mistaken for the
(interpolated) blood pressure used elsewhere. It should be clear from context which one
is meant. Drug content is divided into an extracellular compartment with concentration s1
[WR13, Eqn. 20] and an intracellular compartment with concentration s2 [WR13, Eqn. 21]
where drug is bound immobile. The concentration s1 is subject to diffusion and advection
with the liquid velocity vl. Vessels are sources and drains of drug (s. Sec 2.8, and 2.9) com-
prising diffusive and advective transvascular flux densities [WR13, Eqn. 23]. Lymphatics can
sink drug by advection, assuming that the drug concentration within lymphatics is approx-
imately equal to the concentration in tissue. Consequently, drug diffusion into lymphatics
is neglected. Both compartments 1 and 2 exchange drug via rates k12 and k21 depend-
ing on assumed trans-membrane diffusion coefficient and cell surface area. For simplicity,
degradation of drug molecules is neglected. In future this should be straight forward to add,
provided experimental data. The initial condition is a system clean of drug. Drug is inserted
via the vasculature where the intravascular concentration sv(t) is homogeneous in space
and follows a exponentially decaying pulse in time, imitating an injection.
A major simplifying assumption in our model is that extravasation of blood plasma affects
blood flow negligibly, i.e. we computed blood flow under neglect of extravasation. We deter-
mind the fraction of plasma loss due to extravasation, amounting to an order of magnitude
of one promille. Moreover we estimated the length scale on which the blood pressure would
decrease, amounting to ca. 500 µm in the worst case where the interstitial fluid pressure is
constant zero [WR13, Pg. 12 and Fig. 6]. Therefore the simplification seems justified from
a computational point of view, although in animal models blood flow velocities are generally
lower amounting to 0.1 − 1 mm/s. There severe extravasation causes a rise in hematocrit
and blood viscosity, which can even cause stasis of blood flow [Net+96; BNJ97].
Predicted interstitial fluid pressure (IFP) distributions exhibit an average radial profile that
increases sharply from the tumor edge into the tumor center. There, the IFP approaches a
plateau value asymptotically, close to the level of blood pressure, amounting to ca. 6.5 kPa
(49 mmHg) [WR13, Fig. 4 and 5]. This is expected due to the high vascular permeability,
implying a small pressure drop across the vessel wall. The plateau value lies above exper-
imentally observed mean values taken over various human tumors, but it is still lower than
the absolute maximal observed IFP [JTM07, Tbl. 1]. Since the IFP is generally assumed to
rise very close to the level of blood pressure, this is rather indicative of overestimated blood
pressure. IFF distributions, i.e. the scaled negative gradient of the IFP, follow trivially and
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exhibit the expected sharp rise at the tumor rim amouting to a maximal value of 0.2 µm/s in
good agreement with the literature. Due to the discrete vasculature model used, the IFP and
IFF distributions exhibit heterogeneity, i.e. they vary spatially in-between vessels of different
blood pressure values. Thus vessels are predicted to drain the interstitial fluid in some in-
stances [WR13, Fig. 4C]. The distributions shown are discontinuous because we assumed
a different interstitial permeability for tumor than for normal tissue.
Anti-cancer drugs come in a variety of kinds, from light molecules e.g. Cisplatin or Dox-
orubicin (≈ 543 g/mol) to heavy nano particles and viruses as carrier systems. We consid-
ered Doxorubicin as base case since it is experimentally well studied and widely used. Maps
of predicted concentration distributions are depicted in [WR13, Fig. 7]. The computation
was stopped after a simulated time of 96 h. Corresponding radial averages, are displayed
in [WR13, Fig. 8A] whereas Fig. 8B shows average concentration distributions depending
on the distance from vessels. The distribution of local concentrations is apparently mostly
determined by the local vascular density (MVD) distribution. Thus, drug concentration are
generally high within an annular shell around the tumor interface and otherwise low except
for areas in proximity of tumor blood vessels. Moreover we computed maps of intracellular
drug doses, denoted ICMAX and ICAUC which are the local maximal concentration s2 taken
over time and the local time integral of s2, respectively. Both distributions are qualitatively
similar and likewise reflect the distribution of the MVD [WR13, Fig. 9].
We considered also concentration distributions arising from non-diffusing particles, e.g.
from nano-particles (case i). Due to their high molecular mass we assumed a vanishing
diffusion coefficient so that they are transported purely by advection. The main qualitative
difference to the base case is that predicted concentrations and dose distributions precisely
follow stream lines of the flow of interstitial fluid. As a result there are frequently small sec-
tions of viable tumor, where no noteworthy drug concentration arrives within the simulation
time of 96 h [WR13, Fig. 11]. In case (ii) we considered a prolonged infusion of drug which
yielded similar results as the base case except with higher magnitudes of concentrations
and doses.
Further simulations were performed for simple parameter variations based on the base
case where each time we varied one permeability coefficient in the system (cases iii to v)
as well as the number of lymphatic channels (cases vi and vii) [WR13, Figs. 10, 13 and 14].
The main conclusion here is that increased permeability increases interstitial fluid flow and
fluxes of drug. The model system of interstitial fluid flow is in all respects analogous to an
electrical circuit, and therefore this result is not surprising (s. Sec. 4). Moreover predicted
doses are very sensitive to the variation of tumor tissue permeability, suggesting a possible
therapeutic target.
3.5 Relation between tumor oxygenation, vascular remodeling and blood
flow: A computational model with applications to breast cancer
In previous papers we assumed that intravascular oxygen (O2) concentrations are constant
[WBR09; WR10; WR13] or proportional to hematocrit [WBR08]. In the limit of small transit
times this may be justified. But as mentioned before, this assumption is certainly not valid
for all tumors because during the transit of a control volume of blood through vascular tubes,
its O2 content decreases due to extravasation of O2 (s. Sec. 2.9). Moreover, oxygena-
tion of tumors is currently not well understood. For instance, Grosenick et al. [Gro+05] and
Spinelli et al. [Spi+05] measured tumor oxygenation by optical mammography in a cohort of
patients. They determined average concentrations of total hemoglobin cHb, oxyhemoglobin
cHbO, deoxyhemoglobin cHbD, and average blood oxygen saturations Y within normal and
tumorous tissue sections. The saturation Y is simply defined as the ratio Y = cHbO/cHb.
They found that the tumor hemoglobin concentration cHb(tumor) is always larger than the
hemoglobin concentration in normal tissue cHb(normal). This is already explained by an
increase in regional blood volume rBV due to vaso-dilation. The blood oxygen saturation
in tumors Y (tumor), however, can be larger or lower than the blood oxygen saturation in
normal tissue Y (normal), split approximately to one half among the patients. Moreover,
high hemoglobin concentrations are correlated with high saturations, but tumors with low
34
hemoglobin concentration exhibit a wider range of blood oxygen saturations. These statisti-
cal variations of the saturations were previously not explained, and no attempt was made to
link them to vascular architectures of different kinds, for instance.
In this unpublished preprint [Wel+15] (reprinted in Sec. 9) we tackle these problems
with extensions of previous methods including the computation of varying intravascular oxy-
gen concentrations [Wel+15, Sec. “Models”]. Note that oxygen concentration and partial
pressure (PO2) are denoted as c and P here, not to be confused with quantities of previ-
ous papers. Similar as before [WR13] we consider tumor vascular networks (t = 800 h)
obtained from simulation of tumor growth and vascular remodeling. Regional blood vol-
ume rBV , perfusion rBF , hemoglobin concentrations cHb, oxy-hemoglobin concentrations,
deoxy-hemoglobin concentrations, oxygen saturation Y , as well as tissue and vascular oxy-
gen partial pressure distributions P , and Pt were calculated for initial networks and final
tumor networks (t = 800 h), to name the most important quantities. Transient behavior such
as transient hypoxia due to temporary occlusion of blood vessels is not considered. In previ-
ous work [WBR09] predicted vascular morphologies were sensitive to different initial (t = 0)
arterio-venous blood vessel network configurations in which the tumor grows. Therefore
we again consider different initial network configurations, in greater number, denoted RC1
through RC9 [see Wel+15, Fig. 7], emulating a cohort of patients, and present calculated
parameters as function of these configurations.
Following the work of Hsu and Secomb [HS89] and Goldman [Gol08], our mathematical
model describes stationary consistent states of oxygen PO2 distributions within the vascular
network, P , and of tissue, Pt. The intravascular PO2 is assumed as constant across the
cross sectional area of vascular pipes. Thus the vasculature model reduces to a collection of
one-dimensional segments of which P (x) gives the O2 partial pressure at some longitudinal
position x along the axis of some vessel. Both distributions P , and Pt, are coupled by the
net transvascular flux density of oxygen per vessel unit length 2πr · jtv, depending on the
difference of PO2 levels across the vascular wall. The effective resistance to radial oxygen
transport and extravasation is captured by the phenomenological mass transfer coefficient
γ, according to which the flux density is 2πrjtv = 2πrγ(P − Pt). The intravascular oxygen
content decreases longitudinally according to the flux density jtv, and simultaneously, the
extravasated oxygen flux is a source of oxygen for the tissue oxygen distribution Pt. Tissue
oxygen consumption rates, M(P ), are determined according to the well-known Michaelis-
Menten relation [Gol08]. For more details we refer to Sec. 2.9. A concise model definition is
provided in [Wel+15, Sec. “Models”]. Discretization of the model equations yields a complex
system of non-linear equations. We combined ideas from previous work [HS89; Sec+04;
Gol08; Bea01] into a new numerical solution procedure which is sufficiently efficient, allowing
us to study three-dimensional networks in a simulation box of ca. 0.5 cm3. However the
method suffers from sub-linear convergence with the grid constant h of the discretization grid
of the tissue domain. [Wel+15, S1 Appendix, Fig.4] shows solutions for PO2 distributions
of a single vessel for different h. Solutions are spaced slightly further apart the smaller h
becomes. The difference between the average partial pressure for some h and the solution
at h = 10 µm taken over the vessel length |〈P 〉(h) − 〈P 〉(h = 10 µm)|, scales in proportion
to h0.6. In standard finite difference methods an exponent of 2 is common, where solution
would be spaced less apart the smaller h becomes. However, here convergence is spoiled
by singular source terms.
Complementing the network model, a simple zero-dimensional, i.e. mean-field, model
was developed by Rinneberg [see Wel+15, Sec. “Homogeneous Three-Compartment Model
of Blood Oxygenation”]. In essence this model divides tissue into identical sections, each
supplied by a capillary which are also all identical, similar to the basic idea of the Krogh
model (s. Sec. 2.9). However, in contrast to the Krogh model, variations of tissue oxy-
gen partial pressure PO2 are neglected, and the net transvascular O2 flux density jtv is
determined by an effective mass transfer coefficient γ (13). Thus the longitudinal variation
of the blood oxygen saturation S(x) along the vessel axis coordinate x can be determined,
provided that the inlet O2 saturation Sin and a homogeneous tissue O2 partial pressure
Pt are given. Under the model assumptions, microscopic quantities like blood flow rate q
are easy to related to their macroscopic counterparts. For example, the tissue perfusion
35
is rBF = q/V , where V is the volume of the considered tissue sections. Thus, the aver-
age saturation Y , oxygen extraction OEF and several more parameters were calculated.
Predictions are compared against simulation results and experimental data [see Wel+15,
Sec. “Predictions of Compartment Model and Comparison with Experimental Data”]. By this
model it is easy to see that the average blood oxygen saturation Y = 〈S〉 increases with
perfusion rBF asymptotically to the saturation value Y = 1. Moreover, Y decreases with
increasing vascular surface area to volume ratio.
For each vascular tree configuration RC1 through RC9, we simulated five realizations of
different tumor vascular networks. Moreover, we considered three model variations of tumor
growth and oxygen consumption. For the base case (BASE), we adopted our previous model
with some parameter changes guided by experimental data for breast tumor [Wel+15, Tbl.
1 and 3]. Although we reduced the maximal vascular dilation radius r(max) to only 14 µm,
down from 25, predicted blood flow rates q and tissue perfusion are much larger than experi-
mentally measured [Wel+15, Tbl. 4]. Consequently, oxygenation Y is also predicted to high.
In the second case (CMPR) we essentially consider a shrinkage in radius of high caliber
arterioles and venules which is motivated as the effect of compression forces caused by the
tumor (s. Sec. 1.3). In this case predictions of oxygenation agree well with mammography
data, and flow rates are lower. In the third case (METAB) we picked a different maximal rate
of oxygen consumption M0 of the Michaelis-Menten relation for each simulated tumor on
the basis of a statistical log-normal distribution. Using a plausible spread, i.e. a standard
deviation of 30% and a mean of M0 of the base case, this case fails to lower oxygenation
of tumors Y sufficiently for experimental agreement, i.e. at the given flow rates, the system
is too insensitive to variations of the O2 consumption rate. We further observe that the use
of different initial (t = 0) networks yields a significant spread across all computed quantities
[see Wel+15, Figs. 12 to 15]. We show that this variation can be traced back to the vary-
ing number of vascular trees R within the fixed simulation volume [Wel+15, Fig. 15D, and
Appendix S4]. Note that initial networks generally consists of multiple arterial and venous
trees, the inlets and outlets (tree roots) of which are prescribed arbitrarily [Wel+15, Fig. 7].
It is indeed quite easy to see that, with increasing R, vascular volume must decrease. This
implies the presence of smaller average vascular radii, which has a drastic effect on blood
flow due to the r4 dependence of the blood flow resistance.
Moreover we considered a comparison of the full model to a simplified model of oxygen
distribution where the intravascular PO2 is constant. In contrast to the simplified model,
the full model predicts O2 depletion of the neovascular plexus at the tumor edge due to
decreased hematocrit levels and depletion of isolated vascular threads simply due to their
length. The predicted hematocrit H of intra-tumoral vessels is generally elevated. There-
fore simplified models where P is proportional to H fail to predict O2 depletion of isolated
vascular threads.
4 Summarizing discussion
This section provides a concluding discussion of the papers of this thesis. First, implications
of the incorporation of arterio-venous initial (t = 0) blood vessel networks are discussed. It
follows a discussion of the results of simulations of drug transport, interstitial fluid flow and
detailed intra-and extravascular oxygen distributions.
4.1 Tumor growth in vascularized tissues
Previously, Lee, Bartha and Rieger [BR06; LRB06] developed a model of vascularized solid
tumor growth and capillary network remodeling. This model includes all essential ingre-
dients to predict the morphological compartmentalization of tumor blood vessel networks
in agreement with experimental data of melanoma and glioma [Do¨m+02; HWY99; Hol+99].
This compartmentalization is characterized by dense chaotic vascular sprouting at the tumor
interface, a sharp decrease of vascular density into tumor spheroid where isolated dilated
blood vessels are predominant, and finally the occurrence of necrotic regions caused by
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hypoxia (s. Figs. 3, 4, and 5). The ingredients to obtain such characteristics from a the-
oretical model comprise tumor cells, an initial capillary network, blood flow, a growthfactor
concentration field, an oxygen concentration field, and processes reflecting co-option, an-
giogenesis, vaso-dilation, regression and collapse.
It was concluded to extend the basic theoretical model with more faithful biophysical
model details (s. Sec 3.1, 3.2 and below) and eliminate shortcomings such as unphysiolog-
ical blood flow boundary conditions (s. Sec. 3.2). Thus, relevance for clinical applications
is increased, in particular predictions of drug transport and oxygen distributions are more
relevant for tumors in humans than previous work which was mostly guided by experimental
animal models. Model extensions implemented comprise transvascular oxygen diffusion,
as opposed to constant rate production (not to be mistaken for recent work [RW15]), com-
putation of intravascular hematocrit distributions (phase separation effect), hematocrit and
vessel radius dependent blood viscosity, acute-angled vascular bifurcations (s. Fig. 12c),
arterio-venous initial blood-vessel networks of the host, a versatile continuum model of the
tumor spheroid, and the extension to three dimensions (s. Sec. 3.3, 3.4).
Model predictions of average quantities such as radial distributions of microvascular den-
sity (MVD), blood flow, oxygenation and tumor density are robust against these model al-
terations. The parameters for vessel collapse probability p(col), wall degradation rate ∆w,
critical collapse shear stress f (col) and contact inhibition length of angiogenesis l(spr) nat-
urally determine the MVD. However, we demonstrated that the abnormal qualities of tumor
blood vessel networks are preserved, as described in the introduction, over a wide range of
parameter values. This is true in particular for the rather drastic alteration of the introduction
of arterio-venous blood vessel networks (AVNs) [WBR09]. Previously, state of the art were
capillary-only networks (CNs) even for centimeter sized sections of tissue, without supplying
or draining vessels. Therein, vessel segments are arranged in a lattice pattern, e.g. square
or hexagonal. Initial CNs consist of identical capillaries. AVNs however, introduce vessels of
varying caliber, wall thickness, and presumably resistance to collapse. Varying degrees of
stability were therefore incorporated by the addition of a wall stability variable w associated
with vascular segments. Thus vessels undergo a degeneration period before blood flow is
pinched-off. A certain invariance against model details is expected and even required, be-
cause it would be implausible if the results were dependent on a specific abstraction of the
biological reality (within reasonable accuracy).
Moreover, following [BR06], fractal dimension numbers were computed for vascular net-
works. Fractal dimension df is an extension of the conventional dimension to self-similar
(fractal) objects, i.e. a line has df = 1, but a fractal curve within the two-dimensional plane
can have df between 1 and 2 depending on how densely it permeates space. df = 2
corresponds to a solid object like a disc. For real objects of finite size several approx-
imative metrics exists, e.g. the number obtained by box-counting [Man83]. Gazit et al.
[Gaz+95] measured the dimension of photographs of tumor vascular networks and obtained
dexpf = 1.89 ± 0.04. Furthermore, in conventional percolation, sites of a lattice are ran-
domly occupied with probability p. At some critical probability pc, a percolating cluster forms
that spans across the lateral size of the considered domain. The dimension of this clus-
ter is exactly known dperccf = 1.891 [SA94]. [Gaz+95] hypothesized that fractal properties
of tumor vascular networks emerge from an in-growth process through a heterogeneous
extracellular matrix because dexpf is close to the dimension of invasive percolation, i.e. a
fractal structure created by a random growth process with dinv−percf = 1.81 [Fur+88]. On
the other hand, Bartha and Rieger [BR06] obtained df = 1.85 by box-counting from the
entire vasculature that was changed by tumor vascular remodeling. Since no ECM het-
erogeneities were modeled, it was hypothesized that the mechanism leading to the fractal
properties is a random dilution process similar to conventional percolation. Lee, Rieger, and
Bartha [LRB06] computed box-counting dimensions for three-dimensional networks and ob-
tained df = 2.52, corresponding to the three-dimensional percolation cluster. Later, we
computed box-counting dimensions for tumor networks obtained from the extended models
[WBR08; WBR09; WR10]: For CNs based tumor vascular networks, df was obtained in
the range between 1.6 and 1.9, depending on the MVD, where we varied either the critical
collapse shear-stress f (col) or the collapse probability p(col) [WBR08]. Fractal dimensions
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of tumor vascular networks obtained from simulations based on three-dimensional AVNs
[WR10] yielded df = 2.51 ± 0.03, in good agreement with percolation theory and [LRB06]
where tumors in CNs are considered. However, accurate measurement of fractal dimen-
sions of real and simulated tumor vascular networks is hardly possible due to their limited
size [BR06]. It was suggested previously [BR06] that fractal dimension is mostly a function
of MVD, which is supported in this thesis. Therefore it appears doubtful that df is a reliable
means to discern subtle differences like invasive versus normal percolation.
Morphological analysis was approached from another angle in [WBR09], where spatial
frequency distributions of (i) local MVD, (ii) area of clusters of necrotic tissue, and (iii) area
of hot-spots of high MVD were computed for tumors grown in two-dimensional AVNs (s.
Sec. 3.2). Predicted distributions show good agreement with a power law, and exhibit all the
same exponent of −1.4. A such algebraic decrease, in contrast to an exponential decrease,
is known for systems at a critical threshold where systems undergo a phase transition. In
the case of percolation, the critical threshold at p = pc marks the transition from isolated
clusters to a single connected region. [BR06] suggested that the tumor vasculature is driven
automatically into a state akin to the critical percolation cluster because vessels permeate
the entire tumor. The mechanism responsible for this is shear-stress correlated vascular
collapse, i.e. when vessels collapse, their blood flow is redirected through nearby vessels,
increasing their shear-stress and stability. It is interesting to see this idea supported by
predictions of algebraic distributions. These predictions are experimentally testable and,
if confirmed, would support that real vascular networks of the interior of tumors are the
result of a dilution process rather than the result of sprouting growth into a heterogeneous
environment.
4.2 Arterio-venous blood vessel networks
Theoretical models for the construction of artificial arterial trees [SB93] and arterio-venous
blood vessel networks (AVNs) [GK01] were conceived previously. We adopted the model
developed by Go¨dde and Kurz [GK01] with which they simulated realistic arterio-venous
vascular patterns of the chorioallantoic membrane of chicken eggs. This model fits our
requirements well since it is lattice-based and entire vascular networks are obtained from it,
not just arterial trees. Later, we extended the model to three dimensions [WR10] and face
centered cubic (FCC) lattices [Wel+15]. In principle the construction can be carried out on
a cubic lattice, as done in [WR10], but the restriction to 90◦ branching angles (T-junctions)
is quite unrealistic in contrast to narrower 60◦ angles (s. Fig. 12c) [ZM82]. Hence the
later implementation was made for FCC lattices. By setting appropriate values for the lattice
constant and capillary radii, the MVD and vascular volume of generated networks can be
adjusted. Recently, we demonstrated simultaneous good agreement of quantities obtained
from simulated initial networks [Wel+15] with MVD, relative blood volume (rBV ), venous
volume fraction (vrBV ), perfusion (rBF ) and oxygen saturation (Y ) found in human breast
tissue [Gro+05; Bea84; Vuj+03; Man+02; Wil+92].
Blood flow boundary conditions in CNs were implemented by imposing a global constant
blood pressure gradient on boundary nodes of the network. This, however, leads to a se-
lection of surviving tumor vessels preferably in the direction parallel to the imposed gradient
[BR06; WBR08]. The explanation is simply that junctions of vessels that run perpendicular
to the gradient lie on approximately equal blood pressure potentials and therefore no sig-
nificant blood flow can occur, resulting in collapse of the vessels. AVNs abolish this artifact
since there is no global flow direction.
On the other hand, simulations of tumor growth in AVNs exhibit high-caliber (> 50 µm ra-
dius) vessels protruding into the tumor which form a backbone of stable vessels in-between
which thinner vessels form short and straightforward paths [WBR09]. The flow resistance
decreases in proportion to 1/r4 with radius r and is therefore, in comparison to capillaries,
extremely low in such high-caliber vessels. Therefore, in analogy to electrical networks, the
blood pressure (voltage) drop across them is also low. In zero-th order approximation the
blood pressure is constant, i.e. high-caliber vessels act like a pressure boundary condition
for adjacent capillaries. Short, directed paths, have a survival advantage as discussed above
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for CNs. The distribution of tumor vessels thus becomes dependent on initial (t = 0) vascu-
lar networks and is generally heterogeneous and anisotropic. We attempted to quantify this
behavior by correlation of tumor MVD (t > 0) versus the magnitude of blood pressure differ-
ences in-between vessels of initial (t = 0) AVNs (s. Sec. 3.2 and A). For instance, assuming
an arteriole runs near a venule then a large spatial blood pressure gradient is present. When
a tumor grows near this area, a connection (short cut) is formed by angiogenesis, imposing
the spatial gradient onto blood flow through the newly formed vessel which is the more sta-
ble the steeper the gradient. An auxiliary field, interpolating the blood pressure of vessels,
was computed of which the average gradient 〈||∇p||〉 was plotted versus the MVD. For lo-
cal averages we obtain correlation coefficients ranging from 0.2 to 0.5 taken per simulation.
A correlation coefficient of 0.9 was obtained for averages over entire tumors of a cohort of
simulations [WBR09]. This finding suggests that an analysis of the blood vessel network
surrounding the tumor might be useful in a clinical application, e.g. to calibrate MVD-based
prognosis.
Moreover, we suggest that different architectures of tumor vascular networks which are
observed in real tumors of the same tissue, e.g. breast tumors [Du+08] are the result of
the, to some degree random, layout of the micro vasculature in which the tumor grows,
rather than motivated in genetic origins. This idea is similar to the proposal of [Gaz+95] (see
above). However, our work suggests that heterogeneity of the initial vascular network has
a strong impact on the emerging tumor vasculature rather than heterogeneity of the ECM
through which vascular sprouts grow.
Furthermore, regional blood volume rBV , perfusion rBF , hemoglobin concentrations
cHb, average blood oxygen saturations Y and other derived quantities were computed for
a cohort of simulated tumors [see Wel+15, Figs. 12 to 15]. A significant spread of these
quantities was predicted due to the selection of different initial (t = 0) vascular tree configu-
rations obtained from different, arbitrary, sets of tree root locations (RC1 through RC9) [see
Wel+15, Fig. 7]. The origin of this spread lies founded in the variation of blood volume rBV
with the number of vascular trees within the fixed simulation volume. Fewer trees require that
the existing trees exhibit higher depth. Murray’s law demands that each additional tree level
exhibits vascular radii larger than the radii of child branches. The radii of capillaries is fixed
by definition of the construction method. For these three reasons, the total vascular volume
rBV increases with decreasing number of trees. We use Dirichlet blood pressure boundary
conditions and therefore obtain a corresponding variation of blood flow rBF and of all other
dependent variables. Differences among vascular root configurations are also reflected in
local and global distributions of the gradient of the interpolated blood pressure 〈||∇p||〉 (s.
Appendix A). Naturally, higher tree depths imply more high-caliber vessels, which implies
the presence of steeper blood pressure differences in-between vessels. Whether simulated
conditions reflect the physiological reality is currently unknown, however uncertainties, as
demonstrated, should be taken into account for clinical applications.
Bartha and Rieger [BR06] suggested that MVD is presumably an unreliable tool for di-
agnostic because if the initial vascular network can satisfy the metabolic demand of tumor
cells then tumor growth rate, MVD of the interior, and MVD of the tumor periphery is uncorre-
lated. Our model of AVNs supports this supposition since vascular hot-spots, i.e. clusters of
locally increased MVD, appear in differing size and density depending on the initial network
layout [see WBR09, Fig. 4 and 5]. The density of such hot-spots is used as a diagnostic
tool [Do¨m+02]. A recent meta-study [Nic+08] of clinical data comes to the same conclusion.
We agree with Bartha and Rieger [BR06] that correlations between MVD and the outcome
of the disease is likely due to metastases which was not considered.
4.3 Intravascular drug conduction and blood flow
McDougall et al. [SRM+02; SAC06] first considered conduction of a tracer substance
through tumor vascular networks using a simulation model of a time-dependent intravascu-
lar concentration distribution that was previously used in geo-engineering. Following them,
we studied intravascular tracer conduction in stationary tumor vascular networks based on
CNs [WBR08] and AVNs [WBR09; WR10]. Simply, a pulse, or a constant infusion, is applied
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at inlet vessels, which is from there propagated down-stream through the vascular network.
The unspectacular model predictions show tracer flowing through networks within a dura-
tion of seconds (AVNs) and ca. one minute (CNs). McDougall et al., on the other hand,
consider a model system based on angiogenesis experiments on the cornea of a rabbit eye
[Gim+74] which is denoted in the following as rabbit-eye model of vascularization. There,
the tumor is not connected to an extensive vascular network, but instead, a single parent
vessel spawns a few sprouts (angiogenesis) which travel a long distance of ca. 1 mm and
branch into a dense network permeating a tumor spheroid and adjacent tissue. It was con-
cluded that the tumor vasculature conducts drug poorly and that most drug bypasses the
tumor. The cause of this contradiction appears to be dilution of the tracer concentration
within the dense network near the tumor and much lower flow rates leading to transit times
of the order of 10− 30 min. Moreover a vascular adaptation model was considered, leading
to formation of shunts that bypass the tumor network [SAC06]. In our model this does not
happen because the tumor is embedded within an efficiently conducting host network.
A good perfusion is consistent with several clinical studies of human tumors based on
PET measurements [Wil+92; Man+02; Lee+85; Ito+82] where elevated perfusion rBF by
factors of 4.7 to 5.2 were observed [s. Wel+15, Tbl. 4]. Blood flow velocities predicted by
our model are of the order of magnitude of 1 mm/s, which is also the order of magnitude of
blood flow velocities in normal capillaries [MH13]. However, it is well-known that blood flow
in animal models is can be severely reduced to only 0.1 to 1 mm/s. The exact causes for
discrepancy are presumably vessel compression and excessive blood plasma extravasation
[JS10], both of which were not considered here.
4.4 Interstitial fluid flow
We incorporated arterio-venous networks (AVNs) as sources and drains of interstitial fluid
[WR13] into a system that was previously considered within the scope of continuum mod-
els [Jai99; JTM07; ZSS07], network models based the rabbit-eye model [Wu+08; Wu+09],
and capillary networks (CNs) [Wu+13]. Our model predicts an elevation of interstitial fluid
pressure (IFP) to 49 mmHg within the experimentally measured range for human tumors
[JTM07], and close to the average blood pressure within the simulated tumor. A peak radial
flow velocity of 0.2 µm/s is predicted at the tumor edge, also in agreement with the literature.
It was often suggested that an elevated IFP poses a barrier to drug delivery [MT06;
Hel+04; Jai99; Wu+13]. However, the reason for this cannot simply be a decreased transvas-
cular hydrostatic pressure gradient that drives extravasation according to the Starling equa-
tion (9). To the contrary, in the standard models of the literature (s. Sec. 2.7), interstitial fluid
flow is analogous to an electrical current through a chain of resistors, of which one resistor,
namely leaky tumor vessel walls, is particularly small. Thus, an increas in leakiness, i.e. an
elevation of IFP, would actually increase the liquid flux throughout the tumor, as predicted
by our model. However, our analysis is restricted to good perfusion, where only a negligible
liquid fraction escapes in spite of leakiness. Otherwise the way through tumorous tissue
into lymphatics could presumably present an alternative well conducting pathway, draining
downstream vessels of blood plasma, resulting in reported low flow velocities [JS10].
The recent theoretical work [Wu+13], using CNs and a sophisticated model of tumor
growth that incorporates vessel compression due to IFP, comes to similar conclusions about
the role of various permeabilities However, it was concluded that IFP is a barrier with little
supporting numerical evidence, i.e. no simulation of actual drug transport was performed.
Results from other work [Wu+08; Wu+09] may not be directly applicable for human tumors
since the physiologically unrealistic rabbit-eye model was considered. .
4.5 Interstitial drug transport
In oder to shed light on barrier to drug delivery, transport through tissue by advection and
diffusion after extravasation must be taken into account. For this purpose, we analyzed a
simple model, according to which, we computed time-dependent concentration distributions
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of drug in simulated tissues containing a vascularized tumor, grown in three-dimensional
AVNs [WR13]. The considered tumors were static, and obtained by simulations guided
by melanoma and glioma. In addition to concentration distributions, we also computed
time-integrated local doses as time-independent metrics of drug delivery. The base case
is guided by data for Doxorubicin [Pri+05; Zhe+01; Sin+09], and many more cases and pa-
rameter variations were explored. Experimentally, the spatio-temporal distribution of drugs
has not been studied much due to the lack of suitable markers for direct observation. Dox-
orubicin concentration distributions were observed exploiting auto fluorescence. Predictions
of our model are in fair agreement with the above Refs. However, quantitative data are
hardly available.
The model predicts that, in general, the dose delivered is subject to a compartmental-
ization similar to the vascular density (MVD). For the base case and most other cases, the
average dose within the center of the tumor spheroid is significantly lower than in normal tis-
sue, and doses are highest at the tumor edge. This result provides an additional explanation
of the incompletely understood success of combination therapies of anti-angiogenic agents
and chemotherapy, whereas a single drug fails to improve survival [Jai13]. TCs behind the
tumor edge might be killed by high doses of chemotherapeutics, effective against cycling
cells, whereas the TC population of the tumor center is reduced by necrosis caused by hy-
poxia. A monotherapy might leave the one or the other part of the TC population unaffected.
The mechanism by which combination therapies are known to act is suppression of the ac-
tivity caused by vascular growth factors, leading to a decreased vascular permeability. This
allows throughout better delivery of chemotherapeutics due to improved perfusion [Jai13].
Variation of the various permeabilities shows that average doses delivered increase in
differing sensitivity with the permeability. Doses showed the highest sensitivity with respect
to interstitial hydraulic and diffusive permeabilities which were varied simultaneously. As
Wu et al. [Wu+13] already suggested this could be exploited for therapy, however care must
be taken to not accidentally aggravate tumor invasiveness [SS11] or metastatic shedding
of TCs. Moreover, angiogenic normalization therapy, i.e. a reduction of permeability and
pruning of superfluous vessels [Jai13], might be ineffective or even detrimental for tumors
where blood flow is negligibly impaired.
Doxorubicin molecules have a molar mass of 543 g/mol. Such, and lighter molecules
have the advantage that diffusion helps to distribute a substantial dose homogeneously
around blood vessels. Recent simulations of another group [Sin+09] predicted very smooth
and homogeneous concentration distributions of the more diffusive drug Cisplatin (300 g/mol)
arising from extravasation from a CN. Since the diffusion coefficient decreases with the mo-
lar mass of the solute, transport of drugs like nano-particles is strongly advection dominated.
Such a case was considered previously with the help of a simple one-dimensional contin-
uummodel, predicting that hardly any drug is released by the vascular network into the tumor
center [Jai99]. Our model predicts interstitial drug concentrations that follow the stream of
interstitial fluid in significant concentrations through the largest parts of the tumor spheroid,
starting from the initial insertion through the vasculature. However, simulations frequently
yielded small isolated islands behind the tumor edge where no noteworthy dose had been
delivered within the time frame of the simulation of 96 h. Presumably, this discrepancy to
earlier work [Jai99] is caused by the discrete nature of the blood vessel network allowing for
flow in-between vessel of different blood pressure levels. However the radial flow component
vanishes by chance at some places as dictated by the random layout of the vascular net-
work. Thus locations further outwards are hardly supplied with drug [WR13, Fig. 11]. This
suggests that a mono-therapy with agents of high molar mass would be prone to recurring
cancer.
4.6 Detailed model of oxygen distribution
Extremely good perfusion of tumor vessels cannot be assumed for tumors in general. This
necessitates consideration of spatially varying substance concentrations because a sub-
stantial fraction may be lost during the transit through the tumor. Our recently developed
computational method attempts to solve this problem for oxygen concentration distributions
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on macroscopic scales by solution of coupled systems of differential equations for intravas-
cular and extravascular oxygen transport and diffusion to obtain a self-consistent numerical
solution [Wel+15]. This is computationally very expensive, however, this expense is justified
since few simplifying assumptions need to be made for the vascular network and blood flow.
Maps of tissue oxygen partial pressure (PO2) distributions emerging for various vascular
networks and tissues were calculated previously according to the mathematical description
of oxygen transport that we also use [Sec+04; Gol08, and the refs. therein]. Our numerical
solution is a compromise between computational demand and presumably more accurate
methods [Sec+04; Gol08]. The method allows computation of oxygenation in simulation
boxes of ca. 0.5 cm3 on standard hardware (i7-2600K, 3.4 GHz, 4GB Ram) within an hour.
This was by far not achievable with the Green’s function based method [Sec+04]. However,
our method suffers from sub-linear convergence with the numerical grid constant h, i.e. the
results depend strongly on the fineness of the discretization [s. Wel+15, S1 Appendix, Fig.4].
For a small artificial vasculature we obtained good qualitative agreement with the Green’s
function method but the computed PO2 differs up to 10% of the value at the inlet. In spite of
that, we obtain good agreement with experimentally data of normal breast tissue, and use
the method to analyze oxygenation of breast tumors (see below).
Critical to performance and accuracy is the regularization of the singular source term
2πrjtv of the tissue O2 diffusion equation, containing Dirac δ distributions, in conjunction
with an efficient numerical scheme for the solution of the diffusion equation. In general the
method should yield a sparse system matrix to enable numerical solutions in O(n log n) time
in the number of unknowns n. Moreover, the method should allow for coarse grid constants
h of 5 to 30 µm to keep the number of unknowns low and simultaneously resolve O2 concen-
tration gradients around tumor vessels. D’Angelo [DAn12] achieved optimal convergence by
adaptive tesselation of the tissue domain, i.e. the discretization becomes more fine grained
near singular source terms (blood vessels).
Our method was applied to the case of breast tumors for which several groups measured
hemoglobin concentrations cHb and average blood oxygen saturations Y in large cohorts of
patients [Gro+05; Spi+05; Tar+05; Tar12]. The average saturation Y within these tumors
can be above or below the saturation measured within healthy tissue. Moreover, saturations
Y are high when the hemoglobin concentration cHb is also high, but tumors exhibiting low
cHb exhibit broader ranges of saturations Y . In our base case (BASE), the use of different
initial (t = 0) root node configurations (RC1 through RC9) leads to a spread in tumor oxygen
saturations, but it does not predict the experimentally observed dependency of Y (tumor)
versus Y (normal) since predicted Y (tumor) is always larger than Y (normal) [Wel+15,
Fig.12]. Therefore we considered a phenomenological ad-hoc extension of the model by
vaso-compression, i.e. essentially a reduction of the radii of arterioles and venules. This
leads to good agreement with mammography data (case CMPR) [Wel+15, Fig.13]. The rea-
son for this is the reduction of blood flow, thus draining a greater fraction of the supplied O2
in order to meet metabolic demand. Thus, rather subtle variations in arterial radii can lead to
large blood flow variations, in addition to fluctuations introduced by varying initial networks of
the host. The experimental data might imply that tumor vascular networks that exhibit higher
saturations than normal are vastly different in their vascular architecture than networks that
exhibit low saturations. However, our simulations suggest that these networks nevertheless
share the traits of typical tumor vascular networks, i.e. as outlined in the introduction.
It is standard for tumor growth models to assume a constant vascular PO2. By definition,
this approximation does not explain variation of saturations Y in the cohort of patients, since
then Y becomes an input parameter. In comparison with the full model, the constant-PO2
approximation over-predicts PO2 in the neo-vascular plexus around the tumor periphery, and
it fails to predict local oxygen depletion in vessels threading the tumor center. This should be
taken into account in applications like therapy planing and other pharmacokinetical studies,
or else, the efficacy of the therapy might be overestimated.
Previously, Secomb’s Greensfunction method [HS89] was used to study oxygen concen-
tration distributions in microscopic tissue sections using blood vessel networks of tumors
in animal models [Sec+04] as well as theoretical idealizations of the vasculature of the hu-
man brain [SD13; SSD11]. The finite difference method by Goldman and Popel [GP00] was
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used in several publications [Gol08; FGE13, and the Refs. therein] to study oxygen con-
centrations in capillary networks of muscle fibers. There are several other papers in which
specifically the oxygen distribution in tumors is considered [DM89; Ske+12; KB06; Mon+11;
DTK03; EPK13; Lag+13; LKB14]. However, in these works, the vasculature is represented
by extremely simplified idealizations, i.e. by arrays of disjoint, often parallel, capillaries. The
vascular oxygen saturation (or partial pressure) is an input parameter in these models and
the macroscopic compartmentalization of the tumor vasculature is neglected. Therefore,
such models are more suited to determine precise statistical frequency distributions of oxy-
gen concentration levels in tissue, given a specific microvascular density and blood oxygen
concentration.
4.7 Limitations and outlook
During the course of this thesis, models and computer programs were developed which
could be further developed into an integrated model with which tumor growth and the effi-
cacy of drugs could be simulated in great detail and physiological relevance. For this pur-
pose, several modules, e.g. interstitial fluid flow, detailed oxygen distribution modeling, etc.
should be integrated into the time dependent simulation of tumor growth. In a proper frame-
work, modules could be swapped, for instance for specific pharmacokinetics models. Other
groups, who however are not considering arterio-venous networks, are developing similar
models [Low+10; Wu+13; Sin+09; San+06] with the final goal of patient specific predictive
power.
To obtain a more faithful cohort of initial blood vessel networks, a systematic analysis of
initial networks could be carried out. Experimental data of blood volume, rBV , perfusion
rBF , and so on, could be used to select a cohort of networks that satisfies experimentally
observed statistical distributions. Current networks are unrealistic in some aspects, e.g.
they contain no anastomosis, i.e. cross-links between vascular trees [MH13]. Therefore
it would be ideal to use real scanned and digitized blood vessel networks. In principle it is
possible to automatically reconstruct networks from voxel data, as done previously [Cas+06;
Lee+07; GFP10; Sta+14]. A data base of many large scale networks of normal tissues and
corresponding tumor networks at different growth stages could be built in future. Not only
would this eliminate the need to construct artificial initial networks, but it would also allow
a very detailed comparison between model predictions and real tumor networks. At best,
scanned network should be obtained from human tissue and be complete, i.e. including all
capillaries. However, this is likely not yet possible at the present time.
A major limitation of our model is the restricted applicability to only well perfused tumors.
The prediction of good perfusion is inherent to our basic model of vascular remodeling since
tumor vessels can only dilate, not shrink, and surviving vessels must route the blood vol-
ume coming from the surrounding vasculature. Therefore it would be worthwhile to explore
biophysically motivated extensions to vascular dilation and regression processes rather than
limiting blood flow by ad-hoc shrinkage of arterial radii. One such possible extension already
exists in the vascular adaptation model [PRS05], variations of which are frequently used in
other mathematical models of tumor growth. Essentially, in this model, a shrinking-tendency
is balanced by a wall shear-stress dependent growth signal. Moreover, compression of blood
vessels is insufficiently understood. Forces involved were studied quantitatively, separately,
to some degree (see Refs. below). Obviously, the deformation of vessel walls is governed
by a balance of forces which are tensile and compressive stress within the vessel wall, blood
pressure, interstitial fluid pressure, and solid pressure. Solid pressure compresses vessels
[Cha+13; Sty+12; Cha+14] and there is evidence that an elevated IFP aids in compression
of vessels [Gri+99; Del+14]. However, the interplay of these forces still seems somewhat
elusive, and there is, to our knowledge, no predictive model of the response of the vessel
wall that takes these factors into account. A physical consideration based on first principles
e.g. with the help of a elasto-plastic mechanical model of vascular walls in combination with
a mechanical model of tissue could help elucidate the forces involved and ultimately yield
better predictions of blood flow.
Even with ad-hoc compression, our model predicts regional blood flow rBF that is about
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a factor of 5 to 10 above measured data from breast tumors [s. Wel+15, Tbl. 4]. This failure
might also lie founded in the size of the considered tumors (4 mm in diameter, simulated,
versus centimeter sized real tumors). Kallinowski et al. [Kal+89] showed that blood flow rBF
of experimental tumors (2−0.3ml/g/min) correlates negatively with size (0.1−10 cm3 tumor
volume), consistent with our results. The reasons for this size dependency are currently
unknown. However, it suggests that vasculatures can only provide a fixed blood flow per
surface area [s. Wel+15, Sec. “Results of the computational model”]. Hence rBF would
decrease with increasing surface to volume ratio of the tumor spheroid. If, in future, tumors
with low flow rates will be considered, our models of blood flow, interstitial fluid flow and drug
transport will likely need revision to take loss of blood plasma and intravascular concentration
variations into account. Mathematically this could be treated in the style of our detailed
simulation of oxygen distributions.
In conclusion, it was demonstrated that tumor vascular morphology and all derived bio-
physical quantities such as oxygenation depend on the initial vasculature in which the tumor
grows. The basic transformation mechanism is wall shear-stress correlated vessel regres-
sion. Furthermore, concentric compartmentalization of predicted drug doses provides ex-
planation for the efficacy of combined anti-angiogenic, cytotoxic therapies. Heterogeneous
interstitial fluid flow patterns might be a barrier to delivery of nano-scale therapeutic agents.
Finally our model requires further work to make it applicable to tumors that exhibit low blood
flow rates.
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,Figure 16. Reconstruction of a cranial blood vessel network from three-dimensional
microscopy data: (a) Projection view of the mosaic obtained from microscopy, color coded
by depth. (b) 3D visualization of the reconstructed network with associated vessel radii
(white cylinders) and original data (yellow isosurfaces). (Reprinted from [Cas+06] with per-
mission. Copyright 2006 Taylor & Francis LLC)
Figure 17. Reconstruction of a blood vessel network of a breast tumor: The network
was reconstructed from 3D micro-CT data obtained from a blood vessel network of a breast
cancer bearing mouse (scale bar = 1 mm). The insets (b-d) show magnified views (scale
bars = 100 µm).
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A Correlation of vascular density and blood pressure
Figure 18. Tumor vascular density MVD versus normalized average of the gradient
magnitude ||∇p||. The quantity p interpolates in good approximation the blood pressure
in-between vessels. It is the solution of the partial differential equation ∇2p+a · (pv−p) = 0,
where a is proportional to local volume fractions of the vascular network within numerical
grid cells. A grid constant of h = 40µm was used. The proportionality factor is much larger
than one, so that p of cells that intersect with the vascular network is approximately equal to
the blood pressure pv. This definition is similar to the one given in previous work (s. Sec.
3.2), but not identical because here the numerical grid of p is different from the lattice used to
arrange vessel segments. MVD was determined as line density LD [see Wel+15, Appendix
S2] at t = 800 h and p was determined for t = 0. The gradient magnitude of p, ||∇p||,
computed by finite differences, was averaged over local control volumina that are voxels of
200 µm width. Each point in the plot of (a) thus corresponds to a different voxel of different
tumors, of which only a subset is shown. In the plot (b) the averaging was instead performed
over the entire tumor, i.e. there is one data point per tumor. The legend indicates the initial
network configuration of the networks generated for our paper [Wel+15], see [Wel+15, Fig.
7]. The value of the average 〈||∇p||〉 was normalized against the maximal obtained average.
The computed correlations coefficients are 0.56 (local) and 0.96 (global).
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Figure 19. Distributions of local MVD versus the normalized average of the gradient
magnitude ||∇p||: This figure shows renderings of voxel data used for the scatter plots of
Fig. 18. Of each initial network configuration (RC1 through RC9), [see Wel+15, Fig. 7], one
simulated realization is shown with the vascular density MVD on the left and the “pressure”
gradient 〈||∇p||〉 on the right. MVD and 〈||∇p||〉 were obtained as described in Fig. 18.
Color scales are shown in the bottom right. White outlines indicate the location of the tumor
spheroid. Its diameter is ca. 4 mm. The images shown correspond to slices through the
center of the simulation boxes.
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Abstract
Tumors acquire sufﬁcient oxygen and nutrient supply by coopting host vessels and neovasculature created via angiogenesis, thereby
transforming a highly ordered network into chaotic heterogeneous tumor speciﬁc vasculature. Vessel regression inside the tumor leads to
large regions of necrotic tissue interspersed with isolated surviving vessels. We extend our recently introduced model to incorporate
Fahraeus–Lindqvist- and phase separation effects, reﬁned tissue oxygen level computation and drug ﬂow computations. We ﬁnd,
unexpectedly, that collapse and regression accelerates rather than diminishes the perfusion and that a tracer substance ﬂowing through
the remodeled network reaches all parts of the tumor vasculature very well. The reason for decreased drug delivery well known in tumors
should therefore be different from collapse and vessel regression. Implications for drug delivery in real tumors are discussed.
r 2007 Elsevier Ltd. All rights reserved.
Keywords: Cancer; Angiogenesis modeling; Blood ﬂow heterogeneities; Remodeling of vessel networks; Drug ﬂow simulations
1. Introduction
A malignant tumor, cancer, remodels actively the blood
vessel network of normal tissue into a characteristic tumor
vasculature (Holash et al., 1999a, b): A well perfused
region of the network at the tumor periphery provides
sufﬁcient oxygen and nutrient for further tumor growth,
whereas an extremely sparse network with a low vascular
density in the tumor center produces a necrotic core. The
process leading to a high vascular density at the outer rim
is known as angiogenesis, the production of new vessels
from old ones via the stimulus of tumor secreted growth
factors (Carmeliet and Jain, 2000). The regression of
vessels inside the tumor is related to unstable vessel
morphology and abnormal blood ﬂow dynamics as well
as increased solid stress generated by the tumor—for a
discussion see Bartha and Rieger (2006). The emerging
vascular tumor network is thus extremely inhomogeneous
and has geometric, in particular fractal, properties that are
very different from normal vasculature (Baish and Jain,
2000). As a consequence also blood ﬂow patterns inside
this network are highly irregular and might have an impact
upon drug delivery (Minchinton and Tannock, 2006).
This paper is concerned with a mathematical model for a
situation sketched above. There is already a large amount
of work on the mathematical modeling of tumor-induced
angiogenesis (for reviews see, e.g., Mantzaris et al., 2004;
Preziosi, 2003) and can roughly be classiﬁed into two
groups: The ﬁrst group concentrates on blood vessel
densities rather than vessel morphology, as in continuum
partial differential equation (Byrne and Chaplain, 1995;
Levine et al., 2001) or in locally coupled map lattice
(Sansone et al., 2001) approaches. Todays most sophisti-
cated models (Breward et al., 2003), so-called multi-phase
models even track density proﬁles of different tissue types.
Mechanical interaction is included in terms of constitutive
laws. Hence, also the effect of solid pressure on cells can be
respected. The current research situation is reviewed in
(Byrne et al., 2006). Due to the absence of individual blood
‘‘vessels’’ these models do not contain neither the
information on the geometrical and morphological proper-
ties of the vascular network nor on hydrodynamic blood
ﬂow characteristics.
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The second group of works represents vessels as
interconnected lattice patterns, line segments, or contin-
uous curves. As a crucial simpliﬁcation either a static
tumor is assumed (Anderson and Chaplain, 1998; McDou-
gall et al., 2002; Tong and Yuan, 2001; Sun et al., 2005), or
a proliferating tumor is considered in a static network
topology. An example for the latter is the work of (Alarcon
et al., 2003), where a cellular automaton model was
introduced in which automaton elements, are identiﬁed
with vessels, extracellular matrix (ECM), tumor cells (TCs)
or normal cells. TCs and normal cells can proliferate or die
according to the O2 level and other factors, creating a
competition between TCs and normal cells. The vessel
network is initialized to a hexagonal grid and remains
static. The O2 concentration is computed by a standard
diffusion equation with vessel sites as sources and other
tissues as consumers. Based on this the invasiveness of TCs
under different O2 conditions is studied. This work has
been progressively extended into a complex multi-scale
model (Betteridge et al., 2006) which includes an improved
model for dynamic vessel radius adaption in response to
various stimuli (Pries et al., 1998), ‘‘pressure’’ effects i.e.
competition for space, a vascular endothelial growth factor
(VEGF) concentration ﬁeld, implemented in analogy to
O2, biochemical details, including cell cycles and factors
related to proliferation and apoptosis, modeled via
ordinary differential equations. Despite these improve-
ments the basic limitation of a topologically static vessel
network remains and for many tumor types the applic-
ability of this model is restricted to the ﬁrst few days of the
existence of the tumor.
A paradigmatic angiogenesis model with a static tumor
(Anderson and Chaplain, 1998) describes actually the
experimental situation in the so-called ‘‘rabbit eye model’’
(Gimbrone et al., 1974), in which a small growth factor (or
TAF, i.e. tumor angiogenic factor) source is implanted in
the cornea of the eye. Stimulated by TAF, angiogenesis
occurs, whereupon multiple sprouts migrate toward the
tumor. Excessive branching and loop formation happens
close to the tumor, culminating in an extremely dense
network. Since the cornea is initially free of normal vessels
this situation can also be denoted as ‘‘pure vessel-
ingrowth’’. The continuous theoretical model of (Anderson
and Chaplain, 1998) includes three ﬁelds for: endothelial
cell (EC) density, ﬁbronectin, a component of the ECM
also secreted by ECs; TAF concentration. The TAF ﬁeld is
initialized once with a decreasing proﬁle from the tumor to
the parent vessel. Later on, TAF is locally consumed by
ECs. Fibronectin is produced and consumed locally by ECs
and does not diffuse. EC ﬂuxes are driven by a random
motility (diffusion), chemotaxis via GF gradients, and
haptotaxis via ﬁbronectin gradients (gradients of adhe-
sion). The discretized version uses probabilities (derived
from discretized diffusion equations with source and sink
terms) for biased random walks of individual ECs at
sprouting tips. These tip ECs leave a path occupied with
trailing ECs, which can randomly initiate further sprouts if
TAF concentration is high enough. The basic model has
received considerable upgrades; see (Chaplain et al., 2006)
for a review. The most recent version (McDougall et al.,
2006) includes blood ﬂow rate computations and the
sophisticated dynamic vessel radius adaptation procedure
(Pries et al., 1998) as used in (Betteridge et al., 2006),
making it feasible to study drug delivery by simulations of
a tracer substance ﬂowing through the vasculature. A
shortcoming that needs to be addressed is that vessels do
not penetrate the tumor. In the latest studies (with the most
realistic network), the tumor is actually not explicitly
represented, instead the lower boundary of the simulated
domain is identiﬁed with the invasive edge. Hence drug
uptake by the tumor varies by three orders of magnitude,
depending on whether a thick vessels is near the boundary
or not.
This general concept has been adopted in third group of
tumor simulators for modeling pure vessel in-growth into a
non-static tumor, neglecting existing host vessels. For
instance Zheng et al. (2005), designed a hybrid tumor
simulator to study highly invasive tumor types like glioma
brain cancers. There, an extensive framework is developed,
where the tumor is treated as viscous ﬂuid and the topology
of the sharp tissue-tumor interface is described by
sophisticated level-set techniques. The discrete part in-
volves the angiogenesis model by Anderson and Chaplain
(1998), where the generated capillary network serves as
additional source for nutrients and inﬂuences the evolution
of the tumor considerably. In recent work Lowengrub et al.
(2007) presented a glioma model where temporal and
spatial development of cell densities as well as nutrients is
described by convection–reaction–diffusion equations also
including mechanical properties like intercellular adhesion
forces. For angiogenesis a discrete lattice free variant has
been adopted (Plank and Sleeman, 2003, 2004).
Here we also want to go beyond the ‘‘static network’’
and the ‘‘static tumor’’ models and combine a dynamically
evolving network in the presence of a dynamically
changing tumor. Most relevant for our work is the cellular
automaton model that was introduced recently by two of
us (Bartha and Rieger, 2006) for a two-dimensional and
later for a three-dimensional set-up (Lee et al., 2006),
designed to reproduce experimental results for solid human
melanoma type tumors (Do¨me et al., 2002, 2007). There it
was found that in cutaneous melanoma during tumor
growth, there are no signs of directed vessel ingrowth;
instead, these tumors appear to grow by co-opting the
massive vascular plexus present in the peritumoral con-
nective tissue. The intention in Bartha and Rieger (2006)
was to clarify the basic mechanisms leading to the
abnormal tumor vasculature, and discuss the implications
for assessment of tumor growth. In the model TCs and ECs
occupy sites on a regular lattice. ECs form a vessel network
circulated by blood. Tumor and vessels interact via O2 and
GF diffusion ﬁelds. The temporal evolution of the system is
governed by stochastic rules for certain events like TC
death, proliferation, sprout formation or vessel collapse.
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It turned out that these comparably simple rules and little
numerical effort are sufﬁcient to explain many important
aspects of tumor vessel morphology.
In this paper we modify and extend this model and
incorporate the details taken into account by Alarcon et al.
(2003) for static network topologies as described above,
and discuss their relevance for the tumor vessel morphol-
ogy. Then we analyze on the basis of our model how a drug
injected into the blood stream distributes over time within
the tumor vasculature and compare the results with those
for a pure vessel ingrowth-model (McDougall et al., 2006).
The paper is organized as follows: In Section 2 we
describe our model. In Section 3 we present the results of
the model which can be compared to experimental data,
discuss the effect of parameter variations and the relevance
of various model details for the global model behavior. In
Section 4 we describe how drug ﬂow is modeled and
present results of the simulation of an injection of a tracer
substance into one part of the vasculature. Section 5
summarizes our results and provides an outlook to further
research.
2. The model
The following model deﬁnition is conceptually similar to
Bartha and Rieger (2006) but implements higher level of
detail in the modeling of physiology.
2.1. Description of the system state
Basics: Elements are managed on a regular two
dimensional triangular lattice of l  l ¼ n sites, i.e. we
deﬁne the set of sites as
L ¼
ðdðxÞ; d sinð60ÞyÞ if y even
ðdðxþ 1
2
Þ; d sinð60ÞyÞ else
(
jx; y 2 ½0; lÞ
( )
.
(1)
Each site can be occupied by a single tumor cell, and each
bond by a vessel segment. Unoccupied space is part of the
extracellular matrix and/or healthy tissue. Fig. 1 illustrates
how TCs and vessels are aligned on the lattice. The lattice
constant is d ¼ 10mm, chosen deliberately to be of the
order of the typical diameter of TCs and ECs.
Definition of the tumor: The tumor is deﬁned as a set of
sites T ¼ fx 2 L; TC present at xg. This means sites in T
are associated with single TCs. For any given site x 2 T it
is assumed that the space occupied by the cells corresponds
roughly to the Voronoi region around x, i.e. the points in
space that are closer to x than any other site. The hexagon
shown in Fig. 1 is exactly such a Voronoi region and
indicates a TC. During the growth of the tumor necrotic
regions will arise. At the time t, we refer to these by the set
of sites Tnecro where a TC was removed at some time in the
past t0ot, excluding the current set of tumor cells:
Tnecro ¼
S
t0otTðt0ÞnTðtÞ. To determine whether a site x is
inside of the tumor we use a polar map xT ðyÞ which tracks
the extend of the tumor in radial direction, where y is the
polar angle measured relative to the center of the tumor.
Definition of the micro-vascular system: The micro-
vascular system evolves in a separate layer, i.e. vessel
elements can pass sites where TCs are also present. From
the theoretical point of view the vessel network is a graph
where the edges represent vessel segments with associated
hemodynamic and geometry properties. Hence, the topol-
ogy is described by the graph G ¼ ðN ;V Þ, where V ¼
fði; jÞ; i; j 2 Ng is the set of vessel segments, i,j denote
attached junction nodes in N. We denote the position of a
node i with xi 2 L. Analogously we refer to various
properties of vessels, nodes or TCs via sub-scripts, i.e qa
for the ﬂow-rate in some vessel a.
In our current implementation vessels are allowed to
span multiple bonds/sites. For convenience x 2 a denotes a
site that is covered by a vessel a 2 V , including the
endpoints xi,xj. For each vessel in the set of potentially
perfused vessels V circ  V it is required that least two
disjoint paths to the system boundaries must exist.
Blood flow modeling: Blood ﬂow for vessels in V circ is
modeled as laminar steady ﬂow through ideal pipes of
radius r and length l. Therefore Hagen–Poiseuille’s Law is
applicable to compute ﬂow rate q and wall shear stress f
from the blood pressure difference of the endpoints pi2pj:
q ¼ p
8
 r
4
Z
 pi  pj
l
 
, ð2Þ
f ¼ r
2
 pi  pj
l
 
. ð3Þ
To account for the fact that blood is a non-Newtonian ﬂuid
with complex ﬂow behavior, it is common to introduce an
effective viscosity Z ¼ Z0  ZrelðH; rÞ depending on local
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Fig. 1. Illustration of vessels and TCs. A tumor cell (TC) is indicated as
yellow hexagon. TCs are centered at lattice sites. Sites always represent
single cells. Thereby the diameter of the cells is of the order of the lattice
constant. Vessels are indicated as blue bars. In contrast to TCs, they are
associated with the bonds of the lattice, thereby constraining their
orientation to the main lattice directions. A single vessel a ¼ ði; jÞ is
highlighted by a black outline. This vessel spans between sites labeled xi
and xj . Vessel may span multiple sites like those that are indicated here.
The initial networks for the studies in Section 3.2 consists of a hexagonal
pattern. The hexagonal vessel arrangement here would represent a tiny
part of such a network. Note that the tumor grows in it’s own layer
unhampered by vessel. Interactions are predominantly mediated by
growth factor and oxygen ﬁelds, although information about the spatial
coverage also plays an important role.
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vessel radius r and hematocrit H (red blood cell volume
fraction). In simulations which incorporate this effect, we
base our calculations on the formula in Pries et al. (1994).
It is derived from in vivo data and is used in various other
works (Ji et al., 2006; Alarcon et al., 2003; McDougall
et al., 2006). Since the deﬁnition of Zrel is rather lengthy we
refer to Fig. 8 and to the original work of Pries et al.
In blood vessel networks the distribution of hematocrit is
usually not homogeneous, instead RBCs tend to enter the
branch with faster ﬂow—known as phase-separation or
plasma-skimming effect (Fung, 1993). To calculate the
hematocrit we rely again on an empirical formula. Pries et
al. (1990) found a ‘‘bifurcation law’’:
QHb ¼ gðQHa; ra; rb; rc; qa; qb; qcÞ, (4)
which relates the RBC ﬂow QHb ¼ qbHb in a branch b to
the RBC ﬂow QHa in a parent vessel a in dependence on
the radii and the ﬂow rates of all three vessels a, b, c at the
bifurcation.
For the deﬁnition of the function g we refer again to the
original work. Note that the relation is valid only for
arterial bifurcation. The case where two or more branches
merge into a larger one is trivial for obvious reasons.
Furthermore g is symmetric in b and c such that RBC mass
is conserved QHb þQHc ¼ QHa. During the simulation
it is ensured that no more that three vessels meet at
some node.
To compute the global hematocrit distribution when the
blood ﬂow rates are known, vessels must be processed in
consecutive order such that the upstream hematocrit has
already been determined when a downstream child is
processed. That is because via (4) the hematocrit in a given
vessel depends on the hematocrit of all vessels stream
upwards. The hematocrit H0 at the uppermost in-ﬂow
vessels is ﬁxed as a boundary condition. Graph-theoreti-
cally this problem of traversal order is known as ﬁnding a
topological sorting and standard algorithms can be applied
(Cormen et al., 1990).
Furthermore mass preservation dictates that the sum of
inﬂow and outﬂow equals zero for each node i 2 N
(Kirchhoff’s Law):
0 ¼
X
j2NbðiÞ
qij ¼
X
j2NbðiÞ
Sij  ðpi  pjÞ, (5)
where NbðiÞ are adjacent nodes of i in the network. To ﬁnd
the ﬂow and pressure distribution when the ﬂow con-
ductivities Sij—and therefore hematocrits—are known, the
system of linear equations in the nodal pressures (5) must
be solved with appropriate boundary conditions.
Together (2), (5) and the hematocrit computation
procedure form a complex system of non-linear equations
where it is impossible to solve for ﬂow and hematocrit
simultaneously. Hence an iterative approach was suggested
in the literature Pries et al. (1990) which is commonly used
now (Ji et al., 2006; Alarcon et al., 2003): First an initial
guess for the hematocrit is chosen. Until convergence, ﬂow
and hematocrit are updated successively assuming constant
hematocrit and constant ﬂow respectively. To solve the
pressure–potential equations we use a modern sparse LU
factorization library (Davis, 2004) which can efﬁciently
handle large systems with 10,000 of variables. The naive
outer ﬁx-point iteration however resulted in poor conver-
gence due to over-and- undershooting. Therefore we
employ a dampened iteration which has the same ﬁx-
points:
qiþ1 ¼ qðHiÞ,
Hiþ1 ¼ Hi  2=3þ 1=3 Hðqiþ1Þ, ð6Þ
with the stopping condition kHiþ1 Hik2o103, where i is
the iteration number while H and q denote vectors which
contain data values from the individual vessel segments.
We choose dirichlet type boundary-conditions, where the
pressure in boundary nodes is prescribed and decreases
from pðmaxÞ at ð0; 0Þ to ðpðmaxÞ þ pðminÞÞ=2 at ð0; lÞ and ðl; 0Þ
further to pðminÞ at ðl; lÞ.
Definition of the oxygen field: The tumor and the vascular
system interact via oxygen and growth factor ﬁelds. Our
unit-less oxygen ﬁeld co is given by the solution of the
stationary diffusion-equation:
Dco  kco þ aðcðBÞo  coÞ ¼ 0, (7)
with the consumption-rate coefﬁcient k, the source
coefﬁcient a, and the blood oxygen level cðBÞo . We update
the O2 ﬁeld by ﬁnding the stationary state because the O2
diffusion constant is of the order of 2:4 105 cm2=s which
means that the relaxation time after a conﬁguration change
is negligible compared to cell proliferation rates, which is of
the order of an hour.
For simplicity and efﬁciency we deﬁne a linear O2-
uptake kco, as approximation to a more realistic non-
linear Michaelis–Menten type relationship (i.e.
Aco=½Bþ coÞ. At least within, or close to the tumor the
saturation regime of a MM-uptake would be irrelevant,
since tumor cells usually suffer from hypoxia. Furthermore
k varies with the tissue type: it is set to kðTÞ for x 2 T
(tumor), 0 for x 2 Tnecro (necrotic tumor) and kðMÞ
otherwise (ECM/normal tissue). The O2 transport through
the vessels wall is predominantly a diffusion process driven
by the PO2 difference between blood (c
ðBÞ
o ) and tissue (co) at
the vessel wall. Therefore it is common to model the
oxygen release as the source term aðcðBÞo  coÞ. In the
context of our continuum description the coefﬁcient ahas
the meaning of O2 amount released per time per volume
element, which implicitly includes parameters like wall
permeability and circumference. For simplicity we treat all
vessels equal i.e. aðxÞ ¼ að0Þ at vessel occupied sites
x 2 a 2 V circ, where að0Þ is a constant. Naturally aðxÞ ¼ 0
at non-vessel-sites.
For the blood-O2 level c
ðBÞ
o , we assume that it is
essentially proportional to the blood hematocrit—follow-
ing (Alarcon et al., 2003)—and neglecting the fact that
oxygen leaves the vessel. Considering that the PO2 drops
only by about a factor of 2 while blood ﬂows through the
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body this is likely not to pose a problem. Performing
computations with a sophisticated model as presented by
Secomb et al. (2004), would be numerically very hard.
Their model includes intravascular O2 variability, as well as
the nonlinear saturation behavior of hemoglobin. In our
simple approach however we set cðBÞo ðxÞ ¼ Ha for a given
x 2 a 2 V circ. At junctions, the average hematocrit is used.
An additional pre-factor is not necessary because (i) it
would only scale the ﬁeld values globally; (ii) co is unit-less.
Discretizing the diffusion equation by ﬁnite differences
for the Laplace operator yields the linear system of
equations
2
d2
þ aðxÞ þ kðxÞ
 
coðxÞ
 2jNbðxÞjd2
X
x
02NbðxÞ
coðx0Þ ¼ aðxÞcðBÞo ðxÞ, ð8Þ
where NbðxÞ is the set of neighbor sites. It is solved
numerically by a multi-grid V-Cycle with a ﬁxed number of
Jacobi iterations at each level (Briggs et al., 2001). Since the
sources have only a spatially limited effect, the ﬁeld does
not change much when vessels are added or removed.
Hence, the solution from the previous time-step is taken as
initial guess. This allows rather efﬁcient updates with a
small number of iterations.
Definition of the growth factor field: The modeling of
growth factor distribution cg is also based on a reaction–
diffusion equation:
0 ¼ Dcg  ~kcg þ ~a,
~aðxÞ ¼ ~að0Þ for x 2 Tuo; 0 else,
~k ¼ const, ð9Þ
where Tuo  T denotes the set of tumor sites for which
cooy
ðprolÞ
o . We assume that (i) under-oxygenized TCs
produce GF at a constant rate ~að0Þ, (ii) free GF is removed
with the rate ~kcg due to binding and degradation. This
simple formulation facilitates the solution following a
‘‘Greens-function’’ approach for the operator D ~k by
super-positioning contributions of individual TCs:
cgðxÞ ¼
X
x
02Tuo
~gðx x0Þ, ð10Þ
~g ¼ r 7!max½0; 1 r=RðgÞ, ð11Þ
where RðgÞ is the GF diffusion radius. For our convenience
we use a linearly decaying ‘‘Greens-function’’ instead of the
correct exponential decay. The model is not critically
dependent on the exact GF proﬁle nor on the value range
of cg and this simpliﬁcation allows us to tune the distance
up to which angiogenesis is triggered intuitively via RðgÞ.
RðgÞ also provides a natural cutoff for the ‘‘Greens-
function’’ ~g so updating the ﬁeld after removal(addition)
of TCs is very efﬁcient because it is sufﬁcient to simply
subtract(add) the contribution of the respective cells.
2.2. Description of dynamical processes
The system dynamics are governed by the following
procedures which are executed in sequence for each time-
step of length Dt ¼ 1h.
TC proliferation: New TCs are put on empty neighbor
sites xeT of existing TCs with probability Dt=tðprolÞTC if the
local oxygen level is high enough coðxÞ4yðprolÞo :
T  T [ fxg. Naturally this restricts proliferation to the
outer rim. Experiments (Bru et al., 2003) and simulations
(Drasdo and Ho¨hme, 2005) have shown that following an
exponential growth, proliferation is indeed conﬁned to a
small band behind the invasive edge. The simple model
here, reminiscent of the Eden model (Eden, 1961) does not
capture all the aspects of tumor growth dynamics. For
example cell motility is not included. But we consider this
as an acceptable approximation for studying vessel
morphology under a growing solid tumor (Fig. 2a).
TC death: TCs are removed with probability p
ðDeathÞ
TC ¼
1=2 if the local O2 concentration is low enough cooy
ðdeathÞ
o
for longer than t
ðuoÞ
TC : T  Tnfxg. Since TCs adapt to low
oxygen conditions (Iyer et al., 1998), yðdeathÞo ¼ yðprolÞo =10 is
very small. The survival time under hypoxia actually
depends strongly on the cell genotype (Yu et al., 2002),
promoting the selection of certain species. However for
simplicity t
ðuoÞ
TC has been given a ﬁxed value (Fig. 2b).
Angiogenesis: While adult vessels are normally quiescent,
angiogenesis is induced in close proximity to tumors via
increased growth factor levels. Thereby the migration of
ECs at the sprouting tip is guided by GF gradients
(Gerhardt et al., 2003). Tumors also coopt existing vessels
(Paku, 1998) but no explicit modeling is required for this
phenomenon because tumor cell proliferation is not
occluded by vessels. Incorporation of angiogenesis is split
into two subprocesses: sprout initiation and migration.
Sprouts are initiated with probability Dt=tðsproutÞEC at vessel-
sites if (i) the location x 2 a 2 V is outside of the tumor (i.e.
no sprouting inside the tumor (Holash et al., 1999a));
(ii) the GF level is above a threshold cgðxÞ4yðprolÞg ; (iii) the
path length to the next bifurcation is greater than lðsprÞ. At
the respective sites segments with l ¼ d, r ¼ rðinitÞ are
appended in the direction of the steepest GF increase
(Fig. 2c).
At each sprouting tip one further d segment is added
with probability Dt=tðmigrÞEC . If another vessel is located at a
neighboring site in front of the tip, the new segment creates
a junction to the other vessel, forming a potentially blood
circulated loop. Here we assume that the sprout direction
remains constant, which is not a severe simpliﬁcation
because due to the two-dimensional setting sprouts usually
migrate at most ca. 100 mm until another vessel is hit (the
situation is different in three space dimensions). Sprouts
have been observed to regress after a certain time of not
having formed connections (Nehls et al., 1998). To model
this, vessels have an associated countdown s (in analogy to
hypoxic TCs) which is incremented each time-step. While
sosðmaxÞ vessels are guaranteed not to be removed due to
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being uncirculated. During this period vessels can also start
new sprouts which inherit s from their parents. Vessels for
which sXsðmaxÞ (i.e. normal non-sprouting vessels) regress
rapidly if not circulated (Fig. 2d).
Vessel collapse: Long-term reduction of wall shear stress
can cause vessel regression. In tumors solid stresses might
cause vessel collapses resulting in reduced perfusion and
thereby low shear stresses. Also local angiogenesis inhibi-
tors might be involved in EC apoptosis (Dimmeler and
Zeiher, 2000). Furthermore dilated tumor vessels, although
tortuous and leaky with inadequate support structures,
apparently remain stable (Holash et al., 1999b). In the
model this behavior is realized as follows: Let a 2 V be a
vessel then each occupied lattice bond ðk; lÞ 2 a causes a to
be removed with probability pðcÞða; ðxk þ xlÞ=2Þ. For
uncirculated vessels with saXs
ðmaxÞ it is pðcÞ ¼ 1=2. Sprouts
are protected from removal, i.e. pðcÞ ¼ 0 for saosðmaxÞ. For
normal circulated vessels pðcÞ ¼ pðcÞða; xÞ depending on local
system properties as follows: If either shear force or vessel
radius is above a critical threshold f a4f
ðcÞðxÞ or ra4rðstableÞ
then pðcÞ ¼ 0. Thereby we let f ðcÞ vary spatially to account
for increased solid stresses in the tumor. Several functional
dependencies are studied, but the basic case involves a
radial triangular proﬁle g1, with limited support 2d
ðfcÞ and
peak height f ðc;maxÞ centered dðfcÞ microns behind the
invasive edge:
f ðcÞðx; aÞ ¼ f ðcÞðx xcenterÞ
¼ f ðc;maxÞ  g1ðkx xcenterk; yÞ,
g1:¼x; y 7!max 0; 1
jx xT ðyÞ  dðfcÞj
dðfcÞ
 !
. (12)
This is inspired by Breward et al. (2003) where it is assumed
that the replacement of TCs with necrotic material reduces
the solid pressure exerted on vessels. If f apf
ðcÞðx; aÞ and
rapr
ðstableÞ and a 2 V circ then pðcÞ ¼ pðc;maxÞ  g1ðkx
xcenterk; yÞg2ðraÞ40. For the basic case we also tried to
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Fig. 2. Illustration of the dynamic processes of the system. Tumor cells are indicated as yellow hexagons. Circulated vessels are indicated as blue bars.
Vessels are drawn in gray color if uncirculated. This also includes sprouting tips. The meaning of each subﬁgure is as follows: (a) Tumor cells proliferate by
occupying neighbor sites if coðxÞ4yðprolÞo with a rate DT=tðprolÞTC ; (b) tumor cells die if they have been exposed to low oxygen coðxÞoyðdeathÞo for longer than tðuoÞTC
with a rate DT=tðdeathÞTC ; (c) sprouts form if cgðxÞ4yðprolÞg with rate DT=tðsproutÞEC ; (d) sprouts grow further with by appending segments with rate DT=tðmigrÞEC until
s4sðmaxÞ; (e) vessels dilate with rate DT=tðdilÞEC for each subsegment where cgðxÞ4yðprolÞg ; (f) vessels collapse with rate pðcÞða; xÞ if for some subsegment
f aof
ðcÞðxÞ and (g) Uncirculated network components are eliminated with rate 1/2.
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modulate pðcÞ with a vessel radius dependent linear function
g2 for which g2ðrðstableÞÞ ¼ 0 and g2ðrðinitÞÞ ¼ 1 (Fig. 2f).
Vessel regression: Uncirculated vessels cannot contribute
to nutrient delivery and there is no mechanism in the model
that would ‘‘repair’’ such vessels. Hence uncirculated
vessels VnV circ are simply removed with probability 1=2
(Fig. 2g).
Vessel dilation: Vascularization and remodeling of the
vascular system surrounding the growing tumor is primar-
ily dependent upon angiogenic sprouting as modelled
above. Within the tumor the vascularization program
switches to circumferential growth of the initial vasculature
by proliferation of endothelial cells within the vessel walls
(Erber et al., 2006). This we model by a stepwise vessel
dilation in the presence of a high enough VEGF
concentration. Experimentally it is found that the radius
of tumor vessels is limited by a maximum radius rðmaxÞ
(Do¨me et al., 2002). Using the polar map xy deﬁned above
it is decided whether a vessel segment lies within the tumor.
If it does vessel dilatation can occur: each bond ðk; lÞ 2 a
occupied by a vessel a increases the radius of the respective
vessel with probability Dt=tðdilÞEC if cgððxk þ xlÞ=2Þ4yðprolÞo
and raor
ðmaxÞ. The added value d2=2pla corresponds to the
surface area contribution of an additional EC. To account
for surface tension, a smoothing effect is generated by
dilating the thinnest vessel at junction bonds (Fig. 2e).
3. Results
Following (Bartha and Rieger, 2006), the base case
scenario is one for a malignant melanoma, guided by data
from Do¨me et al. (2002). Further parameter variations and
simpliﬁcations are presented after the base case results.
3.1. Parameters
The size of the lattice is l ¼ 1000 in all of the following
experiments. With the mentioned bond length d ¼ 10 mm,
this corresponds to a 10 8mm2 rectangular area of tissue.
Following (Alarcon et al., 2003), we chose a hexagonal
pattern as initial network which is physiologically more
reasonable than the ‘‘Manhattan’’ or square pattern in
(Bartha and Rieger, 2006) since only three vessels meet at
junctions. Also not at least because this facilitates the
incorporation of the blood phase-separation effect straight
forward as described. Fig. 1 depicts a tiny network section,
whereas in Fig. 3 half of the domain is visible. We
determined the size of the hexagons according to the
microvascular density (MVD) of normal skin. Experimen-
tally MVD is measured by counting the number of vessels
which cross a thin slice of tissue. Data from Do¨me et al.
(2002) indicate an MVD of ca. 100 vessels per mm2. This
means the average inter vessel distance is ca. 100mm. With
60mm edge-length for the hexagons, the vessel–vessel
distance through the center of a hexagon lies between 100
and 120mm. Furthermore the fraction of vessel occupied
sites is ca. 0:15. The rectangular grid in our previous work
yielded the value 0:2.
The initial tumor is generated by placing a single TC in
the center of the system and attaching new TCs at
randomly chosen surface sites until the tumor contains
jTðt ¼ 0Þj ¼ 1000 cells.
We set the TC proliferation time to t
ðprolÞ
TC ¼ 10 h, and
assume that ECs proliferate four times slower. Hence,
sprout generation time is t
ðsproutÞ
EC ¼ 40 h. The sprout
migration time t
ðmigrÞ
EC ¼ 1 h is motivated by the experi-
mental results of Nehls et al. (1998): Apparently the
sprouts extend roughly 200 mm per 20 h. This matches with
the migration rate here, where a 10mm segment is added
per hour. The duration for which sprouts remain active
sðmaxÞ is set to 20 h, also in line with these experiments. The
minimum distance from a new sprout to existing junctions
lðsprÞ, is a crucial parameter as it controls the MVD in the
growth region. It is set to lðsprÞ ¼ 30mm, in order to match
MVD data for the peritumoral region in Do¨me et al.
(2002).
The time for dilation t
ðdilÞ
EC ¼ 20 h as well as the maximum
radius rðmaxÞ ¼ 30mm are estimated from vessel perimeter
measurements in that paper. The stable vessel radius is set
to rðstableÞ ¼ 20mm due to the absence of thin vessels in
tumors. The boundary pressures pðmaxÞ and pðminÞ must now
generate typical ﬂow and shear stress values for capillaries.
In contrast to Bartha and Rieger (2006) the hemodynamics
is here based on empirical formulas. pðminÞ is set to 0
arbitrarily. pðmaxÞ is set to 90 kPa such that the shear force
in the initial network is within realistic ranges for
capillaries: approximately 10 Pa (Go¨dde and Kurz, 2001).
ðpðmaxÞ  pðminÞÞ gives rise to a gradient in the diagonal of
about qP=ql 
ﬃﬃﬃ
2
p
 9Pa=mm. Multiplying this by cosð45Þ
for a horizontal vessel and multiplying by 1
2
r ¼ 5
2
mm to get
the shear force, results in f  20Pa. The actual value
obtained is of4 ¼ 10Pa, due to the network geometry.
Clearly the pressure values are not realistic, but this has
no negative impact on the model because pressures
inﬂuence the model only indirectly via ﬂow and shear
force. The critical shear force f ðc;maxÞ is set to 1 Pa and the
collapse probability to pðc;maxÞ to 0:01. The collapse
probability determines how far the high MVD zone reaches
into the tumor. This value is chosen deliberately, because
higher values lead to drastic vessel regression just at the
invasive edge. Whereas lower values (e.g. o0:005) would
be unfeasible because the mean survival time must not be
longer than the time to reach the stable radius. Having
pðc;maxÞ ﬁxed means that the critical shear force is the
prominent factor determining the central MVD. Parameter
variations thereof will be presented after the base case
results. The support width dðfcÞ ¼ 1mm of the collapse
region is motivated by results from Breward et al. (2003).
að0Þ controls the strength by which co scales with
increasing MVD. Giving an estimate is difﬁcult due to
the quasi two-dimensional layer that is supplied by a
network of three dimensional pipes. We factorized að0Þ into
(i) the volume of a lattice cell C ﬃ d2h, (ii) the length of a
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Fig. 3. Left: Tumor and vessel network at t ¼ 50; 200; 400; 800. The width of the picture equals 5mm of tissue. Tumor is yellow, older cells are darker.
Vessels are colored coded by ﬂow rate. 0 is green, half the maximum is blue, the global maximum value is red. The global ﬂow goes from the bottom left to
the top right. Light green regions indicate GF inﬂuence zones. Gray indicated necrotic tissue. Right: Tissue oxygen level: 0:55 is white. The tumor is
indicated as thin dark outline. The lower bar shows a cross section proﬁle through the center of the system. The vertical lines indicate the thresholds for
proliferation yðprolÞo and death y
ðdeathÞ
o .
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vessel subsegment over one lattice-bond L ¼ d, (iii) the
resistance to radial O2 transport through the vessel wall per
axial length K ¼ 3 108 ½cm smmHg=mlO2 (Secomb
et al., 2004), and (iv) the Krogh diffusion coefﬁcient
Da ¼ 5 1010mlO2=½cm smmHg: að0Þ ¼ L=ðK CD aÞ.
The parameter h corresponds to the height of the supplied
tissue layer and is deliberately set to 333mm. Our choice is
motivated by two considerations: increasing the MVD
should result in noticeable increase in hcoi and the oxygen
diffusion range should support 150 mm tissue above and
below the vasculature. With parameters as chosen above,
we obtain að0Þ ¼ 0:002. The diffusion radius can be related
to the consumption coefﬁcient k via the Green’s function of
the operator ½D k which exhibits asymptotically expo-
nential decay on the length scale
ﬃﬃﬃﬃﬃﬃﬃﬃ
1=k
p
. Therefore we set
kðMÞ to ð80 mmÞ2. The tumor consumption is set to
kðTÞ ¼ 4kðMÞ, i.e. the diffusion radius is halved within the
tumor. These parameters yield a mean O2 concentration of
hcoi ¼ 0:27 in normal tissue and 0:16 at the tumor center.
With the proliferation threshold yðprolÞo ¼ 0:29 the tumor
cannot grow without neovascularization. The threshold for
extreme under-oxygenation is set to a value much smaller
than the proliferation threshold: yðdeathÞo ¼ yðprolÞo =105hcoi.
TCs remain viable under low oxygen conditions for
t
ðuoÞ
TC ¼ 100 h. Because the absolute values of the oxygen
ﬁeld are arbitrary, comparisons to experimental data can
only be done by observing relative variations.
The growth factor radius is RðgÞ ¼ 200mm, motivated by
the size of the peritumoral region with increased MVD in
Do¨me et al. (2002). The vessel proliferation threshold is
very low yðprolÞg ¼ 104, so that essentially all vessels within
the full GF radius are affected. In Table 1 all parameter
values of the base case scenario are summarized.
3.2. Base-case scenario
System conﬁgurations for one representative run at
different times are shown in the left column in Fig. 3. The
right column shows a map of the oxygen level. Since most
TCs are initially under-oxygenized, new vessels emerge
within the GF radius in the region around the tumor.
Sprouts grow toward the tumor and eventually make
contact with other vessels. Once blood ﬂow is established,
vessels contribute to the O2 supply. This leads to increased
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Table 1
List of parameters and their symbol together with the values used for the base case scenario
Parameter Value Description Reference
d 10mm Lattice const.
l 1000 Lattice size
Dt 1 h Time step
jTðt ¼ 0Þj 1000 Initial # TCs
að0Þ 0.02 O2 source coefﬁcient (Secomb et al., 2004)
kðMÞ ð80mmÞ2 Consumption in normal tissue (Carmeliet and Jain, 2000)
kðTÞ 4kðMÞ Consumption tumor tissue
yðprolÞo 0:29  1:07hcoi TC O2 proliferation threshold
yðdeathÞo y
ðprolÞ
o =10 TC hypoxia threshold
RðgÞ 200mm Growthfactor diffusion radius (Do¨me et al., 2002)
yðprolÞg 10
4 Sprouting GF threshold
H ð0Þ 0.45 Initial hematocrit (Pries et al., 1990)
ZðplasmaÞ 4:0 106 kPa s Plasma viscosity (Pries et al., 1990)
pðminÞ; pðmaxÞ 0, 90 kPa Boundary pressure
t
ðuoÞ
TC
100 h TC survival time under hypoxia (Yu et al., 2002)
t
ðprolÞ
TC
10 h TC proliferation time
t
ðsproutÞ
EC
40 h Sprout generation time
t
ðdilÞ
EC
20 h Vasodilation time (Do¨me et al., 2002)
t
ðmigrÞ
EC
1 h Sprout extension time (Nehls et al., 1998)
rðinitÞ 5mm Initial vessel radius
rðstableÞ 20mm Stable vessel radius (Do¨me et al., 2002)
rðmaxÞ 30mm Max vessel radius (Do¨me et al., 2002)
sðmaxÞ 20 h Sprout extension limit (Nehls et al., 1998)
lðsprÞ 30mm Inter-sprout-site distance (Do¨me et al., 2002)
f ðc;maxÞ 0.5 Pa Peak critical shear force
pðc;maxÞ 0.01 Peak collapse probability
For the cases in which experimental data are available a reference is given. The other cases are based on educated guesses and the sensibility of the model
with respect to variations of these values was studied.
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O2 levels, indicated by a small bright band surrounding the
low oxygen region. Simultaneously the radius of the central
vessels increases. This initial remodeling creates a distur-
bance in the almost homogeneous global ﬂow also causing
long range O2-ﬁeld variations due to the coupling via the
hematocrit. Apparently the O2/hematocrit increase dom-
inates regions close to the central diagonal axis where most
blood enters/leaves the tumor. Thereby asymmetrical
growth is induced showing that despite neovascularization
O2 supply is the limiting factor for TC proliferation. When
the tumor grows over the highly vascularized region, vessels
begin to collapse. Vessels in the vicinity of tumor cells are
continuously exposed to growth factors and thus increase
their radius up to rðmaxÞ. In regions void of vessels, tumor
cells die after t
ðuoÞ
TC , due to the lack of oxygen. As expected ca.
100 mm wide cuff remain alive around few surviving vessels.
Despite the star like structure of the network, which is
clearly an artifact of the unrealistic ﬂow boundary
conditions, we can reproduce general tumor-network
features in agreement with the rest of the literature (Holash
et al., 1999a, b; Bartha and Rieger, 2006; Do¨me et al.,
2002). Fig. 4 gives a quantitative analysis of the dynamical
evolution. The curves are averaged over 20 runs, with
different random number generator seeds but otherwise
identical parameters. Statistical ﬂuctuations are of the
order of 10%, growing toward the tumor center. Fig. 4(f)
shows how the tumor density varies with distance r to the
center of the system. The tumor periphery moves outward
linearly with a speed of 2mm=h ¼ 2Dr=tðprolÞTC . The factor 2 is
typical for Eden growth (Eden, 1961). Fig. 4(a) shows the
average microvascular radius (MVR). Since tumor vessels
are always enclosed by TCs that produce GF, the radius
grows everywhere inside the tumor at a constant rate. At a
ﬁxed location this means that as soon as the tumor as
grown over it, the radius increases linearly until the
threshold rðmaxÞ is reached. Hence a plateau is observed
when the spatial variations at a ﬁxed time are considered.
Fig. 4(b) shows the MVD and agrees with the pictures in
Fig. 3 regarding the compartmentalization of the system.
There is a region of high MVD which coincides with the
TC density drop. Inside the tumor, the MVD drops to 1=4
of the original MVD, since only few vessels survive the
collapse process. In Fig. 4(d) it can be seen that the wall
shear stress drops by almost two orders of magnitude, even
below the critical collapse force f ðc;maxÞ ¼ 1Pa. Considering
that the support of the band where vessels collapse due to
solid pressure is dðfcÞ ¼ 1mm broad, this means that vessels
collapse in a narrow shell in the tumor periphery. Hence,
altering the rules for the collapse process, leads to different
MVDs and network structures as evident in Section 3.4.
The drastic reduction in shear stress stems from equally
drastic reduction in pressure gradients. In contrast to ﬂow
and shear stress, the pressure gradients assume near
constant values after the drop at the tumor boundary.
Hence, near the tumor center, the vessel radius dependence
which is rðvÞ4 and rðvÞ for the blood ﬂow rate and shear
stress, respectively is responsible for variations of the latter
properties. Fig. 4(e) shows the radial oxygen variations,
which are strongly correlated to the MVD variations.
Naturally the O2 level drops in the tumor center. The
average value in the tissue is hcoi ¼ 0:275. In the highly
vascularized zone it increases by 30%. In contrast to our
previous work the O2 increase is not proportional to the
MVD due to the O2 dependent source strength.
Quantitatively our results agree well with the morpho-
logical data provided in Do¨me et al. (2002). They analyzed
human malignant melanoma spatially divided into three
regions: (i) the tumor center, (ii) the tumor periphery—a
100mm wide band of tumor immediately adjacent to the
invasive edge, and (iii) the peritumoral host tissue—a
200mm wide band of host tissue immediately adjacent to
the periphery. It was found that for tumors larger than
1.5mm the MVD in (i) drops to 25% of the MVD in
normal skin. In (iii) the MVD reaches values up to two
times the normal MVD. In terms of radii, the MVR grows
from  8 to  30235mm in the center, at day 15, and
remains constant. From day 12 on the MVR in (ii) and (iii)
also remains constant, and grows from (iii) to (ii) to (i).
Boxcounting analysis: The concept of a fractal dimension
is often used to characterize differences between normal
vasculature and tumor vasculature (Baish and Jain, 2000).
One commonly used method to estimate fractal dimension
is box-counting, which is carried out by superimposing a
grid with box diameter l on the fractal object and counting
the number of boxes n which overlap the object. The self
similar nature of true fractal object leads to a power law
relationship between box count and box size with the
fractal dimension df as exponent:
nðlÞ / ld f . (13)
df is usually extracted by a linear ﬁt in a log–log plot.
However in experiments one can usually only measure l over
two orders of magnitude. Furthermore natural objects (or
rather photographs thereof) are usually not perfectly fractal
i.e. box-counting plots exhibit non-constant slopes. There-
fore even a small constant regime is often considered
sufﬁcient to speak of a fractal dimension (or more truthfully
named box-counting dimension); see the discussion in
Chung and Chung (2001a, b). Therefore what we mean in
following with ‘‘fractal dimension’’ is the number that we
obtained by the procedure described below and which is
analogous to the way in which this number is extracted from
the analysis of experimental data (Gazit et al., 1995; Baish
and Jain, 2000; Chung and Chung, 2001a, b).
We did box-counting for the tumor as well as for
different parts of the vessel network at the time t ¼ 1000 h.
At this time the diameter of the tumor is ca. 5mm. Vessels
are treated as ideal line segments, and overlapping boxes
are visited by a digital differential analyzer algorithm
(Glassner, 1994). TC occupied locations were treated as
points. Boxes with size L were shifted by
maxfL=10mm; 16g2 different offsets equidistantly distribu-
ted in ½0;LÞ2, and the minimum box-count was taken. The
fractal dimension is then estimated as average over the
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local slopes of the log–log plot, which are ﬁrst estimated by
least-squares ﬁts of 17 points around the respective pivots.
The averaging is done over a suitable range, i.e. a regime
with constant slope if available and between 200 and
1000mm otherwise. Indicated errors represent root mean
square deviations from the mean local slope. Hence, a large
value would indicate a less fractal object.
The mean fractal dimension of the vasculature was
estimated over three regions as indicated in Fig. 5. The
center of the tumor, for which hd f iðCÞ ¼ 1:59
 0:02 was
obtained. This central region reaches up to a boundary
region ðBÞ, a 400mm wide band along the perimeter,
centered at the invasive edge. The width of the band is
chosen deliberately according to the growth factor radius,
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Fig. 4. Various dynamic variables in dependence on the radial distance r to the tumor center: (a) Shows the vessel radius. It decreases with the distance to
the tumor, whereas at a ﬁxed distance to the tumor center it increases with time. (b) Shows the microvascular vascular density (MVD) dependence. The
MVD is high at the tumor boundary, and low in the tumor center. The maximum value decreases with time due to the asymmetry of the tumor. (c) The
ﬂow rate increases by more than an order of magnitude inside the tumor. Whereas (d) shows that the shear force decreases by almost two orders of
magnitude. (e) The oxygen level follows roughly the same shape as the MVD. Due to implicitly deﬁned source strengths, the increase in high-MVD regions
is much less than simply proportional. (f) Shows the tumor density. One can see that the tumor radius increases linearly in time, as expected according to
the eden rule. The density drop eventually becomes less pronounced due to the asymmetric growth.
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such that the exclusively angiogenesis dominated remodel-
ing is captured. There hd f iðBÞ ¼ 1:63
 0:03 was obtained.
The fractal dimension of the complete tumor vasculature
turned out to be hd f iðC [ BÞ ¼ 1:71
 0:01, and that of the
tumor hd f iðTumorÞ ¼ 1:78
 0:02. These values are lower
than those reported in Bartha and Rieger (2006) for the
simpliﬁed model, but are closer to the value d f ¼ 1:81

0:04 found experimentally for carcinoma (Gazit et al.,
1995; Baish and Jain, 2000).
Fig. 5 also shows that the local slopes for the tumor and
its vasculature are very similar for box-sizes greater
350mm. This can be explained by considering that all
tumor vessels have cuffs of viable TCs around themselves
with a diameter of ca. 200mm- twice the oxygen diffusion
radius. Further away from vessels no living TCs exist.
Therefore in the large box limit ðLb200mmÞ vessels and
TCs will touch mostly the same boxes and thus yield
similar fractal dimensions.
3.3. Parameter variations
Further experiments reveal that the fractal dimension of
the tumor vasculature is apparently not a universal
constant. Multiple simulations were performed where the
maximum critical shear force ranges from 0:1 to 1:1Pa,
producing tumors with decreasing internal MVD. Fig. 6
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Fig. 6. Fractal dimension in dependence on critical shear stress. Left: In analogy to Fig. 5, ðBÞ denotes a 200mm wide band around the invasive edge, ðCÞ
the central region, and ðB [ CÞ the entire tumor vasculature. The MVD is averaged over 20 tumors and over a disc with r ¼ 1:6mm. The data were
generated by running simulations with f ðc;maxÞ ranging from 0:1 to 1:1Pa. Right: Four conﬁgurations are shown with critical shearforces
f ðc;maxÞ ¼ 1:1; 0:5; 0:3; 0:1Pa. The labels on the left ﬁgure correspond to these conﬁgurations. The fractal dimension ranges from 1:61 to 1:82.
Fig. 5. Fractal dimension analysis of the base case tumor via boxcounting. Left: Boxsize vs. boxcount logarithmic plots. ðCÞ denotes the vessel network in
the tumor center region. This ﬁlls the space up to a 200mm wide band centered at the invasive edge around the tumor ðBÞ. ðCÞ [ ðBÞ contains all vessels in
the union of region ðCÞ and ðBÞ. ‘‘Tumor’’ denotes the viable regions of the tumor. Right: Local slopes of the curves on the left.
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shows the results. The fractal dimension of the boundary
hd f iðBÞ remains constant around 1:68, whereas the dimen-
sion of the complete vasculature hd f iðB [ CÞ ranges from
1:61 to 1:83. Naturally hdf iðBÞ is a lower bound because it
corresponds to the case where no internal vessels are
present. With increasing density the dimension is domi-
nated by the internal vasculature. The dimension of the
tumor follows that of the vasculature for reasons already
discussed.
In order to study the relation to conventional random
bond percolation, simulations were performed with critical
shear stresses ten times higher than normal f ðc;maxÞ ¼ 5Pa.
At normal values for the collapse probability
pðc;maxÞ ¼ 0:01, this would remove all vessels almost
instantly when the tumor grows over them. As shown in
Fig. 7 there is however a sharp transition at pðc;maxÞ ¼ 0:001
from the absence of vessels in the center to conﬁgurations
where no vessels collapse at all. Note that the high value
essentially inhibits the shear force stabilization mechanism
which means that collapses are purely random and
uncorrelated with ﬂow. Visually this can be seen by the
absence of the imposed ﬂow direction. As a consequence all
central vessels had the same probability to collapse by the
end of the simulation, namely the probability to collapse
until the stable radius is reached. Therefore the results here
are in agreement with conventional percolation theory as
described in the discussion Section 5.
3.4. Simplifications
In the following the effect of several simpliﬁcations
toward the model discussed in Bartha and Rieger (2006)
are discussed: replacing the viscosity term with a constant
or purely radius dependent value; settings the vessel
collapse probability and critical shear force to step
functions; generating perfused sprouts instantly; and
setting the oxygen source strength constant.
Blood viscosity: To compare the effect of different
models for blood viscosity, we set the blood-oxygen
content constant to the initial hematocrit value:
cðBÞo ¼ H ð0Þ ¼ 0:45. Consequently, this removes the large
scale variations in the oxygen ﬁeld and thus produces
symmetric tumors. With this modiﬁcation multiple simula-
tion runs were performed with
(i) the original viscosity model including hematocrit and
blood phase separation;
(ii) a viscosity term which was derived from in vitro data
(Go¨dde and Kurz, 2001) and which depends only on
the vessel radius Z ¼ ZðplasmaÞZðrelÞðrÞ. (see Fig. 8);
(iii) the vessel viscosity set to the constant blood plasma
viscosity. Z ¼ ZðplasmaÞ.
The result is shown in Fig. 9. While the cases (ii) and
(iii) do not differ signiﬁcantly, the tumor MVD in (i) is ca.
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Fig. 7. Fractal dimension for tumors with uncorrelated vessel collapses. Left: ðBÞ denotes a 200mm wide band around the invasive edge, ðCÞ the central
region, and ðB [ CÞ the entire tumor vasculature. Fractal dimension estimates for the three regions are shown, where pðc;maxÞ ranges from 0:5 103 to
1:5 103. Furthermore critical shear force and collapse probability were set constant within the tumor with pðcÞ as indicated f ðc;maxÞ was set very high to
5Pa in order to reduce shear force correlation of collapses to an insigniﬁcant amount. Right: Three conﬁgurations are shown with pðc;maxÞ ¼
1:25; 1:00; 0:75 103 for (a),(b),(c) respectively.
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two times lower than in (ii),(iii). This is unexpected but we
think the following is a plausible explanation: The viscosity
in (i) rapidly decreases by 50% from r ¼ 5 to 20mm, i.e.
from outside to inside the tumor, whereas it changes less
drastically in (ii) and (iii). The total ﬂow into the tumor is
generally limited by the ﬂow resistance of the surrounding
network. Let us assume a prescribed constant in-ﬂow Q ¼
N q / N f r3=Z which has to be supported by N vessels
threading the tumor. Thereby assuming homogeneous
ﬂow-rate q, radius r, and shear force f. Let us further
assume that f is identical to f ðc;maxÞ. Then it is easy to see
that the number of remaining vessels is proportional to the
viscosity Z.
Increasing the critical shear stress from 0:5 to
f ðc;maxÞ ¼ 1:0Pa drops the MVD back to the level of
the base-case at the cost of increased ﬂow rate and
shear stress in the vessels. Fig. 9 shows respective averaged
curves. Apparently there is no fundamental change in
vessel morphology. This is also reﬂected by fractal
dimension analysis where the mean dimensions only
differ at most by 3%. Thus it is reasonable to assume that
for the purpose of morphological studies an effective
constant blood viscosity—ca. twice the plasma viscosity—
can be used.
Vessel collapse: In the base-case both the collapse
probability pðcÞ and the critical shear force f ðcÞ are
modulated by the function g1 which introduces an explicit
location dependency. In the following we present two cases
with differently designed functions which might be equally
well suited models. With pðcÞ, we refer to the collapse
probability of unstable (fof ðcÞ and rorðstableÞ) normal
perfused vessels.
(i) Denotes the base-case where g1 has a torus-like proﬁle,
as shown in Section 2.2. And where pðcÞ is additionally
multiplied by a vessel-radius dependent term.
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Fig. 9. Comparison of viscosity functions. Top: Shown are radial MVD and ﬂow rate curves for different viscosity models and parameters at t ¼ 1000.
‘‘adapted mvd’’ denotes data where the critical shear force has been tuned such that the MVD matches that of the original model. Bottom: Shown are
snapshots of tumors of the adapted conﬁgurations. (i) Denotes the original ﬂow model. All the simulation runs here where done with the oxygen ﬁeld
unaffected by the blood hematocrit content (ii) uses radius-only dependent viscosity formula of, Go¨dde and Kurz (2001) and (iii) assumes a constant value.
Fig. 8. Plot of the relative viscosity as a function of the vessel radius: (a)
according to the formula derived in Pries et al. (1994), evaluated for
hematocrit values H ¼ 0:3–0:9; (b) data derived from in vitro measure-
ments—see Go¨dde and Kurz (2001). Used here for the simpliﬁed model
without hematocrit.
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(ii) f ðcÞ and pðcÞ assume constant values within the tumor
and zero outside.
f ðcÞða;xÞ ¼ f ðcÞðf;xÞ
¼ f ðc;maxÞ  yðxT ðfÞ  xÞ, ð14Þ
pðcÞða;xÞ ¼ pðcÞðf; xÞ
¼ pðc;maxÞ  yðxT ðfÞ  xÞ  yðrðstableÞ  raÞ,
ð15Þ
where y is the step function, x is the distance to the
center, f the polar angle and ra the vessel radius. Beside
the dependence on the distance to the tumor, the linear
dependence on ra has also been replace by a step
function, such that the collapse probability becomes 0
instantly once raXr
ðstableÞ. Without changes to other
parameters this results in decreased central MVD.
Therefore f ðc;maxÞ ¼ 0:25Pa is chosen, which is 1=2 of
the normal value. pðc;maxÞ ¼ 0:01 is left unchanged. In
the latter case no signiﬁcant difference to the base case
scenario could be observed. Radial curves differ at
worst by 10% and the mean fractal dimension is also in
agreement within the error bounds.
(iii) f ðcÞ decays from f ðc;maxÞ at the center of the tumor to 0
at the invasive edge. For pðcÞ the simple form from (ii)
is chosen.
f ðcÞða;xÞ ¼ f ðcÞðf;xÞ
¼ f ðc;maxÞ maxf0; 1 x=xT ðfÞg, ð16Þ
pðcÞða;xÞ ¼ pðcÞðf;xÞ
¼ pðc;maxÞ  yðxT ðfÞ  xÞ  yðrðstableÞ  raÞ.
ð17Þ
In this case the original parameters work ﬁne:
f ðc;maxÞ ¼ 0:5 Pa and pðc;maxÞ ¼ 0:01. Fig. 10 shows
that compared to (i) and (ii) a smoother transition
from the high-MVD boundary to the tumor center
with low MVD is obtained. In an experiment not
shown here this effect was enhanced by setting
pðcÞðaÞ / maxf0; 1 ra=rðstableÞg. Further on, peri-
pheral MVD has slightly increased since collapse
events happen now closer to the center where the
critical shear force threshold is high enough. Being
directly correlated to the MVD other measurements
such as oxygen level or tumor density exhibit similar
behavior. The mean fractal dimension of the tumor
vasculature is hdf i ¼ 1:80.
Sprout migration: In analogy to our previous work, we
also checked the results when ‘‘sprouts’’ instantly extend to
the next vessel, possibly creating a perfused loop.
This simpliﬁed sprout model works as follows: Starting
at a parent vessel, sites along a straight path are checked
for a destination vessel. As before, the direction is
determined by the local GF gradient at the starting site.
A vessel connection is added, provided that all conditions
for sprout generation—such that it has to be outside the
tumor—are fulﬁlled for the starting site, and that the
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Fig. 10. Comparison of different dependencies of pðcÞ and f ðcÞ on local system properties. Top: row shows mean shear force and vessel density by radial
distance at t ¼ 1000, (i) is the basic case model, (ii) has positive constant values for pðcÞ and f ðcÞ inside the tumor, with the exception that pðcÞ ¼ 0 for
rXrðstableÞ and (iii) has a linear decay from f ðcÞ ¼ f ðc;maxÞ at r ¼ 0 to 0 at the invasive edge. Notice how the MVD decreases much smoother toward the
center. Bottom: shows snapshots of sample tumors.
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destination site has less than three incident vessels.
The resulting tumor’s boundary regions exhibit ca 70%
the MVD of the full model’s tumors. Apparently the
stronger requirements for vessel creation limit the degrees
of freedom for the system’s evolution. For example
in the original model there is the possibility that two
sprouts grow simultaneously and form a perfused wedge
when they meet inside a hexagon. MVD correlated data
vary accordingly, but otherwise no fundamental changes
could be observed.
Oxygen field computation: Solving the O2 diffusion
equation with implicit source strengths can become
expensive, in particular in three dimensions. Therefore we
also performed simulations using a simpliﬁed model.
Instead of solving Dco  kco þ aðcðBÞo  coÞ ¼ 0, we do
now consider
DcoðxÞ  kðMÞco þ acðBÞo ¼ 0, (18)
where the coefﬁcient k equals the tissue consumption kðMÞ,
disregarding the tumor. The occurrence of coðxÞ is omitted
in the source term which means that O2 is produced at a
ﬁxed rate. (18) could be efﬁciently solved by a Greens-
function approach, in analogy to our solution of the GF
distribution. In the present case, q0 is simply a prefactor
that scales the ﬁeld values globally, and it is chosen to get
the mean O2 hcoi ¼ 0:2. The tumor proliferation threshold
remains at the original value yðprolÞo ¼ 0:29.
As a consequence the O2 level increase from normal
MVD to high MVD is overestimated by ca. 50%. Fig. 11
shows snapshots from two runs at t ¼ 1000 h.
(i) shows a snapshot from the full model. To facilitate
comparisons the effect of hematocrit on O2 has been
disabled, i.e. cðBÞo ¼ H ð0Þ;
(ii) shows a snapshot from the simpliﬁed model. As can be
seen the tumor grows slower and develops and
elliptical shape. Here TCs produce GF only if
coðxÞoyðprolÞo . Due to the higher O2 level, the outer
band where TCs are allowed to proliferate—and do
not produce GF—is almost as wide as the GF radius.
Therefore the GF inﬂuence region—indicated by a
bright green background—does not reach as far into
the tissue as in (i), leading to slower vessel generation
and thus slower tumor growth. Depending on para-
meters, the growth of the tumor may even come to halt
in the beginning of the evolution when the O2 level
increases above yðprolÞo for all TCs in the nucleus. In the
full model no reasonable parameter set allows such
increase in O2 and therefore this behavior has never
been observed;
(iii) shows snapshots from the simpliﬁed model—modiﬁed
so that TCs always produce GF. Naturally the GF
inﬂuence zone now has the largest possible extend,
leading to continuous neovascularization and virtually
undisturbed Eden-like tumor growth. Overestimating
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Fig. 11. Comparison of different oxygen and proliferation models. The top row shows vessel, tumor, gf-inﬂuence conﬁgurations. The lower row shows
associated oxygen ﬁelds and central cross section, (i) is the full O2 model for c
ðBÞ
o ¼ H ð0Þ ¼ const, (ii) is the simpliﬁed O2 model with constant source
strength, (iii) is the simpliﬁed model (ii) with the addition that TC always produce GF.
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the O2 levels also the effect of making the model more
robust regarding the choice of the TC proliferation
threshold yðprolÞo . This leads to the observations that
tumor (iii) is denser than tumor (i) and grows slightly
faster. The O2 level in (i) increases by mere 10% at the
high MVD periphery, leaving not much choice for
yðprolÞo because at low values TCs can proliferate quickly
along the original vessels which can create holes as
seen in Fig. 11 (i). At high values the tumor might not
proliferate at all.
Simplifications combined: Measurements from tumors
with simpliﬁcations combined are shown in Fig. 12. In
these simulations blood viscosity is set constant
Z ¼ ZðplasmaÞ, collapse probability and shear force are also
set constant according to (14), oxygen computations are
done with the simpliﬁed model from (18), and all TCs
produce GF. Parameters, f ðc;maxÞ and pðc;maxÞ in particular,
are equal to the settings in the full model simulations. To
get better estimates for data near the invasive edge, it is
compared to the basic model without hematocrit affecting
oxygen levels cðBÞo ¼ H ð0Þ.
All modiﬁcations combined lead to changes in many
measurements. Most of which have already been discussed
in the examples above. For example the almost 10-fold
increase in ﬂow rate due to reduced viscosity, increased
oxygen in high MVD regions due to constant source
strengths, faster and denser tumor growth due to better
oxygen supply. Not observable before is an apparent
difference in vessel morphology. Note the tendency to form
compact straight bundles of 3–8 vessels. Vessels in snap-
shots of the basic case—denoted (i) here, see Fig. 3 for
instance do not seem to have this property, instead those
exhibit many small weakly perfused loops and cross-links.
Radial curves (ii) seem to reﬂect this also by an overall
increase in shear force. Most likely weakly perfused vessels
in (i) survive long enough until the relatively thin ring of
high collapse probability has moved further outwards. If so
they can contribute to the shear force measurement such
that the mean values are lowered. Fractal dimension
analysis also indicates different morphological features.
The mean vasculature dimension has increased to
hd f i ¼ 1:77, although the central MVD has not increased
signiﬁcantly. Fig. 12 also shows results from box-counting
analysis of a single sample tumor. Over a small range the
local slope reaches peak values of ca. 1:82.
4. Drug flow modeling
This section discusses modeling, and results, of simulated
drug ﬂow through the tumor vasculature. The mathema-
tical model for drug ﬂow is based on McDougall et al.
(2002), where it was demonstrated how the concentration
proﬁle of a tracer substance ﬂowing through a vascular
network can be tracked. The drug ﬂow model is designed
on top of the already established network model.
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Fig. 12. Measurements from simulations with simpliﬁed viscosity, oxygen computations and vessel collapse model. Top row shows radial curves for shear
force and MVD, (i) is the original model and (ii) the simpliﬁed version. The bottom row shows snapshots on the left. The right-hand side shows local
slopes from boxcounting analysis for the complete tumor vasculature.
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Hemodynamic parameters, such as ﬂow rate are precom-
puted (taken over from the results of the tumor simula-
tion). The network is completely static during the
simulation, which is reasonable as as the drug injection
does not last longer than one hour. An iterative algorithm
ﬁrst propagates drug mass from vessels to downstream
nodes, followed by a second pass where drug is distributed
among the outﬂow vessels. Thereby mass conservation is
strictly enforced. One such iteration corresponds to a
certain time-step dt. A detailed description is given in the
following.
4.1. Model definition
First, node tupels ði; jÞ which identify vessels now reﬂect
the ﬂow direction by requiring that piXpj. Geometric and
hydrodynamic properties q,l,r,p have meanings as before
and their values are static. With I i and Oi we denote the
inﬂow- and outﬂow-vessels attached to a node i. In
addition to the ideal pipe-ﬂow model, a number of further
assumptions are made: Drug is moved downstream with
the average ﬂow velocity v ¼ q=½pr2 neglecting radial
velocity differences. For each vessel, the simulation tracks
a single drug-containing cylindrical subsection. Let u 2
½0; lÞ be its start at the upstream end, measured along the
central vessel axis. The downstream end is given by
d 2 ðu; l. The occupied volume is thus V ¼ ðd  uÞpr2,
and it is assumed that the drug mass m inside this volume is
always homogeneously distributed at the concentration
m=V . Thus the description of the concentration proﬁle
inside a vessel segment is limited to a single square pulse.
This does not appear to be a problem, but when necessary,
segments can be subdivided to gain a suitable resolution.
For each time step dt the following is done: First, for
each vessel a ¼ ði; jÞ which has drug m40 drug is moved
downstream by the distance Dx. Let t0 ¼ tþ dt, then:
Dx ¼ q=½pr2dt,
ut
0 ¼ ut þ Dx,
d t
0 ¼ dt þ Dx.
The volume is then pruned at the end of the vessel, and the
lost drug mass is accounted to the attached node. This
mean if d4l and uol the drug propagation into the nodes
is as follows:
Dm ¼ mt=V  ½d t0  lpr2,
mt
0 ¼ mt  Dm,
mt
0
j ¼ mtj þ Dm,
d t
0 ¼ l.
If the time step is large enough it can happen that a vessel is
completely drained of drug ut
0
4 ¼ l. Care must be taken
that state variables are kept consistent. Instead of the steps
above, all mass is transferred to the node: Dm ¼ mt, and
the drug start and end variables are reset to ut
0 ¼ dt0 ¼ 0.
In a second stage it is looped over all nodes i 2 N that
have drug mi40. This drug is now propagated further
downstream into connected vessels. At boundary nodes,
drug may be introduced by adding the contribution Dm ¼
ðPa2O qa Pa2I qaÞCðinÞdt from the in-ﬂowing blood
volume. The distribution at branching points assumes
perfect mixing, i.e. the nodal drug mass is split among
outﬂow vessels proportional the blood volume that ﬂows
into a vessel. Let Q be the total out-ﬂowing volume:
Q ¼ max½Pa2Oiqa;Pa2Oiqa. This formal description re-
spects that the correct value has to be computed for
boundary nodes where Kirchhoff’s law is violated due to
exchange with the environment. For internal nodes Q is of
course equal to
P
a2Oi qa. Then for all vessels a 2 Oi drug
mass is updated according to
mtþ1a ¼ mta þ qa=Q mt
0
i .
Furthermore ua is set to 0, because drug just entered at the
upstream vessel junction. Once again care must be taken to
ensure a consistent system state at the end of the iteration.
In our implementation the downstream drug end must
move forward to d tþ1a ¼ qa=½pr2a  dt if the vessel was
empty. Note that in this case it has also been d ta ¼ 0. The
time step dt must be chosen carefully to ensure that the
location of the drug remains consistent with the network
structure. During a time step drug can only move as far as
the length of a vessel. Therefore it must be ensured that the
in-ﬂowing blood volume qdt is less than the volume of the
vessel: qdto ¼ lpr2. The largest possible dt is thus
dt ¼ min
a2V
lapr
2
a
qa
 
. (19)
Drug uptake by the tumor is not considered here. It was
incorporated in McDougall et al. (2006) in a very crude
way: Drug was instantly removed once it reached the
tumor. This is not feasible here, since the goal is to study
the concentration inside tumor and see if there are spots
that are unlikely to be supplied by sufﬁcient drug. It should
be possible with some more numerical effort to include a
diffusion process through the vessel wall in the line of the
O2 concentration computations presented before. But for
simplicity and the lack of experimental data this has not
been done yet. As a consequence the intravascular drug
concentration here can only predict an upper bound to the
real concentration.
4.2. Results
Here we discuss results for two conﬁguration types: (i)
the base-case (Fig. 3); (ii) nearly shear force uncorrelated
systems with pðc;maxÞ ¼ 0:001 and f ðc;maxÞ ¼ 0:5 (Fig. 7).
In both cases ﬁrst a preprocessing step was applied.
Vessels outside a circular region were removed, such that a
band of approximately 1mm width remained around the
tumor. Doing so ensures that drug arrives evenly at the
invasive edge, which would not be the case if the network
spreads over the entire rectangular domain. Fig. 13 shows
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the ﬂow velocity which is of the order of 0.5mm/s. Regular
capillary networks have high ﬂow resistances and do not
support increased ﬂows inside the tumor. On the contrary,
the dilation causes slower velocity, due to the preservation of
mass (Fig. 14). Thereby (i) and (ii) show similar behavior.
Simulations were done with injection durations tðinÞ ranging
from 2 to 60 s. The injected concentration was always set to
CðinitÞ ¼ 1. Fig. 15 shows a sequence of concentration
proﬁles for the hexagonal lattice base-case (i) and
tðinÞ ¼ 60 s. Drug enters at the bottom left boundary, and
ﬂows toward the tumor. The concentration at the drug
‘‘front’’ shows an increasingly smooth transition. That is
because at branching points, the front does not arrive
through all inﬂow vessel simultaneously. Thus drug contain-
ing blood is mixed with ‘‘clean’’ blood, decreasing the
concentration in out-ﬂowing blood. After 60 s tumor vessels
are almost completely saturated with drug. A prolonged
injection would keep the system in a fully saturated steady
state. The second half of the sequence shows how blood
ﬂows out of the tumor after the injection ends.
For shorter injection times, ﬂow results naturally give a
similar picture (no image sequence shown here). A compact
short burst of approximate length vtðinÞ ﬂows unhampered
in diagonal direction through the tumor. However, the
maximum concentration can be signiﬁcantly decreased
due to the mentioned mixing effects. For example in the
extreme case where tðinÞ ¼ 2 s, the number of vessels where
the concentration C40:5 is reduced to 30%.
Fig. 16 shows averaged measurements of case (i). The
plot on the left indicates the percentage of vessel network
length that was exposed to a drug concentration greater
than the value on the x-axis. The data are given for
injection times tðinÞ ¼ 10; 20; 30 s. For the 30 s injection,
90% of the vascular network was exposed to the maximum
possible drug concentration CðinitÞ ¼ 1, while all vessels
were exposed to at least a concentration of C ¼ 0:9. This
simply reﬂects that the systems was nearly saturated with
drug, which is also evident by the snapshots.
The right plot in Fig. 16 shows the percentage of vessel
network length for which the concentration was larger than
a threshold Ct for a total period greater than the value
indicated on the x-axis. The data is again given for several
injection times. For Ct ¼ 0:5 and tðinÞ ¼ 60 s the curve has a
step function proﬁle, whereby the drop occurs at t ¼ 60 s.
This point in time corresponds in good agreement to the
duration in which the high concentration ‘‘pulse’’ passes
through the tumor. The concentration at a ﬁxed location
increases (decreases) smoothly over time before (after) the
plateau of saturation. This means that the lower the
concentration threshold, the longer the exposure times.
Therefore curves for lower thresholds show ‘‘tails’’ beyond
the saturation period. Prolonging the injection interval by
Dt would increase the time where the system is in a
saturated steady state, thus shifting the exposure time
curves uniformly by Dt to the right. This is clear since the
time that the system remains in steady state is irrelevant.
The curves for tðinÞ ¼ 10 and 30 s show the effect very well
that the drop is simply shifted to the end of the injection
period, thereby preserving the trails.
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Fig. 14. Spatial distribution of the blood ﬂow velocity for (i) the base-case scenario (Fig. 3) and (ii) the shear force uncorrelated case (Fig. 7b). Both plots
show an average over 20 simulation runs at time step t ¼ 1000h, the represented area being 12 10mm2. Compared to normal tissue, the ﬂow velocity is
reduced in the tumor. The ﬂow increases in (i) toward the center due to the star like structure with fewer vessels there.
Fig. 13. Radial measurement of the mean ﬂow velocity v ¼ q=½pr2. (i)
denotes the base-case (ii) a shear force uncorrelated system with random
collapses (Fig. 7).
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Fig. 16. Quantitative measurements of the base-case (i) for various tðinÞ. Right: The plot indicates the percentage of vessel network length that was exposed
to a drug concentration greater than the value on the x-axis. When the system has time to reach a steady state all vessels become exposed to CðvÞ ¼ 1, thus
producing a constant line in the plot. Left: The plot shows the percentage of vessel network length for which the concentration was larger than Ct for a
total period of more than indicated on the x-axis. The steep drops occur at the end of the injection duration. Naturally the mean time where vessels are
exposed to C40 is on the order of tðinÞ plus the time it takes to clear the tumor of drug, depending on the vascular morphology and ﬂow rates.
Fig. 15. Concentration proﬁles for an injection of tðinÞ ¼ 60 s into the hexagonal base-case vasculature (i). The color code ranges from red at C ¼ 1 over
yellow and green to blue at C ¼ 0. Light gray area represents viable tumor tissue, darker gray represents dead tissue. Drug reaches the invasive edge within
the ﬁrst 2 s. At the middle of the sequence, the tumor becomes saturated with drug, except for a few tiny spots. Note how the concentration drops gradually
in most vessels as an effect of mixing with ‘‘clean’’ blood.
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Plots for the uncorrelated case analogous to Fig. 16 are
not shown here because they are qualitatively as well as
quantitatively very similar but exhibit a few unreachable
loops. This is reﬂected in a smoother drop in the maximum
concentration curve: ca. 80% of the vasculature had a
concentration greater than 0:8. The exposure time plot
showed slightly smoother drops at the injection times and a
longer trail but is otherwise identical to Fig. 16.
Fig. 17 show concentration proﬁle sequences for the
remaining cases. Most remarkable in the uncorrelated case
(ii) is the occurrence of small unreachable loops. It can
happen when vessels survive which are oriented perpendi-
cular to the global pressure gradient given by the boundary
conditions. Flow rates in these loops are consequently
drastically reduced.
5. Discussion
We have shown that the basic predictions of the model
introduced in Bartha and Rieger (2006) are very robust
against different sophistication levels of mathematical
modeling that we investigated: The base case scenario, in
which model parameters are chosen to the best agreement
with experimental data for melanoma (Do¨me et al., 2002),
the tumor compartmentalizes after a short time into three
regions: A well vascularized peritumoral plexus with an
MVD that is 2–3 fold larger than the normal tissue MVD,
a well perfused peritumoral region and a necrotic core with
low MVD and only a few thick vessels threading the
tumor, which are covered by a ca. 100mm thick cuff of
tumor cells. Oxygen levels are therefore extremely low in
the tumor vessel. The fractal properties of tumor vascu-
lature are substantially different from the normal vascu-
lature, with estimates for the fractal dimension that are
lower than that of the normal capillary network. Their
characteristics have their origin in the vessel collapse
processes and therefore also depend sensibly on collapse
probability and critical shear force. Concerning the
hydrodynamic blood ﬂow patterns our model shows
substantially reduced pressure gradients and shear ﬂow in
the tumor vasculature, although the blood ﬂow rate is
increased in the extremely thick vessels in the tumor center.
The tumor radius grows linearly in time, which is natural as
long as TC proliferation is conﬁned to the tumor surface
region and no growth inhibition effects, like solid stress,
are incorporated.
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Fig. 17. Concentration proﬁles for an injection of tðinÞ ¼ 60 s into the hexagonal shear force uncorrelated vasculature (ii). The morphology created by
random collapses inside the tumor exhibits more poorly perfused loops than any other vasculatures. As can be seen a few vessels have not been reached by
the injected drug during the whole simulation period. The qualitative behavior is otherwise in good agreement with the run presented in Fig. 15.
M. Welter et al. / Journal of Theoretical Biology 250 (2008) 257–280 277
These are robust features that are characteristic for the
model we have studied here and for the simpliﬁed model of
Bartha and Rieger (2006). A few differences between the
two versions occur only on a smaller scale.
Calculating oxygen sources implicitly, i.e. driven by
concentration gradients between blood and tissue, instead
of assuming a constant source strength as in Bartha and
Rieger (2006), have the following effect: Surface TCs can
proliferate in the original vasculature while cells behind the
invasive edge now suffer from hypoxia due to increased
metabolic demand inside the tumor. They are thus
secreting GFs to induce angiogenesis. If the oxygen
threshold for proliferation is of the order of the average
tissue-O2 levels (y
ðprolÞ
o  hcoi), the model predicts a strong
dependency on the micro-scale O2 variations and therewith
also on local vascular morphology. The model with explicit
sources is more stable with respect to the proliferation
threshold, since the O2 level increases rather drastically in
highly vascularized regions. However, by choosing suitable
parameters, the vascular morphology of the model we
studied here and the simpliﬁed version with constant
source strength can be matched. Therefore to study the
global features of tumor vasculature the crude approxima-
tions to O2 diffusion ﬁelds may be used, in particular in
numerically more challenging situations such as 3d
simulations (Lee et al., 2006).
Progressively simpliﬁed blood ﬂow computations alone
have shown limited effects, mainly changes in the ﬂow rates
up to one order of magnitude could be observed within the
tumor. Additional modiﬁcations of the collapse rules
inﬂuenced the shape of the vascular network visibly,
(Fig. 10.(ii) vs. Fig. 12.(ii)), but still the simpliﬁed model
for blood ﬂow can be can be used. Also the incorporation
of the blood phase separation effect does not appear of
signiﬁcance for vascular morphology. When blood oxygen
levels are allowed to vary proportional to hematocrit, the
model predicts asymmetric growth depending on local
hematocrit levels. Therefore if this aspect is to be neglected,
performing computations according to Pries et al. (1994)
with a constant hematocrit H0 ¼ 0:45 appears to be a good
compromise.
Inserting completely new perfused vessels rather than
generating migrating sprouts that eventually join to target
vessels does not lead to substantial changes. The latter
model version merely leaves more degrees of freedom for
forming circulated loop. In two dimensions the space to
grow in is conﬁned between the initial vessels. Therefore
incorporating a randomized sprout migration dynamics
becomes relevant in a three dimensional model, where it is
not a priori clear that sprouts migrating in a random
direction hit a target vessel in a reasonable distance. Here
chemoattractants and the size of the growth cone (i.e.
extension of ﬁlopodia in real sprouts) become essential
model features.
Concerning our drug ﬂow simulations we have demon-
strated that drug ﬂows relatively well through all of the
networks. Even in the extreme case—the uncorrelated
system—an infusion time of the order of a few minutes is
sufﬁcient to saturate the vasculature with drug. Therefore
our model predicts that blood-borne drug transport to and
into tumors that grow within a homogeneously vascular-
ized tissue is not limited by the particular morphology of
tumor vasculature. Considering the underlying mechan-
isms that are responsible for this morphology in our model
(and in real tumors) it is plausible that drug reaches
(nearly) all parts of the vasculature: Shear force correlated
vessel collapse naturally leads to elimination of weakly
perfused vessels. In the case of random collapses, pressure
gradients are still sufﬁcient to drive blood through the
vessels, but an order of magnitude slower.
In related work concerning modeling of tumor induced
angiogenesis, McDougall et al. (2006) found that the
morphology of tumor vasculature plays a crucial role in
drug delivery and that changes to key system parameters
could have big impact on the structure of the vasculature.
The origin of this discrepancy with our conclusion lies in
the different model assumption. As outlined in the
introduction, they consider a strictly avascular tumor,
where sprouts migrate toward the tumor, but are not
allowed to enter it. The resulting vessel networks exhibit
extremely high connectivity close to the tumor surface,
however the involved angio-adaptation mechanisms lead to
vasodilation of comparably few pathways. Depending on
the model parameters, the number of high-throughput
vessels, and their distance to the tumor varies sufﬁciently to
lead to uptake rates which vary by several orders of
magnitude.
In contrast to this we study here a type of tumors like
melanoma, which are primarily vascularized by co-option
rather than vessel ingrowth (Do¨me et al., 2002, 2007). For
them, as we have demonstrated, a blood-borne ‘‘delivery
problem’’ does not exist. This does however not auto-
matically imply that drug reaches all tumor cells since
neither drug transport through the tumor tissue nor drug
uptake have been addressed (Minchinton and Tannock,
2006). Regarding tissue transport it is known that the
difference between interstitial ﬂuid pressure (IFP) and
microvascular pressure (MVP) is low due to vessel
leakiness. Since convective transport is driven by pressure
differences, high IFP could pose a barrier to drug delivery
(Hassid et al., 2006). On the other hand, leakiness and
MVP-IFP gradients could lead to premature release
predominantly in locally restricted regions around vessels
where blood enters the tumor. Vessels in the outﬂow
regions would thus be depleted of drug. Locally released
drug would then be transported by IFP gradients out of the
tumor. Furthermore drugs usually consist of large macro-
molecules. Their low diffusibility through the vessel wall
and generally lower diffusibility than O2 could lead to
situations where sufﬁcient O2 reaches certain TCs to let
them remain viable, but not enough drug reaches them to
kill them off due to the lower diffusion radius. Thus we
conclude that much more than the vessel morphology,
processes like transportation out of the vessels through
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convection and diffusion seem to be a key factor in
successful drug delivery.
In future work it would be useful to study the remodeling
of an arterio-venous network. Getting access to a realistic
initial network is likely to pose a hard problem in
particular if it must be artiﬁcially created. Further aspects
to assess are interstitial ﬂuid transport and O2 release with
associated intravascular O2 decrease. Finally, vessel col-
lapse and regression dominate the network remodelling
process of the vasculature in the tumor center. In addition
to anti-angiogenic factors solid stress is assumed to play a
pivotal role in these processes. Therefore it would be highly
desirable to incorporate an appropriate description of the
dynamic evolution of solid stress in the tumor and its
surrounding tissue to go beyond the phenomenological
treatment of vessel collapse that we used in the model that
we have presented in this work.
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a b s t r a c t
We formulate a theoretical model to analyze the vascular remodelling process of an arterio-venous
vessel network during solid tumour growth. The model incorporates a hierarchically organized initial
vasculature comprising arteries, veins and capillaries, and involves sprouting angiogenesis, vessel
cooption, dilation and regression as well as tumour cell proliferation and death. The emerging tumour
vasculature is non-hierarchical, compartmentalized into well-characterized zones and transports
efﬁciently an injected drug-bolus. It displays a complex geometry with necrotic zones and ‘‘hot spots’’ of
increased vascular density and blood ﬂow of varying size. The corresponding cluster size distribution is
algebraic, reminiscent of a self-organized critical state. The intra-tumour vascular-density ﬂuctuations
correlate with pressure drops in the initial vasculature suggesting a physical mechanism underlying hot
spot formation.
& 2009 Elsevier Ltd. All rights reserved.
1. Introduction
Tumours can grow to a size of approximately 1–2mm3 before
their metabolic demands are restricted due to the diffusion limit
of oxygen and nutrients. In order to grow beyond this size, the
tumour switches to an angiogenic phenotype and induces the
development of new blood vessels mainly via sprouting angio-
genesis, i.e. the formation of new vessels from pre-existing
vasculature. This process is regulated by a variety of pro- and
anti-angiogenic factors and is regarded as a prerequisite for
further outgrowth of the tumour (Carmeliet and Jain, 2000).
However, it has been suggested that many tumours can also grow
in an avascular stage, mainly in well-vascularized tissue like brain
and lung (Wesseling et al., 1994; Holmgren et al., 1995; Pezzella
et al., 1997). Tumour cells (TCs) can grow along existing vessels
without evoking an angiogenic response. This process was deﬁned
as vessel-cooption.
It was already proposed in Thompson et al. (1987) that
tumours acquire their vasculature by incorporation of host tissue
capillaries. The ﬁrst detailed study of vessel cooption was
published in Holash et al. (1999a), where it was found that 1 or
2 weeks after implantation of C6 glioma cells in a rat brain the
small tumours were already well vascularized with vessels that
had characteristics of normal brain vessels. After 4 weeks, blood
vessels had undergone a dramatic regression without any
compensatory angiogenic response. In the centre of the tumour,
tumour cells were organized around the few functional vessels
and massive tumour cell death was detected. In the tumour
periphery, in contrast, a robust angiogenic response was observed.
Vessel cooption has now been observed in different tumour
types like human melanoma (Do¨me et al., 2002), neuroblastoma
(Kim et al., 2002), and ovarian cancer (Zhang et al., 2003); it can
persist during the entire period of tumour growth and it can
even represent the only source for nutrients in angiogenesis-
independent tumour growth (Sakariassen et al., 2006).
From these experimental observations the anatomy of solid,
vascularized tumour grown within in a vascularized tissue
displays a characteristic compartmentalization into essentially
three regions (Holash et al., 1999a; Do¨me et al., 2002): (i) the
highly vascularized tumour perimeter with a micro-vascular
density (MVD) that is substantially higher than the MVD of the
surrounding normal tissue, (ii) the well-vascularized tumour
periphery with dilated blood vessels and a tortuous vessel
network topology, and (iii) a poorly vascularized tumour centre
with large necrotic regions threaded by only a few very thick
vessels that are surrounded by a cuff of viable tumour cells. Thus,
during tumour growth the original, hierarchically organized
arterio-venous blood vessel network has been remodelled into a
completely different compartmentalized morphology. Several
microscopic phenomena on the cellular level have been identiﬁed
to be involved in this remodelling process:
(1) Angiogenic sprouting: Up-regulation of pro-angiogenic
factors in tumour-cells (like vascular endothelial growth factor,
VEGF, and other growth factors) can create additional vessels via
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sprouting angiogenesis in some regions of the tumour, most
frequently in its perimeter (Carmeliet and Jain, 2000). (2) Vessel
regression: The maintenance of incorporated mature microvessels
depends on the survival of endothelial cells (ECs) and their
survival is intimately tied to their local microenvironment and, in
particular, to the presence of pericytes, survival promoting
cytokines, and extracellular matrix (ECM) proteins. The major
molecular players that control this process are angiopoietins and
VEGF (Holash et al., 1999a). Angiopoietin-1 (Ang-1) promotes EC
survival and tumour vessel maintenance, whereas angiopoietin-2
(Ang-2) negatively interferes with these agonistic signals by
blocking the Ang-1 receptor Tie-2 (Maisonpierre et al., 1997;
Holash et al., 1999b; Scharpfenecker et al., 2005). In coopted blood
vessels Ang-2 is up-regulated, causing the destabilization of their
capillary walls, i.e. the detachment of pericytes from the
endothelial tube (Holash et al., 1999b). Once ECs are separated
from pericytes, they become particularly vulnerable resulting in
the regression of destabilized vessels. (3) Vessel dilation: The
vascularization program of the pro-angiogenic phenotype can be
switched from sprouting angiogenesis to circumferential growth
in the interior of the tumour. This switch is mediated by the
guidance molecules EphB4 (and its ligand ephrinB2), both
expressed by ECs of malignant brain tumours (Erber et al.,
2006), which acts as a negative regulator of blood vessel
branching and vascular network formation, and also reduces the
permeability of the tumour vascular system via activation of the
Ang-1/Tie-2 systems at the endothelium/pericyte interface.
The potential morphological consequence of these processes is
(1) the increase of micro-vascular density (MVD) at the tumour
perimeter (via up-regulation of VEGF and other growth factors),
(2) vessel regression in the interior of the tumour (via up-
regulation of Ang-2 and mechanical forces) and (3) vessel dilation
and stabilization in the tumour centre (via VEGF and EphB4).
The complex interplay of these three mechanisms with the
architecture and blood ﬂow organization of the original vascu-
lature and a growing invasive tumour is the topic of this paper.
By formulating and analyzing a mathematical model involving
these features we will get insight into how they and their
interplay affect morphological characteristics of the emerging
tumour vasculature. Among these characteristics are the size,
shape, MVD and blood ﬂow distribution of the different
compartments of the tumour (perimeter, periphery and centre),
geometric properties of the tumour vasculature like the statistics
and distribution of the spatial inhomogeneities and ‘‘hot spots’’
(regions of increased MVD and blood ﬂow, Pahernik et al., 2001)
within the tumour and drug transport along the intra-vascular
blood ﬂow.
In recent work (Bartha and Rieger, 2006; Lee et al., 2006;
Welter et al., 2008) the issue of vascular remodelling in a growing
tumour by the three basic mechanisms—angiogenic sprouting,
vessel regression and dilation—was addressed in a model that
comprised a regular capillary grid as initial vascular network. The
compartmentalization of the tumour as well as other global
features, like the time and radius dependencies of average MVD,
tumour cell density, vessel radius and blood ﬂow characteristics
were predicted in good agreement with experimental data, but
local characteristics, like a single hot spot in the centre and a
general bias in the ﬂow direction, could be attributed to the
special topology of the initial network. In this paper we consider a
more realistic arterio-venous vascular network as initial vascu-
lature and study the effect it has on the emerging tumour
vasculature.
In well-vascularized tissue the average inter-capillary distance
is 502100mm, in highly vascularized tissue like brain even less
(depending on the oxygen demand and the resulting diffusion
length), implying the importance of the incorporation of the
original vasculature into a model for tumour-induced angiogen-
esis. This vasculature is organized in a hierarchical way, in which
an arterial and a venous tree are interdigitated by capillaries.
Oxygen and other nutrients are distributed into the surrounding
tissue by the lowest level capillaries, the two trees representing
their supply and drainage system. The MVD, given by the average
inter-capillary distance, is homogeneous in one kind of tissue to
provide a homogeneous oxygen and nutrient supply, but the two
interdigitating hierarchical trees form a spatially very inhomoge-
neous blood vessel network. Consequently the vascular remodel-
ling process in a growing tumour will also be spatially
inhomogeneous: sprouting angiogenesis occurs mainly from
capillaries and venules, higher level arteries protected by a thick
layer of pericytes are more stable and regress later or not at all,
regression of higher level arteries has fatal consequences for the
whole arterial sub-tree below it, newly formed vessels between
arteries and veins could act as shunts redirecting huge amount of
blood, etc.
1.1. Previous modelling
Mathematical modelling of tumour angiogenesis has been an
active research area in the recent years, but there has been little
work on the role of vessel cooption and regression. Since the early
work of Balding and McElwain (1985), many models of the process
of capillary formation in response to a tumour-derived growth
factor have been constructed. Examples include Chaplain and
Stuart (1993), Chaplain et al. (1995), Byrne and Chaplain (1995)
and Holmes and Sleeman (2000). These models are macroscopic
in that they deal with continuous quantities, such as endothelial
cell density, via a system of partial differential equations. One
disadvantage of this modelling approach is its inability to capture
microscopic features of the process, such as vessel branching and
looping and the morphological properties of the emerging
capillary network.
Several researchers have therefore formulated discrete, or
microscopic, models of tumour angiogenesis. These often contain
a stochastic element and model at the level of the individual cell,
see, for example Stokes and Lauffenburger (1991) and Turner and
Sherratt (2002). Anderson and Chaplain (1998) derived a discrete
model for EC movement in angiogenesis via a discretization of a
continuous model. Here tip-cells located at discrete lattice points
are assigned probabilities to migrate to adjacent lattice points
within the next time-step. These probabilities account for
chemotactic, haptotactic, and diffusive contributions correspond-
ing to a continuum formulation. Capillaries are represented as
masked points on the grid and probabilistic branching rules
depend on the sprout age, VEGF concentration and EC density. An
extension to three dimensions is presented in Chaplain (2000).
The blood ﬂow in capillary networks has been modelled in
Go¨dde and Kurz (2001), McDougall et al. (2002), Stephanou et al.
(2005) and McDougall et al. (2006) and then extended to describe
the dependence of vessel remodelling on blood pressure and shear
stress (Go¨dde and Kurz, 2001; Bartha and Rieger, 2006; Lee et al.,
2006; Stephanou et al., 2006; Welter et al., 2008). Recently
discrete agent-based models for tumour-induced angiogenesis
were coupled to models of tumour growth (Zheng et al., 2005;
Bartha and Rieger, 2006; Lee et al., 2006; Frieboes et al., 2007;
Welter et al., 2008; Wise et al., 2008; Macklin et al., 2008). A
growing tumour coopting the vessels of the normal tissue was
considered with a pre-existing static capillary network without
angiogenesis or regression in Alarcon et al. (2003) and Betteridge
et al. (2006) and with a fully dynamic capillary network in Bartha
and Rieger (2006), Lee et al. (2006), Welter et al. (2008) and Owen
et al. (2008).
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1.2. Present model
1.2.1. Arterio-venous vasculature
To study and quantify these effects during vascular remodel-
ling during tumour growth we employ and extend a mathematical
model for a two-dimensional arterio-venous blood vessel network
that has been presented in Go¨dde and Kurz (2001). Here we
restrict our study to a two-dimensional situation, but it can
straightforwardly be extended to three dimensions (to be
published). The model generates stochastically an arterio-venous
network with physiologically realistic parameters (Go¨dde and
Kurz, 2001). By varying the number and location of sources and
sinks the global topology of the network can be adopted to
different situations for the initial nucleus of the tumour—e.g.
close to a major artery or vein or far away from major vessels. At
each branching point the vessel radius decreases according to
Murray’s law (Murray, 1926), each vessel represents a pipe with
given radius within which blood ﬂows according to Hagen–
Poiseuille with a radius-dependent effective viscosity. Boundary
conditions that imprint and deﬁne the blood ﬂow in the network
are the blood pressure values within the roots of the arterial and
venous trees. The vessels represent the sources of the diffusion
determined oxygen/nutrient concentration ﬁeld, surrounding cells
represent its sinks.
1.2.2. Sprouting angiogenesis
This arterio-venous network serves as the initial vasculature
for our model of remodelling by a growing tumour. Depending on
the local oxygen concentration tumour cells represent the sources
of the diffusion determined VEGF concentration ﬁeld, which
triggers either the generation of tip-cells for angiogenic sprouting
from existing vessels outside or at the periphery of the tumour, or
the circumferential growth inside the tumour. In contrast to vessel
in-growth models as in Anderson and Chaplain (1998) tip-cells are
not dominantly generated by branching of existing tip-cells but by
sprouting from vessels of the original network. This tip-cell
generation from existing vessels is initiated by the activation of
VEGF receptors with subsequent up-regulation of the delta-like-4
(Dll4) ligand in one EC (Liu et al., 2003), and the Dll4-mediated
activation of Notch1 receptors in the neighbouring EC (Sainson
et al., 2005; Williams et al., 2006). This lateral inhibition leads to
an alternating pattern of cell fates in capillary walls under the
inﬂuence of VEGF and results in a separation of one to two non-
tip-cells between each tip-cell. The underlying negative feedback-
loop involving VEGF receptors, Dll4 and Notch has been analyzed
theoretically in Bentley et al. (2008), our model only incorporates
the resulting pattern for tip-cell generation along existing vessels
exposed to elevated concentrations of VEGF.
The subsequent migration, branching and anastomosis of
angiogenic sprouts was recently modelled in a detailed way
(Bauer et al., 2007; Milde et al., 2008), involving besides VEGF
matrix metalloprotease (MMP) and the ﬁlamentous structure of
the extracellular matrix. In our model tip-cells migrate in the
direction of a sufﬁciently large VEGF gradient (chemotaxis),
otherwise randomly. The path they describe is supposed to be
ﬁlled with stalk cells forming a lumen and ﬁnally, once the tip-cell
hits another vessel (anastomosis), a functional vessel carrying
blood ﬂow. These assumptions are analogous to previous work
(McDougall et al., 2002, 2006; Stephanou et al., 2005), but some
details differ: (1) Due to the pre-existing vasculature vessels
typically migrate only 502100mm before the ﬁlopodia of the tip-
cell extending up to 20230mm into the surrounding tissue in all
directions (Gerhardt et al., 2003) touch another vessel. Therefore
directional clues are not as important here as in pure vessel in-
growth models. (2) Tip-cells migrate maximally 1002150mm and
in case they did not make successful contact with another vessel,
they retreat (Nehls et al., 1998). (3) Tip-cell branching is not
included, but we allow for tip-cell generation along the sprout and
the newly formed vessel, which mimics branching.
1.2.3. Vessel dilation and regression
Inside the tumour the VEGF concentration is generally still
high but angiogenic sprouting is replaced by circumferential
growth due to the up-regulation of EphB4 in the ECs forming the
walls of coopted vessels (Erber et al., 2006). The molecular
mechanisms for this up-regulation are unknown but apparently
contact with tumour cells is necessary. Therefore we incorporate
this switch to circumferential growth by a dependence upon the
contact time of ECs with tumour cells.
In an analogous way we model the effect of an up-regulation of
Ang-2 in coopted vessels, which has been analyzed theoretically in
Plank et al. (2004) and which leads to vessel destabilization and
regression: an increasing contact time of vessels with tumour cells,
implying an increasing residence time within the tumour, leads to a
higher collapse probability of tumour vessels. The collapse prob-
ability is also correlated with the origin of the vessel (artery, vein or
capillary) and the shear force exerted by the blood ﬂow upon the
vessel walls. It is conceivable that mechanical forces in the form of
solid stress exerted by the expanding tumour also inﬂuence the
collapse of coopted vessels. This can in principle be included into
the model along the lines described in Frieboes et al. (2007), Wise
et al. (2008) and Macklin et al. (2008) but we choose here a
stochastic approach: the tumour region with the potentially largest
stress is the periphery due to the highest proliferation rate and
because the necrotic centre consists of liquidized biological matter
that generates a homogeneous interstitial ﬂuid pressure, which is
thus not able to sustain solid stress. Thus with increasing distance of
a vessel from the tumour boundary not only its contact time with
tumour cells increases (up-regulating Ang-2) but also the mechan-
ical stress acting upon it. Hence the collapse probability of a coopted
vessel increases with increasing distance from the tumour bound-
ary (and with decreasing shear force).
1.2.4. Tumour model
Our focus in this work is the vascular remodelling process,
which we assume to be dominantly dependent on where vessels
are located, how stable they are (i.e. from which level in the
arterio-venous tree they originate), how long they have been in
contact with tumour cells and how well they are perfused.
Therefore we choose a simpliﬁed representation of the growing
tumour: proliferation of tumour cells takes place, if sufﬁcient
oxygen/nutrients are present and if there is available space. This
captures the most essential features of experimental (Bru´ et al.,
2003) and theoretical (Drasdo and Ho¨hme, 2005) observations
that proliferation of tumour cells is conﬁned to the outer rim of an
avascular tumour. Since in our model for vascular tumour growth
proliferation depends on oxygen and since the oxygen concentra-
tion is highest close to vessels, tumour cells proliferate preferen-
tially along vessels, which is commonly observed in aggressive
tumours growing in vascularized tissue. We do not include
migration of the tumour cells, but this can easily be incorporated
into the model together with cell–cell adhesion and mechanical
stresses (Ambrosi and Preziosi, 2002; Byrne and Preziosi, 2003;
Breward et al., 2003; Frieboes et al., 2007; Wise et al., 2008;
Macklin et al., 2008). Finally tumour cells die when they were
underoxygenated for a speciﬁc time interval.
1.2.5. Scope and outline of this paper
The questions that we address with the model that we
formulate are: What is the fate of the well-organized hierarchical
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structure of an arterio-venous vessel network when it is co-opted
and remodelled by an aggressively growing tumour? What are the
geometrical characteristics of the emerging tumour vasculature
and what are the potential mechanisms leading to spatial
inhomogeneities or hot spots? And what are the global blood
ﬂow patterns and the drug transport performance of the tumour
vasculature? Since we will be interested in the large scale
properties of the vasculature of tumours with a size up to
5–10 cm, we will have to omit some of the mechanical and/or
chemical aspects incorporated into other tumour-angiogenesis
models that neglect the structure of the initial vasculature, and
use a simpliﬁed, stochastic modelling approach instead.
This paper is organized as follows: in the next section the
model is deﬁned, including the method to construct an arterio-
venous initial network. In the model deﬁnition we restrict
ourselves to the mathematical formulation and refer to the
introductory Sections 1.2.1–1.2.4 for the supporting biological
observations and experimental literature. Section 3 presents the
results for global properties for a choice of parameters that is
guided by experimental data for melanoma (Do¨me et al., 2002).
These results include a discussion of the emerging morphologies;
radial distributions of vessel density, vessel radius, tumour
density, ﬂow rates, shear forces, vessel statistics, parameter
dependencies, spatial inhomogeneities, and drug ﬂow. Section 4
concludes the paper with a summary of the main results and a
discussion.
2. Mathematical model
The model represents tumour cells and vessels as discrete
elements which occupy lattice sites and bonds, respectively, on a
two-dimensional triangular lattice (Fig. 1). Tumour and vessel
network interact predominantly via a growthfactor (GF) and an
oxygen concentration (O2) ﬁeld. Most of the mathematical
deﬁnitions follow closely (Welter et al., 2008) apart from the
arterio-venous initial network.
2.1. Definition of the system state
2.1.1. Tumour
Each lattice site of the space occupied by the tumour is
identiﬁed with one TC. A lattice site which was occupied by a
tumour cell in the past represents necrotic tissue, otherwise
unoccupied sites represent normal tissue. The lattice constant of
10mm is of the order of the typical size of a cell so that the
identiﬁcation of cells with sites is meaningful.
2.1.2. Vessel network
The vasculature is modelled as a network of connected ideal
tubes that run along the bonds of the lattice. Its topology of which
can be described by a graph, in which edges are identiﬁed with
vessel segments. Graph nodes thereby occupy sites of the lattice.
Due to the two-dimensionality of the model we allow individual
vessels and TCs to occupy the same space within the lattice, since
otherwise disconnected structures arise. In a three-dimensional
model set-up this construction is not necessary. All elements (TCs,
vessels, nodes) have physiological parameters associated with
them—for instance vessel radius r—which deﬁne their internal
state and which will be introduced below.
2.1.3. Blood flow
To compute the ﬂow rate q of each vessel segment, the shear
force f exerted on the vessel walls, and the blood pressure p, we
adopt the approach widely used in the literature (Go¨dde and Kurz,
2001; Betteridge et al., 2006; McDougall et al., 2006): a system of
linear equations is derived from Poiseuille’s law and mass balance
equations for the nodes, which is solved numerically to obtain the
blood pressure for each node. At arterial/venous supply/drain
boundary-nodes we set the pressure to ﬁxed values. To account
for the complex non-Newtonian ﬂuid behaviour we use a vessel
radius and hematocrit (red blood cell fraction)-dependent
viscosity term (Pries et al., 1994). For simplicity we neglect the
phase-separation effect and assume a constant hematocrit of 0.45
which is the average in humans.
2.1.4. Oxygen
The O2 concentration ﬁeld denoted as c is deﬁned as the
solution of the stationary (i.e. time-independent) diffusion
equation r2c  gcc þ acðc
ðBÞ  cÞ ¼ 0, where gc is a tissue-
dependent consumption rate, cðBÞ the blood O2 level and ac the
source strength incorporating local vascular area-fraction and wall
permeability. It is solved numerically once per time step (see
below), with no-ﬂux boundary conditions on the lattice of the
discrete system. We restrict ourselves to the stationary solution of
the O2-diffusion equation since the relaxation time of the O2
concentration to adapt to source/sink changes is of the order of
seconds whereas changes of the tumour or vasculature conﬁg-
uration occur on the time scale of hours. We further assumed that
oxygen uptake is non-saturated so that a linear consumption term
makes sense. In the presence of the high tumour demand this
simpliﬁcation is justiﬁed. We assume that all vessels have equal
oxygen content and also contribute equally to tissue, i.e. ac and cðBÞ
assume constant values of model parameters at vessel sites.
Under physiological conditions only the thinnest capillaries
release oxygen into the surrounding tissue, but in our two-
dimensional situation also higher order vessels have to release O2
because otherwise large scale depressions of the O2 concentration
would occur around large vessels due to the lack of capillaries,
which would unrealistically conﬁne tumour growth. This con-
struct is again necessary due to the two-dimensionality of our
model, in three dimensions the space around large vessels van
still be ﬁlled with capillaries. We also implemented a three-
dimensional version of the model, where only capillaries are a
source of O2. It turns out that the results are the same as in the
present model in two space dimensions with also larger
capillaries emitting O2 (Welter et al., unpublished).
We also neglect variations of the O2 level within the vessels,
assuming these variations are small over the length of a O2
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Fig. 1. Illustration of the discrete conﬁguration space of the model: all discrete
elements are aligned with the underlying triangular lattice shown in the
background. Blue bars represent single vessels which occupy lattice bonds. One
vessel is highlighted by a black frame, its junctions to other vessels are denoted by
x1 . x2 . Each tumour cell (TC) occupies one lattice sites. A single TC is depicted as a
yellow hexagon. (For interpretation of the references to colour in this ﬁgure legend,
the reader is referred to the web version of this article.)
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releasing capillary. In previous work (Welter et al., 2008) we
compared simulation results for models with constant and
varying hematocrit and found differences only on a micro-scale
but not in large scale characteristics.
2.1.5. Growthfactor
Analogous to the O2 ﬁeld we deﬁne the equation for the GF
ﬁeld denoted g. In practice it is calculated as the superposition of
contributions from underoxygenated tumour cells, which are
characterized by cocðprolÞTC , where c
ðprolÞ
TC is a model parameter. Each
of these cells generates a GF distribution which decays linearly as
ð1 x=RgÞwith the distance x up to the GF diffusion radius Rg . This
is a simpliﬁcation based on assumption that GF has a limited
diffusion range similar to oxygen and that it is secreted at a
constant rate.
2.2. Definition of the dynamical processes
The dynamical evolution of the system is described as a
stochastic process in which elements can be removed or added
and their internal state can be changed according to rates that
depend on the current system state. In practice we implemented
an iterative scheme where update rules that correspond to the
processes described below are applied sequentially for each time
step of length Dt ¼ 1h. A rate thus translates into a probability
p ¼ Dt=t for a speciﬁc transition to happen within the time step of
length Dt, where t is the mean time between transition events.
With our parameter choices, the probabilities are sufﬁciently
small such that this approach is a reasonable approximation to a
continuous stochastic process.
The microscopic biological observations for the following
basic model assumptions were discussed in the introduction in
Section 1.2, including the experimental citations.
TC Proliferation: (see Section 1.2.4) New TCs occupy empty
neighbour sites of the existing tumour with probability Dt=tðprolÞTC if
the local O2 level is above the hypoxia threshold parameter c
ðprolÞ
TC .
The parameter tðprolÞTC is the mean proliferation time (Fig. 2a).
TC Death: (see Section 1.2.4) TCs are removed if the local O2
level is less than the necrosis threshold cðdeathÞTC for longer than the
time tðuoÞTC , where c
ðdeathÞ
TC and t
ðuoÞ
TC are system parameters. For
simplicity potential variations among different TC genotypes are
neglected (Fig. 2b).
Angiogenic sprouting: (see Section 1.2.2) Sprouting can be
initiated by the generation of tip-cells at sites on the vessel
network depending on several factors:
(1) (VEGF dependence of tip-cell generation): The local GF
concentration must be non-zero (for simplicity the sprouting
probability is independent of the concentration value).
(2) (Alternating pattern of tip-cell and non-tip-cell in the vessel
walls): There is no sprouting from the next lðsprÞ sites in the
vicinity of existing branching points.
(3) (Switch from angiogenic sprouting to circumferential growth,
see Section 1.2.3): When the tumour grows over a particular
vessel-occupied site, sprouting is prohibited for this site after
the delay time tðswitchÞEC .
If these conditions are fulﬁlled a new vessel segment may be
added with probability Dt=tðsproutÞEC , where the parameter t
ðsproutÞ
EC is
the mean time to extend a sprout by the length of a lattice-bond.
The direction along the steepest GF gradient is taken. During the
following time steps more bonds are added—one per step with
probability Dt=tðsproutÞEC . For simplicity the direction from the initial
bond is retained. On contact a branching point is created fusing
the vessels and terminating the sprouting behaviour. Otherwise
the extension of the sprouts is limited by the amount of time
tðmigrÞEC , after which sprouts become inactive and count as normal
(unperfused) vessels (Fig. 2c, d).
Vessel collapse: (see Section 1.2.3) We account for varying
vessel stability by a ‘‘degree-of-maturation’’ variable w, which is
initialized with the thickness of healthy vessel walls (see
parameter section). w decreases continuously inside the tumour
with the rate kw. Vessels remain stable while w is larger than 0. In
addition, collapses are correlated with shear stresses f on the
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Fig. 2. Sketch of the dynamical processes in the model: (a) TC proliferation, (b) TC death, (c) sprout formation, (d) sprout migration, (e) vessel regression and removal, (f)
dilation and wall degradation. See text for details.
M. Welter et al. / Journal of Theoretical Biology 259 (2009) 405–422 409
vessel wall: if f is larger than the threshold parameter f ðcollÞ vessels
remain stable. Otherwise vessels are removed with probability
pðcollÞ ¼ Dt=tðdeathÞEC , where t
ðdeathÞ
EC is the mean survival time. Sprouts
are an exception to the above mechanisms (Fig. 2e).
Vessel dilation: (see Section 1.2.3) After a vessel segment
switched to circumferential growth (see angiogenic sprouting) the
vessel radius r increases with the rate kr if the local GF
concentration is non-zero and rorðmaxÞ (Fig. 2f).
2.3. Arterio-venous tree construction
Vasculature in real tissue exhibits a tree like structure. Few
thick arteries branch out into arteriolar microvessels. Terminal
branches are connected to the capillary bed, a dense network
consisting of thin vessels where most of the exchange with the
surrounding tissue happens. Further upstream blood is collected
in venules which fuse into thick veins. The design goal of such a
structure is to provide a sufﬁcient supply of nutrients to all
regions of the tissue, while minimizing the energy necessary to
maintain the circulation.
Go¨dde and Kurz (2001) presented a method to grow and
remodel vascular trees stochastically according to probabilistic
rules that depend on local system properties. The simultaneous
construction of arterial and venous trees makes their approach
well suited for generating an initial vasculature for our tumour
model.
Its basis is the growth of random arterial and venous trees on a
lattice, under exclusion of already occupied sites. This is followed
by stochastical shear stress guided remodelling at the tree leaves.
Thereby weakly perfused leaves regress while strongly perfused
leaves can grow. The vessel radii are computed by ‘‘Murray’s Law’’
(Murray, 1926) from prescribed radii of the leaves. This eventually
leads to a well-perfused space ﬁlling network with a relatively
homogeneous capillary density distribution.
We provide the algorithmic details in the Appendix. Para-
meters are given there as well as in the parameter section below.
Figs. 3a and 5 show the results used as input for our tumour
model described above in Section 2.2.
While it is highly non-trivial to synthesize vascular networks
that are realistic in every way possible, our initial networks
exhibit reasonable hierarchical structures, spatial distributions of
the capillaries, and good agreement with the ﬂow-data of the
original paper (Fig. 8).
2.4. Parameters
In order to observe typical features of the tumour-network
morphology we have to simulate a sufﬁciently large area. The
construction of the initial vasculature is carried out on a much
coarser lattice because it is inherent to the algorithm that ca. 50%
of the bonds are occupied with vessels. Therefore the resulting
microvascular density is primarily a function of the lattice
constant lcoarse. Based on the MVD for human skin (ca. 100 vessels
per mm2 cross-sectional area) and the MVD in the regular lattice
cases (Bartha and Rieger, 2006; Welter et al., 2008), we set lcoarse to
60mm. The a priori capillary radii are 4mm for arterioles and 5mm
for venules, respectively. The radii of the vascular tree roots
depend on the branching pattern. Because of this variation the
blood pressure p at each root node is determined as a function of
the vessel radius r: pðrÞ ¼ 0:133ð18þ 72=ð1þ expððr þ 21mmÞ=
16mmÞÞÞ kPa, where r is negated for arterial vessels. It is based on
the data in Pries et al. (1995), and results in average values of
2.4 kPa in vein (on average 88mmradius) and 10kPa in arteries (on
average 52mmradius).
In the following we deﬁne the parameters for a base case
scenario for the tumour model (see Table 1). The size of the lattice
is 1200 1200 sites, with the lattice constant l ¼ 10mm
( 12 10mm2 since it is a triangular lattice).
The initial tumour is an Eden-grown cluster of 1000 cells and
300mm in diameter. We set the TC proliferation time tðprolÞTC to 10h,
the viability time under hypoxia tðuoÞTC to 100h, and the apoptosis
time to 2h, the O2-threshold for proliferation c
ðprolÞ
TC to 0:3  0:9hci
and the threshold for extreme underoxygenation cðdeathÞTC to
cðprolÞTC =10.
We set angiogenesis related parameters as follows: sprout
extension time (mean waiting time between additions of new
lattice bonds to a sprouting vessel) tðsproutÞEC to 5h, sprout viability
time tðmigrÞEC to 100h (estimated from ﬁgures in Nehls et al. (1998)),
sprouting site separation distance lðsprÞ to 20mm, the initial sprout
radius rðsproutÞ to 4mm, the delay until the switch to circumfer-
ential growth happens tðswitchÞEC to 24 h, the circumferential growth
rate kr to 0:4mm=h, the maximum radius rðmaxÞ to 25mm and the
growth factor diffusion range Rg to 200mm (estimated from
morphological data by Do¨me et al. (2002)).
Parameters related to vessel regression are as follows: we set
the critical shear force f ðcollÞ deliberately to 1 Pa which is 10% of the
average shear stress, and the mean waiting time for regression
tðdeathÞEC to 10h which applies for uncirculated as well as degenerate
vessels (wp0). We had to estimate the dematuration rate kw from
the presentation by Holash et al. (1999a). It is set to 0:04mm=h,
resulting in regression delays from 93h (4mm vessels) to 625h
(50mm vessels). The maturation variable for the original vascu-
lature and new sprouts is initialized with an estimate for the wall
thickness (Pries et al., 2005).
The O2-diffusion parameters are chosen so that the ﬁeld
becomes dimensionless, the diffusion range is ca. 100mm, the O2
level in the middle of two vessels drops to ca. 50% of the peak
values. These are typical observations in Carmeliet and Jain (2000)
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Table 1
Model parameters of the base case.
Parameter Value Description
L 1200 Lattice size
l 10mm Lattice const
lcoarse 60mm Lattice const. (tree constr.)
cðBÞ 0.45 Blood oxygen level
ac 0.002 1=mm2 O2 source coefﬁcient
gc (normal) 1=902 1=mm2 O2 consumption. coeff
gc (tumor) 1=502 1=mm2
Rg 200mm Growthfactor diffusion range
tðswitchÞEC
24h Sprouting/dilation switch delay
tðsproutÞEC
5h=10mm Sprout extension time
tðmigrÞEC
100h Sprout activity duration
l
ðsprÞ 20mm Sprout sites minimum separation
rðsproutÞ 4mm Initial sprout vessel radius
kr 0:4mm=h Vessel dilation rate
rðmaxÞ 25mm Maximum dilation radius
tðprolÞTC
10h TC proliferation time
tðuoÞTC
100h Hypoxic TC survival time
f
ðcollÞ 1Pa Critical wall shear stress
tðdeathÞEC
10h Unstable vessel survival time
kw 0:04mm=h Dematuration ðwÞ rate
cðdeathÞTC
0.03 TC hypoxia O2 threshold
cðprolÞTC
0.3 TC proliferation O2 threshold
88 21mm Venous tree root radius
52 14mm Arterial tree root radius
2:4 0:1kPa Venous tree root blood pressure
10 1kPa Arterial tree root blood pressure
Blood pressures and radii of the root nodes are stated as averages deviations over
all conﬁgurations (see text).
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and Torres Filho et al. (1994). Our respective values are 0.002
1=mm2 for ac, 1=90
2 mm2 for gc in normal tissue and 1=50
2 mm2 in
tumour tissue. An upper bound for the concentration is the blood
oxygen level cðBÞ which we set to 0.45. The choice can be arbitrary
because c scales linearly with cðBÞ. We refer for a full discussion to
Welter et al. (2008).
3. Results
The model predicts the dynamical evolution of the global
morphology consistent with experiments and our previous results
as explained in the introduction.
Fig. 3a shows a sample system in its initial state. The vessel
network was generated by ﬁrst laying out stems of the trees
manually, and then starting the random growth process with
branching points on each site on the stems. This is described in
detail in the Appendix. The layout of the stems is indicated in the
top right corner of Fig. 3. Their lengths and locations are sampled
from uniform distributions. The approach was motivated by the
observation that vasculatures exhibit relatively thick straight
vessels down to a certain level in the hierarchy as can be seen in
photos from the CAM (Mironov et al., 1998), or in recent 3d
vascular imaging (Cassot et al., 2006) experiments.
Fig. 3b–d display snapshots at successive times. Initially the
tumour O2 consumption leads to decreased O2 levels inside the
nucleus and consequently enables vascular remodelling via
growthfactor production of the TCs. The sprouting process ﬁrst
creates a dense capillary plexus which provides more oxygen and
facilitates tumour growth. Vessel collapses begin after a few days
(t ¼200h). Small capillaries can collapse immediately under bad
perfusion while thicker vessels survive longer due to their
stability, i.e. large w, independent on blood ﬂow until they
become unstable. The network is thus progressively remodelled,
predominantly within a thin band around the tumour boundary.
The sparse network left in the centre remains static except for a
few collapses of isolated threads.
The ﬁnal conﬁguration is displayed in Fig. 4a. A magniﬁed view
on the boundary region of the tumour is shown in Fig. 4b. The
resulting network morphologies show the typical high-MVD
periphery and low-density centre. The remaining internal
vessels form short-cuts between arteries and veins which touch
the tumour surface. This is a consequence of the dilation that all
vessels undergo in the tumour. The short-cuts consist of
neovasculature as well as parts of the initial vasculature. Beside
isolated threads we frequently observe regions where vessels are
densely clustered.
The conﬁgurations shown in Fig. 5 were generated from
alternate layouts of the vascular stems which are illustrated
again in the top right corner. The stems represent the sources and
drains of the arterio-venous networks. Biologically they
correspond to different arrangements of the number and
location of the main arteries and veins in the original blood
vessel network in the neighbourhood of the tumour nucleus. The
ARTICLE IN PRESS
1mm
Fig. 3. (a) Snapshot of the initial model conﬁguration. Arteries are red and veins
blue. Their radius originates from the construction algorithms (Section 2.3),
depending on the network topology and a priori capillary radii. The colour code of
the resulting networks shows the blood pressure distribution from 12 (red) to
0 kPa (blue). The small yellow area in the system centre is the tumour nucleus
initialized by Eden growth to a maximum of 1000 TCs. Necrotic tumour tissue
which appears on the other ﬁgures has a dark yellow colour. The background in
normal tissue/extracellular matrix is coloured green where the growthfactor (GF)
concentration can cause angiogenesis. The inlet shows the layout of the vascular
tree stems which serve as starting locations for the network generation algorithm.
The lengths (indicated by wedge shaped part of the bars) and positions (indicated
by the two black vertical bars) of these stems are drawn from uniform
distributions. (b)–(d) Snapshots of the model evolution at times 0, 200, 600h.
The vessel network is progressively remodelled, resulting in the typical
morphology with high peripheral MVD, dilated vessels, low central MVD with
many isolated threads, cuffs of viable TCs around them, and necrotic tissue in non-
vascularized zones. (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article.)
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result of the stochastic arterio-venous tree generation based on
the different source and drain locations is shown in the top row.
They look morphologically quite different, (a) displays a large
artery close to the tumour nucleus, (b) a large vein, and in (c) is
the tumour equally distant from major arteries and veins.
However, the density of capillaries, the MVD, is identical for all
three conﬁgurations.
Starting with these different initial networks the ﬁnal tumour
vasculature predicted by our model is depicted in the bottom row
of Fig. 5. Obviously they differ in the local MVD conﬁguration: in
(d) the MVD is large in a central region (a hot spot), in (e) and (f) it
is low. We conclude that differences in the original vasculature
lead to differences in the arrangement of spatial inhomogeneities
within the tumour (hot spots, necrotic regions), which will be
discussed below. But the global compartmentalization pattern is
identical for all three conﬁgurations, as can be seen from the
radial distributions.
3.1. Radial distributions
Fig. 6 shows various quantities averaged over concentric annuli
centred around the tumour centre. The stochastic construction of
the initial vasculatures can leave the periphery unoccupied, but
the vascularized regions exhibit a homogeneous MVD by design
and have no holes. We run 10Monte-Carlo simulations for each of the
four basic layouts discussed above. We rejected conﬁgurations that
were too small to support tumour growth till the end at t ¼1200h.
MVD and TC density are computed as the fraction of occupied
sites within a shell. Hemodynamic properties are averaged over
occupied bonds only. MVD and vessel-radius show the typical
compartmentalization that has been observed in melanoma
(Do¨me et al., 2002) and glioma (Vajkoczy and Menger, 2000).
We have discussed and compared our data extensively in earlier
papers Bartha and Rieger (2006) and Welter et al. (2008).
Brieﬂy, Do¨me et al. (2002) reported MVD and vessel radius in
three distinct regions: the central region, a 100mm wide
peripheral band just behind the invasive edge, a 200mm wide
peritumoural region outside the invasive edge. In the central
region, they found 25% MVD of normal tissue, and up to 200% in
the peritumoural region. The vessel perimeter grows linearly from
50mm and assumes a plateau at 200mm by day 15.
In contrast to our simulation on a regular vascular network,
ﬂow rates and shear force now show a plateau similar to the
vessel radius. Previously the ﬁxed pressure gradient along the
boundaries of the regular (rectangular or hexagonal) networks
leads to unrealistic star shaped morphologies, directing all blood
ﬂow through the centre. Hierarchical initial networks do not lead
to these artifacts. The axial blood pressure gradient dp=dl which is
not shown here decreases monotonically towards the centre by
more than one order of magnitude. The blood ﬂow rate q is
proportional to r4dp=dl and increases on average towards the
centre beyond a small local minimum at the invasive edge. Thus
the r4 dependency of the radius outweighs the pressure drop. The
shear force dependency is rdp=dl which leads to a decrease
towards the centre.
3.2. Vessel statistics
Fig. 7 shows scatter plots of hemodynamic variables against
the vessel radius r, which are in good agreement with those
obtained in Go¨dde and Kurz (2001). The plots combine samples
throughout the vasculature (tumour and surrounding vessels)
from all runs (at t ¼ 800). At this time a sufﬁcient number of
samples from the initial vasculature are available with negligible
boundary effects.
We generally observe that the variance of the ﬂow related
parameters increases drastically towards the capillaries. This
might be an artifact of our initial network construction, but
averaged quantities display physiologically sound characteristics.
The dilation of internal tumour vessels leads to samples
clustered at the maximum radius and one observes increased
ﬂuctuations at this particular radius. In particular vessels that
connect arteries and veins at the tumour surface and thread
through the tumour interior have blood pressure values in
between the respective extremal values. In contrast, most non-
dilated vessels which are obviously located in the outer rim fall in
the same parameter ranges as normal vessels.
A few capillaries exhibit signiﬁcantly lowered ﬂow rates and
velocities. Fig. 8, containing a spatial representation of the ﬂow-
rates, shows that the weakly perfused vessels are exclusively
located in the tumour perimeter. As in this ﬁgure we observed
that central vessels generally transport as much blood as equally
thick vessels in normal vasculature. In Section 3.5 we show how
this impacts the transport of drugs.
3.3. Parameter dependencies
We analyzed variations of all major model parameters
extensively in Bartha and Rieger (2006) and Welter et al. (2008).
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Fig. 4. (a) Final model conﬁguration at t ¼1200h resulting from continued
expansion from the states depicted in Fig. 3. Typical features of solid tumour
growth are retained. Now the tumour has also coopted a major artery and a vein. It
is apparent that in between an increased number of well-conducting pathways
have formed which serve as arterio-venous short-cuts. These originated from
neovasculature as well as original capillaries which both have undergone
circumferential growth and thus carry high blood throughput. The formation of
clusters with increased local MVD, preferably close to the artery, is also evident. (b)
Magniﬁed view of the invasive edge that shows in detail how the vasculature is
remodelled. Alternating with very high MVD on small scale, there are ‘‘holes’’ of
the size of the intervascular distance in normal tissue. This is an effect of
prohibiting sprouts from arteries, which would otherwise ﬁll the holes, leading to
a homogeneous vascular density. Behind the peripheral zone, the MVD drops
rapidly. One can further see a few isolated dilated vessels directly connected to
arterioles/venules in healthy tissue beyond the invasive edge.
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It was found that model predictions are very robust against
variations and also details of the mathematical modelling. The
effects of most parameter variations are obvious: the TC
proliferation time tðprolÞTC mainly determines the expansion rate of
the tumour provided the oxygen level c in the original vasculature
is sufﬁciently above the proliferation threshold cðprolÞTC . Otherwise
growth can be slowed down depending on the rate at which
peripheral vasculature is created and its ﬁnal density (MVD). The
latter is regulated by the sprout migration rate 1=tðmigrÞEC and
minimum distance between branching points lðsprÞ. The blood ﬂow
characteristics play an important role for the internal tumour
MVD. The higher the shear stresses f (or the lower the associated
threshold value f ðcollÞ) the more vessels will survive. We have
identiﬁed a mechanism that leads to a lower bound for the MVD:
when vessels collapse their blood volume is directed through the
remaining vessels, increasing their ﬂow rate and shear stress, thus
stabilizing them. With the addition of the arterio-venous network
the temporal evolution of the MVD depends on the vessel
dematuration rate kw. Once the tumour has grown over the
peripheral plexus there is a delay until the maturity value w of
vessels has decreased to 0. Together with the mean survival time
tðdeathÞTC of degenerate vessels this delay causes the high-MVD rim to
reach into the tumour by a certain width proportional to the delay
time. Moreover the number of surviving thick arterioles and
venules depends critically on the dematuration rate. If it is high
these vessels will collapse early if it is low they may never
collapse during the time of observation (1200h).
The large shear force variations among capillaries in the
original vasculature poses the question whether an absolute
threshold for the collapse criterion is appropriate. Therefore we
also checked the result of setting the probability pðcollÞ, with which
unstable vessels collapse, proportional to the relative deviation
from the initial shear stress f init (p
ðcollÞ / 1:0 ðf=f initÞ=f
ðcollÞ for
f=f initof
ðcollÞ) instead of using an absolute threshold. This leads to
decreased global MVD ﬂuctuations among the simulation runs
and also to increased local homogeneity, but does not change the
model behaviour qualitatively.
In the present model variant, vessels can collapse any time
after degradation (wp0), depending on shear stress. It is, however,
also an option to restrict collapses to the tumour rim. For example,
it has been suggested that the death of tumour cells releases solid
pressure from near vessels that is otherwise exerted by the
tumour (Griffon-Etienne et al., 1999). Moreover, in previous
papers we assumed the existence of a stable radius, preventing
collapses in the centre where vessel radii are larger. Indeed, the
EphB4 signalling mechanism which induces circumferential
growth also leads to reduced leakiness, tightened EC junctions
and endothelium/pericyte interaction (Erber et al., 2006), making
an actual stability improvement plausible. Therefore we altered
the model, assuming unconditionally stable internal vessels, by
choosing collapse probability pðcollÞ
ring
which takes on pðcollÞ only
inside a band of width lðcollÞring centred at the invasive edge, and
which is zero otherwise. The result depends strongly on the time
vessels spent in the collapse region, given implicitly by lðcollÞring
divided by the radial expansion velocity of the tumour. If this time
is of the order of the survival time inside the tumour a transition
occurs towards a highly vascularized centre, shown in Fig. 9 and
analyzed in detail in Bartha and Rieger (2006) and Welter et al.
(2008). Moreover pðcollÞ
ring
causes less ﬂuctuations with respect to
initial networks because more of the initially thick vessels can
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Fig. 5. (a)–(c) Initial vessel networks generated from different layouts as depicted analogous to the inlets in Fig. 3. (d)–(f) Final model conﬁgurations emerging from the
networks above. The formation of local vessel clusters is clearly visible in the central region in (d), but not so in (e) and (f). In the latter increased MVD can be observed in a
few locations close to the tumour boundary. In our reasoning, varying blood pressure differences between neighbouring vessels in the normal vasculature causes a highly
inhomogeneous shear stress distribution in the tumour periphery. Thus the varying degree of stability leads to these clusters.
M. Welter et al. / Journal of Theoretical Biology 259 (2009) 405–422 413
provide a backbone which never collapses due to w40 while
being in the collapse ring.
3.4. Spatial inhomogeneities
Qualitatively one can already see that the location of highly
vascularized zones in the tumour is connected to the location of
the thicker vessels. They occur frequently where an artery is close
to a vein, or vice versa, since an increased number of vessels
survive in between. This can be seen clearly in Fig. 4 but it is also
apparent in other conﬁgurations (Fig. 5). Qualitatively we can
explain those hot spots through blood pressure gradients that
arise in the tumour vasculature when short-cuts between nearby
arteries and veins are formed. Major vessels can thereby act as
stable backbones with very high or low blood pressure. Close
proximity of two or more such vessels implies high shear stresses
in the intermediate capillary bed and thus increased stability.
Moreover the shear stress in arteries is normally larger than in
veins. This asymmetry apparently leads to hot spot formation
preferably close to the arterial branches.
This motivates the following quantitative analysis where inter-
vascular ‘‘blood pressure’’ gradients of the original vasculature are
related to the tumour MVD: ﬁrst we compute a ﬁeld pðxÞ as
solution to the Laplace equation r2p ¼ 0 subject to the boundary
condition that p is set to the blood pressure at vessel sites. Thus p
interpolates the blood pressure between adjacent vessels. Then,
for a given region, we obtain the spatial average of the gradient
krpk at t ¼0h and plot it against an estimate for the tumour MVD
at t ¼1200h.
The main plot of Fig. 10 shows the MVD versus hkrpki over
entire tumours with one data point per simulation run. The
correlation coefﬁcient is usually very large  0:9 for this global
measurement. Analogously we analyzed single tumour instances
where the average is taken locally over randomly distributed discs
with 150mm radius. The inset shows the resulting distribution of
one such measurement. The correlation coefﬁcients of which vary
between 0.2 and 0.4. Since a single collapse event can cause long-
ranged regressions of adjacent network sections, it is plausible
that local measurements only show weak correlations. Moreover
since the vascular blood pressure at boundary vessels is
prescribed based on their radius, only the location of initial
vessels leads to the variety of emerging tumour morphologies.
Fig. 11 shows intermediate data which stems from the
simulation run shown in Fig. 4. The bottom image (Fig. 11c)
shows the site occupation by the vessel network. It is easy to
identify the tumour network by its typical structure. In Fig. 11a,
where krpk is displayed, one observes that indeed the local
gradients are stronger in the area close to the major artery in the
top half, than close to the vein in the lower half. The snapshots (b)
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Fig. 6. Radial distributions of hydrodynamic and morphological variables of the base case simulations. The radius r here denotes the distance from the tumour centre. One
data point represents an average over a concentric 50mm wide shell, and over 40 runs: (a) shows the MVD, (b) the O2 level and (c) the TC density, (d) the vessel radius, (e)
the ﬂow rate and (f) the shear force. The latter three are given as the average over actually occupied sites within a shell, instead of over all sites. For t ¼1200h also the root
mean square deviations are indicated as error bars.
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and (d) on the right column show respective averages of the left-
hand side data. These distributions show the behaviour that zones
with elevated hkrpki are also probable locations of high MVD.
We further quantify the spatial inhomogeneities by probability
distributions for local MVD (Fig. 12a), necrotic region size (b) and
hot spot size (c). The distributions are determined by histograms
of the respective local samples, combined from 40 runs. The MVD
is estimated as the fraction of occupied sites within boxes
(250mm in size) of a regular grid. The plot displays two peaks.
One large peak at low MVD  0:07 which decays algebraically
with exponent 1:4 and a smaller peak at MVD  0:45. The latter
originates from the high-MVD zone in the tumour periphery. Not
included is a peak which appears at MVD ¼ 0 due to large non-
vascularized regions. The necrotic-region size distribution shows
the probability to ﬁnd a cluster of dead TCs with a given cell
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Fig. 7. Scatter plot showing hydrodynamic variables of a single simulation run
plotted against the vascular radius. Each data point is a sample from uniformly
distributed locations over the entire network. Samples from arteries are red and
plotted with negative radius, capillaries are pink, veins are blue, all drawn from the
original vasculature at t ¼0h. Black dots represent samples from the tumour
vasculature of base case at t ¼1000h. Since tumour vessels have no hierarchical
organization, these points were put with probability 1/2 on one side or the other.
(For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)
Fig. 8. Flow rate distribution in the vessel network shown in Fig. 4 with a
logarithmic scale. The ﬂow rate here is the blood volume per time through the
vessel cross-section, not to be misunderstood as the blood ﬂow per tissue volume.
In our results dilated tumour internal vessels usually exhibit high ﬂow rates like in
this instance. If one would measure in/outﬂow per tissue volume element as in
dynamic MRT measurements one would observe hot spots located at the
respective high-MVD zones.
Fig. 9. Final conﬁguration at t ¼1200h of a simulation run using an alternate
vessel collapse rule where vessel collapses are restricted to a thin band (here
400mm in width) around the invasive edge. The new collapse probability pðcollÞ
ring
equals pðcollÞ modulated with a window-function which depends on the distance to
the tumour centre (see text). In this instance, parameters are such that the mean
survival time of unstable vessels is of the order of the time they spend in the
‘‘collapse region’’. This puts the random collapse process in a dominant role over
the maturity variable. The system is near a transition to a fully vascularized
tumour. The parameter set is the same as in the base case, except for the critical
shear force f ðcollÞ which is set to 3 Pa, instead of 1Pa.
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count. The hot spot size distribution plots the probability to ﬁnd a
cluster with a certain number of sites where the local MVD is
larger than a threshold (here 0.15). Both of the latter distributions
exhibit purely algebraic decay also with the exponent 1:4.
3.5. Drug transport
To analyze the effectiveness of blood-borne drug transport to a
tumour and its distribution inside a time-dependent concentra-
tion proﬁle over the vasculature is propagated according to the
local blood ﬂow rates. A corresponding mathematical model was
presented (McDougall et al., 2002) for a pure vessel-in-growth
capillary network, originating from a single parent vessel. It was
predicted that large amounts of drug bypasses the tumour,
varying by an order of magnitude depending on parameters. We
adopt this method to check whether there are similar obstacles to
successful drug delivery inherent to the tumour vascular net-
works, predicted by our model.
The starting point is a given conﬁguration for the vasculature
with precomputed variables for ﬂow, ﬂow velocity, vessel length,
and radius. In addition, a mass parameter m is now associated
with each vessel describing the amount of drug in the blood
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Fig. 10. Vascular density versus the mean pressure gradient hjrpji originating
from the blood pressure differences between neighbouring vessels (see text). In
the main plot data points stem from different runs of the base case, whereby the
averages are taken over the entire tumour interiors (excluding the vascularized
boundary region) at t ¼1200h. The inset displays data for a single tumour, where
the averaging is done locally over a small disc with radius 150mm (see Fig. 11).
1mm
Fig. 11. Demonstration of the intermediate data that lead to the plots in Fig. 10: (a) shows the local magnitude of the gradient krpk (see text). To correlate the MVD locally
with krpk, mean values where computed at randomly distributed locations, each by averaging over a 150mm radius disc; (b) shows these samples, such that space closest
to some data point is ﬁlled with a grey scale value proportional to hkrpki; (c) shows the site occupation of the vasculature; (d) shows an estimate for the local vascular
density. Value ranges are 0–45 (black to white) for krpk and 0–0.4 for the MVD.
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volume contained in the vessel. The mass content m is
deterministically updated in successive time steps as follows:
ﬁrst the drug amount ﬂowing out of vessels is determined and
added to respective node-mass variables. Under the assumption of
perfect mixing, the nodal masses are then redistributed into
further downstream vessel. Thereby mass conservation is strictly
enforced. A detailed description can be found in Welter et al.
(2008) and McDougall et al. (2002). The most severe limitation of
this model is that there is no exchange with extra-vascular space
and therefore also no uptake by the tumour.
The results in the following were obtained with a continuous
injection into our base case vasculatures. From t ¼ 0 on, blood
with solute drug at conc. CðinitÞ ¼ 1 ﬂows into the vasculature
which is initially ﬁlled with ‘‘clean’’ blood. The ﬂow rates are of
the order ofmm/s, which is sufﬁcient to saturate 80–100% of the
vessels within seconds, depending on the network conﬁguration.
Fig. 13 shows a sequence of snapshots over 6 s. Drug enters the
system via the arteries and ﬂows downstream with a sharp
transition at the drug/clean interface. When vessels merge in
upstream direction mixing with clean blood occurs so that the
concentration proﬁle smooths out in the veins. After 20 s nearly
full saturation is achieved. Dilation of internal tumour vessels and
direct connections to feeding arterioles lead to comparably fast
ﬁlling with drug. The torturous structure and the redirection of
blood ﬂow through shot-cuts, away from the capillary bed, leads
to decreased ﬂow rates in the periphery. Figs. 7c and 8 show such
vessels with low ﬂow rates of the order of 103 mm3=s,
corresponding to velocities of the order of 10mm=s. The average
ﬂow velocity over all vessels in the original network is 1:8mm=s.
Consequently we frequently observe regions which take
signiﬁcantly longer to be ﬁlled.
Quantitative analysis of drug efﬁciency impact is only possible
to a limited degree due to the lack of tumour uptake modelling.
Moreover even few surviving TCs can grow a new tumour mass.
Nonetheless we measured statistics for the total amount of drug
in the vasculature. Fig. 14a shows the fractional length of the
tumour vessel network for which the maximum drug
concentration was larger than indicated on the c-axis. After 20 s,
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Fig. 12. Probability distributions in log–log plots, for (a) the local MVD, given as the local average over 250mmwide boxes, (b) the volume of necrotic tissue clusters, deﬁned
as the number of sites in connected components of dead tissue, (c) the volume of vessel hot spot areas, deﬁned as the connected components of regions where the local
MVD exceeds a threshold (0.15). The distributions are generated by binning observed values in histograms over 40 simulation runs (at t ¼1200h). We note that the
distributions show algebraic decay. In this instance in particular with the same exponent with an error of 2%.
Fig. 13. Snapshots of the drug-ﬂow simulation using the basic conﬁguration (Figs. 3 and 4) at t ¼1000h. The colour code shows the drug concentration as indicated on the
gradient bar. A high drug concentration reaches most parts of the vasculature after a few seconds. In the T ¼ 6.6 s snapshots a few vessels in the boundary region are not
yet perfused. The time until drug saturates the complete vasculature is of the order of minutes. We can observe this behaviour generally for all resulting networks.
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on average 94 3% of the vasculature had been exposed to a drug
concentration of at least 80%. For higher concentrations the curve
decreases drastically. The curve at c ¼ 0 shows that 4 3% had not
been drug perfused at all. In absolute numbers the latter
corresponds to 15 12mm. Fig. 14b shows the fractional length
of the tumour vessel—network for which the concentration was
larger than the threshold c ¼ 0:25 for a total duration greater than
indicated on the x-axis as te. This measurement was also done at
t ¼ 20 s, thus the exposure time cannot be longer than that. It
shows that large parts, say 93 4%, of the vasculature had been
exposed to 50% drug concentration longer than 10 s. Considering
the ﬂow rates/velocities mentioned above one can expect the
remaining few millimetres to be drug perfused within a time
frame of minutes.
4. Conclusion
4.1. Summary
In this paper we formulated a hybrid cellular automaton model
to analyze the vascular remodelling process of an arterio-venous
vessel network during solid tumour growth. It is based on the
modelling approach described in Bartha and Rieger (2006), Lee
et al. (2006) and Welter et al. (2008) and extends it by
incorporating a hierarchically organized initial vasculature com-
prising arteries, veins and capillaries. The model involves sprout-
ing angiogenesis, vessel cooption, dilation and regression as well
as tumour cell proliferation and death.
The model predicts that the tumour vasculature emerging
from the interplay of these processes is non-hierarchical and
compartmentalized into a highly vascularized tumour perimeter,
a tumour periphery with large vessels density and dilated vessels
and a central region containing necrotic regions with a low
microvascular density threaded by extremely dilated vessels. This
tumour compartmentalization is therefore independent of the
initial vasculature, as has been conjectured on the basis of results
for models involving a grid-like initial blood vessel network
(Bartha and Rieger, 2006; Lee et al., 2006; Welter et al., 2008).
Blood-borne drug transport along the tumour vasculature also
turns out to be efﬁcient, the reason for it being the dominant
regression of vessels with low shear-forces leaving only those that
are well perfused.
One consequence of the arterio-venous initial vasculature,
which is absent for grid-like starting networks, is the emergence
of short-cuts or ‘‘shunts’’ and concomitantly an increased blood
ﬂow through the tumour vasculature. There are experimental
studies which agree with this prediction: in Sahani et al. (2005)
perfusion parameters in rectal cancer were measured via
computer tomography where consistently increased blood ﬂow
is reported by approximately a factor of two compared to normal
tissue. It was argued that angiogenesis facilitates the creation of
arterio-venous shunts which bypass the capillary network. The
same mechanism is at work in our model: thick arterioles and
venules provide a well-conducting support structure around the
tumour. Since the total pressure difference between the tree roots
is ﬁxed, the transported blood volume is given by the total
ﬂow resistance of entire vascular tree. Dilation of a few vessels
forming a path between the tree roots can remove bottlenecks
formed by thinner vessels. The creation of new vessels thereby
promotes arterio-venous short-cuts, or shunts, through multiple
partly disjoint paths. After vessel dilation this leads to a decreased
total ﬂow resistance, which implies an increased blood
ﬂow through the tumour vasculature when compared with the
initial vasculature. This is in contrast to grid-like initial networks,
where the total ﬂow resistance is dominated by the network
outside the tumour (Bartha and Rieger, 2006; Welter et al., 2008)
and the ﬂow cannot increase via the dilation of tumour internal
vessels.
Another consequence of an arterio-venous initial vasculature is
the emergence of isolated highly vascularized clusters connected
by thick vessels within the tumour vasculature. These ‘‘hot spots’’
are also observed in real tumours (Pahernik et al., 2001). Already
by a visual comparison of the starting network with the ﬁnal
tumour vasculature one observes that hot spots form more
frequently in those regions where the starting network contained
predominantly arteries. An analysis of the correlations between
various local hydrodynamic quantities of the original network
(blood pressure, blood pressure gradient, blood ﬂow) and the
local MVD in the tumour vasculature revealed a signiﬁcant
correlation between local blood pressure gradients of the original
arterio-venous network and the most probable locations of
hots spots in the tumour vasculature. This is plausible since a
high pressure gradient within the vessels implies a high
shear force exerted by the blood on the vessel walls, which
stabilizes the vessel against collapse and therefore leads to an
increased vessel survival probability when the tumour has grown
over this region. We note that in our model this hydrodynamic
mechanism plays a dominant role in the hot spot formation,
whereas potential local variations in pro- and anti-angiogenic
effectors within the tumour were not involved but could also play
a role in this process. It should be possible to check the model
predictions experimentally by implanting a tumour nucleus into
healthy tissue, whose vasculature has been analyzed before
implantation.
We also ﬁnd that the emerging spatial inhomgeneities in
the tumour vasculature are organized in a complex way: the
probability distribution of local MVD values as well as the
probability distribution of the hot spot volume (deﬁned as
the size of connected clusters of regions with MVD larger than
the original MVD) has an algebraic tail with exponent 1:4. Also
the size distribution of the connected clusters of necrotic tumour
regions showed an algebraic tail (again with exponent 1:4).
These power laws are reminiscent of a self-organized critical state
(Jensen, 1998), for which the absence of a typical length scale
(over which for instance size distributions would decay exponen-
tially) is characteristic, like in a stochastic dilution process at the
percolation threshold or a ﬂow-correlated percolation process
(Lee et al., 2006).
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Fig. 14. (a) Fraction of total tumour network length that has been exposed to a
drug concentration larger than the indicated concentration cmax (at t ¼ 20 s of the
drug simulation). The black line represents the average over 40 runs with different
networks. (b) Fraction of total tumour network length that has been exposed to a
drug concentration larger than 0.25 for longer than indicated time te . The black
line represents the average over 40 runs with different networks. Like in Fig. 15,
tumour networks from the base case at t ¼1000h were used.
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4.2. Discussion
We summarize brieﬂy what biological insights we can extract
from our work. (a) The experimentally observed compartmenta-
lization of the tumour vasculature (Holash et al., 1999a; Do¨me
et al., 2002) is independent of the initial vasculature and a
consequence of the basic mechanisms that we identiﬁed: (1) the
existence of an original vasculature, (2) angiogenic sprouting in
the tumour perimeter, (3) blood ﬂow correlated vessel regression
and (4) a switch from angiogenic sprouting to circumferential
growth within the tumour. If the latter is absent, thick vessels will
be rare, leading to increased shear ﬂow and concomitantly to
increased stability of the tumour vessels—thus altering the
compartmentalization. In addition we predict that (b) blood-
borne drug transport is efﬁcient through a tumour vasculature in
which vessel regression is blood ﬂow correlated—experimentally
observed deﬁciencies in drug delivery must have other reasons.
And (c) the experimentally observed hot spots or MVD inhomo-
geneities of the tumour vasculature are correlated with the blood
pressure gradients of the original vasculature.
Potential experimental tests for these predictions are: (i) if it
would be possible to experimentally switch off circumferential
growth or prevent vessel collapse the model predicts a different
compartmentalization of the tumour vasculature, which could be
analyzed experimentally with immunohistology; (ii) intravital
microscopy with ﬂuorescently labelled drug proteins or nano-
particles could be used to check the model predictions on blood-
borne drug transport; (iii) again using intravital microscopy the
local blood pressure in the original vasculature could be analyzed
before implanting subcutaneously a small ðradiuso2mmÞ tumour
spheroid. Then the emerging spatial inhomogeneities of the
tumour vasculature could be correlated with the spatially
resolved blood pressure in the original vasculature.
In this work we were mainly interested in the morphological
transformation of an arterio-venous initial vasculature by a
growing tumour. Our intention was to characterize the complex
geometry of the emerging networks and to identify the basic
initial conditions and processes determining the emerging vessel
network. There have been attempts to utilize such geometric
characteristics of the tumour vasculature (like the fractal dimen-
sion) as a diagnostic tools in cancer research (Baish and Jain,
2000), but the purpose of our present work was not to extend
these ideas. Rather, the messages that we intended to deliver were
simply: (1) the initial vasculature is an important determinant of
the tumour vessel network morphology and (2) the complex
geometry and characteristic spatial inhomogeneities of the
tumour vasculature emerges already from a few basic processes
which we described here phenomenologically with stochastic
rules.
Obviously one can pose the question, in how far our results
depend upon our stochastic modelling approach. This describes
certain processes on a coarser scale than ab-initio calculations
(Frieboes et al., 2007; Bauer et al., 2007; Wise et al., 2008; Milde
et al., 2008). For instance rather than calculating the solid stress
within the tumour explicitly and incorporating it, among other
factors, into the vessel collapse probability we use the prediction
of continuum mechanical models for tumour growth (see, e.g.
Breward et al., 2003) that solid stress is largest in the strongly
proliferating periphery of the tumour and increase the collapse
probability correspondingly in this region. Or rather than model-
ling adhesion forces between different cell species (ECs and
tumour cells) and providing tumour cells with the capability to
migrate, we do not involve migration and allow proliferation only
when space and nutrients are available. Although we restricted
ourselves in this paper to a parameter regime that leads almost
exclusively to circular tumours a signiﬁcantly enhanced nutrient
demand of the tumour cells can also produce protrusions along
the major vessels. Obviously, from a puristic modelling point of
view it would be desirable to replace the phenomenological
stochastic rules by deterministic processes involving solid stress,
cell–cell adhesion and cell motility. But we think that we
described the effect of these aspects on a sufﬁciently large scale
correctly such that the main message (see above) will not change
by a more detailed modelling, which is underway (to be
published).
Besides these mechanical aspects there are important bio-
chemical processes that we also modelled phenomenologically:
(1) Instead of incorporating the negative feedback-loop involving
VEGF receptors, Dll4 and Notch that restricts tip-cell generation
during angiogenic sprouting (Bentley et al., 2008) we simply
employed a rule, by which tip-cells can only be generated every
2nd or 3rd vessel segment (corresponding roughly 2–3 EC
lengths). Such a rule is necessary when the initial vasculature is
ubiquitous as in our model since otherwise the presence of VEGF
generats tip-cells in an uncontrolled fashion. (2) Instead of
modelling angiogenic sprout migration and branching involving
matrix metalloproteases and collagen ﬁbres (Bauer et al., 2007;
Milde et al., 2008) we used commonly accepted stochastic rules
(Anderson and Chaplain, 1998). The ubiquity of original vessels in
our model diminishes the importance of the migration and
branching process per se, since the intercapillary distances are
rather short, which is different from models without initial
vasculature. (3) We omitted an explicit mathematical description
of the up-regulation of Ang-2 in ECs of coopted vessels within the
tumour in Plank et al. (2004), but conﬁned ourselves to describe
only its destabilizing effect behind the tumour progresion front.
(4) Similarly we did not model explicitly the up-regulation of
EphB4 in tumour vessels that triggers the switch of the tumour
vascularization program from angiogenic sprouting to circumfer-
ential growth but incorporated this switch with a heuristic rule.
Our intention in connection with the aspects 1–4 was to
demonstrate that they have important consequences for the
global morphology of the emerging tumour vasculature, and not
to formulate a detailed ab-initio model for it. The simpliﬁcations
were mainly motivated by computational tractability considera-
tions for large scale simulations, in particular when transferring
the model into a three-dimensional environment. In any case we
would like to stress that if one would endeavour to implement a
simulation environment that is expected to predict the growth of
a particular tumour type in a speciﬁc tissue these aspects must be
incorporated. In particular the geometry and characteristics of the
initial vasculature has to be taken into account, which is missing
in almost all existing tumour growth models. Not only the
morphology of the emerging tumour vasculature is completely
different in vessel-in-growth models (Anderson and Chaplain,
1998; Zheng et al., 2005; Frieboes et al., 2007; Wise et al., 2008;
Milde et al., 2008) when compared with our results, but also their
blood ﬂow characteristics and their determinants for blood-borne
drug transport are completely different (McDougall et al., 2002,
2006).
Hence the question remains, in which situations (or for what
tumour types in which tissue) a vessel-in-growth model might be
sufﬁcient or whether the initial vasculature has to be taken into
account. One has to consider that living tissue is always
vascularized and that intercapillary distances for any tissue range
from 50 to 150mm. It appears therefore highly improbable that a
tumour nucleus resides more than 200mm away from the next
capillary, and once it starts to grow parts of it will penetrate
vascularized tissue. A pure vessel-in-growth situation is therefore
only realized under artiﬁcial circumstances like in animal models
(Gimbrone et al., 1974), and represents possibly a good approx-
imation in cases where the tumour grows asymmetrically on a
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vascularized tissue sheet and extends perpendicularly into non-
tissue region, as for instance in the dorsal skinfold chamber. In all
other situations, in particular when tumours grow completely
within well-vascularized tissues, an appropriate description of the
surrounding tissue blood vessel network needs to be taken into
account.
As we have mentioned before we have already generalized our
model to a three-dimensional situation. Most aspects of the model
can be transferred in a straightforward manner (Lee et al., 2006),
only the construction of a three-dimensional arterio-venous
network poses a non-trivial technical problem (to be published).
We will also model O2 release with associated intravascular O2
decrease and replace the current discrete representation of
tumour cells by a continuum description involving mechanical
stress, tumour cell migration and cell–cell adhesion. For the study
of drug-delivery within tumours in addition to blood-borne drug
transport also extravasation and the interstitial ﬂuid transport has
to be incorporated into the model.
Appendix A
In this Appendix the construction of vascular trees is described.
The construction is based upon a small set of prescribed
vascular stems from which arterio-venous trees will be grown.
The basic structural element for this process is a tripod consisting
of three vessel segments arranged in 120 angles. These tripods
are appended successively at randomly chosen sites, either at the
leafs of the growing trees or on the starting vessels. Thereby
overlap with already occupied sites/bonds is forbidden, and so the
process continues until there are no more valid conﬁgurations
where tripods could be added. The resulting network consists of at
least two binary trees with at least one arterial and one venous
side (Fig. 15b, c).
To compute blood ﬂow vessel radii must be known. ‘‘Murray’s
Law’’ (Murray, 1926) relates the radius of a parent vessel ar to the
radii of branches br , cr . a
a
r ¼ b
a
r þ c
a
r , where a ¼ 2:7 is a realistic
value as used by Go¨dde and Kurz (2001). The radii of the tree
leaves are set to 4mm for arteries, and 5mm for veins. Thus all
other radii can be computed in a recursive algorithm which visits
a vessel once its descendants have been processed.
To get a complete network, for each lattice bond a ‘‘capillary’’
vessel is added (3:5mm radius) if it connects an arterial tree with a
venous tree, if less than three vessels will connect to the nodes,
and if all connected vessels fulﬁl ro20mm.
Fig. 15d illustrates a sample conﬁguration at this point before
the second stage, in which the network is optimized by an
iterative remodelling process. This consists of radius computation,
capillary creation, ﬂow rate and shear force computation, capillary
removal, and the actual remodelling sweep, until the system
reaches a steady state. Our remodelling sweep works as follows:
an event type E 2 growth; death is drawn randomly for each
segment according to the respective weights wg ;wd. Relating
these to shear stress f such that wg is monotonically increasing
and wd is monotonically decreasing leads to expansion in well-
perfused branches while non-perfused branches regress and make
room for further growth. The details of the f dependence are not
crucial. A linear mapping ~f :¼ðf  fminÞ=ðfmax  fminÞ of the interval
between the extremal values fmin and fmax over the vasculature
usually sufﬁces. Moreover we add a constant ‘‘offset’’ w0 to both
weights. This reduces the rate at which uncirculated vessels
regress. And secondly it adds ﬂuctuation to prevent deadlocks in
high shear stress regions. Thus the ﬁnal weights are wg ¼ ~f þw0,
wd ¼ 1
~f þw0. Tree vessels are then traversed in random order.
An event Emay take place but it can be rejected. This would be
the case for the death of a segment in the middle of the tree since
removal is restricted to the tree leaves. Growth happens at the
downstream end of a vessel, not limited to leaves. It is rejected if
there are already two daughter branches, or if the vessel radius
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Fig. 15. Sketch of the construction method of vascular trees. The snapshots show a sample system, three times smaller than those needed for the simulation runs, during
the growth stages. Arteries are shown in reddish tones, veins in blue. A dim colour indicates that no blood ﬂow takes place. A saturated colour means that the vessel is
perfused: (a) shows initial vessel chains randomly placed within speciﬁed bounds, (b) shows an intermediate conﬁguration during the ﬁrst stage where tripod elements are
randomly attached to the tree tips, (c) shows the result of this stage, in (d) connecting capillaries (colour coded white) have been added as well as all vessel radii determined
and blood ﬂow computed. In between the perfused branches many other branches were unable to connect to their opposing type. Moreover the capillary distribution is
concentrated half way between the major vessels, (e) shows an intermediate snapshot of the subsequenct optimization stage. Remodelling at the tree tips takes place based
on the shear stress distribution. Weakly perfused vessel are removed, leaving space for growing heavily perfused vessels. Eventually this leads to a homogeneous capillary
distribution in a well perfused network (f). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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r450mm, or trivially if there are no unoccupied lattice sites. Else
one of the admissible conﬁgurations is randomly picked. Beside
tripods we also allow single vessel to be added. This facilitates
growth into regions where bottlenecks evolved due to close
proximity of two or more major vessels. Fig. 15e shows an
intermediate step during stage. And Fig. 15f shows the ﬁnal
conﬁguration.
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Abstract. The process in which a growing tumor transforms a hierarchically organized arterio-venous blood
vessel network into a tumor speciﬁc vasculature is analyzed with a theoretical model. The physical deter-
minants of this remodeling involve the morphological and hydrodynamic properties of the initial network,
generation of new vessels (sprouting angiogenesis), vessel dilation (circumferential growth), vessel regres-
sion, tumor cell proliferation and death, and the interdependence of these processes via spatio-temporal
changes of blood ﬂow parameters, oxygen/nutrient supply and growth factor concentration ﬁelds. The
emerging tumor vasculature is non-hierarchical, compartmentalized into well-characterized zones, displays
a complex geometry with necrotic zones and “hot spots” of increased vascular density and blood ﬂow
of varying size, and transports drug injections eﬃciently. Implications for current theoretical views on
tumor-induced angiogenesis are discussed.
1 Introduction
Tissues in living organisms need a persistent supply with
oxygen and other nutrients provided by the vascular blood
flow through the vessel network threading the tissue. Fast
proliferating cells in a growing tumor have an increased
oxygen/nutrient demand, for which reason tumors usually
cannot grow beyond a size of 1-2mm3 without modifying
the original vasculature. This modification, comprising a
substantial increase of microvascular density in the growth
zone of the tumor, is denoted as angiogenesis, the creation
of new blood vessels from existing ones [1].
The emerging tumor vasculature is in many respects
diﬀerent from the hierarchically organized arterio-venous
blood vessel network in normal tissues. The expected in-
crease in microvascular density (MVD) is usually observed
in the periphery of the tumor, whereas the morphology of
the vasculature in the tumor center is characterized by
decreased MVD, dilated vessels, and regions of necrotic
tumor tissue [2–5]. The resulting tumor-specific capillary
network is very heterogeneous, composed of dense and
void regions, and has geometric properties diﬀerent from
normal arterio-venous or normal capillary networks.
Besides pro- and anti-angiogenic molecular factors,
mechanical, hydrodynamical and collective processes must
be involved in the process that transforms or remodels the
original arterio-venous blood vessel network into a tumor-
specific vasculature. In this paper we want, with the help
of a theoretical model, to address the physical determi-
nants of the dynamical evolution, final morphology and
a e-mail: h.rieger@mx.uni-saarland.de
blood flow properties of a tumor blood vessel network. We
hypothesize that co-option of existing vessels and vessel re-
gression, besides angiogenic sprouting and vessel dilation,
are essential processes that determine the geometric and
hydrodynamic properties of the tumor vasculature.
The study of theoretical models of tumor growth has a
long and multifaceted history (for recent reviews, see [6,7]
and references therein). Earlier work focusing on tumor-
induced angiogenesis can roughly be divided into three
categories: 1) continuum models without a proper repre-
sentation of a blood vessel network and blood flow [8–12];
2) hybrid models with a fixed vessel network geometry
and a dynamically evolving tumor [13–15]; and 3) hy-
brid models with a fixed tumor (as a source of a diﬀusing
growth factor) and a dynamically evolving tumor vascu-
lature starting from a single parent vessel far away from
the growth factor source [16–19].
The latter models are also denoted as vessel-ingrowth
models since the whole tumor vasculature grows from out-
side towards the tumor surface. Subsequent work was
still inspired by these vessel-in-growth models [20–24]:
although in these studies the tumor also evolved dy-
namically, focusing on a detailed analysis of the inter-
actions between tumor and host tissue, all new vessels
started to grow from one or more parent vessels in a non-
physiologically far distance from the tumor. The remod-
eling process that transforms the original arterio-venous
vasculature of the host tissue into a tumor-specific vessel
network has not been addressed with this Ansatz, which
is the topic of the work that we present in this paper.
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In recent work [25–27], see also [28], the issue of vas-
cular remodeling in a growing tumor by the three basic
mechanisms —angiogenic sprouting, vessel regression and
dilation— was addressed in a model that comprised a reg-
ular capillary grid as initial vascular network. The com-
partmentalization of the tumor as well as other global
features, like the time and radius dependences of aver-
age MVD, tumor cell density, vessel radius and blood flow
characteristics, were predicted in good agreement with ex-
perimental data, but local characteristics, like a single hot
spot in the center and a general bias in the flow direction,
could be attributed to the special topology of the initial
network. In this paper we consider a more realistic three-
dimensional arterio-venous vascular network as initial vas-
culature and study the eﬀect it has on the emerging tumor
vasculature. It is based on a simplified two-dimensional
model that was studied in [29].
In well-vascularized tissue the average inter-capillary
distance is 50–100µm, in highly vascularized tissue like
brain even less (depending on the oxygen demand and
the resulting diﬀusion length), implying the importance of
the incorporation of the original vasculature into a model
for tumor-induced angiogenesis. This vasculature is orga-
nized in a hierarchical way, in which an arterial and a
venous tree are interdigitated by capillaries. Oxygen and
other nutrients are distributed into the surrounding tis-
sue by the lowest-level capillaries, the two trees represent-
ing their supply and drainage system. The MVD, given
by the average inter-capillary distance, is homogeneous
in one kind of tissue to provide a homogeneous oxygen
and nutrient supply, but the two interdigitating hierarchi-
cal trees form a spatially very inhomogeneous blood ves-
sel network. Consequently the vascular remodeling process
in a growing tumor will also be spatially inhomogeneous:
sprouting angiogenesis occurs mainly from capillaries and
venules, higher-level arteries protected by a thick layer of
pericytes are more stable and regress later or not at all, re-
gression of higher level arteries has fatal consequences for
the whole arterial sub-tree below it, newly formed vessels
between arteries and veins could act as shunts redirecting
huge amount of blood, etc.
With this background we want to analyze the trans-
formation of the well-organized hierarchical structure of
an arterio-venous vessel network when it is co-opted and
remodeled by an aggressively growing tumor. We are in-
terested in the geometrical characteristics of the emerging
tumor vasculature and the potential mechanisms leading
to spatial inhomogeneities or hot spots. And we will study
the global blood flow patterns and the drug transport per-
formance of the tumor vasculature. The paper is organized
as follows: In the next section the model is defined, in-
cluding the method to construct an arterio-venous initial
network. Section 3 presents the results for global proper-
ties for a choice of parameters that is guided by experi-
mental data for melanoma [4,5]. These results include a
discussion of the emerging morphologies; radial distribu-
tions of vessel density, vessel radius, tumor density, flow
rates, shear forces, etc., vessel statistics, parameter depen-
dencies, spatial inhomogeneities, and drug flow. Section 4
concludes the paper with a summary of the main results
and a discussion.
2 Model definition
An arterio-venous network serves as the initial vascula-
ture for our model of remodeling by a growing tumor.
Depending on the local oxygen concentration, tumor cells
represent the sources of the diﬀusion determined growth
factor (GF) concentration field, which triggers either the
generation of tip cells for angiogenic sprouting from ex-
isting vessels outside or at the periphery of the tumor,
or circumferential growth within the tumor (for potential
molecular mechanisms for this switch in the angiogenic
program within the tumor, see [30]). In contrast to vessel
in-growth models as in [16], tip cells are not dominantly
generated by branching of existing tip cells but by sprout-
ing from vessels of the original network. Lateral inhibition
leads to a minimum spatial distance in a vessel segment
between individual tip cell generation events [31].
Tip cells migrate in the direction of a suﬃciently large
GF gradient (chemotaxis), otherwise randomly. The path
they describe is supposed to be filled with stalk cells form-
ing a lumen and finally, once the tip cell hits another ves-
sel (anastomosis), a functional vessel carrying blood flow
is formed. Due to the pre-existing vasculature, vessels typ-
ically migrate only 50–100µm before the filopodia of the
tip cell extending up to 20–30µm into the surrounding tis-
sue in all directions [32] touch another vessel. Therefore
directional cues are not as important here as in pure vessel
in-growth models. And tip cells migrate maximally 100–
150µm and in case they did not make successful contact
with another vessel, they retreat [33].
Inside the tumor, vessels destabilize and regress (for
the potential molecular determinants of this destabiliza-
tion, see [2,3]). In our model an increasing contact time
of vessels with tumor cells, implying an increasing resi-
dence time within the tumor, leads to a higher collapse
probability of tumor vessels. The collapse probability is
also correlated with the origin of the vessel (artery, vein
or capillary) and the shear force exerted by the blood flow
upon the vessel walls [34].
2.1 Configuration space
The model consists of a discrete representation of the vas-
culature and continuum models for a non-specific growth
factor concentration g, oxygen concentration o and tumor-
cell density c.
The vasculature can be described as a graph where
edges represent vessel segments and nodes represent
branching points, respectively. This graph is embedded in
a regular cubic lattice with the lattice constant Δl, which
means that the nodes are located at the lattice sites and
edges are coincident with the lattice edges. Vessels and
nodes are dynamically created and destroyed over time. In
Addition they have attached biophysical properties which
can also vary over time.
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Fig. 1. Relative viscosity ηrel as a function of the vessel radius
r. The actual viscosity is the viscosity of blood plasma η =
4 ·10−6 kPa s×ηrel. The shape of ηrel was obtained from a best
ﬁt of experimental in vitro data [37]. ηrel is also a function of
the hematocrit H. For simplicity, we assumed that H = 0.45,
the average in humans.
2.2 Blood flow
To compute blood flow, vessels are treated as a network of
pipes with radius r, volume flow rate q and wall shear force
f . q is determined by Poiseuille’s law i.e. q ∝ r4/η(p1−p2)
given the hydrostatic pressure diﬀerence p1−p2 at the at-
tached nodes. The viscosity η is radius dependent, follow-
ing [37], see fig. 1. For simplicity under the assumption of
a homogeneous hematocrit of 0.45. As boundary condition
the pressure is fixed at the arterial and venous roots of the
vascular trees. Together with the mass conservation, i.e.
inflow equal outflow rates at the nodes, we obtain a sparse
linear equation system which is solved numerically.
2.3 Tumor cell density
Here we introduce a continuum model for the tumor cell
density c(r, t). Under stress-free conditions without cell
proliferation and death, the tumor cell density is c(norm),
which we assume to be 1/10µm3, reflecting a typical lat-
eral size of tumor cells of 10µm. The dynamical evolution
of the tumor cell density in the presence of cell prolif-
eration and death is assumed to be given by a reaction-
diﬀusion equation
∂c/∂t = −∇ · J + c+ + c−, (1)
where J is the tumor cell flux and c+ and c− are source
and sink terms describing cell proliferation and death, re-
spectively.
In the following c+, c− and J are defined: We as-
sume that tumor cells need suﬃcient oxygen to prolifer-
ate, which means that the local oxygen concentration o
must exceed the threshold o
(prol)
TC , else c
+ = 0. Moreover
we assume that a maximum packing density c(max) exists
where cells are compressed so that they cannot proliferate
further. We use the simplest expression to reflect that
c+ = 1/t
(prol)
TC c
(
1−
c
c(max)
)
if o ≥ o
(prol)
TC else 0, (2)
where t
(prol)
TC is the mean proliferation time of uncon-
strained cells. Furthermore we assume that cells undergo
apoptosis with the constant death rate 1/t
(death)
TC if the lo-
cal oxygen level o drops below o
(death)
TC . The model includes
this by the definition of c−,
c− = −1/t
(death)
TC c if o < o
(death)
TC else 0. (3)
For simplicity, interaction with the resulting cellular de-
bris is neglected. In the following the cell flux J is defined.
We assume that cells migrate only in response to compres-
sion. Therefore a phenomenological “solid pressure” P is
introduced. Its equation of state depends on the cell den-
sity c as follows: Below the density c(norm) cells are not
compressed, thus feel no forces, thus we set P = 0 for
c ≤ c(norm). Else we define P as linear function which is
zero for c = c(norm) and increases to P = 1 for c = c(max).
In the style of Darcy’s law, momentum terms in the equa-
tions of motion are neglected so that the cell migration
speed is proportional to the driving force, which means
that
J = −Dc∇P, (4)
where D is an additional mobility constant. The cell den-
sity cannot exceed c(max) since there are no external forces
and c+ → 0 for c→ c(max) even though P remains finite.
In the general framework of such a model it would be
possible to add cell-cell adhesion. In this case one would
consider volume fractions of other species, e.g., normal
tissue and necrotic tissue which interact via a free energy
potential. See [21] and the references therein. The result is
an eﬀective surface tension force. Combined with expan-
sive forces which drive the tumor rim outward, it can cause
a fingering instability. In our simpler model where we have
omitted such forces, tumor cells move diﬀusively opposed
to their density gradient. Since tissue oxygenization is ho-
mogeneous on a coarse scale, this results in approximately
spherically growing tumors. Biologically our model corre-
sponds to a situation where tumor cells adhere to each
other as much as to other cells. Also the tumor can ex-
pand without significant resistance from the surrounding
tissue. We can justify this considering that i) not all tu-
mors exhibit fingering instabilities, ii) we consider small
tumor of less than 1 cm diameter and iii) pH level changes
can happen that kill normal cells.
Below we compare our results with experimental data
from melanoma. To accommodate the model to this spe-
cific tumor type, which can extend through multiple
skin layers from the surface to muscle tissue, it would
be straight forward to include inhomogeneous and/or
anisotropic environments. We would expect this to trig-
ger a diﬀerent front shape of the growing tumor. However
we think —as is the case with a “fingering” tumor— that
the characteristics of the blood vessel network which we
are interested would be invariant with respect to such ad-
ditions.
In order to identify necrotic regions, we record the
maximum local TC density over time. If the current TC
density is zero and there were TCs in the past, we consider
the location to be necrotic. On the basis of the rest of our
framework, there are no forces that would impose inter-
esting dynamics on the shape of necrotic regions. Thus we
use this crude approximation.
The equations are discretized with a simple explicit
finite-volume scheme on a cubic grid with 30µm grid cell
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size. We compute the fluxes through the cell faces sepa-
rately. Knowing the fluxes, ∇·J in (1) is discretized using
a convective upwind scheme. To ensure stability, the time
step for the integration is 0.1 h, whereas the updates of
the rest of the system (see below) are done in 1 h steps.
2.4 Oxygen concentration field
The time scale for oxygen diﬀusion to reach a stationary
state is of the order of seconds whereas the times scale for
tumor cell proliferation, tip cell migration and endothelial
cell proliferation is of the order of hours. Therefore we
use for the oxygen concentration the quasi-static solution
o of the diﬀusion equation, which adopts instantaneously
any change in the source (vessels) and sink (tumor cells)
configuration,
0 = ∇2o− γoo+ αo(o(B) − o), (5)
where γo is a consumption rate coeﬃcient, o
(B) the blood
O2 level and αo a source coeﬃcient. γo is a linear combi-
nation of the tissue specific constants γ
(norm)
o , γ
(tum)
o and
γ
(necro)
o = 0, for normal tissue, tumor tissue and necrotic
regions, respectively. The definition of the density param-
eters implies that the necrotic areas inside the tumor do
not consume oxygen. The factor αo determines the amount
of extravasated oxygen per concentration diﬀerence at the
vessel wall. It is defined as permeability times wall surface
area per concentration and tissue volume. For simplicity
it assumes a constant value for all blood circulated ves-
sels. o(B) is the oxygen concentration in blood plasma, for
which local variations are also neglected.
The coeﬃcients γo and αo comprise the diﬀusion con-
stant and therefore it does not appear in (5). We estimate
γo based on the diﬀusion range Ro of oxygen around iso-
lated vessels found in tumors. Therefore we use that a
delta peak as source distribution generates an exponen-
tially decaying radial profile exp(−x√γo). Thus Rg is of
the order of 1/
√
γo. The parameter o
(B) is determined
such that, given γo, the concentration between vessels is
ca. 50% of the concentration at the vessel wall.
2.5 Growth factor concentration field
The growth factor concentration g is computed by a
Greens’ function-like method. Underoxygenized tumor
cells, which means that locally o < o
(prol)
TC , produce growth
factor at a constant rate. It diﬀuses through the tissues
and degrades with a constant rate. Therefore each source
cell produces an exponentially decaying distribution. Thus
we can write g as
g(x) =
∫
d3x′G(‖x′ − x‖) θ(o(prol)TC − o(x′)) c(x′), (6)
where θ is the Heaviside step function. For simplicity we
define G(x) ∝ max(0, 1−x/Rg) as a linearly decaying nor-
malized function which vanishes at x = Rg, where Rg is a
“diﬀusion range” and limits the region where angiogenesis
is induced.
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Fig. 2. (Colour on-line) Sketch of the vessel network remod-
eling processes. Initial/ﬁnal states are shown to the left/right
of the arrow with the rate parameter below and essential pre-
conditions above the arrow. Vessel segments are shown as blue
bars, the tumor is depicted as yellow mass and the underlying
lattice is illustrated in the background. (a) A new sprout is
generated by potentially splitting an existing segment, adding
a node and adding the new sprout segment. (b) A sprout is
extended by adding further segments to its tip. (c) Vessel re-
gression is modeled by removal of respective segments. This
can disrupt blood ﬂow, leaving non-circulated vessels which
are depicted in gray. (d) Vessel walls degenerate within the tu-
mor due to detachment of support cells. This is modeled by
a decreasing maturation parameter and depicted here as de-
creasing wall strength and surrounding debris. (e) Within the
tumor vessels dilate. See text for details.
2.6 Vessel network remodeling dynamics
The evolution of the network is subject to three stochasti-
cal processes: sprout initiation, sprout migration and col-
lapse as well as continuous wall degeneration and vessel
dilation (fig. 2). The definition of these processes closely
follows the definition in [29], where 2d networks are con-
sidered. Therefore we only give a brief description here
and refer in particular for the biological motivation of the
details to [29].
Sprout initiation: A new vessel segment can be added
with probability Δt/t
(sprout)
EC at any location on the
network if the local growth factor concentration is
non-zero, the distance to the next branching point is
less than l(spr) and the time spent within the tumor
is less than t
(switch)
EC . “Within the tumor” is defined
as 〈c〉 > c(norm)/2 averaged over the segment. The
new segment occupies an edge on the lattice (length
Δl) and points in the direction of the largest growth
factor increase.
Sprout migration: Those segments are tagged as sprouts,
which means that further segments can be attached
with probability Δt/t
(sprout)
EC , extending the original
sprout. Sprouts can also spawn sub-sprouts like
normal vessels can. They are, however, excluded
from the collapse, degeneration and circumferential
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growth mechanisms. Sprout vessels are untagged and
become normal vessels if the tip fuses with another
vessel such that blood can flow, or if their respective
lifetime variable τ , which every sprout has attached,
has reached its predefined maximum t
(migr)
EC . If the
tip fuses with another sprout without creating a
conducting branch, it remains tagged as sprout.
Wall degeneration: The structural support provided by
the cell layers surrounding the endothelial cells is
represented by the wall stability variable w. For new
vessels and the original vasculature it is initialized
with the wall thickness of healthy vessels, see [29].
For vessels inside the tumor its value decreases at the
constant rate Δw until zero.
Vessel collapse: A segment can be removed with proba-
bility Δt/t
(coll)
EC if its wall stability variable w is zero
and the wall shear stress f is below the threshold
f (coll).
Vessel dilation: The vessel radius r increases at the con-
stant rate kr if r < r
(max), the average growth factor
concentration over the segment is non-zero and if the
time spent within the tumor is larger than t
(switch)
EC .
Per time step (Δt = 1h), a Monte Carlo sweep is done
per stochastical process and all continuous variables and
fields are advanced in time. The parameter values that we
use throughout the paper are given in table 1 (references
to physiological data are given in [25,27,29]).
The model is stable with respect to parameters, since
our observables vary smoothly with parameter deviations.
For brevity we omit an analysis here. In our previous pa-
pers [25,27] we have discussed variations for 2d models
which are also relevant for the present study.
2.7 Arterio-veneous tree construction
The vasculature in real tissue exhibits a tree-like structure.
Few thick arteries branch out into arteriolar microvessels.
Terminal branches are connected to the capillary bed, a
dense network consisting of thin vessels where most of the
exchange with the surrounding tissue happens. Further
upstream blood is collected in venules which fuse into thick
veins. The design goal of such a structure is to provide a
suﬃcient supply of nutrients to all regions of the tissue,
while minimizing the energy necessary to maintain the
circulation.
In [35] a method was presented to construct represen-
tations of vascular trees stochastically according to prob-
abilistic rules that depend on local system properties. The
construction of the blood vessel network is based on the
stochastic remodeling of a collection of binary trees. Each
tree represents either an arterial or a venous branch. Anal-
ogous to the definition of the tumor growth model, the
tree edges coincide with the edges of a cubic lattice, and
have associated hydrodynamic properties. The remodel-
ing is executed in successive sweeps where tree leaves are
Table 1. List of parameter values used for all simulations.
Parameter Value Description
N 800 Lattice size
Δl 10μm Lattice constant
ΔlV 60μm Lattice constant (tree construction)
D 300μm2/s TC mobility
c(norm) 1/(10μm)3 Normal cell density
c(max) 2/(10μm)3 Maximum cell density
o(B) 1 Blood oxygen level
αo 0.004/μm
2 O2 source coeﬃcient
γ
(norm)
o 1/(100μm)
2 O2 consumption coeﬃcient
by normal cells
γ
(tum)
o 2/(100μm)
2 O2 consumption coeﬃcient
by tumor cells
Rg 200μm Growth factor diﬀusion range
t
(switch)
EC 24 h Sprouting/Dilation switch delay
t
(sprout)
EC 5 h/10μm Sprout extension time
t
(migr)
EC 100 h Sprout activity duration
l(spr) 20μm Sprout sites minimum separation
r(sprout) 4μm Initial sprout vessel radius
kr 0.4μm/h Vessel dilation rate
r(max) 25μm Maximum dilation radius
t
(prol)
TC 10 h TC proliferation time
t
(uo)
TC 100 h Hypoxic TC survival time
f (coll) 2Pa Critical wall shear stress
t
(coll)
EC 20 h Unstable vessel survival time
Δw 0.05μm/h Dematuration (w) rate
o
(death)
TC 0.01 TC hypoxia O2 threshold
o
(prol)
TC 0.1 TC proliferation O2 threshold
removed or extended depending on the wall shear stress
in the parent edge. Thereby moves that would result in
overlapping nodes are rejected. The initial configuration
is generated by first placing tree roots randomly at the
boundary sites of the lattice, followed by random growth
until the lattice is filled. Blood flow is computed between
remodeling sweeps. Prior to that, the individual trees are
connected by “capillary” edges, which are temporarily
added between leaves of opposing type. For brevity we
refer the reader to the appendix of [29], where the pro-
cedure is described in detail for a triangular 2d lattice.
The diﬀerence to the cubic 3d case considered here lies
in the number and location of root nodes and the pieces
appended at nodes where growth happens. Here we chose
initial locations of the root nodes randomly according to
a uniform distribution over the system domain faces. Ar-
terial and venous types are selected in alternating order.
A new location is rejected if it is closer than NΔl/10 to
either another root or an edge of the system domain. The
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Fig. 3. Visualization of the vessel and tumor conﬁguration generated by a simulation of the model at diﬀerent times. A cut
through the cubic simulation volume is shown. The vessels are depicted as cylinders which are color coded by their blood
pressure (blue = 0 kPa; red = 12 kPa). Non-circulated vessels are shown in gray. The spheroid in the center shows the isosurface
where the tumor cell density equals 50% of the normal packing density c(norm).
growth pieces are selected from three planar configura-
tions: a single edge, a ⊣ shape consisting of three edges,
and a − ⊏ shape consisting of five edges. The latter two
should approximate the more realistic Y shapes in real
vasculatures. Among all admissible configurations and ori-
entations, one is randomly picked.
While it is highly non-trivial to synthesize vascular net-
works that are realistic in every way possible, our initial
networks exhibit reasonable hierarchical structures, spa-
tial distributions of the capillaries, and agreement with the
flow data in [35] and the experimental references therein.
Figure 6 shows analogous plots which can be used for com-
parison. They are discussed with respect to the tumor net-
work in sect. 3.2.
3 Results
In fig. 3 we show snapshots of the dynamical evolution
of the tumor and vessel network configuration at succes-
sive times. Initially the tumor O2 consumption leads to
decreased O2 levels within the nucleus and consequently
enables vascular remodeling via growth factor production
of the TCs. The sprouting process first creates a dense
capillary plexus which provides more oxygen and facili-
tates tumor growth. Vessel collapses begin after a few days
(t = 200 h). Small capillaries collapse immediately under
bad perfusion while thicker vessels survive longer due to
their stability, i.e. large w, independent of blood flow until
they become unstable. The network is thus progressively
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Fig. 4. Left: ﬁnal conﬁguration (at time t = 600 h) of the simulation run shown in ﬁg. 3. Right: for comparison a ﬁnal
conﬁguration resulting from a simulation run that started with a diﬀerent initial arterio-venous network. Generally one observes
that the MVD behind the tumor rim is increased due to a large number of sprouting vessels. Most of them are not viable because
they cannot form blood circulated circuits, in addition also many original capillaries regress. The tumor becomes interspersed
with a few isolated, dilated vessels. The lack of oxygen in non-perfused regions leads to the empty (necrotic) regions in the
center.
remodeled, predominantly within a thin band around the
tumor boundary. The sparse network left in the center
remains static except for few collapses of isolated threads.
The resulting network morphologies shown in fig. 4
display the typical high-MVD periphery and low-density
center. The remaining internal vessels form short-cuts be-
tween arteries and veins which touch the tumor surface.
This is a consequence of the dilation that all vessels un-
dergo in the tumor. The short-cuts consist of neovascula-
ture as well as parts of the initial vasculature.
Starting with diﬀerent initial arterio-venous networks
yields diﬀerent final configurations, as shown in fig. 4, but
their global characteristics, as quantified by the radial dis-
tribution functions analyzed in the next subsections, do
not vary significantly.
The tumor masses grow approximately sphericaly.
After a short initial phase their radius increases lin-
early, since proliferation is predominantly restricted to the
boundary where suﬃcient space and oxygen is available.
The cell density profiles c exhibit steep slopes at the in-
vasive edges, dropping from c(norm) to zero. In the tumor
interior c fluctuates between zero and c(max), depending
on oxygenization.
3.1 Radial distributions
Figure 5 shows the tumor density (in all panels), aver-
age vessel radius (panel a), microvascular density (MVD,
panel b), oxygen concentration (panel c), blood flow rate
through the vessels (panel d), vessel wall shear force (panel
e) and growth factor concentration (panel f) as a function
of the radial distance r from the tumor center for diﬀer-
ent times. The data are averaged over 50 simulation runs
with diﬀerent initial networks and over concentric spheri-
cal shells centered around the tumor center. The microvas-
cular density (MVD) is defined as the volume fraction
occupied by the vessels. The quantities which are associ-
ated with vessel segments (radius, flow, shear force) are
averaged over the number of vessel-occupied lattice sites
within the respective shells.
In each panel the radial tumor density at the appropri-
ate times is represented by broken lines: it facilitates the
comparison of various features of the vessel quantities with
the tumor extension. The peak in the radial tumor density
indicates the boundary of the tumor (stochastic fluctua-
tions within the shells as well as from sample to sample
cause the finite width of this step). Since the individual
curves are for equidistant times, it is clear from the lin-
ear shift of the peak density that the tumor radius grows
linearly in time. Behind the peak, at smaller distances r
from the center, the tumor density drops monotonously,
reflecting the emergence of necrotic zones in the tumor
center.
The MVD in panel (b) of fig. 5 has a peak in the per-
itumoral region, i.e. outside of the tumor at a distance
slightly larger than the peak of the tumor density. It is 1.5
to 2 times higher than the normal MVD (plateau value at
large distances). Inside the tumor (at small distances) the
MVD drops monotonously to zero (at long enough times),
again reflecting the emergence of the necrotic core.
Correlated with the peak in the MVD is a small peak
in the oxygen concentration (panel (c) of fig. 5), and a dip
in the average vessel radius (panel (a)), the average flow
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Fig. 5. Results for (a) vessel radius, (b) microvascular density (MVD), (c) oxygen concentration, (d) blood ﬂow rate through
the vessels, (e) vessel wall shear force, and (f) growth factor concentration as a function of the radial distance from the tumor
center for diﬀerent times (see lower left panel for legend). The broken lines indicate the radial tumor density at the times
corresponding to the other data shown.
rate (panel (d)), and the average shear force (panel (e)):
The peak in the MVD in the peritumoral region reflects
the presence of many new capillaries, which increase the
oxygen supply but simultaneously decrease the average
vessel radius since capillaries have minimum radius. Fur-
thermore, since the average blood flow that is supplied by
the arterio-venous network is approximately constant, this
flow has to be distributed over 50–100% more microves-
sels in the tumor perimeter, which induces a reduction in
average flow rate and shear force.
Within the tumor (i.e. for distances smaller than the
location of the peak of the MVD) the vessel radius in-
creases monotonously with decreasing distance from the
tumor center (panel (a) of fig. 5), which is the eﬀect of
the switch from angiogenic sprouting to circumferential
growth within the tumor. The axial blood pressure gra-
dient within the vessels, dp/dl, which is not shown here,
decreases monotonically with decreasing distance from the
tumor center by more than one order of magnitude. Al-
though the pressure gradient decreases, the average blood
flow rate (q, panel d) within the vessels increases towards
the tumor center, since it is proportional to the 4th power
of the vessel radius R, q ∝ R4dp/dl. The average shear
force f is proportional to the 1st power of R, f ∝ R dp/dl,
therefore it decreases with decreasing distance from the
center.
The average oxygen concentration (panel c) decreases
rapidly towards the tumor center and drops below the GF
production threshold o
(prol)
TC = 0.1 (relative to normal oxy-
gen) at approximately the same distance rlow oxy, where
the growth factor concentration (GF, panel f) displays a
peak. This peak is therefore not at the same position as
the peak of the tumor density. For distances smaller than
the “underoxygenization radius” r < rlow oxy, all tumor
cells produce GF and the shape of the GF concentration
versus distance r is identical with the tumor density.
MVD and vessel radius show the typical compartmen-
talization that has been observed in melanoma [4,5] and
glioma [36]: For instance in [4] the MVD and vessel ra-
dius were measured in three distinct regions of human
and mouse melanoma: the central region, a 100µm wide
peripheral band just behind the invasive edge, a 200µm
wide peritumoral region outside the invasive edge. In the
central region, they found a MVD that was reduced to
25% of the MVD of normal tissue, and increaesd up to
200% in the peritumoral region. They found that the ves-
sel perimeter grew linearly from 50µm to a plateau at
200µm by day 15.
In contrast to our results for regular vascular net-
works [25–27], flow rates and shear force now show a
plateau similar to the vessel radius. In [25–27] the fixed
pressure gradient along the boundaries of the regular
(rectangular or hexagonal) networks led to unrealistic
star-shaped morphologies, directing all blood flow through
the center. The hierarchical initial networks that we con-
sider here do not have these artifacts and display a phys-
iologically realistic morphology.
3.2 Vessel statistics
Figure 6 shows scatter plots of hemodynamic variables
against the vessel radius r, which are in good agreement
with those obtained in [35]. The plots combine samples
throughout the full vasculature from all runs at t = 400 h.
We generally observe that the variance of the flow-
related parameters increases drastically towards the cap-
illaries. This might be an artifact of our initial network
construction, but averaged quantities display physiologi-
cally sound characteristics.
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Fig. 6. (Colour on-line) Scatter plots of vessel-related hydrodynamic quantities —shear force, pressure, and blood velocity—
against the vessel radius r (each dot corresponding to one vessel). Red dots (to the left with negative radius for better visibility)
correspond to arteriolar vessels, blue dots (to the right) to venous vessels, black dots (at r = 0) to capillaries, gray dots to tumor
vessels. The latter are randomly plotted on either side (arteriole or venous) because they do not exhibit a clear hierarchical
distinction. The plot combines samples uniformly distributed over the full vasculatures of all simulation runs at t = 400 h.
The blood pressure plot shows that the tumor vessels
tend to exhibit low blood pressure. The few larger tumor
vessels (r > 10µm), however, show a more uniform dis-
tribution. The velocity plot shows that these vessels have
high blood flow rates, whereas the average for capillaries
is about one order of magnitude lower. Both observations
support the view that tumor-internal vessels form short-
circuits between arteries and veins intruding into the tu-
mor rim. Responsible for this is the vasodilation mecha-
nism which acts on all tumor vessels and decreases their
flow resistance.
Compared to hierarchical 2d networks [29], flow pa-
rameters are distributed similarly. However, a few details
are apparent. i) The sigmoidal shape of the pressure distri-
bution seems to be more pronounced. ii) The shear force
in the arteries decreases for large r whereas it increases for
the 2d networks. iii) In fig. 7 of ref. [29] one could observe
tumor vessels which have reached the maximum dilation
radius and exhibit flow parameters spanning over several
orders of magnitude. We think that i) and ii) can be at-
tributed to the three dimensionality of the system which
enables diﬀerent initial network geometries to emerge. iii)
is the result of the shorter simulation time, since most tu-
mor vessels might not reach the maximum dilation radius.
3.3 Fractal dimension
The vascular tumor network is extremely inhomogeneous
and has geometric, in particular fractal, properties that
are very diﬀerent from normal vasculature [38]. The con-
cept of a fractal dimension is often used to characterize
diﬀerences between normal vasculature and tumor vascu-
lature [38,39].
One commonly used method to estimate fractal dimen-
sion is box-counting, which is carried out by superimpos-
ing boxes of size ǫ arranged as a regular grid on the fractal
object and counting the number of boxes Nǫ which overlap
the object. The self-similar nature of true fractal object
leads to the power law Nǫ ∝ ǫ−Df , where Nǫ is the number
of overlapping boxes. Df is usually extracted by a linear
fit in a log-log plot. However in experiments one can usu-
Fig. 7. Top: log-log plot of the box counts Nǫ against the
box size ǫ for the determination of the fractal dimension of
the tumor vasculature of one ﬁnal system. For the intersection
with the boxes, the vessels were approximated as lines. An
estimate for the fractal dimension is obtained from the best ﬁt
to Nǫ ∝ ǫ
−Df . Bottom: the data represent the (negative) local
slopes of the data points for Nǫ in the log-log plot above.
ally measure ǫ at most over two orders of magnitude. Fur-
thermore natural objects (or rather photographs thereof)
are usually not perfectly fractal i.e. box-counting plots ex-
hibit non-constant slopes. Therefore even a small constant
regime is often considered suﬃcient to speak of a fractal
dimension (or more truthfully named box-counting dimen-
sion); see the discussion in [41]. Therefore what we mean
in the following with “fractal dimension” is the number
that we obtained by the procedure described below and
which is analogous to the way in which this number is ex-
tracted from the analysis of experimental data [38,39,41].
For the application of the box-counting procedure, our
vessel networks are approximated as a collection of line
segments. For the measurement of the tumor network we
discard segments which are not within the tumor (“within
the tumor” is where 〈c〉 > c(norm)/2, see sect. 2.6). Our
data for log(Nǫ) as a function of log(ǫ) do not follow a
straight line as one would expect if Nǫ ∝ ǫ−Df but are
slightly bended, see upper panel of fig. 7. From the data
we can extract the local slopes and plot them as a function
of ǫ as done in the bottom panel of fig. 7. At small box
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sizes the local slopes are close to −1, reflecting the fact
that in the analysis we assumed the vessel segments to
be 1-dimensional objects. For larger box sizes the local
slopes start to reflect the network geometry (rather than
the geometry of individual vessels) and we can consistently
identify a small plateau at Df ≈ 2.5, which we take as our
estimate for the fractal dimension of the vessel network:
Df = 2.5±0.03 on average. This is in very good agreement
with the value obtained earlier for regular cubic initial
networks (in 3d) Df = 2.52± 0.05 [26].
In [26] it was hypothesized that the fractal properties
of the emerging tumor vasculature are independent of the
initial (3d) blood vessel network. Our present finding that
Df of the tumor vasculature for a 3d arterio-venous ini-
tial network is close to Df for 3d regular initial networks
supports this hypothesis.
We also checked the non-capillary parts of the ini-
tial network and obtained with equally well matching fits
〈Df 〉 = 1.46 for arteries, 〈Df 〉 = 1.51 for veins, and
〈Df 〉 = 1.64 for both combined, which is close to the es-
timate for real arterio-venous subcutaneous vascular net-
works [39].
Moreover, in [25,26] we identified the basic mechanism
responsible for the fractal properties of the tumor vascu-
lature as the stochastic, blood flow correlated removal of
vessels via vessel collapse and regression, denoted as flow
correlated percolation (see also [42]).
3.4 Spatial inhomogeneities and hot spots
“Hot spots” are regions of increased blood flow within the
tumor. It is possible to compare our results at least qual-
itatively with clinical imaging of tumor blood flow using
tomography techniques, e.g. [43]. Therefore we generated
maps of local average flow velocities 〈v〉 = 1|C|
∫
C
v(x)dx,
where C is a small subvolume, v(x) = q/πr2 is the flow
velocity at locations within a vessel and zero everywhere
else, and q denotes the flow rates of the respective ves-
sels. The integral is evaluated stochastically. An example
is shown in fig. 8. Analogous to imaging experiments, we
can find regions of zero flow and so-called hot spots with
high velocities. Unperfused regions coincide with necrotic
regions by design of our model. Likewise, hot spots are
identified by vessels threading the tumor. Since the tumor
vessels have high flow rates and are dilated, even one such
vessel can show up as a “hot spot”. Our model thus sup-
ports the hypothesis raised in [43] that hot spots are due
to highly conductive arterio-venous shortcuts.
In 2d [29], one could observe the formation of dense
vessel clusters accompanying the predominant isolated
strings of surviving vessels in the tumor center. It could
be shown that these clusters are more likely to form in
regions with high hydrodynamic pressure diﬀerences be-
tween neighboring vessels. A map of these pressure diﬀer-
ences can be constructed by determining the solution of
the Laplace equation for a pressure field p(r) defined on
the space between the vessels with the boundary condi-
tion that p(r) is identical to the blood pressure inside the
vessel at location r. Thus, the field p(r) interpolates the
Fig. 8. (Colour on-line) Local ﬂow velocity distribution in
a slice through a tumor vasculature. The yellow line shows
the c(norm)/2 isocontour of the tumor cell density. The plotted
quantity is the blood ﬂow velocity averaged over (50μm)3 grid
cells. The resulting image is reminiscent of MRI blood ﬂow
studies and shows regions with low ﬂow and hot spots. Since
we did not incorporate the interstitial ﬂow, the distribution is
zero where vessels are absent.
Fig. 9. Local values of |∇p| are shown, where p(r) is a continu-
ous ﬁeld which interpolates the blood pressure between neigh-
boring vessels of an initial network conﬁguration. (a) Shows a
slice through the center of a 3d system considered here and
(b) shows the result for a 2d network obtained in [29]. While
in (b) large-scale ﬂuctuations can lead to dense clusters of in-
ternal tumor vessels, (a) is comparably homogeneous and the
tumor networks consist of isolated strings in the tumor interior.
pressure between vessels. The (local) gradient magnitude
|∇p| of this map for the original vasculature shows posi-
tive correlation with the (local) microvascular density in
the emerging tumor vasculature in 2d [29].
However, dense vessel clusters observed in 2d [29] are
absent in the tumor vasculature emerging from the 3d
arterio-venous networks considered here. Concomitantly
the pressure (gradient) fields for the 3d initial networks
considered here are more homogeneous, except on a very
short scale between neighboring vessels. Figure 9 demon-
strates this by a comparison of the pressure gradient |∇p|
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for (a) a 3d initial network and (b) a 2d network. The
spatial variation of the pressure gradient |∇p| is deter-
mined by the geometry of the initial vessel network, which
again depends on the precise location of the roots of the
arterial and venous trees (sources and sinks) and the de-
tails of the construction algorithm. We think it would be
possible to construct an arterio-venous initial network in
3d, where results would resemble those reported for 2d
in [29], see fig. 9(b), but we have not checked this yet.
4 Drug transport
To analyze the eﬀectiveness of blood-borne drug transport
to a tumor and its distribution inside, a time-dependent
concentration profile over the vasculature is propagated
according to the local blood flow velocities. A corre-
sponding mathematical model was presented [17] for a
pure vessel-in-growth capillary network, originating from
a single parent vessel. We adopted this method to check
whether there are similar obstacles to successful drug de-
livery inherent to the tumor vascular networks.
The starting point is a given configuration for the vas-
culature with precomputed variables for flow, flow veloc-
ity, vessel length, and radius. In addition, a mass parame-
ter m is associated with each vessel describing the amount
of drug in the blood volume contained in the vessel. The
mass content m is deterministically updated in succes-
sive time steps as follows: First the drug amount flowing
out of vessels is determined and added to corresponding
node mass variables. Under the assumption of perfect mix-
ing, the nodal masses are then redistributed into further
downstream vessel. Thereby mass conservation is strictly
enforced. A detailed description can be found in [27,17].
The most severe limitation of this model is that there is
no exchange with extravascular space and therefore also
no uptake by the tumor.
The results in the following were obtained with con-
tinuous injections into the final tumor networks. Initially
the networks are filled with “clean” blood. Extravasation
of drug is neglected.
When drug is inserted simultaneously through all ar-
terial inlets, it is distributed very rapidly over the whole
network. Within the order of several seconds the network
is saturated with the maximum drug concentration. To il-
lustrate that, fig. 10 shows a sequence of snapshots over
5 seconds. At the tumor border, where the MVD is high
and the network contains many loops, there may be tiny
regions (ca. 100µm diameter) that take an order of magni-
tude longer to fill. Note also that the dilated tumor vessels
through the center conduct very well and act as short-
circuits between arteries and veins. The outer regions of
the system where the network remains normal can also
transport drug towards the tumor periphery. Therefore
the tumor as a whole is well perfused.
In [17,18] it was predicted that large amounts of drug
bypass the tumor, varying by an order of magnitude de-
pending on parameters. Drug bypassing also occurs nat-
urally in our model since all vessels (original and tumor)
are perfused with drug after ca. 5 s (see fig. 10). This is
independent of the details of the vasculature be it from
healthy or pathological tissue: whenever one wants to hit
a specific region of the vascularized tissue with a blood-
borne drug, one has to inject it into a high-level artery
which also branches into parts outside the target region.
The more relevant question therefore is: How long, during
an injection of length δt, are all target vessels exposed to
a drug concentration larger than a predefined threshold?
For realistic situations the question “how much drug vol-
ume” bypasses the tumor is somewhat ill-defined, since
the answer depends on the level of the arterial tree one
injects the drug in.
We analyzed how long tumor vessels are exposed to
a drug concentration larger than a predefined minimum
drug level cthres and show the result in fig. 11. It con-
firms the former visual impression that drug perfusion is
fast: For instance, in our 30 s simulation time over 90% of
the vessel network was exposed to at least c = 0.5 for at
least 25 s, and 99% for at least 15 s. Also the curves for
cthres = 0.5 and 0.01 nearly match, from which one can
conclude that drug advances through the network with
a sharp front, exposing vessels “on contact” instantly to
high drug concentrations.
Although we consider here continuous drug infusions, a
bolus injection of fixed drug volume or limited time should
be extremely short (less than 5 seconds) in order to be dis-
tinguishable from a continuous infusion due to the speed
at which drug is transported. Therefore our predictions are
also relevant for bolus injections longer than 5 seconds.
Qualitatively the results for drug flow reported here
agree with those for 2d arterio-venous networks [29]. A
notable diﬀerence is that in 2d the tumor networks can
disrupt the flow in larger regions (≫ 100µm diameter)
than here, which also extend into sections of the original
network. This is because the initial network configurations
considered in [29] have fewer pathways to major feeding
vessels. Therefore blood flow to aforementioned regions
passes through the comparably badly conducting tumor
boundary, resulting in low flow rates.
We remain with our conclusion that experimentally
observed deficiencies in drug delivery must have other rea-
sons, and these most probably lie within the characteris-
tics of extravasation of drug and interstitial fluid trans-
port within the tumor, which we did not include into the
present version of our model.
5 Discussion
In this paper we formulated a hybrid cellular automaton
model to analyze the vascular remodeling process of three-
dimensional arterio-venous vessel networks during solid
tumor growth. The model involves sprouting angiogenesis,
vessel co-option, dilation and regression as well as tumor
cell proliferation and death. It predicts that the tumor vas-
culature emerging from the interplay of these processes is
non-hierarchical and compartmentalized into a highly vas-
cularized tumor perimeter, a tumor periphery with large
vessel density and dilated vessels and a central region con-
taining necrotic regions with a low microvascular density
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Fig. 10. (Colour on-line) Snapshots of a drug ﬂow simulation in a tumor vessel network produced by our model. The color
code shows the dimensionless concentration (red: 1; blue: 0). The drug is injected with the initial concentration 1 at the arterial
root nodes. The transport is very eﬀective. Already after 5 s the vasculature is almost completely saturated.
threaded by extremely dilated vessels. This is a general
feature of the remodeling process of the normal vascula-
ture into the tumor vasculature in the model, and we pro-
pose this to hold also for in vivo tumor: none of the initial
characteristics of the original vessel network survives this
process. In this work this proposition was demonstrated
for a 3d arterio-venous initial network, and analogous ob-
servations have been made for 2d arterio-venous initial
networks [29] and for regular networks consisting of cap-
illaries of equal diameter arranged in a regular grid with
a given MVD, in 2d [25] and 3d [26]. Once the tumor
grows over it, it gets transformed into a compartmental-
ized network with irregularly arranged dilated vessels and
a decreasing MVD from the tumor periphery to the tumor
center, resulting in an inhomogeneous oxygen distribution.
5.1 Comparison with earlier work in 2d and 3d
Before more general conclusions are discussed, we high-
light some notable diﬀerences and similarities of the re-
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Fig. 11. Exposure durations: A point in the diagram means
that a certain fraction of the vessel network is exposed to a
drug concentration larger than cthresh for a duration longer
than te. Simulation time: 30 s.
sults of our model systems. The global morphology of the
vascular tumor networks, as reflected by measurements of
radial distributions of various parameters agrees qualita-
tively very well in all of our model versions. Quantitative
diﬀerences arise primarily in the flow rate distributions
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since these depend strongly on the network morphology.
Moreover, the vessel statistics of arterio-venous initial net-
works agrees very well in 2d [29] and 3d (fig. 6), and also
with [35] from where we adopted the initial network con-
struction method.
Concerning the emerging tumor vessel network mor-
phology, significant diﬀerences to the results reported here
exist for regular initial networks [25–27]. In these studies
a linear blood pressure gradient was imposed as a bound-
ary condition which drives blood from from one corner of
the simulation domain to the opposite corner. This aligns
surviving tumor vessels in the flow direction, and can even
impose artifacts where vessels converge to a singular point
in the center of the tumor. These artifacts are absent in
hierarchical arterio-venous initial networks studied in this
paper and in [29]. Resulting tumor networks are isotropic,
but may not be homogeneous. One can divide them into
sections which consist of dense clusters of capillaries and
on the other hand vessels which thread the tumor as iso-
lated strings. We can attribute their relative occurrence to
the morphological details of the initial networks —location
of major feeding/draining vessels in particular.
Analysis of the fractal dimension Df (see below) can
give valuable insight into the fundamental mechanism of
the emergence of the specific tumor network morphology.
In all of our model systems the value for Df agrees rea-
sonably well with the value of the fractal dimension of
the critical percolation cluster in site percolation, either
in 2d [25,29] or in 3d, [26] and this study.
Lastly, our simulations show that drug transport is
much more eﬃcient for arterio-venous networks than for
regular (capillary) networks [27]. The latter case is not
a very realistic choice for transport studies, since it lacks
the fast pathways provided by arteries and veins. For grid-
like initial capillary networks it takes ca. 60 seconds for
drug to travel from one end of the system to the other.
Arterio-venous networks, in contrast, both in 2d and 3d,
lead to the saturation of 90% network with drug, includ-
ing the tumor section, within ca. 6 s. There are isolated
regions where vascular remodeling cuts oﬀ high-level arte-
rial/venous vessels and redirects flow through the weakly
conducing neo-vasculature in the tumor boundary. This
leads to locally decreased flow rates, so that drug deliv-
ery is an order of magnitude slower. This eﬀect is more
pronounced in 2d than in 3d.
5.2 Conclusion
We propose that vessel collapse and local blood flow char-
acteristics have to be correlated via the local shear stress.
If the collapse events would occur independently from one
another with some probability p, a fundamental law in
percolation theory [44] predicts that either the interior of
the tumor is completely filled (i.e. does not contain large
connected necrotic regions) or it is completely void up to
a small boundary region —except for one special value for
the parameter p, the percolation threshold pc. We con-
firmed this scenario by testing diﬀerent model variants
containing uncorrelated collapse events. The existence of
a model parameter like the collapse probability that has
to be fine-tuned to a special value in order to reproduce
vessels that thread the whole tumor would obviously be
unsatisfactory. Only if we correlated the vessel collapse
with the shear stress, the model predicts a realistic vas-
cular network morphology that is robust against parame-
ter variations. The basic mechanism for this robustness
is the redirection of the flow after collapse events into
still intact vessels resulting in an increased shear stress
in the remaining vessels and thus a drastically reduced
collapse probability. Shear stress rather than blood flow
as a hemodynamic criterion for vessel stability appears to
be plausible, since the endothelial cells in the vessel wall
have information about the shear stress but probably less
about the total flow. We checked that a correlation of ves-
sel collapses with the blood flow also leads to unrealistic
network morphologies in which only a few vessels survive
within the whole tumor (i.e. a tumor periphery with in-
creased MVD is completely missing). The reason for this
is the dependence of the flow from the fourth power of
the vessel radius. This leads to a strong variation of the
flow between vessels of only slightly diﬀerent radius, im-
plying the survival of only the thickest vessels if collapse
is correlated with the flow.
The emerging tumor vasculature has a complex ge-
ometry and a fractal dimension1 diﬀerent from the initial
arterio-venous network. It has been suggested [38,39] that
the origin of the fractal architecture of tumor vasculature
might be based on an underlying invasion percolation pro-
cess [45,46] due to inhomogeneities in the growth support-
ing matrix. Since our theoretical model does not involve
any such matrix inhomogeneities, we propose that it is
rather the flow-correlated percolation process that deter-
mines the fractal properties of the tumor vasculature. A
commonly accepted view for a large class of tumors like
melanoma [4,5], also shared by our theoretical approach,
is that neo-vascularization mainly occurs at the tumor
perimeter and a drastic reduction of vessel density occurs
in the interior of the tumor. Within such a scenario it ap-
pears unlikely that the fractal properties attained during
growth in the periphery, independent of having character-
istics of invasion percolation or not, survive the random
dilution process in the tumor center.
Our drug flow simulations demonstrated that drug
flows relatively well through all of the networks and an in-
fusion time of the order of a few seconds is suﬃcient to sat-
urate the vasculature with drug. Therefore, without fur-
ther refinements, the model predicts that drug eﬃciency is
not limited by the transportation process through the vas-
culature. Considering the model mechanisms which lead
to the tumor vasculature, it is plausible that drug reaches
(nearly) all parts of the vasculature: Shear force correlate
vessel collapse naturally leads to elimination of weakly
perfused vessels. In the case of random collapses, pressure
1 Fractal dimension denotes here the number that one ob-
tains by a box-counting procedure and does not intend to imply
that the tumor vasculature, neither in vivo nor in silico, rep-
resents a mathematical fractal, or a good physical realization
of a mathematical fractal.
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gradients are still suﬃcient to drive blood through the
vessels, but an order of magnitude slower.
In [18] it was found that the morphology of tumor
vasculature plays a crucial role in drug delivery and that
changes to key system parameters could have a big impact
on the structure of the vasculature. The origin of this dis-
crepancy with our conclusion lies in the diﬀerent model
assumption: In [18] a strictly avascular tumor was consid-
ered, where sprouts migrate towards the tumor, but are
not allowed to enter it. These networks exhibit extremely
high connectivity close to the tumor surface but the in-
volved angio-adaptation mechanisms lead to vasodilation
of comparably few pathways. Depending on the model pa-
rameters the number of high-throughput vessels and their
distance to the tumor varies suﬃciently to lead to uptake
rates which vary by several orders of magnitude.
In contrast to this we study here a type of tumor like
melanoma, which are primarily vascularized by co-option
rather than vessel ingrowth [4,5]. For them, as we have
demonstrated, a blood-borne “delivery problem” does not
exist. This does however not automatically imply that
drug reaches all tumor cells since neither drug transport
through the tumor tissue nor drug uptake have been ad-
dressed [47]. Regarding tissue transport it is known that
the diﬀerence between interstitial fluid pressure (IFP) and
microvascular pressure (MVP) is low due to vessel leak-
iness. Since convective transport is driven by pressure
diﬀerences, high IFP could pose a barrier to drug deliv-
ery [48]. On the other hand, leakiness and MVP-IFP gra-
dients could lead to premature release predominantly in
locally restricted regions around vessels where blood en-
ters the tumor. Vessels in the outflow regions would thus
be depleted of drug. Locally released drug would then be
transported by IFP gradients out of the tumor. Further-
more drugs usually consist of large macromolecules. Their
low diﬀusibility through the vessel wall and generally lower
diﬀusibility than oxygen could lead to situations where
suﬃcient oxygen reaches certain TCs to let them remain
viable, but not enough drug reaches them to kill them oﬀ
due to the lower diﬀusion radius. Thus we conclude that,
to a higher degree than the vessels morphology, processes
like transportation out of the vessels through convection
and diﬀusion seem to be key factors in successful drug de-
livery. It is straightforward to include and analyze these
mechanisms into the model presented here.
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Interstitial Fluid Flow and Drug Delivery in Vascularized
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Abstract
Interstitial fluid is a solution that bathes and surrounds the human cells and provides them with nutrients and a way of
waste removal. It is generally believed that elevated tumor interstitial fluid pressure (IFP) is partly responsible for the poor
penetration and distribution of therapeutic agents in solid tumors, but the complex interplay of extravasation,
permeabilities, vascular heterogeneities and diffusive and convective drug transport remains poorly understood. Here we
consider–with the help of a theoretical model–the tumor IFP, interstitial fluid flow (IFF) and its impact upon drug delivery
within tumor depending on biophysical determinants such as vessel network morphology, permeabilities and diffusive vs.
convective transport. We developed a vascular tumor growth model, including vessel co-option, regression, and
angiogenesis, that we extend here by the interstitium (represented by a porous medium obeying Darcy’s law) and sources
(vessels) and sinks (lymphatics) for IFF. With it we compute the spatial variation of the IFP and IFF and determine its
correlation with the vascular network morphology and physiological parameters like vessel wall permeability, tissue
conductivity, distribution of lymphatics etc. We find that an increased vascular wall conductivity together with a reduction
of lymph function leads to increased tumor IFP, but also that the latter does not necessarily imply a decreased extravasation
rate: Generally the IF flow rate is positively correlated with the various conductivities in the system. The IFF field is then used
to determine the drug distribution after an injection via a convection diffusion reaction equation for intra- and extracellular
concentrations with parameters guided by experimental data for the drug Doxorubicin. We observe that the interplay of
convective and diffusive drug transport can lead to quite unexpected effects in the presence of a heterogeneous,
compartmentalized vasculature. Finally we discuss various strategies to increase drug exposure time of tumor cells.
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Introduction
Cancer is a complex disease which involves phenomena across
different scales from the molecular genetic level to the tissue as a
whole. Cancerous cells of solid tumors have undergone mutations
all of which combined lead to cancer [1]. These involve a
dysfunctional control of proliferation, the ability to survive under
low nutrient conditions and the stimulation of increased vascular-
ization through angiogenesis [2]. This leads to an advantage in the
competition over space and nutrients whereby cancer cells are also
able to evade the immune systems which would otherwise kill
malfunctioning cells. Solid tumors grow as compact masses. In
order to grow larger than a few millimeters they must acquire
additional nutrient supply through a blood vessel network. In
response to inadequate supply cells produce signaling substances
called growth factors which diffuse through the tissue and
stimulate sprouting of new blood vessels from preexisting host
vessels (angiogenesis). In tumors this angiogenic activity is located
within a few hundred micrometers from the tumor rim. Fueling
further growth, the resulting neovasculature is progressively co-
opted together with the original blood vessels by the expanding
tumor mass while also pushing the neovascularization zone further
into normal tissue. Chemical signaling by the tumor is however
abnormal, leading to chaotic non-hierarchical vascular organiza-
tion. Behind the invasive edge, angiogenic activity ceases. Further
proliferation of endothelial cells instead leads to circumferential
growth and dilated tumor vessels. Also vessel walls degenerate via
detachment of structural support cells like pericytes and smooth
muscle cells. In conjunction with decreased blood flow rates vessels
become prone to collapse leading to large unvascularized regions.
Some surviving vessels thread the tumor, distal to which the tumor
tissue becomes necrotic due to the lack of nutrients. As a whole
such a typical tumor vasculature is characterized by tortuous
vessels, chaotic connectivity and heterogeneous distribution as well
as a compartmentalization into a zone with high micro-vascular
density (MVD) near the invasive edge and a rapid density drop
towards the center.
The interstitial fluid (IF), which is a solution that bathes and
surrounds the human cells and originates from blood plasma
extravasating from capillaries through pores and intercellular clefts
in the vessel wall, plays an important role in the development and
treatment of tumors. Due to degenerate walls many tumor vessels
are leaky leading to a stronger coupling of the interstitial fluid
pressure (IFP) with the blood pressure. This leads to an interstitial
hypertension which can be elevated up to the blood pressure. The
resulting decreased pressure difference across vessel walls is
believed pose a barrier to drug delivery due to decreased
convective trans-vascular transport or even back-flow [3–8].
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Moreover functional lymphatics which would normally drain the
superfluous fluid are absent in most tumors aggravating the IFP
increase [2]. As a result the IFP profile assumes a plateau in the
center of the tumor and drops off rapidly across the boundary.
This gradient drives a strong outward directed convective flow at
around 0.1 mm=s. Signaling chemicals or tumor cells can therewith
be transported into normal tissue or into lymphatics, promoting
invasive behavior and metastatization [8,9]. Indeed high IFP is
associated with a negative prognosis. High IFP also has negative
implications for chemotherapeutic treatment. Through the out-
ward convection, drug may be removed from the peripheral
regions.
Mathematical modeling of interstitial fluid flow and delivery was
first approached in a radially symmetric geometry with homoge-
neously distributed source and sink terms using a porous media
model for the interstitial flow velocity [3]. This predicted in
agreement with experimental results an elevated IFP profile and
the corresponding velocity profile. Convective (drug) extravasation
was virtually limited to a small peripheral region. Later, extensions
were developed using explicit representations of the blood vessel
network in two dimensions. In [10] individual vessels were
arranged as rectangular grid and their blood pressure was coupled
to the IFP at their lattice sites, including the effect of fluid loss
through the vessel walls. A similar approach was taken in [11] but
with a tumor vasculature which was generated from in-growth
from two parent vessels. Except for [3] these studies did not
consider drug transport. Recently, simulations of IF flow and drug
transport were conducted based on imaging data from real tissues
[12]. An analysis of biophysical parameters governing the
distribution of the local drug concentration was performed in
[13] primarily focusing on the effects of varying tissue permeabil-
ities for diffusing drugs. The modeling incorporated a tumor
vasculature, realistic tumor lesions and cellular uptake and
binding. However convective transport was neglected. In [14] a
model was introduced in which interstitial fluid interacts with a
growing tumor, also incorporating a vascular network that evolves
dynamically from an initial capillary grid. IFF and hence
convective transport of macro-molecules depend crucially on the
spatial distribution and strength of IF sources and sinks within the
tumor, which are determined by the spatial arrangement of blood
vessels together and their local blood pressure. Even when
lymphatics are absent within the tumor, leaky vessels with low
blood pressure represent also sinks for IFF inducing non-trivial
flow patterns inside the tumor with unexpected effects for the
convective transport of macro-molecules. It is clear that the
predictive power of a computational model for IFF and drug
delivery depends critically on the physiological relevance of the
underlying model for the tumor vasculature. In the present paper
we present for the first time a IFF and drug delivery study with a
realistic, hierarchically organized arteriovenous initial vasculature,
circumferential growth of tumor vessels and IF back flow into
tumor vessels.
In earlier work we developed a mathematical model for
vascularized tumor growth which involved an initial vasculature
[15,16] arranged as a grid and updating rules representing
angiogenesis, dilation and collapse. More recently, it was extended
with an arteriovenous initial vasculature where quite realistically
few arteries and veins branch out in a tree-like manner down to
the lowest level where they are connected by capillaries [17–19].
Using this framework, biophysical aspects of tumor blood flow and
the spatial distribution of tumor blood vessel were analyzed but it
did not involve the IF explicitly nor the presence of drugs.
In this paper we want to compute the interstitial fluid pressure
and flow within a tumor and use this information to predict drug
delivery within the tumor and its various dependencies on
physiological parameters. These parameters include the blood
vessel network morphology as opposed to simplified vasculature
models, blood flow characteristics, blood pressure, permeabilities
of the vessel walls, the interstitium and lymphatic walls, the mass of
drug particles, i.e. the ratio of convection vs. diffusion. The tumor
phenotype that we consider is a vascularized solid tumor for
example a melanoma or glioma which grow in their natural
environment in a human host with characteristic features as
described above. Samples of such tumors were studied experi-
mentally in [20,21,32].
One particular question is how far an elevated IFP is an obstacle
to drug delivery. The general consensus is that elevated IFP
reduces the convective flux through the vessel walls, due to the
lowered pressure difference. However, our results indicate that this
does not necessarily need to be true and that the relation between
IFP and IFF is more complex, also involving vessel wall and tissue
conductivity. Moreover our model predicts Peclet numbers (ratio
of diffusion to convection) of the order of 1 in the tumor periphery.
There the IF flow is largest and almost perpendicular to the
boundary into normal tissue. Hence neither diffusion nor
convection can be neglected. Finally our model also allows to
study extreme cases like the delivery of very heavy drug particles,
which are transported purely by convection. Their distribution is
harder to predict than for a highly diffusive drug since it is
dependent on long range transport along chaotic IF flow patterns
which are eventually governed by vascular morphology.
This paper is organized as follows: Our mathematical model is
defined in the next section. We first define the representation of
the vessel network followed by remodeling rules during tumor
growth and the procedure to construct the initial network. Then
we define continuous parts, including the representation of tissue,
modeling of tumor growth, IF flow, chemical concentration fields
involved in tumor growth and finally drug transport. Finally a brief
overview of our numerical implementation and a derivation of
parameters are given. The subsequent results section comprises a
discussion of a typical base case including a brief presentation of
results obtained from tumor growth simulations and an in-depth
analysis of IF flow and drug delivery. After that various other cases
are analyzed before the paper is finally concluded.
Model
The model has been developed for simulations in three
dimensions in Cartesian space. It is a hybrid model with discrete
(vessels) and continuous parts (everything except vessels), see
Figure 1 for an illustration. Continuous distributions are defined in
the spatial domain V that we choose to be a cubic box. Discrete
vessels are defined on a face centered cubic (FCC) lattice L, which
has 60
0
branching angles between parent and child branches.
Varying branching angles would require modeling the vessel
network in continuous space, which is computationally much more
demanding but would not change the large scale morphology of
the resulting network. V overlaps with L and both are centered at
the origin. The lateral size of L is 8 mm and that of V is 4.5 mm.
The size of L is chosen to be larger to reduce boundary effects. V is
initially filled with normal tissue and contains a small tumor
nucleus located in its center.
We study IF flow and drug delivery for static tumor
configurations. This means the tumor growth is simulated up to
a specific time without explicit involvement of IF or modeling
effects of drugs. Then IFP and IF flow are computed, and finally
the spatiotemporal distribution of the drug concentration with the
tumor frozen in time. A coupling would be interesting in the
Interstitial Fluid Flow and Drug Delivery
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context of studying various therapeutic protocols, which we defer
to forthcoming publications.
Blood Vessel Network
Let V~ffvg, fngg be the graph which formally describes
vessels (edges) fvg and junctions (nodes) fng. Vessels coincide with
bonds from L, starting at one site of L and ending at another. They
can span multiple bonds but must be straight. Each vessel carries
biophysical properties like radius or blood flow. We will introduce
them as needed.
Blood flow is an essential part of our model. For vessels we
compute the flow rate qv (volume through its cross-section per
time) and shear stress on the vessel wall fv and the blood pressure
pv at the endpoints. The indices are dropped in the following. We
assume ideal pipe flow within the vessels, obeying Hagen-
Poisseuille’s law
q~
p
8
r4
g
Dp
l
f~
r
2
Dp
l
,
where Dp is the pressure difference between the vessel ends, l is the
vessel length, g the blood viscosity and r the vessel radius. g is
composed of the blood plasma viscosity 4:10{6 kPa s times the
relative viscosity gr(r,H) which is a function of the hematocrit H
and the radius. For gr we use a formula based on in vivo
experimental data [22]. For simplicity, we assume that H~0:45,
the average in the human body. Mass conservation at each node
requires that the flow rates of attached vessels sum to zero:
Svqv~0 (Kirchhof’s law). Together with appropriate boundary
conditions a system of linear equations for the nodal pressures
arises which is solved numerically. As boundary condition the
pressure is fixed at the arterial and venous roots of the vascular
trees. These boundary pressures are determined as function of the
vessel radius, also guided by experimental data [23] (see
Supplement S1 (1)). Note that we do not incorporate the
extravasated fluid into the mass balance, which is justified since,
as we will demonstrate in the results section, the amount of
extravasated liquid is orders of magnitudes smaller than the total
vascular blood flow. In the rest of the paper q and f will denote the
absolute value of the flow and shear force within a vessel - above
they carried a sign.
Blood vessel network remodeling, the process in which the
hierarchically structured initial network is reorganized by the
growing tumor is defined by a set of stochastic and continuous
processes which model angiogenesis, dilation, degeneration and
collapse. They are implemented as updating rules which are
applied consecutively in each time step. As a result, vessels are
created, deleted or they change their properties. These rules are
adopted straight forward from the 2d case [18] and presented here
again for completeness.
Our time stepping scheme advances the vessel network in fixed
steps of width Dt. Assuming that the frequency of a stochastic
event is determined by a rate parameter k we approximate the
probability for its occurrence in one time step as p~kDt. We
chose Dt sufficiently small such that pv1.The time evolution of
continuous processes described by differential equations of first
order in time is handled by Euler’s method with time step Dt. In
the following we describe the individual vascular remodeling
processes that are incorporated into our model, for an illustration
of theses processes (see Supplement S1).
Sprout initiation models the event when endothelial cells
(ECs) leave the parent vessel in order to grow a new sprout. It is a
stochastic process that adds new vessel segments to the existing
network. Lattice sites occupied by the existing network are visited
in random order and at each of these sites a new segment is
attached with probability Dt=t(sprout)EC provided that the following
conditions are met: the growth factor concentration is non-zero,
the distance to the next branching point is larger than l(spr) and the
time spent within the tumor is less than t
(switch)
EC . The new segments
are created along neighboring lattice edges where the growth
factor gradient is maximal and where no other vessels are already
present. A vessel is tagged as ‘‘within the tumor’’ if at least one of
the endpoints is within the tumor, which is true where the level set
function h(x)v0 (see below). Vessels also have a property which
can tag them as sprouts and tell for how long they have been
sprouts. We denote this ‘‘life-time as sprout’’ as t.
Sprout migration is the process in which initial sprout vessels
continue to grow. The probability is Dt=t(sprout)EC for vessels which
are tagged as sprout. A growth event is realized by appending a
vessel segment along a single lattice edge in the same direction as
the existing sprout. Sprout vessels are untagged and become
normal vessels if the tip fuses with another vessel such that blood
can flow or if their twt
(migr)
EC , where t
(migr)
EC is a parameter which
defines the maximal sprout growth time. If the tip fuses with
another sprout without creating a conducting branch then it
remains tagged as sprout. Sprout initiation can also start from
sprouts which emulates tip splitting as observed in-vivo and in-
vitro. Sprouts are excluded from the collapse, degeneration and
circumferential growth mechanisms.
Wall degeneration models the detachment and disintegration
of cell layers and membranes around the vessel lumen. Therefore
Figure 1. Illustration of the model components. L denotes the
lattice on which edges can be occupied with vessel segments. A few
exemplary segments are shown as blue bars. L coexists with V which
denotes the region over that continuum equations are defined. The
tumor region VT is indicated in yellow. The darker tone indicates
necrotic regions. Viable regions, denoted VV are brighter.
doi:10.1371/journal.pone.0070395.g001
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we implement the property w which reflects the vessel wall
thickness for normal vessels, and continuously decreases for tumor
vessels with the rate Dw until zero. For values smaller than e.g. the
size of an EC, w becomes an abstracted representation of the
stability and tightness which the remaining EC layer provides. w is
initialized (sprouts and initial vessels) with the wall thickness of real
healthy vessels in dependence on their radius [24] (see Supplement
S1).
Vessel collapse models pinch off of blood flow and complete
disintegration of the vessel. It is a stochastic process where a vessel
can be removed with probability Dt=t(coll)EC under the condition that
its wall stability variable wvw(coll) and its wall shear stress
fvf (coll). Thereby r(max), t
(switch)
EC , t
(coll)
EC , w(coll) and f
(coll) are model
parameters. Recently the Ang-Tie system was modeled in a similar
context [25]. This is straight forward to include in future work.
Here we model the effects of it, rather than the system directly.
Vessel dilation models the switch to circumferential growth
within the tumor [21]. During circumferential growth the vessel
radius increases continuously with the rate Dr. The requirement is
hereby that rvr(max), the average growth factor concentration
over the segment is non-zero and the time spent within the tumor
is larger than t
(switch)
EC .
Initial Blood Vessel Network Construction
To our knowledge there are no data sets from real networks
available that cover a few millimeters of tissue and represent the
complete vasculature including micro vessels in a form which is
convertible to a ‘‘network of pipes’’ as required for our modeling
purposes. Therefore we decided to generate it algorithmically. Our
aim is to maximize the lattice occupation with a network which
exhibits a hierarchical topology and homogeneously distributed
capillaries.
A well known method is constraint constructive optimization
(CCO) [26] in which a tree is grown by successively adding branch
segments at locations given by some optimality criterion e.g.
minimal total surface area. The constraints are that there is no
geometrical overlap of the branch segments and that new
segments must reach certain previously unperfused tissue blocks.
The radii at branching points rb,rc behave according to Murray’s
law [27] raa~r
a
bzr
a
c , where ra is the radius of the parent branch
and a is an exponent. a has been found to range between 2:55 and
3. The latter is a common choice which is also taken here.
In [28] a method was presented in which vascular trees on a
lattice are stochastically grown and remodeled. This has the
advantage of being relatively simple and being capable of building
connected networks comprising arteries, capillaries and veins,
whereas in CCO one typically has ‘‘dangling’’ terminal branches
where capillaries should connect to. In [18] we adopted this
method in order to obtain initial networks for 2d simulations.
Later we applied it on a cubic lattice [19] and here we apply it on
a FCC lattice. An illustration of the steps can be found in
Supplement S1.
The initial network construction is based on a relatively coarse
lattice with a lattice constant that corresponds to the mean inter-
capillary distance ~hL~80mm. After the construction of the network
on the coarser network it has to be mapped on the finer lattice
with ~hL~10mm for use in the subsequent simulation. FCC lattices
can be subdivided not unlike cubic lattices, meaning that sites and
edges of the coarse lattice coincide with site and edges on the fine
lattice. The tedious details are omitted here.
The construction is initialized by placing nodes which serve as
roots for the trees onto boundary sites of the lattice. The type of
these nodes is either arterial or venous, placed in alternating order.
The subsequent construction is then carried out in two stages. In
stage one, trees are grown by a stochastic process in which
‘‘structural elements’’ are successively appended to one of the
current tree leafs. As structural element we take either single
vessels or a Y-shaped aggregate of three vessels. The element, its
orientation and the leaf are determined by randomly (see
Supplement S1). Eventually the lattice is filled but arterial and
venous side are not interdigitating sufficiently to yield a
homogeneous capillary distribution.
This is corrected in a second remodeling stage. Capillaries are
temporarily inserted in-between neighboring arterial and venous
terminals. We set the capillary radii to 4mm. Radii of terminal
branches are set to 4:5mm for arteries and 5mm for veins. Radii of
higher level vessels are determined by Murray’s law. As a result an
intermediate functional vascular tree is obtain for which blood
flow is computed. Shear-stress dependent growth and shrinkage is
carried out by stochastic removal and attachment of vessels from
or to terminal branches. High shear-stress means higher proba-
bility to grow and vice versa. The idea originates from the
observation that high shear stress indeed promotes vessel survival
and stability [29]. We repeat this stage until the number of
capillaries reaches a plateau. Trees can potentially grow from each
of the root nodes. A few of these trees establish themselves while
most of them regress and disappear.
For this paper we extended the algorithm from [18,19] with an
‘‘outer’’ loop producing increasingly fine resolved networks in a
hierarchical fashion. This effectively reduces the tortuousity of
major vessels. The first level (coarsest network) is constructed as
described above. Then the lattice is refined, halving the lattice
spacing and doubling the number of sites in each direction.
Arteriovenous trees are kept in place and capillaries are discarded.
Each vessel segment now occupies two lattice bonds. The lattice
spacing is then reset to its former value. Hence, the spatial extend
and segment lengths are effectively doubled. Now the random
growth and remodeling steps are executed as above, where the
previous terminal nodes now serve as new roots. This up-scaling
and growth procedure is repeated a preset number of times. The
results shown here were generated from a 25|31|31 base lattice
and 2 up-scaling steps.
The Continuum Model for Tissue
Our tissue model is based on the framework developed in [30]
which describes the tissue as a mixture of various tissue
constituents. A mathematical model is formulated in terms of
smoothed fields of quantities such as density, velocity, stress, etc.
Several constituents can coexist at one material point due to
smoothing. Assuming incompressibility, one can describe the
composition in terms of volume fractions with the constraint that
the fractions sum up to one at every point in space. For brevity, we
just give the final set of equations. A derivation can be found in
[30], see also [31]. The result is a system of partial differential
equations of the diffusion convection reaction type.
First, let us denote tissue constituents and their volume fractions:
N wT : tumor cells
N wN : normal cells
N wD : necrotic cells
N w~wTzwNzwD
N m : ECM
N l~1:{w{m : interstitial fluid
Tumor cells and normal cells are immiscibly separated by the
interface LVT (t), where VT (t) is the tumor region.
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w~
wTzwD, inVT ,
wNzwD, inV\VT

This is analogous to immiscible liquids, where cell-cell adhesion
forces correspond to the atomic forces in the liquids. We assume
however that the adhesion forces are very weak, which allows us to
neglect the surface tension term which would normally appear in
the momentum balance equation. It will be included in future
work.
All w constituents move with the same velocity field vw which is
driven by the gradient of a solid pressure (the isotropic component
of the stress tensor) pw. It is based on the assumption that inertia is
dominated by friction against a rigid ECM through which cells
flow like a liquid through a porous medium. Therefore we have
vw~{Kw+(wpw) ð1Þ
Lw
Lt
z+:(wvw)~Qw ð2Þ
LwD
Lt
z+:(wDvw)~QD ð3Þ
_x:n~vw:n, for x[LVT , ð4Þ
where (1) is the condensed momentum balance, Kw is a mobility
constant and Qw and QD are source terms to be defined below.
Note that this set of equations is applicable to tumors that have a
clearly delineated rim as for instance rat C6 gliomas and human
glioblastomas [21], human malignant melanoma [20], leiomyo-
mata [32], etc. It is not valid for non-solid cancers like Leukemia
and highly invasive tumors which do not have such a clearly
delineated rim.
The motion of LVT is formally defined by (4). In practice we use
the level set method [33] to represent VT and LVT and introduce
an auxiliary field h(x) which gives the closest distance to LVT . It is
signed so that h(x)v0 for x[VT . Over time it evolves according to
the advection equation
Lh
Lt
zvw
:+h~0: ð5Þ
We can now define wT~(1{Hh(h))(w{wD) and
wN~Hh(h)(w{wD), where h is the lattice spacing of the numerical
grid (see below) H denotes a smoothed Heaviside step function
with width (see Supplement S1).
For the pressure we take
pw(w)~max½E(w{~w0),0:
For simplicity and the lack of better knowledge we use a linear
elastic law with elastic modulus E. Also, we assume that cells do
not exert pressure upon each other when w is less than the volume
fraction in a fully relaxed state ~w0.
The source terms are composed of contributions from T ,N and
D as follows
Qw~Q
z
NzQ
{
NzQ
z
TzQ
{
TzQ
x
NzQ
x
T ,
QD~{Q
x
T{Q
x
N ,
where Q+a stands for proliferation and apoptosis of phase a and
Qxa stands for necrosis.
We assume proliferation depends on packing density [34], i.e.
volume fraction w, and on available nutrients co. Cells do not
proliferate in regions with high density where apoptosis reduces
the density towards the so called homeostatic (equilibrium) density
w0,a. At w~w0,a, and for sufficiently high co, apoptosis and
proliferation rates cancel so that the net production rate Qza zQ
{
a
vanishes. Moreover Qza varies linearly with w{w0,a. Under low
nutrient conditions proliferative activity stops, i.e. Qza ~0 for
covf
z, where fz is a threshold parameter. Consequently,
apoptosis and possibly necrosis reduce the cell density. The
difference between these events is that apoptosis leaves no debris as
cells are deconstructed in an orderly fashion, i.e. the respective
cellular material vanishes. Necrosis occurs under very low nutrient
conditions if covf
x
vfz, where fx is also a threshold parameter.
The fraction of cells undergoing necrosis is transferred to wD via
the rates Qxa . In total this behavior is summarized in the following
formulas:
Qza ~wa max½min½
cza
sw
(w0,a{w)zc
{
a , c
z
a H(co{f
z),0
Q{a ~{wac
{
a
Qxa~{wac
x
a(1{H(co{f
x)),
for a~T ,N, where cza , c
{
a and c
x
a are constant rate coefficients
(proliferation, apoptosis and necrosis), sw determines the sensitivity
to density variations andH is the Heaviside function. Note, the use
of ‘‘min’’ in conjunction with the Heaviside function. It limits the
proliferation rate by either cza or 0 (no proliferation) depending on
nutrients.
Interstitial Fluid Flow
IF is commonly modeled as a liquid within a porous medium,
e.g. [11,12,14,35]. We follow this approach and assume that cells
and ECM collectively constitute the porous medium. Here we
consider only stationary states, with a static tumor and a rigid
medium, thus Ll=Lt~0. Mass balance for the IF fraction l requires
that
+:(lv l)~Ql , ð6Þ
with its velocity vl and source distribution Ql . Neglecting inertia
terms one obtains the momentum balance equation
0~+:Tlzf l , ð7Þ
where Tl is the stress tensor of the liquid, (+)ij~LTij=Lxj and fl an
interaction force with the other constituents. We use the results in
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[31] and [30] where constitutive relations for Tl and fl were
obtained for the case of a solid-fluid mixture. Assuming that the
interstitial fluid is an ideal inviscid liquid, its stress tensor consists
only of the contribution from the interstitial fluid pressure pressure
pi or in the following just p.
Tl~{lpI ð8Þ
The interaction force is defined in such a way that we later obtain
a variant of Darcy’s law
fl~{
1
Kl
v lzp+l: ð9Þ
The first term represents friction with cells and ECM fibers,
where Kl is a tissue dependent permeability coefficient. Substitu-
tion of equations (8) and (9) in (7) yields a variant of Darcy’s law
v l~{lKl+p, ð10Þ
which leads to an elliptic equation for the pressure
{+:(l2Kl+p)~Ql : ð11Þ
Note that l2Kl is the classical conductivity of the porous medium.
We define Kl~Kl(h) so that it smoothly interpolates between
parameter values for tumor Kl,T and normal tissue Kl,N . Kl,T and
Kl,N are chosen so that the conductivity in the bulk assumes
experimentally determined values. Note that l is almost constant
distal to the tumor boundary and varies over a small value range
since w [ ½0:5,0:6.
The source term is composed of contributions from the vessel
network Qlv and lymphatic sinks Qll so that Ql~QlvzQll . Both
are determined by the flux across the channel walls. For vessels,
this flux is driven by the pressure difference pv{pi and an osmotic
contribution s½pv{pi (Starlings equation) [36]. For lymphatics
we assume an analogous relation but neglect osmosis due to the
lack of data.
Qlv~L
(v)
l S=V (pv{pi{s½pv{pi) ð12Þ
Qll~L
(L)
l S
(L)=V (pL{pi), ð13Þ
where pL is the lymphatic pressure, L
(v)
l and L
(L)
l are permeabil-
ities, S=V and S(L)=V are the channel surface area densities per
volume and pi and pv denote the so called oncotic pressures. s, the
reflection coefficient, is a tissue specific value.
The standard approach for modeling exchange with vessels on a
small scale would use boundary conditions at the vessel walls,
while tessellating the surrounding space with a fine grained mesh.
However this would make the large length scale which we are
interested in inaccessible due to the size (we have of the order of
106 vessel segments). Instead we integrate the flux approximately
over the vessel surfaces within each numerical grid cells and add it
as source term. An approximation inherent to this method is that
the space covered by the vasculature is not excluded from the
interstitial space.
Hence (12) is not applied in this exact form. The source flux is
implemented as superposition of smoothed delta functions dE (see
Supplement S1 ). Their locations y are generated from a stochastic
uniform sampling of the surfaces of the cylindrical pipes which
make up the vessel network. We write this formally as y [ v, where
v symbolizes a vessel. For a numerical grid cell with index i and
center xi, Qlv then becomes
(Qlv)i~
X
v
X
y[v
c
v,y
i (pv(y){pi{s½pv{pi) ð14Þ
c
v,y
i ~dh(xi{y)L
v
lS
v,y=h3,
where h is the grid spacing, Lvl the wall permeability, S
v,y is the
area corresponding to a sample on v, and pv(y) is the blood
pressure in v at position y, linearly interpolated between the nodes.
Different degrees of vessel leakiness are incorporated based on
the maturity state w. We assume that w reflects the vessel wall
thickness for sufficiently large vessels and that the wall’s resistance
(Lvl )
{1 increases proportionally to the wall’s thickness. This
eventually leads us to
(Lvl )
{1
~max (ll,T )
{1,
(ll,N )
{1
w(init)(r~5mm)
wv
( )
, ð15Þ
where ll,T and ll,N are experimentally determined permeabilities
for capillaries in tumor and normal tissue, respectively, and
w(init)(r) is a formula based on experimental data [24] from which
we obtain the physiologically normal thickness of the vessel wall
depending on the radius (see Supplement S1 (2)). For small w the
identification with the wall thickness breaks down and it becomes a
mere abstract quantity inversely related to the amount of leakiness.
In order to obtain realistic permeabilities for tumor vessels as well,
we are therefore free to bound Lvl from above by ll,T .
Lymphatics on the other hand are modeled as continuous sink
distribution, where their surface area S(L) depends on the tissue
type via h analogous to Kl and moreover L
(L)
l and pL are assumed
to be constant. Hence we can use (13) directly in the numerical
implementation.
Chemical Concentration Fields
The basis for the description of dissolved chemicals is the
following diffusion convection reaction equation which determines
the evolution of the concentration c(a) in constituent a [30].
Lac(a)
Lt
z+:(ac(a)va)~+: aD
(a)
c +c
(a)
 
zQ(a)c , ð16Þ
where D(a)c are effective diffusion constants (assumed to be scalar)
and Q(a)c a source term. For nutrients and growth factors, we
approximate the concentration as the equal in all phases c(a):c
under the assumption that the exchange among constituents is
very fast. Then, summation of (16) over all a gives
Lc
Lt
z+:(c c ~+:(Dc+c)zQc ð17Þ
vc~wvwzlv lzmvm,
Interstitial Fluid Flow and Drug Delivery
PLOS ONE | www.plosone.org 6 August 2013 | Volume 8 | Issue 8 | e70395
v )
where Dc is the composite effective diffusion coefficient, and vc the
composite velocity of the mixture. In the following we will use
subscripts to c to denote specific chemical species: co denote
nutrients, cg are growth factors. For drug we distinguish
concentrations in two different compartments si :~cd,i for which
i~1,2 denote the extra-and intra cellular space, respectively.
Nutrients are represented by the most prominent one, namely
oxygen with its concentration co. The time scale on which co
relaxes after changes is negligible, of the order of seconds, and thus
co is assumed to be always in a quasi stationary state,
instantaneously adapting to changes in the system. Convection is
neglected due to the dominance of diffusion. Consequently we
obtain
0~Do+
2co{c
{
o cozLoS=V (c
v
o{co), ð18Þ
where we already replaced Q with a particular form of the source
term: The second term represents consumption with the tissue
dependent rate c{o . The third term represents the diffusive flux
across the vessel wall, which we treat analogous to the interstitial
fluid source term (14), only Lvl is replaced by L
v
o, and pv by the
blood oxygen concentration cvo. Since we already assumed that the
hematocrit is constant over the whole vasculature, we further
assume for simplicity that the oxygen concentration cvo also
constant over the perfused parts and zero in unperfused vessels.
Growth factors are collectively represented as a single diffusible
species with its concentration cg. A prominent representative is
VEGF which is over expressed in under-oxygenated tumor cells.
We assume a constant production rate by tumor cells in locations
where covf
z and that it diffuses, binds and degrades everywhere
equally. Instead of solving a diffusion equation we use a simpler
and faster approximation based on a Green’s function approach:
every source site generates a linearly decaying contribution to cg
with the cutoff or diffusion radius Rg. Thus we have
cg(x)~
ð
d3x0 G(jx0{xj)wt(x0)H(fz{co(x0)) ð19Þ
where we define G(x)!max(0,1{x=Rg), with a normalization
constant so that
Ð
G(jxj)~1. Note that consequently, by
definition of the angiogenesis rules, sprouting occurs within Rg
of oxygen deprived TCs and a cg gradient arises along which
sprouts are oriented.
Transport and uptake of drug is modeled as diffusion advection
process in the interstitial fluid and sequestration into the cell
constituent. We distinguish between the concentrations s1 in the IF
and s2 within cells as average over the solvent volume. The tissue
volume average reads s~s1lzs2w with the volume fractions l and
w as defined above. Following (16), we define specialized mass
balance equations as
l
Ls1
Lt
z+:(s1lv l)~+:(lDs+s1)zQs1zQ12 ð20Þ
w
Ls2
Lt
~{Q12, ð21Þ
where Q12 is the exchange rate between the two compartments,
Qs1 the source contributions from vessels and lymphatics and Ds
the diffusion coefficient in the IF. For a simple derivation of Q12,
we assume the total flux of molecules across the cell-fluid interface
area S within some volume V has the form J~S(~k21s2{~k12s1)
with the rate constants ~kij which model the combined effect of
diffusion through the cell membrane and intracellular binding and
unbinding. We write S in terms of the single cell volume Vc and
surface area Sc as S~lwVSc=Vc, assuming that only the fraction l
of the cell surface is in contact with the IF. Then we obtain with
kij~
Sc
Vc
~kij
Q12~J=V~wl(k21s2{k12s1): ð22Þ
Furthermore the contributions from vascular and lymphatic
exchange are given by
Qs1~Q
z
lv s
v
{(Q{lvzQ
{
ll )s1zL
v
sS=Vl(s
v
{s1), ð23Þ
where S has the original meaning of vessel surface area again. The
diffusive permeability Lvs is defined exactly like L
v
l in (14) and (15)
with correspondingly exchanged subscripts including the perme-
abilities of tumor vessels ls,T and normal capillaries ls,N . Q
z
lv
stands for extravasated fluid volume per mixture volume carrying
the concentration sv which is the concentration within the vessels.
We assume that sv is homogeneous over the whole network but
time dependent where the dependency is given as closed formula
e.g. an exponential decay after a hypothetical injection at t~0.
Q{lv stands for fluid uptake by vessels. Analogously Q
{
ll for uptake
through lymphatic. Since these terms represent flow out of the
interstitial space, they are multiplied by s1 in order to obtain the
respective solute flux. We could define a Qzll for symmetry but in
practice fluid always flows into lymphatics, never in the opposite
direction. We treat Q+lb analogously to Qlb, for b~l,v in (12) and
(13) with the exception that only contributions are added where
the blood or lymphatic pressure is larger (z) or lower ({) than the
IF pressure. Indeed QzlvzQ
{
lvzQ
z
ll zQ
{
ll ~Ql .
Numerical Implementation
Solutions to partial differential equations are computed by finite
difference schemes on a regular uniform staggered grid [37].
Numerical values for concentrations, volume fractions, etc. are
defined on grid cells, while velocities and fluxes are defined on
faces. The grid spacing h is 30 mm which corresponds approxi-
mately to two to three tissue cells. The diffusion terms are
discretized by standard 9 point centered difference stencils. All
system of linear equations are solved with (algebraic multigrid - if
needed) preconditioned conjugate gradient method. Specifically,
we use the solvers in [38]. Advection terms are treated by a central
scheme for conservation laws [39]. In the time, the operator
splitting technique [37] allows treatment of various sub-systems
separately, i.e. sub-systems are advanced one by one, always using
the newest available state. The cell volume fractions w and wD are
updated simultaneously with the 2nd order improved Euler
method. The level set function h is updated likewise. The vessel
network is updated in 1 hour steps. In these periods for w,wD and h
smaller sub-steps must be taken the length of which is dictated by
the stability conditions of the time integration methods. In practice
these steps are about 0:02h wide. Sometimes h must be
‘‘redistanced’’ in order to restore the distance function property
j+hj~1. The WENO method presented in [40] works very well
for our purposes. The computation of cg and co as well as
redistancing are not performed every step. We determine the time
between updating these fields by the time it takes tissue cells to
cross a numerical grid cell and also by the time scale of the source
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term, which gives the time min (h=vw,(LQw=Lt)
{1), where we take
the minimum over space and time since the last update. The
numerical solution of the drug concentrations s1 and s2 is carried
out using the central advection scheme [39] and the improved
Euler method.
Parameters
A list of parameters for our base case system can be found in
tables 1 and 2. The sprouting parameters t
(sprout)
EC and t
(migr)
EC are
estimated from in-vitro endothelial cell (EC) migration experi-
ments in [41]. It is known that angiogenesis is inhibited in ECs
near existing branching points. For this l(spr)~20mm seem
reasonable, which are about two nearby ECs. The vessel dilation
rate Dr and maximal radius r(max) was extracted from [21] where
the spatial compartmentalization of human melanoma was
described. The wall thickness w is initialized at t~0 depending
on the vessel radius (see Supplement S1 (2)) guided by
experimental data [24]. The wall degradation rate was estimated
from [21] based on tissue section at increasing stages of tumor
progression. We simply observed how long it takes until the
supporting wall structures of a vessel with a certain radius are
removed. For the critical collapse shear stress f (coll) we assumed
that it is a low percentage of the average shear stress within the
system, also guided by comparison of predicted vascular density
levels with data from [20].
The oxygen level in our model is dimensionless and normalized
to 1 which is the level within vessels. We divide the diffusion
equation (18) by Do. Hence it is left to determine the quotients
with the consumption rates c{o,a=Do and vessel permeability
lo,a=Do for a~N,T . For this purpose we use that the penetration
depth (i.e. the length scale on which the solution decays around
vessels) in tumor tissue is about 100mm and can be expressed asﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Do=c{o,T
q
. We assume that c{o,T~4c
z
o,N . The precise number is
arbitrary and non-crucial but reflects that tumor cells have a
higher oxygen consumption rate leading to decreased tissue
oxygen levels. We then tuned lo,N=Do so that the oxygen level in
normal tissue is above ca. 1=2. For simplicity we assume that the
permeabilities in tumor and normal tissue are equal lo,T~lo,N .
We assume that tumor and tissue cells have the same fastest
possible proliferation rate (czN and c
z
T ) of once per day. The time
to live for normal cells is assumed to be 10 days after which they
undergo apoptosis, yielding c{N . Tumor cells have acquired
mutations which enable them to circumvent the apoptotic
mechanisms. Therefore we set c{T~0. Cells under severe hypoxia
are assumed to die off relatively quickly within 48 h (cxT and c
x
N )
and become necrotic tissue.
The oxygen threshold below which cells become necrotic is
fx~0:03. Cells stop proliferating when the oxygen level is below
fz~0:3 which is ca. 60% of the lowest level in normal tissue.
Since only tumor cells are ever exposed to low oxygen levels, we
also do not distinguish between tumor and normal tissue here.
Our cell volume fractions reflect a high-density prototypical
tissue. We assume that tumor cells have become less sensitive to
solid pressure from nearby cells and so their homeostatic level is
0.6 (w0,T ) while it is 0.4 (w0,N ) for normal cells. Here we follow [34],
where the idea for this pressure regulated proliferation originated.
A similar model was also employed in [42] but with different
parameters.
Parameters for interstitial fluid flow and drug transport are
summarized in table 2. The permeability coefficients Kl,a and ll,a
as well as osmosis parameters pi, pv and s are obtained from [35]
and the references therein. Where the actual permeability is
provided, e.g. l2Kl , we compute the coefficient by dividing with
the typical l&0:2 in the respective tissue. For lymphatics we
assume a wall permeability (L
(L)
l ) which is of the same order of
magnitude as for capillaries (ll,N ). The lymphatic surface area per
volume (S
(L)
N =V ) is estimated by assuming that there is a grid-like
network with a channel every 100mm and a radius of 10mm. We
leave the tumor without lymphatics (S
(L)
T ~0), since these are
absent or dysfunctional in tumors (see [5] and the references
therein).
The drug distribution model is guided by experimental data on
the pharmacokinetics of Doxorubicin, which has been used for a
Table 1. Model Parameters: Tumor Growth.
Parameter Value Unit Description
nL (825,990,961) Lattice size
hL 10 mm Lattice spacing
nV (150,150,150) Lattice size
hV:h 30 mm Lattice spacing
500 mm Initial tumor diameter
t
(switch)
EC
24 h Circumferential growth switch delay
t
(sprout)
EC
0:5 mm=h Sprout extension speed
t
(migr)
EC
100 h Sprout activity duration
l(spr) 20 mm Sprout sites minimum separation
r(sprout) 4 mm Initial sprout vessel radius
Dr 0:4 mm=h Vessel dilation rate
r(max) 25 mm Maximum dilation radius
f (coll) 2 Pa Critical wall shear-stress
t
(coll)
EC
20 h Unstable vessel survival time
Dw {0:05 mm=h Vessel wall degradation (w ) rate
m 0:2 ECM fraction
~w0 0:4 Relaxed cell fraction
KwE 5103 mm2=h Cell mobility | elastic modulus
czT 1=24 h
{1 Tumor cell proliferation rate
czN 1=24 h
{1 Normal cell proliferation rate
c{T 0 h
{1 Tumor cell apoptosis rate
c{N 1=240 h
{1 Normal cell apoptosis rate
cxT 1=48 h
{1 Tumor cell necrosis rate
cxN 1=48 h
{1 Normal cell necrosis rate
sw 0:2 Cell pressure sensitivity
w0,T 0:6 Homeostatic tumor cell fraction
w0,N 0:4 Homeostatic normal cell fraction
fz 0:3 Oxygen threshold for proliferation
fx 0:03 Oxygen threshold for necrosis
c{o,T=Do 80
{2 mm{2 Oxygen consumption rate in tumor
c{o,N=Do 200
{2 mm{2 Oxygen consumption rate in normal
tissue
c{o,D=Do 200
{2 mm{2 Oxygen consumption rate in necrotic
tissue
lo=Do 0:04 mm{2 Vessel permeability to oxygen
Rg 200 mm Growth factor diffusion range
List of parameters for tumor growth.
doi:10.1371/journal.pone.0070395.t001
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long time to treat various cancers. For the diffusion coefficient Ds
and exchange rates kij we follow [13] who presented a similar
model with additional cellular compartments. The diffusion
constant stems from [43] where it was estimated as ca.
1000mm2=min, which we use as well. Given an isolated system
with two compartments and transition rates k12 and k21, the steady
state concentration ratio equals the ratio of the rates. In
experiments with cell cultures [44], intra-cellular to medium ratios
of ca. 100 were observed. It seems reasonable to associate k12, the
cell uptake rate with diffusion through the vessel wall. In [13] this
rate was estimated as 5:4min{1. Thus we simply use
k12~10
{2s{1 and k21~10
{4s{1. Note that k21 is close to the
estimated lysosomal release rate which is also the slowest rate in
the model proposed in [13], so this may be identified as bottleneck
for release. It remains to determine the vascular permeabilities.
We estimate these based on the diffusivity in plasma. As an
approximation we write the permeability of a planar sheet of
thickness L as D=L, where D is the diffusion constant. We take
180mm2=s for D in plasma and we identify L~10mm with the
thickness of the capillary wall. We assume that drug only diffuses
through the gaps between endothelial cells (ECs). Assuming that in
very leaky tumor vessels, there would be a circular gap with 1:5mm
radius per EC [35], we arrive at the fraction of gaps over the vessel
surface G~0:017, assuming 102mm2 per EC, thus ls,T~DG=L.
Assuming the difference between tumor and normal capillaries is
due to leakiness, we determine ls,N by requiring that the ratios are
equal: ls,N=ls,T~ll,N=ll,T .
Results
Tumor Growth
Snapshots from a simulation are displayed in Figure 2. We
performed 15 simulation runs, producing 15 final states which
differ in their initial blood vessel networks (and the seeds for the
random number generator used for the stochastic events during
the simulation). For a video visualizing the spatiotemporal
evolution of the model see Supplements S14 and S14.
Initially, the tumor is prepared as a small sphere in which the
tissue consists of tumor cells instead of normal cells. We define the
distance function h at t~0 as the signed distance from the sphere
boundary. The tumor is located in the center of the simulation box
and has a radius of 0.5 mm. Increased oxygen consumption leads
to decreased oxygen levels within the tumor which leads to
expression of growth factors which again stimulates angiogenesis
within Rg. Eventually blood-perfused neovasculature raises the
oxygen level in the tumor periphery and enables further tumor
growth. The first snapshot in Figure 2 shows the system after
100 h. At this point the system is in a state displaying the typical
compartmentalization into high micro vascular density (MVD)
rim, decreasing MVD toward the tumor center, isolated vessels
threading the tumor, necrotic regions associated with unvascular-
ized regions and tumor proliferation confined to its rim. The
tumor continues to grow by vascularizing and pushing into the
surrounding tissue, leaving a torturous chaotic tumor network
behind. The final snapshot is taken at t = 700 h where the tumor
has reached the edge of the continuum domain V. Its final radius
is ca. 2.5 mm. By design of the tumor-vessel interactions similar
observations were reported in earlier work in [15], [16], [18],
where much simpler tumor models were used. See also Figure 3
where important system variables as a function of the distance
from the invasive edge h are shown.
To generate these plots we sorted data points based on their
spatial position into bins, or shells surrounding the invasive edge
according to their h value. The width of the bins is 30mm. Unless
stated otherwise, we computed the averages of the binned values
for each simulation run. The plotted data displays the means and
standard deviations of the ensemble, not the spatial fluctuations.
Spatial fluctuations can be seen in the map plots and are analyzed
Table 2. Model Parameters: Interstitial Fluid and Drug.
Kl,N 20 mm2kPa{1s{1 Normal tissue permeability coeff.
Kl,T 20 mm2kPa{1s{1 Tumor tissue permeability coeff.
Kl,D 200 mm2kPa{1s{1 Necrotic tissue permeability coeff.
pL {0:5 kPa Lymphatic fluid pressure
S
(L)
N =V
0:01 mm{1 Lymphatic surface area per volume in normal tissue
S
(L)
T =V
0 Lymphatic surface area per volume in tumor tissue
L
(L)
l
0:02 mmkPa{1s{1 Lymphatic wall permeability
sl,N 0:85 Osmotic reflection coefficient in normal tissue
sl,T 0 Osmotic reflection coefficient in tumor tissue
pv 2:7 kPa Vessel oncotic pressure
pi 1:33 kPa Interstitial oncotic pressure
ll,T 1 mmkPa{1s{1 Tumor vessel wall permeability
ll,N 0:01 mmkPa{1s{1 Normal capillary wall permeability
Ds 16 mm2=s Drug diffusion coefficient
ls,N 0:17103 mm=s Vessel permeability to drug in normal tissue
ls,T 17103 mm=s Vessel permeability to drug in tumor tissue
k12 0:1 s{1 Drug transport rate, extra-to intracellular
k21 0:001 s{1 Drug transport rate, intra-to extracellular
List of parameters for interstitial fluid flow and drug delivery.
doi:10.1371/journal.pone.0070395.t002
Interstitial Fluid Flow and Drug Delivery
PLOS ONE | www.plosone.org 9 August 2013 | Volume 8 | Issue 8 | e70395
in more detail only for the distribution of drug. Note that we may
define averages over (parts of the) vessel network formally as line
integrals over the vessel center lines divided by the total length of
respective parts. In practice we generate sampling points on
center-lines and sort these into bins as we do with numerical grid
values. This is applied e.g. in Figure 3B (vessel radius).
The predictions described above are in good agreement with
experimental data from [20] and [21] for human melanoma
xenografts and gliomas respectively. Our new continuum model
describes tissue more realistically by the incorporation of actual
host tissue cells, cell motility and cell-cell adhesion. We will report
a more detailed analysis of the resulting morphological aspects
elsewhere.
Interstitial Fluid Flow
Pressure, velocity and source terms were computed numerically
for the final tumor configurations at t = 700 h. For the IF flow
studies we assumed that the tumors are static from this time on.
Generally the motion of the IF is coupled to the motion of the
other tissue constituents since ‘‘empty’’ spaces are filled with the
IF. However in our case the velocity of the fluid is orders of
magnitude larger than the velocity of cells, for which reason we
can neglect these interactions.
Figure 4 shows slices through simulation data of one sample.
Figure 4A displays the vessel volume fraction hv. The data are
generated by superposition of smoothed delta functions which are
distributed stochastically within the cylindrical volumes comprising
the network edges. In Figure 4C we plotted the source term Ql
which is the IF volume flowing in or out of the interstitial space per
volume and time. By definition, lymphatics are absent within the
tumor, thus therein the only sources and sinks are blood vessels,
which appear as lengthy blobs with positive (extravasation) or
negative (uptake) contributions. Uptake is possible since the blood
pressure can also be lower than the local IFP. At the tumor rim we
see a significant amount of fluid being taken up, since there is a
strong outward flux from the tumor which is absorbed into
lymphatics and potentially also into parts of the neovascular
plexus.
The IFP profile is elevated within the tumor and decays rapidly
over its boundary. See Figure 4D and Figure 5A. The peak
pressure in the tumor center is ca 6 kPa (45 mmHg). Outside it is
0.5 kPa (3.75 mmHg). We set the lymphatic pressure to20.5 kPa,
and the average blood pressure is ca 6.25 kPa (47 mmHg). In
Figure 2. Snapshots from the simulation of a growing tumor. (A) to (C) depict 400mm thick slices through the origin. The scale bar indicates
1mm. (A) is a close-up. (B) and (C) have the same scale. The snapshots are taken after 100 h, 400 h, 700 h. (D) shows the same time as (C) from a
different point of view where a quadrant was cut out. The boundary to the viable tumor mass is rendered as solid yellow surface. Necrotic regions
appear as void spaces within the tumor. The blood vessel network is rendered as collection of cylinders, color coded by blood pressure. Red is high
(arteries), and blue is low (veins).
doi:10.1371/journal.pone.0070395.g002
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Figure 3. Radial distributions of biophysical properties in the tumor growth model. (A) MVD, (B) vessel radius, (C) cell velocity, (D) oxygen,
(E) wall thickness, (F) wall shear stress. The distributions are plotted vs. the distance from the tumor surface h. Each data point corresponds to the
average over a small h-interval. The errorbars indicate the standard deviation among different simulation runs (see text). The inset in (C) shows the
approximate radius of the tumor and a linear fit. This radius is determined by averaging the distance from the origin over numerical grid cells where
{hvhvh.
doi:10.1371/journal.pone.0070395.g003
Figure 4. Snapshots of interstitial fluid flow quantities. (A) Vessel volume fraction, (B) IFP, (C) Fluid source term, (D) x-component of the IF
velocity, (E) Magnitude of the IF velocity, (F) Projection of IF velocity onto the outward direction, i.e. onto the gradient of h. The plots were generated
from 2d slices through the center of a typical simulation result from the base case. The contour line indicates the boundary of the viable tumor mass.
The internal regions consist of necrotic tissue, while the outer area is normal host tissue.
doi:10.1371/journal.pone.0070395.g004
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models using pure capillary networks a pressure range from 15 to
25 mmHg is commonly either directly set or imposed via
boundary conditions, e.g. in [10,12,14,15]. In the presence of
higher level arteries (as in our model) a much higher IFP can be
observed, because of the elevated pressure in arteries and
connected vessels. Mean in vivo tumor IFPs are reported in [35]
from 0 to 5 kP (38 mmHg) for various tumor types. Most tumors
exhibit a high degree of heterogeneity, with deviations from the
mean of 100%. The elevated IFP has a finite ‘‘penetration depth’’
into normal tissue (see below). Beyond that the IFP appears
relatively homogeneous. Fine grained fluctuations are introduced
by fluctuations of the capillary surface area per grid cell.
The order of magnitude of the interstitial fluid velocity is
considered to be 0.1 to 1mm=s [4,45–47]. In particular, it is found
to be highest close to the tumor boundary where the pressure
gradient is steepest, leading to a strong outward flux. Our results,
shown in Figure 4A and Figure 5B are in agreement with this
experimental observation. The velocity peak in the region is at
0:2mm=s.
Furthermore the velocity patterns in our data show a significant
amount of fluid being transported in between tumor vessels. In
Figure 4D this can be directly observed. For the whole ensemble
we measured the outward projection of the velocity vector
vjj:vl :+h=j+hj together with the velocity magnitude jvj:jvl j,
which are plotted in Figure 5. Spatial distributions from one
simulation can be seen in Figure 4E and F. Within the tumor
center, vjj vanishes whereas jvj decreases to ca. 0.05 mm=s. This
means that the flow becomes increasingly isotropic toward the
center, where the IF apparently flows in between isolated tumor
vessels instead of to the tumor boundary. This flow is more than an
order of magnitude faster than IFF in normal tissue.
In the tumor periphery fluid uptake by lymphatics is signifi-
cantly increased compared to normal tissue further away
(Figure 5C, Qll ) because since lymphatic vessel are absent in the
tumor, the extravasated fluid must cross the tumor boundary to be
absorbed in normal tissue. The determining equation for the IF
pressure p, and the equations for oxygen and growth factors, have
a structure like +2u{cu~r, for some constant c, dependent
variable u(x) and arbitrary distribution r(x). For this equation any
local change in r causes an exponentially decaying disturbance in
u. The length scale of the decay is 1=
ﬃﬃ
c
p
. Since
c~L
(L)
l S
(L)=V (Kl l
2){1 for the IFP, we see a ‘‘penetration depth’’
of 98mm.
Furthermore, in addition to the fluid that originates from the
tumor interior, we find that the neovascular plexus extravasates a
huge amount of fluid (Figure 5C, Qzlv ). The collective surface area
of these vessels is large due to the amount of vessels, they are very
permeable and the pv{pi difference is relatively large, so this is
not surprising but it has implications for the escape of tumor cells
from the rim into the lymphatic system, and subsequently
metastasis.
At this point we should discuss the validity of our approximation
that neglects the loss of blood plasma from the vasculature due to
extravasation. Apart from the study of IF flow this approximation
is standard but in particular for tumor blood flow the coupling
through leaky thread-like vessels it is a more severe simplification,
where one would ideally solve for the IFP and blood pressure
simultaneously and fully coupled. To clarify this we first
determined the fraction of extravasated fluid relative to the total
vascular blood flow into the tumor. To be precise we computed
Q
z(rel)
l ~
Ð
VT
Qzlv dxP
v[V\LVT
qv
,
where V\LVT symbolizes the set of all vessels which intersect
LVT with blood flow directed into the tumor. We obtain
Q
z(rel)
l ~4+1:6
:10{4 over our base case states, which suggest
that a fully coupled solution would not differ significantly from our
solution. For completeness, the absolute values are presented in
Table 3.
Moreover, we estimate the length scale over which IFP coupling
would cause a decrease of the blood pressure along a single
isolated vessel. For this purpose let q(x) be the flow rate as volume
per time through a blood vessel with the axial coordinate x. It is
determined by q~{Ap
0
, i.e. Poiseuille’s law, where
0
denotes the
derivative with respect to x, A a conductivity constant and p~p(x)
the blood pressure. The fluid loss through the gaps of the vascular
walls is the derivative of q, i.e. q
0
~B(pi{p), whereby we have
incorporated the osmosis contribution s(pv{pi) into an effective
blood pressure p. B is defined as B~2prLvl , where L
v
l is the wall
permeability constant. pi denotes the interstitial pressure.
If we now assume that pi:const, we can easily derive a
characteristic length scale l over which p approaches pi. By
combining the above equations, we solve for p(x) and obtain
p(x)~ exp (x=l)C1z exp ({x=l)C2zC3xzC4, where
Figure 5. Radial distributions of interstitial fluid flow quanti-
ties. (A) IFP, blood pressure and the pressure drop across the vessel
wall. (B) IF velocity: jvj plots the magnitude and vjj the projection onto
the direction of the shortest path to the tumor boundary vl+h=j+hj,
respectively. (C) The total fluid source term Ql as well as contributions
to it which are: extravasation Qzlv , uptake by vessels Q
{
lv and uptake by
lymphatics Q{ll . Each data point corresponds to the average over a
small h-interval. The error bars indicate the standard deviation among
different simulation runs (see text).
doi:10.1371/journal.pone.0070395.g005
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C1,C2,C3 and C4 are constants which must be determined by
boundary conditions. For l one obtains l~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
A=B
p
i.e. the root of
the ratio of flow to wall conductivity. Note that for l?? one can
recover the standard Poiseuille’s law. Based on our model
parameters, the order of magnitude of l is estimated to lie within
103 to 106mm, depending on the vessel. Actual measured values
are shown in Figure 6D. Within the tumor l is actually longer than
the system size. For capillaries l may be around 1 mm, which is
still much longer than the length of typical capillaries. The value of
l for major normal vessels is similar to tumor vessels. Other
relevant variables namely B, q
0
and q are shown in Figure 6A, B,
and C, respectively. In spite of the simplifications used we think
this justifies the uncoupled evaluation of the interstitial fluid flow.
In the following we further comment on blood flow and
extravasation. In silico data for B~2prLvl in Figure 6A shows a 20
fold increase from normal tissue to tumor tissue. Remarkably we
can distinguish between an increase of r and Lvl . The clustering
with short ramp-up is associated with initially thin vessels which
dilate to the maximal radius r(max). Their permeability Lvl
increases simultaneously and eventually hits is upper bound ll,T .
A plateau of maximal B forms where r and Lvl reached their
bounds which is here about 250mm behind the tumor boundary.
The lower ramp corresponds to thicker vessels, too thick to dilate
(because rwr(max)), but for which Lvl increases.
The flow rate q, shown in Figure 6C, displays a clear distinction
between tumor and normal tissue as do most other variables. In
the tumor center it is more uniform and orders of magnitude
higher than in normal tissue. q varies with the radius like r4, thus
dilated vessels provide very well conducting pathways acting as
arteriovenous shunts. Most of the data points in normal tissue stem
from capillaries which have respectively slow flow rates. Going up
the vascular hierarchy, we find increasing flow rates beyond those
of tumor vessels and of course less vessels. In the neovascular
plexus close to the tumor boundary we observe lower-than-normal
flow rates, which is plausible since the blood volume is distributed
over more vessels, which implies slower flow velocities in order to
to satisfy mass conservation. See also our results and discussion in
[18].
The flow rate through the vessel wall q
0
, shown in Figure 6B,
correlates well with the wall permeability B weighted by the vessel
circumference. Its magnitude within the tumor is about an order of
magnitude larger than in normal tissue. This contradicts the
common hypothesis that increased interstitial pressure hinders
fluid extravasation. However, the permeability increase dominates
the decreased IF pressure difference, which is only halved within
the tumor compared to normal tissue.
Drug Transport
Here we analyze the spatiotemporal evolution of the concen-
tration distribution s of some substance over the time frame of 96
Table 3. Tumor volume, blood flow and interstitial fluid
sources.
jVT j 2:72+0:04:1010 mm3 Tumor volume
jVT j=jVj 0:286+0:004 Fractional tumor volumeP
v[V\LVT
qv 7:7+3:4:109 mm3s{1 Blood flow through tumor
boundaryÐ
VT
Qzl dx 2:5+0:3
:106 mm3s{1 IF influx (tumor)Ð
VT
Q{l dx {1:3+1
:105 mm3s{1 IF uptake (tumor)
V\VTQ
z
l dx 1:16+0:06
:107 mm3s{1 IF influx (normal)
V\VTQ
{
l dx {1:40,+0:08
:107 mm3s{1 IF uptake (normal)
Q
z(rel)
l
4+1:6:10{4 Ratio of IF extravasation to
blood flow.
jVT j and the quantities involving Q were computed by numerical integration,
i.e. summation over grid cells, weighted by H(h) or 1{H(h) as required by the
respective region. Tumor blood flow was computed by summing qv over
vessels where (i) the sign of h changes between the endpoints, (ii) blood flow is
directed into the tumor, which is straight forward to check based on the nodal
blood pressures and h. Of course, mass is preserved, i.e. inflow and outflow are
equal (in particular since we neglect extravasated fluid). Also due to mass
conservation, the IF uptake in normal tissue is slightly higher than influx
because flux from the tumor is absorbed as well. Uptake within the tumor is low
due to the lack of lymphatics. Qz(rel)l is the ratio of
P
v[V\LVT
qv to
Ð
VT
Qzl dx,
indicating that only a very small fraction of the blood plasma which is entering
the tumor is lost into the tumor interstitium.
doi:10.1371/journal.pone.0070395.t003
Figure 6. Radial scatter plots of properties related to (trans)-
vascular flow. (A) the vessel wall permeability multiplied by the
circumference Lvl 2prv (B) the transvascular flow L
v
l 2pr(pv{pi), which is
the fluid volume that flows through the vessel wall per vessel length
and time. (C) the flow rate of vessels q, i.e. the blood volume per time
that flows through the cross section. (D) an approximate length scale
over which pv decays toward pi (see text). Data points stem from
uniformly distributed sampling points on the vascular networks of 15
simulation runs.
doi:10.1371/journal.pone.0070395.g006
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hours. s was computed numerically according to (20) based on the
data from previous simulations of tumor growth and interstitial
fluid flow. Thereby the tumor is considered static and the IF flow is
in a stationary state. Normally a tumor would grow further during
this time frame. However since we do not model pharmacody-
namics (i.e. cell killing) it seems reasonable to make this
simplification. Parameters for our base case are derived from data
for Doxorubicin, a commonly used chemotherapeutic drug.
assume that initially the tissue is ‘‘clean’’ i.e. without drug. A
bolus injection into the hosts body is modeled by the time varying
blood plasma concentration sv(t). For an injection we take the
exponential function sv(t)~exp({t=tsv) with the time scale tsv~
1 h. Our results are presented with unit-less normalized concen-
trations for which sv(0)~1.
The distribution of Doxorubicin is usually observed in vivo with
the aid of fluorescence imaging, e.g. in [43,44,48]. Typically one
observes exponentially decaying concentration profiles around
tumor vessels, at least during the first few hours. Eventually
eventually drug is distributed relatively evenly. When the blood is
cleared of drug, molecules diffuse back into the blood stream and
so the concentration near vessels decreases again. The overall drug
level decreases over the course of a few days until all drug is
cleared from the tissue.
Our simulations results agree well with this observation. To
illustrate this, Figure 7 shows the spatiotemporal evolution of the
concentration s in a sequence of snapshots. The data are taken
from one of the 15 systems we considered as the base case. See
Supplement S16 for a video.
Upon closer inspection of these figures and comparison with
Figure 4 A it becomes apparent that some vessels are not releasing
drug. The explanation is that close to the tumor rim we have two
classes of vessels with comparable radii but different permeabil-
ities: (i) Mature vessels stemming from arterioles or venules which
release little drug and (ii) dilated capillaries. Toward the tumor
center these differences vanish due to wall degeneration.
In Figure 8A drug concentrations are plotted as average SsTh
against h in the same way as Figure 3, i.e. as average over shells of
constant h. Initially these drug profiles show a strong similarity
with the profiles of the vessel volume fraction which is also plotted.
Both have a peak at the tumor rim and decay into the tumor to
significantly lower levels than in normal tissue. Of course, we
expected such a correlation, because the ‘‘bulk’’ transvascular flux
is proportional to the vessel surface area. This proportionality also
implies a faster drug uptake by diffusion once blood is cleared from
drug. Therefore one might naively expect that the tumor rim is
cleared fastest of drug, afterwards normal tissue, and finally the
tumor center. The actual result at t = 96 h is different, namely that
the profile is relatively flat and monotonously increasing into
normal tissue. Following the discussion below, it is clear that
convection fulfills a significant contribution to transport, moving
drug outwards and flattening the profile. This is studied in more
detail considering a diffusion dominated system in the the case (iii)
(see below).
The ratio of convection to diffusion is quantifiable by the Peclet
number which is defined as PeL~LV=D, where L is a
characteristic length, V the velocity and D the diffusion constant.
PeLw1 means that transport is convection dominated and
PeLv1 means diffusion domination. It depends on L, so we
analyze our system by determining L while requiring that PeL~1
whereby we denote respective L as Ldc~D=V . The mean over the
tumor SLdcTT is 150+4mm. This practically the same length as
the diffusion range of oxygen, i.e. the distance from drug sources
(vessels) up to which viable tumor cells are present. Hence
diffusion and convection are predicted to be equally relevant. In
contrast Ldc is two orders of magnitude larger within normal tissue
which means that transport to spaces in-between capillaries is
strongly diffusion dominated (see Supplement S13 Figure 1A for a
spatial Ldc map).
In Figure 8B the mean drug concentration SsTr is shown
against the distance from tumor vessels r. The profiles were
generated exactly like the plots against h by defining r as the
(signed) distance from the region where the vessel volume fraction
wvw0:01 which captures all vessels. Another interpretation of r is
a penetration depth into the cuffs surrounding vessels and further
into necrotic regions. It shows that over the first few hours Ss(r)T
is very well fitted by an exponential decay function
! exp (r=r0(t)). Where the length scale r0 is approximately
30mm, which is in good agreement with [43,44,48]. During the 3
to 24 hours period the exponential behavior vanishes. Thereby the
level at the ‘‘tail’’ increases while the level in vascularized regions
Figure 7. Series of snapshots of the rug distribution s of a typical base case system. Times and length scale are as indicated. The contour
delineates the viable tumor mass.
doi:10.1371/journal.pone.0070395.g007
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decrease. After 48 hours the profile is almost flat within the local
fluctuations at about 30% of the peak value at 30 min.
For the further analysis and quantification of drug delivery we
have to introduce an appropriate metric that represents the time-
independent spatial distribution of drug doses. Quantities which
commonly enter pharmocodynamical models are the maximal
concentration over time and the area under curve (AUC) which is
the time integral of the concentration. Even in the case of
Doxorubicin, which has been known for a long time, models using
either one have emerged, see e.g. the discussion in [49].
Mathematically those quantities correspond to the jj:jj
?
and
jj:jj1 norms (over time), respectively. jjf jj1 can be bounded by
jjf jj
?
ƒjjf jj1ƒtjjf jj? where f is a proper function and t is the
observation duration. This bound is of course not very strict so it
seems justified to consider both. We use intracellular concentra-
tions since we assume that drug has to enter the cell to e.g. bind to
DNA in order to efficacious. Our denotations are ICMAX for
jjs2jj? and ICAUC for jjs2jj1.
As expected we find the highest values near tumor vessels from
where the it decreases into the unvascularized (necrotic) regions
further away, see Figure 9A and B. ICMAX and ICAUC are
qualitatively similar and also display strong similarities with early
concentration distributions at ca. t = 3 h. ICMAX is comparably
sharp and in fact approximately s=w at t = 3 h. The extracellularly
dissolved drug is negligible since its concentration is two orders of
magnitude lower. Hence, s&ws2. Obviously ICMAX is very
sensitive to the high initial drug levels, whereas ICAUC gives
more weight to later smoother distributions and thus appears more
blurry. Their penetration depth is about 200mm so the whole
viable tumor mass obtains significant (meaning non-zero) contri-
butions. The ratio of local maximum to minimum for the AUC is
23+ whereas it is 122+2 for ICMAX. In Figure 9C and D,
ensemble averages of ICMAX and ICAUC are plotted as radial
distributions together with the vessel volume fraction. The
correlations are obvious and can be explained by the same
reasoning as for the time-dependent concentration distributions.
The displayed compartmentalization in decreasing exposure
towards the center and peripheral peak is qualitatively retained
for most of the parameter variations except for extreme cases with
drastically increased interstitial transport rates such as case (v) (see
below).
Variations
In this section we discuss a number of physiologically relevant
variations of the base case scenario. We consider the following
cases separately:
(i) Heavier drug particles.
(ii) Prolonged infusions.
(iii) Neglected Convection.
(iv) Vascular permeability.
(v) Hydraulic conductivity of interstitium.
(vi) Amount of normal lymphatics.
(vii) Tumor lymphatics.
For all cases we produced the corresponding data shown in
Figures 3, 4, 5, 6, 7, 8, and 9. They are compiled in Supplements
S2, S3, S4, S5, S6, S7, S8, S9, S10, S11, and S12. Videos
visualizing the spatiotemporal evolution of the concentration
distributions in cases (i), (ii) and (iii) are provided as Supplements
S17, S18 and S19.
Below we discuss the physiological implications of these results.
In Figure 10 we present a comparison of the mean S:Tj and
standard deviation (STD) stdj(:) of the ICAUC and ICMAX
distributions. j stands for a region over which mean and STD are
taken. V denotes the viable tumor where wtw0:5, TB the
boundary where {250mmƒhƒ0 and TI the interior where
hv{250mm. This serves as an assessment of drug delivery
efficiency. Higher mean, and smaller STD (i.e. less spatial
fluctuations) means better delivery. Histograms representing actual
probability density functions for ICAUC and ICMAX are shown
in comparison in Supplement S13.
(i) Heavier drug particles. In this case we consider a drug
with a molecular weight of 105g=mol. This corresponds to the
application of viruses or nano particles as delivery system, which
we realize by the adjustment of diffusion related parameters,
namely ls,N ,ls,T ,Ds and kij . For a particle performing Brownian
motion, the diffusion constant scales with 1=
ﬃﬃﬃﬃ
m
p
of the particle
mass m. Hence we scale those parameters by
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
540=105
p
, where
540g=mol is the molecular weight of Doxorubicin from the base
case. This leads to a strongly convection dominated transport
where Ldc is of the order of 1mm.
Figure 8. Profiles of drug concentrations at different times. (A) radial distributions of the drug concentration vs. h similar to Figure 5. (B) the
same concentration distributions are plotted vs. the distance r from nearby vessels. wv and wT show the profiles of the volume fractions of vessels
and tumor cells, respectively. Early on, the concentration plots in (B) can be fitted with an exponential in agreement with experimental data as given
in the legend. Each data point corresponds to the average over a small h or r-interval, where r is the distance from vascularized regions similar to h
(see text). The error bars indicate the standard deviation of the ensemble.
doi:10.1371/journal.pone.0070395.g008
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We see that for heavy particles the IF flow clearly dominates the
drug distribution as seen in Figure 11 (see also Supplement S2, and
the video provided in Supplement S17). As a result the tumor
contains many small, isolated regions where a small amount of
drug is delivered. This is reflected by the PDFs (~p(ICMAX),
~p(ICAUC)) which are broader and lower values are more
common. Interestingly, the pauc distribution completely changes
from bell shaped to almost box shaped, see Supplement S13
Figure 2. The mean values SICMAXTV and SICAUCTV
decrease by ca. 50% which can be expected due to the decreased
transvascular diffusivity.
(ii) Prolonged infusions. Chemotherapy often follows a
complicated schedule with several prolonged infusions, which is
important to avoid toxicity to normal tissue. The basic idea is that
drug given in low concentrations accumulates in the tumor,
whereas the concentration in normal tissue remains tolerable. As a
simple case we consider the administration of a prolonged
infusion. In (ii)a during a 24 h period and in (ii)b continuously
during 96 h. The ICMAX and ICAUC distributions, are
surprisingly similar to the base case (see Supplements S3, S4 and
the video Supplement S18). The difference lies in the scale. The
average concentration SsTT increases approximately linearly in
time for as long as the infusion is active.
That means even by the end of our simulation at t = 96 h the
tumor is far from saturated. We expect this to occur when influx
equals removal of drug. Assuming that s2=s1~k12=k21 in a quasi
steady state the time scale for a purely diffusing particle to move
1 mm can be estimated via the diffusion law SxT2~Dt as 1700 h,
which is a reasonable estimate for the saturation time scale. Note
that our results likely overestimate concentrations and underesti-
mate the speed of the transport due to the lack of saturable cellular
components.
(iii) Neglected Convection. This case serves to gain insight
in the role of convective transport of drug through the interstitium.
For this purpose the convective term in (20) was neglect. Figure 12
shows that initially (t~1=2 and 3h) this case is indistinguishable
from the base case. But later, SsTh profiles remain peaked within
the tumor, leading to significantly increased peripheral drug
concentrations. In fact the average concentration in the center
remains nearly constant up to a ca. 250mm wide peripheral shell
(see also Supplement S5, and the video Supplement S19). Thus,
convection has the effect of ‘‘flattening’’ the profile apparently by
driving additional drug drug into the neovascularized rim where it
is reabsorbed once the blood stream is cleared of drug.
In the following cases (vi), (v), (iv) and (vii) we analyze the effect
of varying permeabilities. In [3] it was shown that the IFP profile
depends only on the ratio of vascular to interstitial hydraulic
conductivity. Here we have spatially varying coefficients but the
same scaling law is expected. Nonetheless we vary both parameters
since their effect on the velocity and thus drug transport is
different. Beside the IFP it seems appropriate to consider the
actual flow through the tumor. We quantify this by the mean
values S:TT of the following components of the source term in (12)
: SQlTT measures the amount of fluid that must leave the tumor
through its boundary in interstitial space. SQzl TT is the amount of
extravasated fluid since vessels are the only sources. SQ{l TT is the
amount of fluid taken up by vessels or lymphatics. Note that
SQ{l TT is typically an order of magnitude less than SQ
z
l TT ,
which is clear since there should be very little back flow into
vessels. Their response to parameter variations is shown in
Figure 13.
(iv) Vascular permeability. We vary ll,T between 1/1000
and 10 times the b.c. value for leaky tumor vessels. Note that this
does not simply scale all permeabilities (i.e. Lvl ) equally, rather ll,T
is the cutoff for Lvl which increases up to this value for w?0 (see
(15)). Also note the conductivity of normal capillaries is
ll,N~1=100ll,T (b:c:).
Figure 9. Spatial distributions of drug exposure metrics. (A) Snapshot of the intracellular maximal concentration ICMAX, and (B) snapshot of
the time integrated concentration ICAUC from a typical simulation result from the base case. The contours delineate the viable tumor mass. (C) and
(D) Plots of ICMAX and ICAUC from the base case as ensemble averaged (15 systems) radial distributions (black) similar to Figure 5. In addition,
the vessel volume fraction is plotted as well (grey).
doi:10.1371/journal.pone.0070395.g009
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Figure 10. Comparison of the means and STDs of the probability distribution functions (PDFs) of ICMAX and ICAUC. These
quantities are presented for different regions, where each region is associated with its own PDF using j as index, where V stands for the viable tumor
mass, TB for tumor boundary and TI for tumor interior (see text). Spatial mean, indicated by brackets (or STD, indicated by std) are first computed for
all systems in the ensemble and then averaging over the ensemble. The error bars show respective deviations from the average within the ensemble.
The meaning of the case labels is as follows: (b.c.) base case, (i) heavier drug particles, i.e. molecular mass increased by a factor of 2:103 . (iii) neglected
interstitial convection, (iv) tumor vascular permeability scaled by a factor of 10 (a), 1=10 (b), and 1=100 (c), (v) hydraulic conductivity of interstitium
scaled by a factor of 10, (vi) amount of normal lymphatics scaled by a factor of 10, (vii) presence of 10% (a) and 100% of the normal lymphatics
amount in the tumor. Note that (ii) (prolonged infusions) are not shown due to the scale.
doi:10.1371/journal.pone.0070395.g010
Figure 11. Spatial distributions of (A) ICMAX and (B) ICAUC for the case (i). Here 104 times heavier drug particles are considered which renders
diffusive transport insignificant (see text). The presentation is analogous to Figure 9 of the base case.
doi:10.1371/journal.pone.0070395.g011
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Increasing ll,T has little effect on the IFP and IFV profile since
the IFP already approaches rapidly the blood pressure, see
Figure 14 A. The plots of the source terms (Figure 13 A show that
for increasing permeabilities most of the little additional flow is
reabsorbed into vessels (SQ{l TT ). The flow that crosses the
boundary is insignificantly altered. For lower permeabilities the
uptake SQ{l TT decreases much more rapidly than the influx
SQzlv TT . The latter varies weakly within one order of magnitude
over the whole ll,T range, implying that the hydraulic resistance of
other components, i.e. interstitium and lymphatics limits the flow.
Interestingly, setting ll,T to the level of normal vessels is not
enough to lower the IFP to a normal level. It is only reduced by
about 50%. Further reduction to 1=1000ll,T (b:c:) yields near zero
IFP (& 0.1 kPa) but an outward gradient persists.
Predictions for drug delivery were made for
ll,T~10,1=10 and 1=100ll,T of the base case. See Figure 10
(iv)-A to C (see also Supplements S6, S7 and S8, respectively). In
conjunction with ll,T we also varied the diffusive permeability ls,T
by the same factor. The mean ICMAX and ICAUC level in VTB
are invariant since this regions exhibits rather normal vessels since
leakiness increases gradually toward the center. In the interior,
SICMAXTTI and SICAUCTTI increase with the permeability as
expected. Here too, for (iv)-A we find ICMAX levels in the tumor
which are comparable to normal tissue.
(v) Hydraulic conductivity of interstitium. The base case
considers a dense tissue which implies a low conductivity due to
the dependence on the available interstitial volume. Sparser tissues
were estimated to be orders of magnitude more permeable [50].
To analyze such a situation we scale the tissue permeability
coefficient Kl,a up to 100 times simultaneously for a~N and T .
For brevity, a is omitted in the following. Increasing Kl alone
produces unrealistic results where the IFP within normal tissue
rises well above 0. Hence the lymphatic permeability L
(L)
l , was also
increased by the same factor.
With increasing Kl we observe a decreasing IFP which drops to
ca. 1=7 of the base case value for a 100 times increase of Kl , as
shown in Figure 14B. The IFV decreases sub-proportionally, up to
a factor of 20. Interestingly, the region where most fluid is
extravasated shifts from close to the boundary to the tumor center.
Concomitantly one finds a shift of the peak in the v(h) toward the
tumor center and less back flow through vessels as compared to the
base case as indicated by lowered SQ{l TT . For the total flow
SQlTT we can identify two regimes: Up to a 10 times increase we
see an approximately linear variation, and for larger Kl a
logarithmic behavior.
Drug delivery is analyzed for an increase of Kl by a factor of 10,
where we additionally upscale the diffusion constant Ds by the
same amount (see Supplement S9 for additional figures). This is
rather ad-hoc but based on the assumption that the free volume
fraction and the amount of ECM components varies, on which the
effective diffusion constant and IF permeability linearly depend on
as a first order approximation. As a result we obtain a significantly
more homogeneous ICMAX and ICAUC distributions. See the
comparison Figure 10B,C-(v) vs. (b.c.). The effect is most drastic
for ICAUC but also the ICMAX fluctuations over VTB are
significantly reduced. Remarkably, the tumor interior now shows
higher drug concentrations (Figure 10A-(v)) than the exterior. The
fact that the drug delivery to the interior is comparable to normal
tissue is surprising since permeabilities were adjusted also for
normal tissue not just the tumor.
(vi) Amount of normal lymphatics. The lymphatic system
is not well documented due to the lack of specific markers for its
Figure 12. Drug concentrations in the case (vii) where
convective transport was neglected. Results are presented as
averaged profiles plotted vs. h as in Figure 8.
doi:10.1371/journal.pone.0070395.g012
Figure 13. Mean fluid source rates over the whole tumor in dependence on varying parameters. Q with its sub and super scripts refer to
contributions to the source term as defined in (12), (23). The plotted mean values are defined simply as ensemble averages of the spatial means over
the tumor. The error bars show the standard deviations within the ensemble. The subplots depict the following cases: (A) Variation of the upper
vessel wall permeability bound ll,t (case (iv)). (B) Variation of the interstitial permeability coefficient Kl (case (v)). (C) Variation of the lymphatic wall
permeability in normal tissue (case (vi)). (D) Variation of the lymphatic density in the tumor given as fraction of the normal tissue lymphatic density
S
(L)
T =S
(L)
N (case (vii)). Except for in (D) the ordinate scale is relative to the base case.
doi:10.1371/journal.pone.0070395.g013
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channel walls. In our parameter determination we assumed that it
has a similar capacity as the capillary bed. Moreover tumors can
induce lymph angiogenesis similar to normal angiogenesis [9]
thereby increasing the amount of lymphatics nearby. Hence we
consider variations of the source term coefficient L
(L)
l S
(L)=V from
100 to 1/100 times the base case (b.c.) value.
As discussed above, the IFP has a ‘‘penetration depth’’ across
the tumor boundary which is proportional to
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Kl,N l2=L
(L)
l S
(L)
q
and indeed we see a variation of this magnitude in the radial
profile. Moreover with increasing L
(L)
l S
(L)=V the IFP drops
asymptotically to the lymphatic pressure pL, which can be
explained by the analogy of an electrical resistor. A L
(L)
l S
(L)=V
decrease on the other hand drives the IFP in unrealistically high.
The central tumor IFP is thereby relatively invariant to these
parameter changes, see Figure 14C. The IF velocity varies
according to the gradient across the boundary and can be
increased by up to 50% in the extreme case. The global flow
SQlTT increases by about the same magnitude. The average back
flow SQlv{TT decreases insignificantly within the error bars. On
the other hand for low L
(L)
l S
(L)=V more back flow is observed,
which is reasonable since the uptake capacity of lymphatics is
decreased.
For drug transport we only consider the case with a factor of 10.
Qualitatively the ICMAX and ICAUC distributions appear
similar to the base case (figures are provided in Supplement S10).
The increased flow apparently leads to higher drug levels all over
the tumor, but the effect is strongest in the TB region. Spatial
fluctuations are also insignificantly changed. Thus we can
conclude that the delivery slightly improved. Given that the fluid
transport rate SQlT increased by 50% this is surprising since case
(i) demonstrated that a larger convection-diffusion ratio can have a
negative effect.
(vii) Tumor lymphatics. In this hypothetical case we assume
that functional lymphatics exist within the tumor. We model this
by a non-zero lymphatic sink coefficient L
(L)
l S
(L)=V as a fraction
of the coefficient in normal tissue. This differs from taking a higher
tissue conductivity by the assumption of the underlying channel
Figure 14. Radial distributions as result of parameter variations. Left: IFP, right: IFF, averaged over 15 system analogous to Figure 5. The
relative deviation from the original base case parameter values is given in the figure legends, except in (D). The considered cases are as indicated in
the sub-figure heading: (A) Variation of the upper vessel wall permeability bound ll,T (case (iv)). (B) Variation of the interstitial permeability coefficient
Kl (case (v)). (C) Variation of the lymphatic wall permeability L
(L)
l in normal tissue (case (vi)). (D) Variation of the amount of tumor lymphatics
S
(L)
T =S
(L)
N , where the legend shows S
(L)
T =S
(L)
N directly (case (vii).
doi:10.1371/journal.pone.0070395.g014
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organization. The latter case implies a grid like structure whereas
the former implies a hierarchical structure where exchange takes
place over the thinnest channels analogously to blood vessel
network. Those lymphatic capillaries can be expected to exhibit
approximately equal blood pressure over the whole tissue. Hence
the use of homogeneously distributed sinks with lymphatic
pressure pL.
Resulting IFPs and IFV plots are shown in Figure 14D. As can
be seen an increasing presence of lymphatics ‘‘pulls’’ down the IFP
to pL. The outward velocity component vjj decreases proportion-
ally as can be expected based on the IFP gradient. But the actual
velocity magnitude jvj increases with the amount of lymphatics.
This can be expected as well since the velocity field is increasingly
superimposed by flow away from vessels to nearby locations where
fluid is absorbed. This is also reflected by increasing transvascular
flow SQlzTT , decreased flow across the boundary, SQlTT and
the back flow SQ{lv TT as shown in Figure 13C.
We computed the drug transport for systems with (a) 0.1 and (b)
1 times the normal lymphatics (see Supplements S11 and S12,
respectively). What we would expect is that the changed flow
patterns (directed away from vessels) facilitate the delivery to more
distant regions. As Figure 10A and B-(vii) show this is indeed the
case. Even in (a) a significant improvement is achieved. The
ICMAX and ICAUC levels in the rather unrealistic case (b) are
increased dramatically. This must also be attributed to leaky
tumor vessels. Thereby spatial fluctuations are either unchanged
(std:(ICMAX)) or significantly reduced std:(ICAUC).
Discussion
Based upon an extension of our model for remodeling of tumor
vasculature introduced in [15,16,18,19] we studied interstitial fluid
flow (IFF) and drug transport.
Since the spatial details of IFF depends crucially the spatial
arrangement of blood vessels and their blood pressure we
considered, for the first time, a model for IFF and drug transport
that involves a realistic arteriovenous initial vascular network
evolving dynamically with the tumor. As a result tumor vessels are
connected to a wide variety of original host vessels - from
capillaries to ca. 50 mm arterioles and veins. Blood flow is
determined for the whole system including the whole remaining
host vasculature which comprises not only a single parent vessels
but many vessels covering the entire simulation domain. It should
be emphasized that an arteriovenous initial vasculature produces
blood flow patterns and blood pressure fields that differs
substantially from grid-like arrangements [15,18]: the latter usually
have a fixed blood pressure gradient direction imposed upon them
which can also (unrealistically) impose a preferred direction on
tumor vessel growth and skew the IFP distribution. For a tumor
blood vessel network emerging from an arteriovenous initial
vaculature we obtain much higher blood ow rates through
individual vessels due to arteriovenous shunts and circumferential
growth, and more irregular (spatial) blood pressure distributions.
Due to transvascular coupling these circumstances are also
relevant for the IFP, IFF and drug transport.
A first remarkable result is that in spite of an expected IFP
plateau within the tumor IFF does not cease and still allows for
substantial convective transport, which is opposite to the currently
prevailing view [3–9] that states that increased IFP poses a barrier
to successful drug delivery within tumors. The physical explana-
tion is simply that it is misleading to consider the pressure drop
along the vessel wall alone as the driving force for IFF - in
principle the complete network of hydraulic resistors has to be
taken into account to obtain reliable predictions. Qualitatively it is
sufficient to bear in mind that for IFF the tumor is series of
resistors with a fixed potential outside the tumor (the lymphatics of
healthy tissue) - decreasing one resistor, for instance by increasing
the permeability of the vessel walls, generally increases the flow, in
spite of the lower potential drop along the decreased resistor.
Another interesting result is that heavy macro-molecules are still
distributed more or less evenly into viable areas in the tumor
perimeter in spite of a pronounced outward IFP gradient there,
which one could naively expect to remove drug before an
efficacious dose is achieved. The reason is IFF between tumor
internal vessels, that transports macro-molecules convectively from
leaky high pressure vessels through the tumor tissue into
neighboring low pressure vessels. In the following we discuss our
results quantitatively in detail.
It is already established that leaky tumor vessels and lack of
tumor lymphatics lead to a drastically increased hydraulic pressure
of the interstitial fluid (IFP) in the tumor and that the resulting
gradient drives fluid out of the tumor with a velocity of 0.1 to
1mm=s [4,51] and our results agree with these experimental
observations very well. Our model predictions of the central IFP is
ca. 6 kPa, which is at the upper limit of experimentally observed
values. This value is also higher than in normal capillaries due to
the coupling with higher level arterioles in which the blood
pressure is naturally higher. The vessel walls of arteries and veins
within the tumor become leaky [21] and thus increase their
conductivity, which means tighter coupling between IFP and
blood pressure which as a result causes the IFP to approach the
level of nearby arteries or veins. Indeed, the predicted mean
pressure difference between blood and interstitium vanishes
towards the tumor center. Local fluctuations produce flow into,
out of and in-between vessels which is not necessarily directed
outwards. The outward component of the velocity vector
dominates in the tumor periphery. Around the tumor perimeter
we find a thin layer where where the fluid is absorbed into
lymphatics. Absorption into blood vessels frequently occurs deep
inside the tumor. It should be noted that the fluctuations among
samples are very large, about 100%. Consequently, depending on
their location in the microenvironment, seemingly by chance some
tumors could be more likely to metastasize through the blood
stream than others of the same kind. Although the transvascular
flow of tumor vessels is elevated by an order of magnitude
compared to normal capillaries, we estimated that only a small
fraction of the order of 0.01 percent of the blood flow which enters
the tumor is lost into the interstitium. The biophysical factors upon
this ratio depends are the vascular morphology and the
permeability of vessel walls, interstitium, and lymphatics. Here,
dilated vessels and arteriovenous shunts lead generally to elevated
flow rates (q) in tumor vessels. Note that q depends strongly on the
vessel radius r, i.e. q!r4.
In addition to the base case we considered scenarios in which
the conductivities of vessel walls, lymphatics and the interstitium
are varied individually. We observe universally that the influx
through vessels, and therewith the IFF through the tumor,
increases with the conductivity. The sensitivity to these changes
is rather low, even for variations of several orders of magnitude.
Lower IFP does thereby not correlate with increased flow. For
example the reduction of IFP can be achieved by increasing the
tissue conductivity or decreasing the vessel wall conductivity. In
the first case the IFF is increased while in the second it is
decreased. This relationship between IFF and conductivity can be
easily understood on the basis of analogy of our flow equations
with an electrical network of ohmic resistors: As an extreme
idealization let us consider a linear chain of three resistors,
representing the walls of the tumor vasculature, the interstitium
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and lymphatic walls, whereby the potentials are fixed at the ends.
Then of course the current is determined by the total resistance
and the voltage drop over one resistor grows with its resistance. An
increase of the first resistor (decrease of vessel wall conductance) as
well as decrease of the second resistor (increase of tissue
conductivity) both imply a lower voltage drop at the second
resistor (lower IFP). But the current (the IFF) decreases in the 1st
case and increases in the 2nd.
We quantify the local exposure to drug with the help of both the
time integrated intracellular concentration (denoted as ICAUC
for intracellular area under curve) as well as the maximal
concentration (denoted as ICMAX for intracellular maximal
concentration), which we consider separately. Our model predicts
that on a large scale, drug delivery is compartmentalized similar to
the vasculature. Let us subdivide the system into concentric shells
with increasing distance from the invasive edge and consider
averaged quantities over such shells. Close to the invasive edge we
typically find an exposure peak, the location of which is not exactly
aligned with the MVD peak due to outward convection. Towards
the tumor center the decreasing vessel density leads to a sharp
drop down to a plateau at a certain lower bound which is for our
base case ca. 50% of the level at the tumor periphery. The height
of this plateau depends on various factors including extravasation
rate, transport rate through the interstitium, but predominantly
vessel density.
The tumor center is threaded by many isolated vessels, and our
model predicts exponentially decaying concentration gradients
around them in agreement with experimental results e.g. [43,48].
Over longer time scales of many hours to days, the initial
distributions smear out akin to the behavior of freely diffusing
particles, and also decrease globally due to reabsorption. The
magnitude of these time scales depend on the transport rates,
cellular uptake and binding dynamics.
Although we did not study it in detail, we want to stress that
cellular uptake and retention dynamics also govern the total
amount of extravasated drug to a certain extend because the faster
the uptake rate, the lower the interstitial concentration, the larger
transvascular gradients which drive diffusive fluxes and counteract
re-absorption by convection.
It has been suspected for over a decade that IFF could wash out
drug from the tumor. Our model predicts this effect but as drastic
in magnitude as expected. Simulation runs in which convective
transport was neglected show that a ca. 2.5 times higher drug
concentration is retained in the periphery whereas the radial
profile of the time-independent exposure measures (ICAUC,
ICMAX) merely exhibit a smoother decay from periphery to
center. In the opposite extreme case of non-diffusing particles
under normal convection the the interstitial flow causes sufficient
flux to achieve significant drug delivery which is on a coarse scale
comparable to the base case. Here we do however observe islands
in the viable tumor region where no drug is delivered, implying
that such tumor fragments could remain viable after treatment. In
cases with diffusion, at least small amounts of drug are delivered.
Different tissue types as well as the effect of therapies that
improve drug delivery can be described within the model by
changing various permeability constants. We varied diffusion
constants simultaneously with conductive constants by the same
factors as first approximation to hypothetical changes e.g. of the
intercellular channel geometry. As a result, global exposure levels
and the amount of extravasated fluid correlate well with these
permeabilities as well as with each other. Unfortunately relative
local fluctuations, i.e. the STD over space of ICAUC and
ICMAX are not correlated with these variations, making them
unsuited as basis for achieving are uniform efficacy or dose.
Within the biologically relevant parameter space of which we
only considered a small part, analysis of other cases will certainly
lead to additional insight. For example in [14] tumor interstitium
and capillary permeabilities (Kl,T and ll,T in terms of our model)
were varied simultaneously, leading to a flattened tumor IFP
profile for increasing permeability. From such observations in an
experimental setting one could draw conclusions about the nature
of the tumor tissue.
With this in mind a tumor therapy that comprises a treatment
that solely reduces the vessel leakiness appears not to be effective.
A currently frequently discussed alternative is to improve the
efficacy of drugs by turning the ill-formed tumor vasculature
normal again [52] by pharmacological means during or before a
conventional therapy. A step in this direction is obviously to
reduce the leakiness of tumor vessels. However, our simulations
predict an actual reduction of the global ICAUC and ICMAX
levels while their relative fluctuations may even increase. On the
other hand increased permeability leads to significantly improved
delivery in the tumor center. Unfortunately this case is unlikely to
be a therapeutic goal since it could increase the direct exposure of
the blood stream to tumor cells increasing the chance of tumor
cells entering it. A good treatment strategy would be to prioritize
the maintenance, or fabrication of a dense tumor vasculature,
rather than exclusively tightening the leaks in the already sparse
vasculature. If a tumor is detected early enough the vasculature
could thus be kept intact and deliver drugs effectively, simply due
to the amount of functional capillaries, even though their walls are
expected to conduct drug worse than leaky walls.
Vascular targeting therapies that take the opposite direction
namely that aim to destroy the remaining tumor vasculature
completely exists hand have proven to be promising, see e.g. [53].
A common problem in therapy is that tumor cell in vivo are more
resistant to treatment than cell cultures. Many factors are involved
but not all are purely of genetic nature. For example the lack of
oxygen plays an important role for the development of radiation
resistance. Or the drug delivery through the sparse tumor
vasculature is insufficient, which is supported by our model
prediction that the drug concentrations in the tumor are much
lower than in normal tissue. If cells in the interior were killed
indirectly by vascular targeting, a viable shell around the boundary
would remain which could be effectively treated conventionally
due to the better vascularization. It is plausible that the removal of
the inner tumor vessels would lead to a reduction of the IFP and
thereby lower IFF across the boundary. As our results show, the
absence of this peripheral flow can improve the drug exposure of
the boundary significantly potentially leading to better treatment
in combination with vascular targeting.
Interestingly, the ICMAX and ICAUC levels increase with the
interstitial permeability, lymphatic permeability, or when provid-
ing the tumor with a fraction of surviving lymphatics. In addition
to that and perhaps more importantly, drug concentrations
become more homogeneous as well. This effect is much more
prominent for ICAUC than for ICMAX, where for the former the
spatial STD decreases from over 0.4 to ca. 0.2. With a 10 times
increased interstitial conductivity the ICAUC distribution even
becomes completely smooth over the whole tumor at levels higher
than in normal tissue. Unfortunately, in those cases the IFF is also
increased which would likely increase the shedding of TCs into
lymphatics, not to mention the danger of having TCs in direct contact
with tumor lymphatics. Hence, despite significantly improved delivery
the parameters above are certainly not a useful therapeutic target.
The final ICMAX and ICAUC distributions for continuous
infusions are hardly distinguishable from the bolus case except for
the scale. The reason is that the time scale to achieve a stationary
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state (estimated ca. 1700 h) is much longer than the infusion
periods (24 h and 96 h) which we tried. For Doxorubicin cellular
uptake is relatively fast (of the order of minutes) and release is slow
(of the order of hours), hence the local concentrations are in a
steady state where most of the drug is arrested in cells, lowering the
effective transport rates. It can be expected that drugs with low
uptake rates perform better in this respect.
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S1 Details of the model
Illustrative figures
Figure 1: Illustration of the vessel network remodeling processes. The contents of the boxes display
exempliﬁed states of the vessel network. The vessel segments are shown as blue boxes if perfused with blood,
else they are in a gray shade. Dark-blue borders (in C and E) represent vessel walls of varying thickness.
The presence of a tumor is hinted at by the light orange region. The state transitions go from left to right
as indicated by the arrows whereby the rate parameter is denoted below- and essential preconditions above
the arrows, respectively. The note “in tissue” or “in tumor” refers to the location of a segment, see text for
the precise deﬁnitions these conditions. In (A) a new sprout is generated. In this instance the preexisting
segment is split at the branching point. Subsequently a new sprout segment is added with its life-time counter
τ initialized to 1. li denote the distances to neighboring branching points. Since vessels can be chained together
without branching points it is in general required to traverse such chains until li > l
(spr) or a branching point is
found. (B) depicts the further extension of the sprout from (A). It has already been extended to two segments
and a third segment is appended. The lengths of sprout segments are always exactly one lattice bond. τ
is inherited from the parent segment and incremented by 1 for all sprouts once per remodeling sweep. (C)
depicts the degradation of the vessel walls with the rate ∆w. Though w is deﬁned as an abstract measure, it
can be related to the wall thickness as shown here. w′ stands for the value at the next time step, i.e. using
Euler’s method w′ = w+∆t∆w. In (D) an unstable vessel is removed, representing occlusion of blood ﬂow and
complete disintegration. Such event is assumed to happen only to vessels with maximally degenerate walls and
low wall shear-stresses. Previously attached vessels can become dead ends which means blood cannot circulate
through them any more. Such segments are identiﬁed by the biconnected component graph-algorithm [1] and
excluded from blood ﬂow computations. Since these vessels trivially have f < f (coll), they can collapse easily,
resulting in a long ranged eﬀect. (E) depicts the dilation of tumor vessels. The new radius after one time step
is r′ = r +∆t∆r.
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Figure 2: Sketch of the vessel network generation algorithm. For illustration we display subsequent
actual conﬁgurations from a run on a 10 × 10 × 2 lattice. The background mesh depicts the z = 0 layer of
lattice. The color code for the vessels generally shows arteries in red and veins in blue. If blood ﬂow data is
available (D to H) the blood pressure is mapped to a red-blue gradient. The two circles (see A) display the
location of the root nodes. Here are just two, but for our other results we placed them in alternating order at
all boundary sites of the lattice. (A) shows the state after two growth iterations. Stars indicate the open ends
where further elements can be appended (also in B). (B) shows the state during the random growth process.
(C) shows the state at the end of the random growth process. Further additions would cause overlap which
is forbidden. In (D) capillaries were added, radii computed and blood ﬂow computed. Unperfused branches
are displayed in dark gray. Capillaries are green. (E) displays the state after shear-stress based remodeling.
(F) shows the network on a lattice which was upscaled once, doubling the number of sites and the length of
the original vessel segments to span over two lattice bonds. Previous tips served as starting points for random
growth as in A to C. This was followed by determination of radii, generation of capillaries, and computation
of blood ﬂow as in C to D. (G) shows the result from (F) after remodeling. Here perfused capillaries are well
distributed. (H) shows the ﬁnal state after an additional up-scaling step.
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Initial blood vessel network construction
Random growth: The addition of a new element q at a tree tip is determined by probability weights wq for
all possible additions q. Speciﬁcally, we must consider the type and orientation of a new element. Additions
resulting in overlap with the existing network are forbidden. Also we allow only additions in the forward
direction. For non-admissible conﬁgurations we set wq = 0, else we set wq = cos(ϕ), where ϕ denotes the angle
between the element and the parent branch. A speciﬁc element for addition is then picked according to the
probabilities generated from the normalized weights pq = wq/(
∑
q wq).
Remodeling: In addition to the selection of the growth direction we must determine for each site on the
network whether a new element is attached, a segment is removed, which is only possible at tree tips or if no
changes are made. For these cases the following probability weights for growth wg, regression, wd and idleness
wi are given
wg = f/fmax
wd = 1− f/fmax
wi =∞ if f = 0 and not N(x ), else 0,
where N is a boolean indicator function which maps to true if and only if there are perfused vessels within
the range of 3h˜L = 240µm, f is the shear stress and fmax is the maximal stress over all of the tree tips. The
probabilities for an event are given by the normalized weights as above, as well as the probabilities for the
element type and its orientation. Against this background we wrote wi = ∞ in the symbolic meaning that it
yields pg = 0, pd = 0, pi = 1.
Pressure radius relation
The root nodes of the trees have ﬁxed blood pressures as boundary condition. Their value is determined by an
empirical formula which was ﬁt to Fig. 5 in [2].
r′ = r for a vein, else − r
A1 = 89, A2 = 18, r0 = −21,∆r = 16
P = 0.133[A2 + (A1−A2)/(1 + exp((r′ − r0)/∆r))] (1)
in units of µm for the radius r and kPa for the pressure P . For our typical networks this yields pressures from
ca 2.5 to 12 kPa, where the radii of the root vessels are ca. 100 µm.
Radius wall-thickness relation
Initially the vessel wall thickness w(t = 0) = w(init) must be well deﬁned. Guided by [3], we use
w(init) = 2r(0.65− 0.2 log(2r)), (2)
depending on the vessel radius r. Sprouts are also created with w = w(init).
Smoothed Heaviside and Dirac Delta functions
We adopt sin/cosine based formulas commonly used in level set and immersed boundary methods, see e.g. [4, 5].
δǫ(x) =
1
ǫ
{
1
2 (1 + cos(
πx
ǫ )) if |x| ≤ ǫ,
0 otherwise
(3)
δǫ(x ) = δǫ(x 0)δǫ(x 1)δǫ(x 2).
In addition to the convergence to the “sharp” Dirac delta it has the nice properties that it is continuous and
has limited support. The smoothed Heaviside function is the integral over δǫ(x) and reads
Θǫ(x) =


0 if x ≤ −ǫ,
1
2 [1 +
x
ǫ +
1
π sin(
πx
ǫ )] if |x| < ǫ,
1 otherwise
.
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Abstract
The oxygenation of tumor tissue is in general very heterogeneous, not only spatially inhomogeneous
in one tumor but also varying strongly among different individuals with the same kind of cancer,
where the average blood oxygen saturation can be lower or larger than the surrounding tissue.
This wide variation of tumor oxygenation must be related to corresponding heterogeneities in
the underlying blood vessel network, which again could be used as diagnostic markers in cancer
treatment. Unfortunately the spatial resolution of non-invasive oxygen measurements techniques as
tissue optics or MRI is too low to allow for even an approximate reconstruction of the underlying
vessel network, which itself is hardly accessible experimentally. Therefore computational models for
tumor vascularization, blood flow and oxygenation are needed as a tool to interpret the available
data. In this paper we present such a computational model for trans-vascular oxygen transport
in tumor blood vessel networks formed by vascular remodeling via cooption, angiogenesis, and
regression. A specially adopted numerical procedure allows the computation of the intra- and
extravascular partial oxygen pressure distribution of macroscopic tumor tissue regions of sizes up to
1 cm3. Spatial inhomogeneities in the extra-vascular partial oxygen pressure distribution can be
related to different tumor compartments characterized by varying capillary densities and blood flow
characteristics. We calculated regional blood volume rBV, average hemoglobin concentration cHB ,
and average blood oxygenation Y in tumors and their surrounding normal tissue. In addition, the
relation between average blood oxygenation and hemoglobin concentration was determined. The
results qualitatively reproduced published experimental data obtained for a cohort of 87 breast
cancer patients. We show that the wide range of blood oxygenation data from above to below
normal tissue can be related to strong variations in the location and morphology of high caliber
vessels threading the tumor.
Author Summary
Blood vessel networks supply all parts oft he body with oxygen, but also nourish growing tumors,
which in return remodel the existing tissue vasculature via angiogenesis, vessel cooption and
regression. The emerging tumor vasculature characteristics are in many respects very different
from normal tissues, lacking a hierarchical arterio-venous organization and being spatially highly
inhomogeneous, resulting also in spatially inhomogeneous oxygenation with hypoxic and hyperoxic
regions. Tissue oxygenation and regional blood volume and flow can be measured non-invasively and
it would be highly desirable to infer from the obtained data tumor vascularization characteristics,
which are important for cancer diagnosis and therapy. Unfortunately the spatial resolution of these
non-invasive techniques is very restricted so that computational models are needed to interpret the
oxygenation and blood flow data. In this paper we present such a computational model and apply it
to experimental data from breast cancer patients obtained with optical mammography and MRI.
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Introduction
Tumor Oxygenation and Experimental Methods
Adequate supply of tissue with oxygen and nutrients critically depends on the structure and function
of its vasculature. For tumors to grow beyond 2 mm in size, new vasculature must develop, i.e.
angiogenesis must occur [1]. The vasculature of solid tumors, however, is known to differ distinctly
from that of surrounding normal tissue. Whereas vasculature in normal tissue is arranged in a
hierarchy of arteries, arterioles, capillaries, venules and veins and grows under tight control of
inter-capillary distances, tumor vasculature develops in a chaotic manner without such control,
leading to spatial vascular heterogeneity. In solid tumors necrotic regions, and regions of low
microvessel density (MVD) may occur, whereas tumor blood vessels are more abundant at the
tumor-host interface [2]. Tumor vessels are known to be immature, fragile, tortuous, dilated, to
form (large diameter) arterio-venous shunts and often it is even difficult to distinguish arterioles
and venules, i.e. the classification of tumor vessels as arterioles, capillaries and venules is no longer
adequate [2, 3, 4, 5, 6, 7]. In addition, tumor vessels exhibit high permeability to macromolecules
[3]. The structurally abnormal tumor vasculature results in spatially and temporally heterogeneous
blood flow, affecting tissue oxygenation (acute or perfusion-limited hypoxia). From intravital dorsal
window microscopy on tumor models it is known that blood flow through tumor capillaries is
frequently sluggish and at times may even be stationary and reverse direction . It follows that blood
flow through tumors may not follow a constant unidirectional path. In addition, red blood cell
(RBC) flux varies greatly among tumor vessels, many tumor vessels do not carry RBCs but contain
plasma only [2, 3, 4, 6, 8]. Furthermore, tissue solid pressure, generated by proliferating cancer
cells, may compress tumor blood vessels thus reducing or impairing blood flow [9, 10, 11]. Tumor
cells separated from nearby capillaries beyond the diffusion limit of oxygen suffer from chronic
(diffusion-limited) hypoxia. Hypoxic tumor cells are known to be resistant to ionizing radiation,
since oxygen is needed to stabilize radiation-induced DNA defects and, in addition, are considered to
be resistant to some anticancer drugs. Therefore, tumor hypoxia is associated with poor prognosis,
because it causes resistance to standard therapies and promotes more aggressive phenotypes [12, 13].
Because of their limited spatial resolution present-day non-invasive imaging techniques used in
clinical practice do not allow to visualize tumor vasculature, blood flow and distributions of e.g.
oxygen and nutrients at the capillary and cellular level, despite the diagnostic relevance, e.g. of
MVD and the presence of hypoxic tumor cells. Therefore, computational modeling is an appropriate
tool to analyze the relations between experimentally measurable characteristics of tumor vasculature
and oxygenation.
Tissue oxygenation has been measured in human tumors by oxygen polarography using needle
electrodes [14] . However, needle techniques are invasive and suffer from sampling errors. In
this way oxygen partial pressures were found to be highly heterogeneous in tumors with median
oxygen pressures below that of the host tissue. More importantly, tumors often exhibit hypoxic
regions with oxygen partial pressures below 10 mmHg. Today, non-invasive positron emission
tomography (PET) is employed clinically to image oxygenation status of tumor tissue [15]. The
radio-labeled hypoxia imaging agent 18F-fluoromisonidazole (18F-MISO), e.g., freely diffuses in
tissue after intravenous injection and extravasation from the vasculature. However, it is immobilized
by binding to intracellular macromolecules in viable tumor cells that are located in areas with
oxygen partial pressures below 10 mmHg, thus indicating hypoxia. In order to deduce 18F-MISO
concentrations from measured tissue activity curves, modeling of concentrations of the radio-labeled
imaging agent and of oxygen in tumor tissue is required [16, 17, 18]. Previously, PET together
with the steady state 15O2 inhalation method were used to measure cerebral metabolic rate of
oxygen consumption CMRO2 and oxygen utilization, i.e. the oxygen extraction fraction OEF in
normal brain tissue [19]. This method had also been applied to human breast [20] and brain tumors
[21, 22]. However for tumors this method is considered not to be accurate because homogeneous
compartment models used to analyze the PET data do not take into account the inherent perfusion
heterogeneity of tumors [23]. Dynamic PET measurements following application of a diffusible tracer
allow to quantitatively deduce perfusion (blood flow rBF ) of normal tissue and tumors. For example,
perfusion of normal breast tissue and of breast tumors was measured by intravenous application of a
bolus of H2
15O or inhalation of C15O2 that is converted to H2
15O in the lungs [24, 25]. Furthermore,
blood volume is obtained from PET measurements using C15O, or 11CO that irreversibly bind to
2
hemoglobin.
Measurements of intravascular oxygen concentrations being complementary to extravascular
tissue oxygenation measurements can be carried out by a variety imaging methods. There are several
methods based on magnetic resonance imaging (MRI) that are sensitive to blood oxygen saturation
in brain tissue ([26, 27]. Quantitative blood oxygen level dependent MRI (qBOLD-MRI) exploits
magnetic field perturbations close to blood vessels originating from paramagnetic deoxy-hemoglobin.
Such magnetic field perturbations increase the relaxation rate 1/T ∗2 of water, obtained from gradient
echo images. Based on a mathematical model of magnetization in each voxel, qBOLD-MRI was
used to measure blood oxygen saturation in brain tumors and in contralateral healthy brain tissue
of a tumor model [28]. While good spatial resolution is achieved, a number of parameters other than
blood oxygen saturation affect the measured proton relaxation rate 1/T ∗2 , e.g. macroscopic field
inhomogeneities and blood volume rBV , requiring additional MRI measurements to reliably deduce
blood oxygen saturation. Blood volume can be inferred by measuring the water relaxation rates 1/T ∗2
before and after application of a superparamagnetic blood pool contrast agent [28, 29]. Traditionally,
T ∗2 -weighted dynamic contrast enhanced MRI following application of a bolus of low-molecular
weight paramagnetic contrast agent (e.g. Gd-DTPA) has been used to estimate perfusion from
gradient echo images taken at high temporal resolution [30]. More recently cerebral perfusion was
measured quantitatively by arterial spin labeling (ASL) followed by fast MRI techniques [31, 32].
Arterial spin labeling generates a bolus of magnetically tagged intravascular water in the artery
feeding the tissue. The magnetically tagged water is then imaged in the capillaries and brain tissue
of the imaging plane selected. Perfusion is deduced quantitatively from signal intensities of images
with and without ASL applied.
In vivo tissue optical spectroscopy extending from the red to near infrared (NIR) spectrum allows
to measure absorption by deoxy-hemoglobin (HbD) and oxy-hemoglobin (HbO) and hence to deduce
blood oxygen saturation. Optical mammography [33, 34, 35] has been developed over the past
one to two decades and a large body of data on concentrations cHbD c and cHbO in normal breast
tissue and breast tumors has been collected from many patients [36, 37, 38]. Mostly, the breast
is slightly compressed between two glass plates and transmittance of laser radiation through the
tissue is measured with the photon source at selected positions. Because of light scattering, photon
trajectories through the (slightly compressed) breast are much (about 5 times) longer compared
to the geometrical distance between photon source and detector, i.e. between the point of entry
and point of exit of the photons, resulting in high sensitivity towards absorption. The transmitted
photons sample a banana-shaped volume of the tissue with spatially varying optical properties.
Assuming the host tissue and the tumor to have homogeneous but different optical properties,
absorption and scattering properties of tumors and surrounding host tissue can be determined
separately. Alternatively, methods have been developed to reconstruct the tissue absorption and
scattering coefficients in 3D, provided transmittance of laser radiation is measured over a sufficient
range of projection angles. Because of light scattering, optical mammograms obtained by diffuse
optical imaging generally have poor spatial resolution.
The analysis of optical mammograms generally showed total hemoglobin concentration cHb,
cHbD, cHbO to be larger in breast tumors compared to their host tissue by a factor of 3.5 on average.
This observation can qualitatively be explained by a larger blood volume in tumors compared to the
host tissue. Average blood oxygen saturation cHbO/cHb = Y in tissue, on the other hand, reflects
the balance between vascular flux of oxygen that enters the tissue, i.e. oxygen supply, and oxygen
flux from the vascular network into tissue, reflecting oxygen demand. Besides total hemoglobin
concentration, blood oxygen saturation is thus another parameter characterizing the tumor and
host vascular networks. Average blood oxygen saturation in breast tumors was observed to be
both larger or smaller than that of their host tissue [37, 38]. Tumor tissue is - at least in parts
- hypoxic, thereby increasing the intravascular-extravascular gradient of partial oxygen pressure
and hence transvascular flux of oxygen into tumor tissue. Likewise blood flow, i.e. perfusion rBF ,
was measured by PET in breast tumors to be mostly above that of normal tissue amounting rBF
in tumors to be larger by a factor 5 on average. Actually, the balance between oxygen supply
and demand may have diagnostic value for therapy control. Recently it was reported [14] that
breast cancer patients who underwent neoadjuvant chemotherapy before surgery and who were
subsequently not classified as complete responders by immuno-histochemistry (non-pCR), tended to
initially exhibit tumor blood oxygenation below that of the host tissue. On the other hand, patients
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who were ranked as pathological complete responders (pCR) exhibited on average the same blood
oxygen saturation in tumor and host tissue.
In this paper we simulate average blood oxygen saturation in normal breast tissue and breast
tumors using two different models. Within a simple three-compartment model, taking into account
concentrations of oxygen bound to hemoglobin, of oxygen dissolved in plasma and in tissue we
calculate average blood oxygen saturation as a function of the ratio κ = PO2SρO/rBF of permeability
rate constant over regional blood flow for selected partial oxygen pressures in tissue. Alternatively
the dependence of average blood oxygen saturation on the ratio of oxygen demand and supply, i. e.
on the oxygen extraction fraction OEF is simulated. The computational model, on the other hand,
tries to solve an ill-posed inverse problem, i.e. to determine vascular networks of normal breast tissue
and of breast tumors that are consistent with experimental data on regional blood volume rBV and
average blood oxygen saturation Y obtained previously from a cohort of 87 breast cancer patients
[37]. For this purpose we algorithmically construct 3D vasculature of normal tissue and tumors
following methods developed by us previously [39]. Because of its stochastic nature each growth
process produces a different vascular network of the host and tumor tissue. The growth of the tumor
results in vascular remodeling via vessel co-option, angiogenesis, and vessel regression. The bulk
of tissue, excluding the vascular network, is considered as consisting of two homogeneous parts,
an expanding sphere of tumor tissue, and the surrounding normal breast tissue. In this paper we
extended our computational model to simulate oxygen supply and consumption. Taking each vessel
segment as oxygen line source with a strength given by its transvascular oxygen flux, oxygen diffusion
and consumption in tissue are calculated, yielding partial oxygen pressure distribution in tissue and
blood oxygen saturation in the vascular network. Only stationary solutions are sought, ignoring
transient variations of blood flow through tissue as discussed above. For each vascular network
generated our model allows us to calculate biophysical and metabolic quantities, e.g. vascular (blood)
volume rBV , microvessel density MVD , surface density, i.e. vessel surface per unit volume of tissue
Sρ, perfusion rBF , total hemoglobin concentration, cHb, average blood oxygen saturation Y , oxygen
extraction fraction OEF and metabolic rate of oxygen consumption MRO2 in host and tumor tissue.
By comparing calculated parameters with experimental data, algorithmically generated vascular
structures of host and tumor tissue can be optimized. Furthermore a first step is taken is taken
to elucidate the relationship between vascular morphology and oxygen delivery in tumor specific
networks. Although our model is generally applicable, e.g. to PET measurements using 18F-MISO
to detect tumor hypoxia and to qBOLD-MRI data to deduce blood oxygen saturation in brain
tumors, in this paper we restrict ourselves to optical mammography.
Computational models allowing for oxygen diffusion in tissue
Krogh et al. [40] published a theoretical analysis of oxygen delivery in a piece of muscle tissue based
on densely packed, parallel tissue cylinders each with a blood vessel running along its center line.
Since each vessel was assumed to supply oxygen to its own cylinder only, the problem is reduced to
that of a single cylinder. The diffusion-reaction equation for partial oxygen pressure in tissue is
solved analytically assuming radial symmetry and neglecting diffusion along the cylinder orientation.
In addition, blood is taken as homogeneous hemoglobin solution and intravascular radial gradients
of oxygen partial pressure were neglected [41].
The current literature contains a large body of work on improved Krogh models which take the
granular nature of blood into account by incorporating detailed modeling of convective and diffusive
processes in and around red blood cells (RBCs), as well as hydrodynamic and mechanical aspects of
RBCs. These improved models play an important role for the development of network transport
models since they can be used to derive effective radial mass transport coefficients of oxygen, but a
full review of all related work is beyond the scope of this paper. We restrict ourselves to references
[42, 43, 44, 45, 46] the results of which were used in this work and refer for further reference to [41].
The detailed solution of three dimensional transport models for vascular tubes is prohibitively
expensive for entire networks. Instead the problem is commonly approximated as piecewise one-
dimensional advection on a segment by segment basis. Moreover the assumption of parallel tissue
cylinders is unjustified in general and in particular for tumor networks due to their varying MVD
and chaotic connectivity. In the literature regarding the simulation of tumor growth [39, 47, 48, 49,
50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60], the vascular oxygen distribution is universally assumed
to be either homogeneous or proportional to the hematocrit for simplicity and efficiency reasons.
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However, models, where this assumption had not been made, were used extensively to study given
static networks in muscle fibers, various animal model tissues and also tumor networks of limited
extent. Relevant literature will be reviewed below.
Goldman et al. [61] developed a computational model to determine oxygen distributions within
a small blood vessel network and the surrounding tissue. Their model simulates the blood vessel
network as interconnected perfused pipes (Poiseuille flow) and accounts for convective oxygen
transport by the blood stream. This network is coupled to interstitial space (i.e. tissue) via
boundary conditions which relate the radial transvascular oxygen flux at each point on the vessel
surface with the PO2 gradient at the respective location in tissue. In order to determine the
tissue PO2 level, a diffusion equation had to be solved which was handled numerically by finite
differencing methods. While being accurate, the method of transvascular coupling requires fine
resolution of the numerical grid to resolve the PO2 gradients around the vascular walls. Indeed, the
authors considered a tissue block of length 400 µm discretized into 200 grid points, compared to a
typical capillary radius of 3 µm. The authors and co-workers published several follow-up papers
[62, 63, 64, 65, 66] studying various scenarios and pathological alterations of the vascular network of
a muscle fiber. The limitation to relatively small systems has, however, remained.
Hsu and Secomb [67] conceived a different computational approach based on Green’s functions
which was later improved upon [68]. An advantage of their method is fast convergence and the
elegant handling of transvascular coupling, alleviating the need for excessively fine tessellation for
boundary conditions. The model was applied to analyze tissue oxygen distributions from a small 3D
tumor network comprising a few dozen segments only [68, 69]. However, due to the long ranged
Green’s function, the method is difficult to apply to large systems. Recently Secomb et al. published
their source code [70]. Using their code, we succeeded in computing oxygen distributions for small
systems of up to 1 mm3 but further increase of the system size to 1 cm3, which we require, incurs
an infeasible computational cost, both in time and memory.
Recently Secombs Green’s function method [68] was applied to models of cranial blood vessel
networks [71, 72]. Safaeian et al. were particularly interested in the structure of cranial blood vessel
networks and the effects caused by an occlusion of blood flow. The blood supply of the cranial
cortex is organized in a two-dimensional top layer and a sub-surface bulk. The top layer contains
arterial and venous trees, from the ends of which arterioles proceed vertically down into the bulk.
After some distance these arterioles branch out into a very dense and rather tortuous capillary
plexus. Safaeian et al. mimic this structure with a simplified artificially generated network.
Beard [73] developed a computational framework for solute transport in vascular networks. The
general idea is similar to the aforementioned work where advective transport through a network is
coupled with diffusion based transport in a tissue domain. The diffusion equation is discretized by a
finite volume/difference approach, and source terms corresponding to the surface area of nearby
vessels are added locally. This is also the idea behind our method applied in this paper. However,
oxygen-hemoglobin binding dynamics were neglected.
If less detailed knowledge about the oxygen distribution is acceptable, a single-vessel model can
provide useful insight. He et al. [74] developed a model to predict the heating of a tumor in a
human breast by laser irradiation and the consequential alteration of the oxygen supply. In this
model, perfusion data is derived from flow through single vessels and in turn fed back into the heat
transport equation. It incorporates an elastic vessel wall, thermal expansion and pulsatile flow. The
average tissue oxygen level is determined based on a Krogh cylinder model. A shortcoming of this
model ,as with the standard Krogh model, is the neglect of the complex flow patterns within tumor
networks since only one tube acts as representative for all vessels.
Several works [16, 17, 18, 75, 76] consider (tumor) tissue oxygenation with the help of models
where variations of the vascular oxygen content are neglected and vessels which are sources of
oxygen are represented by point sources in two dimensions or lines in three dimensions. The
spatial distribution of these sources [75] was generated according to probability distributions for
intercapillary distances. Various scenarios were analyzed for hypoxic/normoxic conditions. Espinoza
et al. [76] used a particle based numerical calculation [77] (lattice-free discretization) and placed
discretization sites coincident with vascular oxygen sources. The oxygen level at these sites was
set to fixed values analogous to traditional Dirichlet boundary conditions. Predictive models have
gained importance since the development of tracer substances which accumulate in hypoxic tissue
and can be used to derive the oxygen status of tumors. Kelly used a probability density function
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derived from empirical MVD distributions to statistically generate vascular maps in 2D. These
vascular maps were then used to calculate the steady state oxygen distribution in tissue besides
the binding kinetics of the radio-tracer [17] F-miso. Skeldon et al. [16] first analyzed simplifying
assumptions for theoretical computations of tissue oxygen distributions, and then considered the
distribution of this tracer at a previously computed two-dimensional map of the local PO2.
Lagerlo¨f et al. [78] considered the effect of varying degrees of hypoxia on radio sensitivity. To this
end they obtained a voxelized three dimensional representation of a real vasculature from microscopy
data, taken on an excised animal tumor. Tissue images were binarized, matched and resampled
according to a numerical grid over which the PO2 distribution was computed. Sites occupied by
vessels were kept constant. Very recently this group published a study [79] on an idealized 3D
vascular structure of a tumor, consisting of equidistant parallel vessels. Oxygen is transported by
blood flow from the inlets to the ends of the vessel tree, while being able to diffuse from vessels into
surrounding tissue voxels. The authors studied the effect of longitudinally decreasing blood oxygen
saturation on the predicted radiation sensitivity.
Within the framework of our computational model we algorithmically construct 3d vascular
networks of normal tissue and tumor tissue to reflect the various breast carcinomas of a patient
cohort. Subsequently, besides geometric and hemodynamic properties intravascular and tissue
oxygen concentrations are simulated. Previously, the 3d vascular network of tumors grown in tumor
models were reconstructed from high resolution imaging data [80, 81]. Recently, Stamatelos et al. [7]
reconstructed the 3d vascular architecture of a human breast cancer xenograft model of size 280 mm3
from micro-computed tomography (µ-CT) data taken ex-vivo. While geometric and hemodynamic
properties of the reconstructed vascular network were simulated, distributions of intravascular and
tissue oxygen concentrations or of other solutes were not considered. To our knowledge it has not
been attempted yet to apply a theoretical model with a realistic tumor vasculature, e.g. vasculature
obtained from that of the host tissue by vascular remodeling to explain the experimentally observed
blood oxygen saturation and hemoglobin content in tumors [37, 38] and their relation to the vascular
structure of the tumor. In order to explain the oxygen saturation variability observed among a cohort
of breast cancer patients, it seems necessary to incorporate the vascular oxygen concentration as a
model variable and the change thereof due to transvascular exchange. In particular, it is not sufficient
to approximate the oxygen concentration as being strictly proportional to the hematocrit for instance
because this assumption yields a constant saturation by definition Y = cHbO/cHb, i.e., for such
models, Y is an input parameter. Moreover, the typical tumor vasculature compartmentalization
only manifests itself for tumors of a certain size, typically larger than 1 mm diameter, which current
methods are not well suited for due to computational expenses.
Compartment models for brain vascular and tissue oxygenation
Compartment models have long been used to simulate tracer kinetics, new developments of such
models and their application to MRI have recently been reviewed [82]. Valabregue et al. [83]
used a three compartment brain model comprising oxygen bound to hemoglobin, oxygen dissolved
in plasma and in brain tissue to simulate the dependence of cerebral metabolic rate of oxygen
consumption CMRO2 and of oxygen extraction fraction OEF on perfusion rBF , both under dynamic
and stationary conditions. These authors applied their model to calculate relative signal changes
based on the BOLD effect, measured by human functional magnetic resonance imaging (fMRI)
following execution of motoric, visual or neurological tasks. Hayashi et al. [84] used the same
compartment model, yet neglected the brain tissue oxygen pool to analyze the CMRO2-rBF
relationship assuming various pathophysiologic brain conditions such as ischemia, hypoxia, anemia,
or hypo- and hyper-capnic CBF variations. More recently, Jespersen and Ostergaard have extended
the three-compartment model by including transit time heterogeneity [85]. Rather than considering a
single vascular tube together with a well defined vascular transit time as previous authors, Jespersen
et al. assumed a Krogh-like arrangement of parallel capillaries and a distribution of single capillary
transit times. The authors investigated the impact of transit time distribution on oxygen extraction
and metabolic rate of oxygen consumption in normal brain tissue. However, the three compartment
model had never been applied before to simulate average blood oxygen saturation Y in normal tissue
and tumors. Although average blood oxygen saturation Y will likewise be affected by transit time
heterogeneity, consideration of transit time heterogeneity is beyond the scope of the present paper.
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Experimental data from optical mammography
The present paper frequently refers to the results on hemoglobin concentrations cHb and average
blood oxygen Y of breast tumors and surrounding normal breast tissue obtained from a cohort of 87
breast cancer patients using optical mammography [37]. For the sake of readability, we reproduce
the relevant figures. See Fig. 1 and Fig. 2.
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Figure 1. Physiological parameters of tumors versus those of corresponding healthy
breast tissue for 87 patients: (a, left) total hemoglobin concentration ctHb; (b, right) blood
oxygen saturation Y . Reproduced from Ref. [37, Fig. 3a,b], by permission of IOP Publishing. All
rights reserved.
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Figure 2. Blood oxygen saturation versus total hemoglobin concentration: Error bars
[37, cf. Fig.3a,b] on tumor data correspond to uncertainties of tumor radius aT and location zT
along compression direction, besides statistical contributions, error bars on healthy breast tissue
data reflect statistical uncertainties only. Reproduced from Ref. [37, Fig. 5], by permission of IOP
Publishing. All rights reserved.
Models
In the following section we explain the theoretical model employed here. This model has been used
in the literature before [67, 68] but for clearness we review it here again in detail. Further below we
present our attempt to solve the fully coupled equations for vascular and tissue PO2 distributions
efficiently. Finally a simple homogeneous three-compartment model of blood oxygenation is presented
and approximate analytic solutions are considered.
Blood Oxygen
The concentration of oxygen dissolved in blood plasma or in tissue is proportional to the oxygen
partial pressure (PO2), i.e. cp = αP and ct = αtPt, where P , Pt are the oxygen partial pressures in
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plasma and tissue, respectively, and α, αt the oxygen solubilities. Conventionally, the partial pressures
are measured in mmHg and solubilities in mlO2/ml/mmHg, yielding the oxygen concentrations
expressed as oxygen gas volume at standard conditions (STP 0◦C, 1 bar) per unit volume of plasma
or tissue. In blood, oxygen, besides being dissolved in plasma, is bound to hemoglobin. Up to 4
molecules of oxygen can be bound per hemoglobin molecule. The chemical equilibrium between
dissolved oxygen and oxygen-carrying hemoglobin depends on the number of oxygen molecules
bound to hemoglobin, and the reaction is sufficiently fast, that the equilibrium state needs to be
considered only. The cooperativity of oxygen-hemoglobin binding leads to the well-known oxygen
dissociation curve [86], that can be approximated by the Hill equation [41]
S(P ) =
Pn
Pn + PnS50
, (1)
where S(P ) is the blood oxygen saturation, PS50 denotes the partial pressure at 50% saturation
and n is the Hill exponent (see Table 1). Consequently, the total blood oxygen concentration,
denoted by c, is the sum of the concentrations of dissolved and bound oxygen.
c = cp + cb = αP +Hc0S(P ), (2)
where H is the hematocrit, i.e. the volume fraction of red blood cells, and c0 denotes the
concentration of oxygen per unit volume of red blood cells (RBCs) at maximal saturation (s. Table
1).
Oxygen Transport within a Single Vascular Cylindrical Tube
The intravascular PO2 variation along the longitudinal axis of a cylindrical vascular tube is described
by P (x), where x is the spatial coordinate. Following [67], we make the zeroth order approximation
that the variation of PO2, hematocrit, and flow velocity in the radial direction within vascular tubes
are negligible. This approximation reduces the problem to advection in one dimension. Radial
transport, i.e. transvascular oxygen exchange is accounted for by the addition of suitable mass
transfer terms (see below). Hence, the product of the oxygen concentration with the blood flow rate
yields the oxygen flux ι representing the total amount of oxygen at any given point that flows per
unit time through the tubes cross-sectional area
ι(P ) = qc(P ). (3)
While blood flows along the vessel, some oxygen is continuously lost through the vessel wall.
The respective transvascular flux density jtv is given in units of amount of oxygen per lumen surface
area and time. It causes a change in the longitudinal oxygen flux, which is expressed as
dι
dx
= q
[
Hc0
dS
dP
dP
dx
+ α
dP
dx
]
= −2πrjtv(x), (4)
where the second expression is just the evaluation of dι/dx, and r is the vessel radius. Reordering
yields the derivative of P
dP
dx
=
−2rπjtv(x)
q
[
Hc0
dS
dP + α
] . (5)
For simplicity only losses due to diffusion are considered. This is certainly a good approximation
for normal vessels because oxygen is a light molecule and has a proportionately high diffusion speed.
Its diffusion constant in water is ca. 2 · 103µm2/s. Walls of tumor vessels, on the other hand, are
leaky e.g. for plasma which is why a significant convective transport is plausible. Interstitial fluid
velocities of up to v = 1µm/s have been reported near tumor vessels [90, 91, 92, 93]. In order
to judge whether diffusive or convective transport in tissue is dominant, we calculated the Peclet
number Pe = vL/D which relates advective transport rate to diffusive transport rate over a certain
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Table 1. Oxygen transport parameters
Symbol Unit Value Ref/Note
n 2.7 [45]
PS50 mmHg 27 [45]
α mlO2ml−1mmHg−1 3.1 · 10−5 [45] (a)
αt mlO2ml
−1mmHg−1 2.8 · 10−5 [45] (a)
c0 mlO2 /ml 0.5 [87] (b)
Dt µm
2/s 2410 [45]
Dp µm
2/s 2750 [45]
PM50(normal) mmHg 4 (c)
PM50(tumor) mmHg 2 (c)
M0(normal) µl O2ml
−1min−1 3.7 (d)
M0(tumor) µl O2ml
−1min−1 14.8 (d)
γ µm3O2µm−2 s−1mmHg−1 0.0057− 0.0208 (e)
H(BC) 0.45
P
(BC)
c mmHg 100 [88] (f)
∆P (BC) mmHg/µm 1 [88] (f)
P
(BC)
0 mmHg 55 [88] (f)
hv µm 4
h µm 40
Shows parameters for throughout all simulations except case METAB where M0(tumor) is picked
at random for each simulation. (a) Assuming 22.4 l/mol under normal conditions. (b) Computed as
the product of the hemoglobin binding capacity 1.34 ml O2/g and the hemoglobin mass per RBC
volume 0.34 g/ml. (c) Literature [66, 68, 76, 89] values for MP50 range from 1 to 4 mmHg. MP50
represents a threshold below which cells become hypoxic. We lowered MP50 in tumor tissue by a
factor of 1/2 because cancer cells are generally associated with a resistance to hypoxia. (d) A
consumption rate for physiological conditions amounting to 3.7 · 10−3 ml O2 ml Tissue−1 min−1
was estimated from perfusion rates (rBF ), assuming an oxygen extraction fraction of 0.4 [24, 25].
The reference [19] refers to the cerebral oxygen consumption. See also Table.2. For tumors we
assumed an four fold increased consumption M0. (e) The first value is obtained for r = 60µm and
the latter for r = 3µm. (f) The PO2 at the inlet vessels is prescribed in dependence on the vessel
radius r according to (12). For the lack of a better source, we used intra-vascular PO2
measurements from rat brains [88] as reference.
distance L. A reasonable L is 100µm, corresponding to typical intercapillary separations, yielding
Pe = 1/20. It follows that the transport is diffusion dominated.
Intravascular radial oxygen transport is in itself a complex problem. To make transvascular oxygen
flux workable, the mass transfer coefficient (MTC) γ is introduced that relates the transvascular
oxygen flux density with the PO2 difference between the plasma and tissue partial oxygen pressure
P and Pt.
jtv(x) = γ · (P (x)− Pt(x)). (6)
Since vessels are represented as lines, we also assume that Pt is constant over the entire
circumference. Note that γ2πr = K−1, where K is the radial transport resistance used in [46, 67, 68].
The MTC depends on several factors like tube radius, oxygen saturation, RBC shape [41] and
vessel morphology [94]. We consider a radius dependency according to a simple fit model, based on
empirical data for radial oxygen transfer in vascular tubes [43, 44, 45]:
γ(r) =
Dpαp
r
p2(1− exp(−r/p1)), (7)
where p1 and p2 are fit parameters and Dp and αp are oxygen diffusion coefficient and solubility
in blood plasma. This form provides a good fit to the MTC obtained from Nusselt numbers nu [44,
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Fig. 14] according to the relationship γ = nuDpαp/r [41]. We calibrated p1 and p2 with several test
cases of vascular tubes from theoretical [45] and experimental data [43] oxygen saturation S, by
the end of the tubes, gives a good fit (s. S1 Appendix). In this way we obtain p1 = 7.2 µm and
p2 = 4. A straight forward fit of [44, Fig. 14] yields p2 = 4.7, but we found that the former value of
p2 gives gives better agreement when blood oxygen saturation increases caused by uptake through
an external medium [43, Fig. 3], with negligible impact on other cases.
Blood Flow and Hematocrit in Vascular Networks
The vascular network is represented by a graph where edges represent vessel segments each connected
to two nodes, whereas nodes may be attached to one to three vessel segments. Following the work
of Pries et al. [95] we calculated blood pressure p at each node as well as blood flow rate q and
hematocrit H associated with each vessel segment. A direction is imposed on each vessel segment
according to its blood flow direction. The primary unknowns are the nodal pressures and segment
hematocrits. The hematocrit, i.e. the fractional volume of red blood cells (RBCs) in blood may
differ between various vessel segments due to phase separation.
The flow rates are given by Hagen-Poiseuilles law for flow through pipes q = πr4∆p/(8ηl), where
r denotes the radius of the segment, l its length, η the (apparent) blood viscosity, and ∆p the
difference of the blood pressure at both nodes the vessel segment is attached to. Mass conservation
demands at each non-boundary node that
∑
i∈I
qi =
∑
j∈O
qj (8)
∑
i∈I
Hiqi =
∑
j∈O
Hjqj , (9)
where the sets I and O contain the adjacent up-and downstream vessels depending on the current
node. In contrast to the Ref. [95] we use pressure boundary conditions (BCs) where p at root nodes
is set to a fixed value p(root) = p(BC)(r) depending on the radius and the type of vessel (artery
or vein) (s. Eq. (1) in S5 Appendix). Eq. (8) and BCs lead to a system of linear equations, the
solution of which yields the nodal pressures. The system is very large, of the order of 106 unknowns.
We found that the Conjugate Gradient algorithm with the Multilevel (ML) preconditioner from the
Trilinos software library [96] solves it efficiently.
The apparent blood viscosity in microvessels varies with r and H (Fahraeus-Lindqvist effect)
and is expressed by decomposing it into η = ηplasmaηrel(r,H), where ηplasma is the viscosity of pure
blood plasma and ηrel(r,H) is known as relative viscosity. We implemented the ηrel formula from
more recent work Pries et al. [97] where ηrel is based on in vivo data. For brevity we refer to the
original publication for the expression for ηrel.
Furthermore RBCs at arterial bifurcations tend to flow into the faster perfused branch (phase
separation effect) resulting in an uneven hematocrit distribution across the network. Pries et al. [95]
devised a phenomenological formula which describes the hematocrit H in the downstream branches
of a bifurcation as a function of q and r of all adjacent vessels. For details we refer to [95]. With the
help of this formula we compute the RBC flow qH in down stream vessels of arterial bifurcations,
i.e. where one vessels splits into two downstream vessels. On the other hand, venous bifurcations
have only one downstream branch where H is determined by (9). Our initial vascular network,
representing the vascular network of normal tissue, contains by default only bifurcations and the
trivial case of two adjacent vessels. The tumor growth model [39] on the other hand was modified,
rejecting sprout connections to other vessels that resulted in junctions with more than three vessels
attached. The hematocrit over the entire network can thus be computed with a simple depth-first
search graph traversal algorithm [98] starting from the venous ends and determining the downstream
H while backtracking.
The ansatz to solve this coupled system of equations is iterative. In each iteration, the nodal
pressures are computed using the results for the vessel segment hematocrit of the previous iterations,
followed by the computation of the hematocrit with new flow rates. Details can be found in [95].
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Oxygen in Vascular Networks
The ansatz to determine the PO2 across the vascular network is similar to the method followed
for calculating the distribution of hematocrit. First we consider the distribution at an arbitrarily
selected node. Let Pi for i ∈ I be the PO2 at downstream ends of adjacent inlet vessels. Then Pj
for j ∈ O at the upstream ends of outlet vessels are to be determined. The main assumption made
is that RBCs flowing into the junction instantly assume a common equilibrium partial pressure P˜ ,
that by definition equals the PO2 at all outlets Pj = P˜ for j ∈ O. P˜ is determined with the help of
the oxygen mass balance
∑
i∈I
qi(c0S(Pi)Hi + αPi) = ι˜ =
∑
j∈O
qj(c0S(P˜ )Hj + αP˜ ), (10)
where the left hand side is known and provides the total oxygen flux ι˜ at the node under
discussion. The right hand side is rearranged as
ι˜ =

∑
i∈O
Hiqi

 c0S(P˜ ) +

∑
i∈O
qi

αP˜ , (11)
where quantities in brackets are known RBC, and blood, flow rates. Eq. (11) was solved
numerically for P˜ using a bisection search. At inlet (root) nodes, boundary conditions (BCs) must be
specified. We use Dirichlet BCs where P = P (BC) is given according to a curve P (BC)(r) depending
on the arteriolar radius.
P (BC)(r) = min(P
(BC)
0 +∆P
(BC)r, P (BC)c ). (12)
For the parameter values of P
(BC)
0 ,∆P
(BC), P
(BC)
c see Table 1.
The the determination of PO2 across the entire network can be define procedurally with the help
of the depth-first search graph traversal [98] analogous to the propagation of hematocrit. Starting
from venous root nodes, the network is traversed towards the upstream ends. Let us consider a
given node while backtracking. P is known at the upstream ends of adjacent inlet vessels, and
according to (5) the down-stream P is determined. Hence, (11) provides P for further backtracking
downstream. This procedure holds under the caveat that jtv is known, which is addressed below.
Oxygen in Tissue
The oxygen concentration in tissue, denoted ct(y), as a function of position y, is determined by the
solution the following steady state diffusion equation, considering a cubic domain Ω = (0, L)3 with
lateral size L and Neumann boundary conditions.
Dt∇2ct −M +Q = 0 (13)
∇ct · n = 0 on ∂Ω, (14)
where M is the oxygen consumption rate and the last term Q represents the oxygen exchange
with vessels. With the help of the solubility αt this equation is rewritten in terms of the partial
pressure Pt.
αtDt∇2Pt −M +Q = 0 (15)
∇Pt · n = 0 on ∂Ω, (16)
where the symbols Q = Q(Pt,y) and M = M(Pt) are redefined as functions of Pt. They emerge
from their former versions by simple scaling of their arguments by αt.
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We model consumption according to the well-known Michaelis-Menten (MM) model [41]. The
MM model takes into account that cells consume oxygen up to a maximal rate M0 even at high
(excess) oxygen availability, and that consumption must drop to zero when the local oxygen partial
pressure drops to zero. M is consequently defined as
M(P ) =M0
P
P + PM50
, (17)
where the subscript for P has been dropped. The partial pressure at which M equals 50%
of its maximal rate M0 is denoted by PM50. M(P ) increases monotonously and approaches M0
asymptotically. The advantage of the MM model over zero-or first order kinetics is a realistic
description of hyper-and hypoxic situations.
To find the vascular contribution Q, representing sources and drains, we follow [67] where line-like
sources are embedded into the volume (tissue) with a magnitude equal to jtv. Symbolically written,
this corresponds to
Q(y) =
∑
v∈V
∫
v
2πrjtv(x, r)δ(x− y)dx, (18)
where the summation is taken over all vessels and the integration along their center lines. δ is
the Dirac delta distribution and jtv is given in (6,7).
Numerical Solution
The equation for the vascular oxygen distribution (5,11) together with the diffusion equation for
tissue (15) form a complicated non-linear system of equations with the partial pressures values as
unknowns. The only practical way to treat this is through a numerical solution.
Previously a similar approach to ours was followed by Beard [73] who distributes the exchange
flux with vessels to nearby sites of a discretization grid of the tissue domain. We justify this approach
with a formulation based on a Finite Element Method (FEM) and in contrast to [73] also include
hemoglobin binding dynamics. As a result we obtain a sparse system of equations which is efficiently
solved by an iterative scheme.
The principal idea of the FEM is to seek an approximate solution within a finite dimensional
vector space V that is spanned by basis functions ϕi. Various choices are possible, e.g. Fourier bases,
but the common approach is to introduce a grid and organize the ϕi such that their contribution is
centered around a corresponding grid site xi, requiring that ϕi(xi) = 1 and ϕi(xj) = 0 for i 6= j.
Here the choice falls for simplicity on piecewise linear (P1) tensor product bases which are defined
on a regular cubic grid. Then ϕi reads
w˜(x) = max(0, 1− |x|/h)
w(x) = w˜(x0)w˜(x1)w˜(x2)
ϕi(y) = w(y − xi),
where h is the lattice constant and y = (y0, y1, y2) and likewise x in three dimensions. Incidentally
evaluation of a function f(y) =
∑
fiϕi(y) with some coefficients fi is equivalent to a (tri-) linear
interpolation of the coefficients between grid sites that are nearest to y. Hence, let the tissue PO2
be an element of V such that
Pt =
∑
j
Pt,jϕj . (19)
At this point it is advisable to proceed with the treatment of the vascular system. It is by
definition already represented as discrete collection of segments but these are implicitly further
subdivided by the integration points that are introduced for the solution of the axial transport
equation (5) (see below). We impose an equidistant subdivision with the constant step length
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hv = 10µm. In general, the last point needs to coincide with the end of the vessel. For our choice
of hv this holds true because our networks are generated on a lattice, the constant of which is a
multiple of, or equal to, 10µm. We also evaluated more general cases with smaller hv for increased
accuracy but found that this produces no significantly different results.
In the following the index k, l is used for points on the vessel network whereas i, j index sites on
the tissue grid. Now it is convenient to introduce vector and matrix notations. Hence let coefficient
vectors be denoted in bold face, such that Pt = {Pt,i} and P = {Pk}. And let further linear
operators (matrices) be denoted in bold face underlined ·.
The solution procedure relies on an outer iteration where the tissue degrees of freedom {Pt,i} and
the vessel degrees of freedom {Pk} are updated in alternating order. This can be written with the
aid of two functions F (P ,Pt) and F t(P ,Pt) determining P and Pt from the last known quantities.
An iteration variable n is introduced denoting the current step number. This is not to be confused
with n in the Hill-equation (1).
for n = 1, 2, 3, . . .
P (n+1) = F (P
(n)
t
) (20)
P
(n+1)
t
= F t(P
(n+1),P
(n)
t
) (21)
while ||P (n+1)
t
− P (n)
t
||∞ > ǫ and ||P (n+1) − P (n)||∞ > ǫ,
where ||.||∞ denotes the maximum norm. We set the initial guess for tissue P (1)t to Proot,max/2
on all grid points. P needs no initial value since it is entirely determined by Pt. The iteration is
stopped when the change between the updates becomes less than ǫ, where we consider ǫ = 0.1mmHg
to be small enough. Usually 200 to 400 iterations are needed for convergence, when applied to our
tumor networks.
Evaluation of F : The vascular tree is traversed down stream as explained. At each vessel, first
the upstream PO2 is determined according to (11) or according to the boundary condition (12) if it
is an inlet node .
Then (5) is integrated with the implicit Euler method [99]. Explicit methods are not well suited
to the problem since their stability requirements [99] lead to a step size hv < const · q. Since many
tumor vessels are slowly perfused this would lead to to sub micro meter steps, incurring a prohibitive
performance penalty. Note that the representation of Pt as superposition of basis functions readily
provides a means to obtain its function value for the r.h.s of (5). Since the bases ϕi have a small
support this can be efficiently implemented. Moreover storage of all Pk values is not required.
Instead we perform required operations “on the fly” when the vascular PO2 is computed in F .
This means we either record oxygen exchange contributions for Pt into the system matrix (35) or
compute observables for final output. It is sufficient to just store Pk at the upstream end of each
vessel which is just P˜ from (11).
Evaluation of F t: Our approach for the solution of the diffusion equation (15) can be derived
from the Galerkin method, where in brief, the general idea is as follows. First, the standard scalar
product over the space of integrable functions over Ω is introduced (f, g) =
∫
f g dx. Furthermore
instead of the true solution, an approximation within the vector space V is searched for. This
solution is defined as f ∈ V for which the residual R after evaluation of the differential equation
w.r.t. f is minimal, i.e. we look for f ∈ V such that (R,R) = min. Here Pt takes the role of f and
we have
R = αtDt∇2Pt −M(Pt) +Q(Pt). (22)
It can be shown that minimization of ||R|| is equivalent to finding the Pt where R is orthogonal
to V
(R,ϕi) = 0 ∀i. (23)
Eventually this results in an equation per grid site i in the unknowns {Pt,i}. The l.h.s. of (23)
decomposes into the summands
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αtDt(∇2Pt, ϕi) (24)
(M(Pt), ϕi) (25)
(Q(Pt), ϕi), (26)
for which algebraic expressions are needed.
The benefit of considering a finite element formulation lies in the straight forward treatment
of the transvascular exchange Q with its the Dirac delta. Also FEM makes it straight forward to
use higher order elements for better accuracy. Here however we use P1 elements. Moreover, it has
been shown that the FEM discretization with the P1 basis can be made to look identical to the
standard finite difference discretization. (See e.g [100].) The trick is to perform the integration in
(·, ·) according to the trapezoidal rule. Performing the integration using the trapezoidal rule, one
indeed obtains for a smooth enough function g that
(g, ϕi) ≈ h3g(xi), (27)
i.e. obtaining g sampled at the grid point i which equals gi if g =
∑
i giϕi. Likewise one obtains
for a sufficiently smooth function f
(∇2f, ϕi) ≈ h3[∆hf ]i + boundary terms, (28)
where
(∆hf)i =
∑
j∈Neighbors of i
(fj − fi)/h. (29)
∆h is the discrete Laplacian [99] known from finite differences. Neighbors of i denotes the 6
nearest grid neighbors. At the boundaries we modify ∆h to account for the missing neighbors [99].
The consumption term M(Pt) is expanded to first order around the oxygen level from the last step.
Following the above rationale, it is evaluated per grid point which yields
1
h3
(M,ϕi) ≈M(P (n)t,i ) +M ′(P (n)t,i )[P (n+1)t,i − P (n)t,i ], (30)
where ′ denotes the first derivative. More conveniently in matrix notation and with dropped
super scripts, we write
MA+MB IPt, (31)
where I denotes the identity, and
MAi =M(P
(n)
t,i )−M ′(P (n)t,i )P (n)t,i (32)
MBi =M
′(P
(n)
t,i ) (33)
The last contribution is derived by expanding (26). For better readability, the super scripts are
dropped again. Also the dependence of r and γ on the current vessel v is implied but for readability
not indicated.
(Q(Pt), ϕi) =
∫
Ω
∑
v∈V
∫
v
2πrjtvδ(x− y)ϕi(y)dxdy
=
∑
v∈V
∫
v
2πrjtvϕi(x)dx
=
∑
v∈V
∫
v
2πrγ[P (x)− Pt(x)]ϕi(x)dx
=
[∑
v∈V
∫
v
2πrγP (x)ϕi(x)dx
]
+

∑
j
∑
v∈V
∫
v
2πrγPt,jϕj(x)ϕi(x)dx

 (34)
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The expression given in (34) approximates the total volume rate of oxygen that extravasates
from the entire vascular system into the tissue volume associated with the basis function ϕi. Now
the integral over the vessel network is approximated with a Riemann sum based on the integration
points {Pk} from step (20). Each integration point k represents a finite length segment ∆xk = hv
except at the end points of each segment where ∆xk = hv/2. In order to achieve good accuracy,
we require hv << h. Else, the integration kernel 2πγϕi or 2πγϕiϕj will be under-sampled. This
limitation could be removed to some degree by interpolation of the numerical solution of P (x),
decoupling it from the integration quadrature formula. From (34) one obtains for the total volume
rate of oxtravasated oxygen per cell volume
1
h3
(Q(Pt), ϕi) ≈
∑
k
∆xk2πr
h3
γPkϕi(xk)︸ ︷︷ ︸
QAi
+
∑
j
Pt,j
[∑
k
∆xk2πr
h3
γϕj(xk)ϕi(xk)
]
︸ ︷︷ ︸
QBij
. (35)
The factor ∆xk2πr/h
3 is intuitively understood as vessel surface area per cell volume. Finally,
the completely assembled system of equations reads
[
αtDt∆h −MB I+QB
]
Pt =MA−QA. (36)
It is easy to see that this is a sparse symmetric system. The Laplacian gives rise to 6 off-diagonal
entries. The operator QB gives rise to 26 off-diagonal entries corresponding to the nearest and
second nearest grid neighbors. For points which are spaced further apart, ϕi and ϕj have no overlap
so their product in (35) becomes zero .
In order to improve the efficiency we approximate Pt(xk) with the value from the current site
Pt,i. This approximation is justified physically since the oxygen diffusion length considerably exceeds
the lattice spacing h. Consequently, QB is diagonalized such that the new version, now denoted Q˜B,
reads
Q˜Bij =
∑
k
∆xk2πr
h3
γϕi(xk)δij . (37)
This is a sparse linear system where the only off-diagonal terms stem only from the Laplacian,
removing the off-diagonal entries corresponding to the second nearest neighbors. We solved these
systems with an algebraic multigrid method (Trilinos ML [96]). We found the difference between
the Q˜B and QB solutions negligible.
Homogeneous Three-Compartment Model of Blood Oxygenation
Before simulating various biophysical variables using artificial vascular networks of normal and
tumor tissue, we calculate blood oxygen saturation Y in breast tissue and breast tumors within a
simple model consisting of the three compartments oxygen dissolved in plasma, oxygen bound to
hemoglobin and oxygen dissolved in tissue surrounding a cylindrical blood vessel of radius r and
length l. By comparing calculated average blood oxygenation with experimental data published
previously , blood oxygenation of breast tumors and associated normal breast tissue is analyzed for
oxygen extraction fraction OEF , the ratio of oxygen extravasation rate constant over blood flow
rate PO2Sρ/rBF and the metabolic rate of oxygen consumption MRO2 that serve as reference for
the computational model described above. The compartment model was used previously to simulate
metabolic rates of oxygen consumption of normal brain tissue [83, 85].
In contrast to the previous sections, oxygen concentration in tissue is assumed to be uniform,
i.e. with respect to oxygen, tissue is well mixed and hence diffusion of oxygen in tissue is not
taken into account. Furthermore, rather than considering a network of blood vessels, oxygen
concentration is calculated along a single vessel, representing the total vascular length of the network.
We approximate Eq. (5) together with Eq.(6) as
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dcp(ξ)
dξ
= −γ(r)
α
2πrl
q
cp(ξ)− c¯t[
1 + Hc0α
dS
dP
] . (38)
The longitudinal variable has been normalized to the vessel length, ξ = x/l, i.e. 0 ≤ ξ ≤ 1,
cp(ξ) = αP (ξ) is the concentration of oxygen dissolved in plasma, c¯t = αt 〈Pt〉 the average oxygen
concentration in tissue, and α = αt was assumed. Eq.(38) can be rewritten for the oxygen
concentration in blood c = cp + cb yielding
dc(ξ)
dξ
= −κ {cp(ξ)− c¯t} , (39)
where cb(ξ) = Hc0S(ξ) is the concentration of oxygen bound to hemoglobin, S(ξ) the blood
oxygen saturation, κ = PO2Sρ/rBF is the ratio of the oxygen extravasation rate constant PO2Sρ
over the blood flow rate rBF , and Sρ is the surface area per unit volume of tissue. Formally,
in Eq.(38) 2πrl/|Ω| and q/|Ω| were replaced by Sρ and rBF , respectively. Alternatively, κ =
PO2Sρ (rBV )
−1MTT may be expressed in terms of the regional blood volume rBV and the
product of the oxygen extravasation rate constant PO2Sρ and the mean transit time MTT . Setting
cp(ξ) = β(S)cb(ξ) with
β(S) =
αP50
c0H · S
(
S
1− S
)1/n
Eq. (39) is reformulated as
dc(ξ)
dξ
= −κ
{
αP50
(
c(ξ)
c0H − c(ξ)
)1/n
− c¯t
}
, (40)
where the small contribution of dissolved oxygen to the total oxygen concentration has been
neglected on the right hand side of Eq.(40). From the solution c(ξ) of Eq.(40), obtained for assumed
values of κ, c¯t and the arterial oxygen concentration c(0) = c0H · S(0), the oxygen saturation S(ξ),
and the concentration of dissolved oxygen cp(ξ) along the vessel axis, as well as the oxygen extraction
fraction OEF = 1 − S(1)/S(0) are derived. Furthermore, the average blood oxygen saturation
Y =
∫ 1
0
S(ξ)dξ and the average concentration c¯p =
∫ 1
0
cp(ξ)dξ of oxygen dissolved in plasma are
calculated.
In tissue optics [36, 37, 38] and MRI [28], however, average blood saturation Y is measured rather
than the oxygen extraction fraction proper. Furthermore, integrating Eq.(39) along the vessel axis
yields for the transvascular oxygen flux per unit volume of tissue rJtv ≡ Jtv/|Ω| = PO2Sρ {c¯p − c¯t}.
Assuming stationary conditions, the metabolic rate of oxygen consumption equals the transvascular
oxygen flux per unit volume of tissue, i.e. MRO2 = rJtv. Hence with κ, c¯t and c(0) selected, the ratio
MRO2/rJin = OEF of the metabolic rate of oxygen consumption over oxygen flux rJin = c(0) · rBF
is determined, entering the vascular network per unit volume of tissue. Adopting additionally a
value for the perfusion rBF , the metabolic rate of oxygen consumption MRO2 and the extravasation
constant PO2Sρ are deduced.
For a qualitative discussion, illustrating the dependence of Y on PO2Sρ/rBF and c¯t, we use the
simple Renkin-Crone model, that neglects cooperativity of oxygen binding to hemoglobin, i.e. the
dependence β(S) on saturation, thus considering a fixed position on the oxyhemoglobin dissociation
curve. Then Eq. (39) is rewritten as
dc(ξ)
dξ
= −κeff {c(ξ)− c¯t/β} (41)
where κeff = PeffSρ/rBF = βP and β ≪ 1 was used. Eq. (41) is readily integrated to yield
the average blood saturation
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Y =
{
S(0)− c¯t
c0Hβ
}
1− exp(−κeff )
κeff
+
c¯t
c0Hβ
. (42)
Within this approximation, average blood oxygen saturation Y varies as {1− exp(−keff )} /keff
and experiences a shift towards higher values at finite tissue oxygen partial pressures. A maximal
loss of oxygen from the vasculature to tissue is simulated by setting c¯t = 0, i.e. when neglecting
the backflow of oxygen from the tissue to the vascular system, as supposed by the Renkin-Crone
model. In this case, Eq.(42) represents a lower limit for the average blood oxygen saturation Y .
For keff ≪ 1, i.e. for low extravasation constant PeffSρ or high blood flow rBF (permeability
limited case) average blood oxygen saturation Y approaches S(0), independently of the average
blood oxygen concentration c¯t in tissue. For κeff ≫ 1, i.e. for high extravasation constant PeffSρ
or low perfusion rBF (flow-limited case) average blood oxygenation Y increases linearly with 1/κeff .
While the simple Renkin-Crone model provides some physical insight, for a quantitative discussion
of the results of the compartment model, Eq. (40) needs to be integrated numerically [83]. In
addition, the permeability coefficient PO2 is a lumped parameter, that does not represent the
true capillary permeability γ(r)/α, but implicitly depends on the mass transfer coefficient γ and
on the distribution of tissue partial oxygen pressure and therefore depends on its average 〈Pt〉
(s. Eq. (14) in S2 Appendix) We note in passing that the apparent oxygen extraction fraction
OEF app = 1−Y/S(0) always falls below the oxygen fraction OEF proper, apart from the trivial case
OEF = 0. Furthermore, the metabolic rate of oxygen consumption, normalized to the extravasation
rate constant PO2Sρ is equal to the difference between the average plasma c¯p and tissue c¯t oxygen
concentrations. In contrast, no such relation exists for the average blood oxygen saturation Y which
roughly follows c¯p as given by the Hill equation, at least in the range of tissue oxygen saturations
considered in this paper. Stationary models of oxygen transport in a single vascular tube that do not
assume perfect tissue oxygen mixing and therefore account for diffusion of oxygen in tissue [43, 45]
allowing for longitudinally decreasing tissue oxygen partial pressure. In contrast Eq.(39) causes
dc(ξ)/dξ to tend to zero, when the plasma oxygen concentration cp(ξ) approaches the constant
tissue oxygen concentration c¯t. In this case oxygen flux from plasma to tissue is balanced by the
reverse flux from tissue to plasma and no net exchange of oxygen takes place further downstream.
When cp(ξ = 1) = c¯t, the maximal oxygen extraction fraction is reached, given by
OEFmax = 1−
{
1
1 + (P50/Pt)n
+
αPt
Hc0
}
{S(0)[1 + β(S(0))]}−1
where the small contributions of dissolved oxygen at c(0) and c(1) have been taken into account.
Hence, for a selected tissue oxygen partial pressure Pt there is an upper limit MRO2,max to the
metabolic rate of oxygen consumption, corresponding to OEFmax. At sufficiently large ratios κ =
PO2Sρ/rBF the transvascular oxygen flux per unit volume of tissue, i.e. the product PO2Sρ(c¯p− c¯t)
tends towards MRO2,max apart from the small contributions of dissolved oxygen to MRO2,max.
Actually, in this situation, the predominant drop of intravascular oxygen concentration from its
initial value at ξ = 0 occurs at positions ξ < 1. The meaning of the permeability coefficient PH2O
of water and the limitations of the Renkin-Crone model used to derive blood flow from dynamical
PET data were discussed by [101].
Results
Predictions of Compartment Model and Comparison with Experimental
Data
Besides arterial oxygen concentration, two parameters, i.e. the ratio κ and the tissue concentration
c¯t enter the compartment model. Therefore, experimental data on two parameters, e.g. average
oxygen saturation Y and metabolic rate of oxygen consumption MRO2 are needed to define the
model and to calculate other biophysical parameters. From experimental data on average blood
oxygen saturation Y the associated parameters PO2Sρ/rBF , the average intravascular partial oxygen
pressure 〈P 〉 and the OEF can be deduced, provided c¯t is known or assumed. Provided perfusion
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rBF is known in addition, the metabolic rate PO2Sρ and the metabolic rate of oxygen consumption
MRO2 can be calculated.
The median blood oxygen saturations of 87 breast tumors and of their surrounding normal breast
tissue were found to be the same within error limits Ytum,median ≈ Ynorm,median = 0.73 [37]. Using
this value we have calculated corresponding oxygen extraction fraction OEF and ratio of the oxygen
extravasation rate constant over perfusion PO2Sρ/rBF for various tissue oxygen partial pressures
Pt between Pt = 0 and Pt = 37 mmHg (s. Table 2). By imposing the constraint Y = Yexp = 0.73
the ratio κ and tissue oxygen concentration c¯t are no longer independent parameters, but implicitly
dependent on each other, e.g. κ = κ(c¯t). Together with the published median blood flow rates
rBF tum,median, rBFnorm,median, the extravasation rate constants PO2Sρ and metabolic rates of
oxygen consumption MRO2 were additionally deduced for tumors and normal breast tissue. As
can be seen from Table 2, the difference between the average oxygen concentration in plasma and
tissue decreases with increasing tissue oxygen partial pressure, whereas the ratio κ = PO2Sρ/rBF
increases by about a factor of 10 within the range of tissue oxygen partial pressures considered
to yield the same average tissue blood oxygen Y . The oxygen extraction fraction OEF drops
from 0.41 at Pt = 0 to 0.26 at Pt = 37 mmHg, i.e. the saturation S(ξ = 1) is higher at the
higher tissue oxygen pressure (s. Fig.1 in S3 Appendix). Correspondingly, the metabolic rate of
oxygen consumption decreases from 5.2 to 3.4µlO2/ml tissue/min for normal breast tissue. The
reported value of MRO2 = 4.5µlO2/ml tissue/min for normal breast tissue falls well within the
range of calculated rates (s. Tab. 2) [20]. At the same tissue oxygen partial pressure Pt, the
metabolic rates of oxygen consumption of tumors are five times higher in tumors than in normal
breast tissue because of the higher perfusion in breast tumors, provided average blood oxygen
saturation Y and arterial oxygen concentration is the same in both cases. From steady state PET
measurements after 15O2 inhalation the metabolic rate of oxygen consumption for breast tissue was
deduced to be MRO2 = 6.6µlO2/ml tissue/min. This value is considerably lower than the range
19− 26µlO2/ml tissue/min of metabolic rates deduced from the median value Ytum,median = 0.73
assuming an arterial oxygen concentration of c(0) = 0.214ml O2/ml blood. However, the PET result
was challenged [23], because tumor heterogeneity precludes the method of data analysis used by
Beaney et al. [20].
The computational model assumes partial pressure dependent metabolic rates of oxygen con-
sumption M = M(Pt) (s. Eq. (17), Table 1) with different parameters M0 and PM50 chosen for
normal breast tissue and breast tumors. Within the range of tissue partial oxygen pressures Pt
considered by the compartment model (s. Table 2) the metabolic rates M = M(Pt) of oxygen
consumption (0− 3.36µl O2/ml tissue/min, normal breast tissue, 0− 14.1µl O2/ml tissue/min,
breast tumor) generally fall below the values for MRO2 listed in Table 2 for normal tissue and
breast tumors. Using the published median blood flow rates rBF tum,median, rBFnorm,median the
corresponding values for the oxygen extraction fraction OEF are lower compared to the results listed
in Table 2. Correspondingly, the range of average blood oxygen saturation (0.77 ≤ Ynorm ≤ 0.95,
0.80 ≤ Ytum ≤ 0.95) are above the median value Ytum,median ≈ Ynorm,median = 0.73
The compartment model allows to derive the conditions, when average blood oxygen saturation
Ytum falls above or below Ynorm of the surrounding normal breast tissue. In Fig. 3 we have plotted
blood oxygen saturation Y , calculated by numerically integrating Eq. (40) for constant tissue oxygen
partial pressures of ct = 0, 5, 15, 30, 45 mmHg versus the ratio of blood flow rate over extravasation
rate constant 1/κ = rBF/PO2Sρ as suggested by the approximate expression of the Crone Renkin
model (s. Eq. (42)). At ct = 0, oxygen extravasation is maximal, because there is no backflow of
oxygen from the tissue to the vascular system. Therefore, the bottom curve (ct = 0) represents a lower
limit for blood oxygen saturation. Finite tissue oxygen concentrations, on the other hand, decrease
the loss of oxygen to tissue by extravasation and cause shifts towards higher saturation values Y .
To discuss conditions when Ytum falls above or below Ynorm we choose the partial oxygen pressures
for normal breast tissue and tumors to be Pt,norm = 15 mmHg and Pt,tum = 5 mmHg respectively.
Previously invasive needle measurements of tissue oxygen tension by oxygen polarography were
carried out on 16 breast cancer patients at a large number of breast positions [14]. Generally,
broad distributions of partial oxygen pressures were observed in normal breast tissue and tumors
with median values of Pt,median = 65 mmHg and Pt,median = 30 mmHg, and lower bounds of
Pt,min = 12.5 mmHg and Pt,min = 0 − 2.5 mmHg for normal breast tissue und breast tumors,
respectively. The partial pressures chosen presently for normal breast tissue and breast carcinoma are
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close to these lower bounds. Since tissue oxygen partial pressure of a particular breast tumor is likely
to be lower than oxygen pressure in the surrounding normal breast tissue, Y (ct,tum) is larger than
Y (ct,norm), provided the shift in blood oxygen saturation of normal breast tissue due to higher tissue
oxygen concentration ct,norm, is at least compensated for by a higher value of (rBF/PO2Sρ)tum
compared to (rBF/PO2Sρ)norm, e.g. by larger blood flow rBF tum or lower oxygen extravasation
rate constant (PO2Sρ)tum, otherwise the opposite holds true. The former condition is illustrated in
Fig. 3 for the maximal blood oxygen saturation Ymax,norm = 0.85 observed experimentally in normal
breast tissue within the patient cohort of the clinical study [37]. In this case, Ymax,norm < Y (ct,tum)
for 0.037 < (rBF/PO2Sρ)tum (s. Fig. 3, vertical dashed line). Tumor volumes with rather few,
yet fairly large blood vessels are likely to exhibit high blood flow rates rBF tum resulting in blood
oxygen saturation values above that of normal breast tissue (Ynorm < Ytum). The opposite situation
occurs, when tumor perfusion is lower (rBFtum < rBFnorm) and extravasation rate constant is
higher (PO2Sρ)norm < (PO2Sρ)tum compared to normal breast tissue. For example, tumors with a
well developed plexus of blood vessels may exhibit reduced values of (rBF/PO2Sρ)tum, , resulting
in average blood oxygenation tum norm Ytum < Ynorm. Regional blood volume rBV of tumors is
known to be almost exclusively larger than that of normal breast tissue. It is likely that surface
area per volume of tissue Sρtum also increases besides blood volume in cases of a well developed
plexus. Furthermore, solid pressure present in tumors may compress blood vessels reducing blood
flow. It is therefore conceivable, that tumors with Ytum < Ynorm can be associated with networks of
enhanced surface area per unit volume of tissue, and/or reduced blood flow. Furthermore, although
The median of blood flow rates in breast tumors rBF tum,median = 0.3ml blood/ml tissue/min is 5
times that of normal breast tissue (rBFnorm,median = 0.06ml blood/ml tissue/min), there is some
overlap of the rBF tum and rBFnorm ranges (0.08 ≤ rBF tum ≤ 0.9ml blood/ml tissue/min, versus
0.03 ≤ rBFnorm ≤ 0.17ml blood/ml tissue/min) indicating that rBF tum < rBFnorm may occur
[24, 25].
The minimal and maximal blood oxygen saturations Ymin,Ymax observed experimentally [37,
Fig.3b] (reproduced in Fig. 1) for normal tissue (Ymin = 0.49, Ymax = 0.85) and tumor tissue
(Ymin = 0.41, Ymax = 0.91) are indicated in Fig. 3 by short-dashed and dash-dotted horizontal lines,
respectively. For the partial oxygen pressures Pt,norm = 15mmHg, and Pt,tum = 5mmHg chosen,
these boundaries are converted to the rBF/PO2Sρ ranges 0.27 · 10−2 ≤ rBF/PO2Sρ ≤ 3 · 10−2
(normal tissue, s. vertical short-dash lines) and 0.34 · 10−2 ≤ rBF/PO2Sρ ≤ 0.1 (tumor tissue,
vertical dash-dotted lines). Both ranges overlap, reflecting the observation that Ytum may fall
below and above Ynorm [37, Fig. 3b]. We consider a position on the diagonal of Fig. 3b of [37],
corresponding to Ytum,0 = Ynorm,0 = Y0. Moving along the vertical line Ynorm = Y0 = constant to
a position in the upper triangle of Fig. 3b with Ytum > Ytum,0 we may write in first approximation
Ytum − Ytum,0 = ∂Y
∂κ
|κtum,0;c¯t,tum,0(κtum − κtum,0) +
∂Y
∂c¯t
|κtum,0;c¯t,tum,0(c¯t,tum − c¯tum,0). (43)
Note, that ∂Y/∂c¯t > 0 whereas ∂Y/∂κ < 0. For the right hand side to be positive, at
least one of the terms should be positive and outweigh the other term, in case it is negative.
For example, for higher perfusion rBF tum > rBF tum,0 and lower rate constant of extravasation
PO2Sρtum < PO2Sρtum,0 the ratio κtum < κtum,0 results in higher average oxygen saturation,
provided tissue oxygen concentration only moderately decreases (c¯t,tum < c¯tum,0) or even increases,
i.e. the tumor tissue is only moderately more hypoxic or even less hypoxic. An increase in vessel
radius leads to enhanced rBF , rather few vessels with fairly large radii to a smaller vascular surface
area per unit volume of tissue Sρ and hence to a reduced rate constant for extravasation, while
a lower metabolic rate of oxygen consumption in tissue tends to lead to higher tissue oxygen
concentrations. Conversely when κtum > κtum,0 due to reduced perfusion or higher rate constant of
extravasation the oxygen concentration in tissue needs to increase sufficiently c¯t,tum > c¯tum,0 for
Ytum > Ytum,0 to hold true.
Roughly speaking the upper triangle of Fig 3b of Ref. [37] predominantly corresponds to
well perfused tumors (rBF )tum > (rBF )norm or tumors with low extravasation rate constants
PO2Sρtum < PO2Sρnorm that are only moderately more hypoxic or even less hypoxic. The opposite
holds true for the lower triangle, encompassing tumors with higher ratio κ i.e. lower perfusion or
higher rate of extravasation as well as lower tissue oxygen concentration. It follows that average
blood oxygen saturation Y reflects structural properties of the vasculature, its hemodynamics and
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Figure 3. Blood oxygen saturation Y calculated by numerical integration of Eq. (39)
for constant tissue oxygen partial pressures of 0, 5, 15, 30 and 45 mmHg (bottom to
top). Y is plotted versus ratio 1/κ = rBF/PSρ of blood flow rate over oxygen extravasation rate
constant. For 1≪ rBF/PSρ, the saturation Y approaches the value of the blood oxygen saturation
S(0) = 0.95 at input (horizontal dashed line). The bottom curve corresponds to zero tissue oxygen
pressure (Pt = 0) representing the lower limit for the average blood oxygen saturation. Assuming
oxygen partial pressures of Pt = 15 mmHg (third curve from bottom) and Pt = 5 mmHg (second
curve from bottom) for normal tissue and tumor tissue respectively, blood oxygen saturation
Y (tumor) of breast tumors with 0.037 < rBF/PSρ (s. dashed vertical line) exceeds that of normal
tissue Y (normal) while the opposite is true for rBF/PSρ < 0.037. In the former case tumors fall
into the upper triangle of [37, Fig. 3b], while the lower triangle contains tumors with
rBF/PSρ < 0.037. The minimal and maximal blood oxygen saturation Ymin, Ymax observed
experimentally [37, Fig. 3a] for normal tissue (short-dashed horizontal lines Ymin = 0.49,
Ymax = 0.85) and tumor tissue (dash-dotted lines, Ymin = 0.41, Ymax = 0.91 are also indicated in
Fig. 3. These boundaries are converted into the ranges 0.27 · 10−2 ≤ rBF/PSρ ≤ 3 · 10−2 (normal
tissue, s. vertical short-dashed lines) and 0.34 · 10−2 ≤ rBF/PSρ ≤ 0.1 (tumor tissue, vertical
dash-dotted lines) for rBF/PSρ.
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metabolic properties of the tissue investigated. Besides relating blood oxygen saturation Y to the
ratio 1/κ = rBF/PO2Sρ of perfusion over extravasation rate constant (s. Fig. 3) we calculated Y
as a function of the ratio MRO2/rJin = OEF of the metabolic rate of oxygen consumption over
the (arterial) oxygen flux rJin = c(0) · rBF entering the vascular network per unit volume of tissue
for selected values of the tissue oxygen partial pressure Pt (s. Fig. 4). Fig. 4 provides another way
to compare Ytum to Ynorm. At constant tissue partial oxygen pressure Pt, average blood oxygen
saturation Y monotonously decreases with increasing oxygen extraction fraction OEF . Furthermore,
at constant OEF average blood oxygen saturation Y decreases with increasing tissue partial oxygen
pressure Pt. Likewise, at constant average blood oxygenation Y oxygen extraction fraction OEF
decreases with increasing Pt. These trends are also evident from Fig.1 and Fig.2 in S3 Appendix,
illustrating blood oxygen saturation S(ξ) along the vessel axis for selected tissue partial oxygen
pressures Pt and constraints Y = const and OEF = const, respectively. Thus, data falling into
the upper triangle of Fig. 3b of Ref. [37] correspond to cases (Ytum > Ynorm) for which the ratio
of oxygen demand over oxygen supply is smaller for tumors compared to the surrounding normal
tissue,(MRO2/rJin)tum < (MRO2/rJin)norm apart from shifts of the oxygen extraction fraction
OEF due to different oxygen partial pressures in normal breast tissue and breast tumors. Conversely,
data appearing in the lower triangle of Fig. 3b of Ref. [37] (Ytum < Ynorm) correspond to tumors
with (MRO2/rJin)norm < (MRO2/rJin)tum apart from OEF shifts due to different tissue oxygen
partial pressures in tumors and normal breast tissue.
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Figure 4. Simulated average blood oxygen saturation Y versus oxygen extraction
fraction OEF for selected partial oxygen pressures Pt = 0, 5, 10, 15, 20, 25, 30, 35, 40 mmHg
(from top to bottom), corresponding to κ = PO2Sρ/rBF varying between κ = 0 and κ = 300.
We have plotted average blood oxygen saturation Y measured in normal breast tissue (Fig. 5) and
breast tumors (Fig. 6b) by optical mammography versus regional blood volume. The data in Fig. 5
and 6 are exactly the same as the data in Fig. 5a of Ref. [37], reproduced in Fig. 2, however plotted
versus rBV rather than hemoglobin concentration cHb and separately for normal and tumorous
breast tissue. Hemoglobin concentrations cHb = cHb,bloodrBV were converted to regional blood
volume assuming an average of cHb,blood = 140 g Hb/l blood. Furthermore, average blood oxygen
saturation Y calculated for selected tissue partial oxygen pressures Pt are also included in Fig. 5
and 6. For this purpose 1/κ = rBF/PO2Sρ was converted to rBV = PO2Sρ ·MTT/κ taking the
product PO2Sρ ·MTT from the values PO2Sρ listed in Table 2 together with median values of the
regional blood volume rBV = 0.008ml blood/ml tissue (from cHb = 17.3 µmol/l [37], normal breast
tissue) and rBV = 0.0244ml blood/ml tissue (from cHb = 53 µmol/l [37], breast tumors) together
with the published median values for rBFnorm and rBF tum (s.above). The products PO2Sρ ·MTT
derived in this way depend to some extent on tissue oxygen partial pressure (cf. Table 2). For
Fig. 5 and 6 we selected the values PO2Sρ ·MTT = 1 (normal breast tissue) and PO2Sρ ·MTT = 3
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(breast tumors), respectively, derived at Pt = 20 mmHg. Despite some data scatter, Fig. 5 and
6 clearly exhibit the low threshold behavior. Data appearing above the lower threshold (Pt = 0)
interpreted as reflecting finite tissue oxygen concentrations, i.e. indicating tissue oxygen status. In
addition, reduced values of PO2Sρ, resulting in smaller losses of oxygen to the tissue environment,
and shorter mean transit times MTT result in higher average blood oxygen saturation. Of course,
the low threshold behavior is also visible in Fig. 5a of Ref. [37], reproduced in Fig. 2. Although we
focus on results of optical mammography, we point out the striking similarity between Fig. 5a of
Ref. [37] relating to measurements taken on a cohort of breast cancer patients and Fig. 4 of Ref.
[28] showing blood oxygen saturation Y versus blood volume fraction rBV of a large number of
voxels of normal brain tissue and of a brain tumor in a particular tumor model, deduced from MRI
measurements. Compared to the optical data, the MRI measurements are taken at considerably
higher spatial resolution, resulting in many more data, clearly showing the lower threshold of Y and
the many data above it.
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Figure 5. Experimental (open symbols) and calculated (solid lines) average blood
oxygen saturation Y in normal breast tissue of 87 breast tumor patients (cf. Fig. 6) versus
regional blood volume [37, Fig. 5]. Solid lines correspond to oxygen partial pressures
Pt = 10, 15, 20, 25, 30, 35mmHg (from bottom to top). Experimental values for regional blood
volume rBV were deduced from measured hemoglobin concentrations cHb, theoretical values
rBV = PO2Sρ ·MTT/κ were obtained scaling 1/κ with PO2Sρ ·MTT = 1 (s. text).
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Figure 6. Experimental (open symbols) and calculated (solid lines) average blood
oxygen saturation Y of 87 breast tumors versus regional blood volume [37, Fig. 5]. Solid lines
correspond to oxygen partial pressures Pt = 10, 15, 20, 25, 30, 35mmHg (from bottom to top).
Experimental values for regional blood volume rBV were deduced from measured hemoglobin
concentrations cHb, theoretical values rBV = PO2Sρ ·MTT/κ were obtained scaling 1/κ with
PO2Sρ ·MTT = 3 (s. text).
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Table 2. Oxygen consumption and extravasation rate computed by the compartment model
Pt / mmHg OEF rBF/PSρ PSρ /ml O2/ml/min
(rBF tum = 0.06/min)
PSρ /ml O2/ml/min
(rBF tum = 0.3/min)
MRO2 /µl O2/ml/min
(rBFnorm = 0.06/min)
MRO2 /µl O2/ml/min
(rBF tum = 0.3/min)
0 0.407 0.015 4.04 20.2 5.2 26.1
5 0.401 0.013 4.52 22.6 5.15 25.6
10 0.393 0.012 5.16 25.8 5.05 25.3
15 0.385 0.010 6.0 30.2 4.94 24.7
20 0.373 0.008 7.3 36.4 4.79 23.9
25 0.357 0.006 9.25 46.2 4.58 22.9
30 0.332 0.005 13.2 66.0 4.26 21.3
35 0.289 0.003 23.8 118.9 3.71 18.6
This table shows the dependence of oxygen extraction fraction OEF , ratio of blood flow rate over extravasation rate constant 1/κ, extravasation rate constant
PSρ, metabolic rate of oxygen consumption MRO2 on partial oxygen pressure Pt in tissue using average blood oxygen saturation
Ynorm = Ytum = 0.73 (median). cin = c0H · Sin = 0.214ml O2/ml blood, H = 0.45ml RBC/ml blood, Sin = S(0) = 0.95,OEF app = 1− Y/Sin = 0.232,
median blood flow rate for normal breast tissue and breast tumors [24, 25]
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Artificial Blood Vessel Networks Representing Normal Breast Tissue
Ideally, one would start from digitized 3D blood vessel networks of each breast patient to simulate
hemodynamic properties, as well as intravascular and extravascular oxygen concentrations in tumor
and surrounding normal tissue. Although 3D vascular networks of tumors grown in tumor models
can be generated from µ-CT data [80, 81], such techniques are not applicable to humans. Therefore,
3D vascular trees are algorithmically constructed, following methods previously applied to model
vasculature in melanomas and gliomas [39, 55, 56, 57, 58, 59]. The model employed in this paper is
described in detail in Ref. [39], representing an extension of the model used in [102] which is based
on wall shear stress guided random growth of interdigitating vascular trees on a lattice.
For the sake of readability we briefly review the model and refer the reader to the supplemental
material S1 of Ref. [39]. Simulations are performed on a cubical domain with lateral length of
L = 8 mm. At first a 3D network is constructed, representing the blood vessel network in a
section of normal tissue, i.e. the host. Starting from arterial and venous root nodes, located at
boundary sites of the face centered cubic lattice used to carry the vascular network, vessel segments
of different shape (linear, tripod) are statistically appended along several possible directions. This
process is continued until further addition of vessel segments causes segments to overlap, assumed
to be forbidden. Subsequently nearby open ends at terminal branches of the arterial and venous
trees generated in this way are (temporarily) connected by (straight) vessel segments representing
capillaries. Radii of capillaries, of arterial and venous terminal segments are set to 2.5 µm, 2.5 µm
and 3.8 µm, respectively, whereas radii of parent segments are determined from Murray’s law , i.e.
rαc = r
α
a + r
α
b with rc being the radius of the parent vessel, ra, rb the radii of the two downstream
vessels and α = 3 has been selected. Blood flow through the temporary network is calculated,
including shear wall stress of segments. With the capillaries removed additional vessel segments are
stochastically attached to or removed from terminal branches with probability based on wall shear
stress. The entire process is continued until the number of capillaries reaches a plateau. Eventually
the whole lattice is filled with a reasonably realistic arteriovenous network, the lattice constant
h(gen) being the determinant of MVD. h(gen) = 130 µm has been selected.
In Fig. 7 nine different root node geometries are shown used to generate vascular networks of
normal breast tissue and of tumors. The resulting vascular networks depend strongly on root node
geometry chosen. For each root node geometry 10 vascular networks (10 network realizations) were
grown, differing among each other because of the statistical nature of the growth process. Thus a
total of 90 different vascular networks were generated representing normal breast tissue.
Artificial Tumor Blood Vessel Networks
Starting from one of the 90 vascular networks representing normal tissue the associated tumorous
vessel network is formed by vascular remodeling via cooption, angiogenesis, and regression. For
this purpose a small sized spherical tumor (Rtumor(t = 0) = 250µm), the radius of which grows at
constant speed vtumor = 2 µm/h, is placed initially at the center of the simulation domain. During
fixed time intervals ∆t the vasculature within the tumor is modified by the following biological
processes at prescribed probabilities [39, 58]:
(i) Angiogenic sprouting: In normal tissue, lattice sites occupied by vessels, i.e. sites, have a
chance (probability ∆t/t
(sprout)
EC ) to spawn a sprout segment on an adjacent lattice bond
provided the site is close enough to the tumor, i.e. within the growth factor diffusion distance
Rg rather than requiring the growth factor concentration to be sufficiently high, as previously
postulated [55]. Furthermore, no other branching points must be nearby, i.e. within the
distance of l(spr). Vessels within the tumor sphere, switch to circumferential growth (s. below).
(ii) Sprout growth: sprouting vessels have a chance (probability ∆t/t
(sprout)
EC ) to be extended by
another lattice bond. Sprouts have a total lifetime of t
(migr)
EC . When sprouts hit an existing
vessel during their lifetime, they fuse by anastomosis and form a functional vessel carrying
blood. Otherwise sprouts are prone to collapse after their lifetime.
(iii) Circumferential growth: vessels switch from sprouting to circumferential growth after their
residence time t
(switch)
EC within the tumor. After switching to circumferential growth we assume
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Figure 7. Illustration of vascular tree configurations: Schematic views from above on
simulation cubes indicate vascular tree root locations for configurations denoted RC1 to RC9. In
RC1 to RC3 boundary sites are occupied in alternating order either with arterial or venous nodes.
In RC1 only one face of the simulation cube is used, in RC2 two opposing sides are used and in RC3
four faces are used. In RC4, RC5 and RC6 we place nodes at 33% and 66% of the length of the
cube faces diagonals on the diagonals. As before, one, two and four faces are used, where in total
only two (RC4, RC5) and four nodes (RC6) are placed. In RC7 and RC8 we first create fixed
parent vessels protruding along the x-axis to 60% of the cube length into the interior. On each site
occupied by these parent vessels a regular root node is created for further growth. Flow boundary
conditions are specified at the actual inlets and outlets at the cube boundaries. In RC9 each
boundary site of the lattice is occupied with a root node with probability proot. Before a network is
created, proot is drawn equally distributed between 0 and 1, however a configuration is only
accepted if there is at least one arterial and one venous node.
that each endothelial cell (10× 10 µm2 surface area) at the inner wall to duplicate every t
(prol)
EC
hours leading to an increase of vascular radius r. We impose an upper limit on the radius
(r(max)) after which circumferential growth stops.
(iv) Degradation of vessel wall stability: vessels possess a wall stability value w as an abstract
measure of the state of degeneracy of their vessel wall. The stability measure w is initialized
relating it to the wall thickness of healthy vessels [39, Suppl.1, Eq.(2)]. The wall stability of
tumor vessels decreases over time at the rate ∆w until zero. Once zero, vessels are allowed to
collapse and regress (see below).
(v) Vessel collapse and regression: If the wall shear stress f of a segment falls below a threshold
(f (coll)) and w = 0, then the segment is removed from the network at probability p(coll),
representing collapse, occlusion and complete regression. In this study we set p(coll) to 1,
making collapses deterministic.
These processes are implemented in time-discrete steps ∆t during which the network morphology
is modified. For this purpose the simulation sweeps over all vessels and makes alterations accordingly.
Since vessel collapse and regression can take place provided shear stress falls below a lower threshold
, blood flow and hence shear stress are updated after each time interval ∆t. The simulation growth
process was deliberately stopped at t = 600 h when the tumor diameter had grown to ca. 3 mm to
minimize boundary effects which would occur if the tumor was allowed to grow to the size of the
simulation box.
Some of the processes modifying tumor vasculature, such as sprout initiation and growth of
sprouts, vessel dilation and vessel wall degeneration depend on the presence of growth factors in tumor
tissue, such as vascular endothelial growth factor VEGF. In previous work [39, 55, 56, 57, 58, 59]
therefore incorporated a concentration field for growth factors in tumorous tissue produced by
tumor cells. Modification of the existing vasculature required vascular endothelial growth factor
concentration to be sufficiently high. In the present paper, however, this growth factor concentration
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field is omitted. Instead we define another concentric (growing) sphere with a slightly larger radius
Rtumor(t) +Rg, where the parameter Rg reflects the VEGF diffusion distance, i.e. the distance the
growth factor diffuses, before its concentration drops to insignificant levels due to degradation and
binding. Within the sphere of radius Rtumor(t) +Rg, the aforementioned processes, e.g. angiogenic
sprouting, can take place, as if there was sufficiently a high concentration of growth factors. This
considerable simplification of the growth process is justified because results obtained in this way
are consistent with the predictions of more complex models. Also, proliferation in solid tumors
is confined to the outer rim due to competition for space and nutrients leading to a constant
expansion rate of the tumor radius. However, some very aggressive brain tumors are known to
exhibit morphological instabilities leading to fingering growth patterns but we have no indication
that this applies to breast tumors.
The vasculature obtained at the end of the tumor growth process (t = 600 h) represents the
tumor specific network together with modifications of the normal vasculature occurring at the
tumor-normal tissue interface. Generally, wWe take the starting network at t = 0 with the initial
small tumor inserted (Rtumor = 250µm) to represent normal breast tissue. For each of the 90
network realizations at t = 0 we calculated blood flow, hematocrit distribution and intravascular and
tissue oxygen PO2 distributions according to Sec. ‘Models‘. Parameters related to oxygen transport
(s. Table 1) are to a large extend taken from [45], compiled from various sources, not specifically for
breast tissue. In order to qualitatively reproduce experimental data obtained from 87 patients, i.e.
in order to account for biological variability, each of the 90 tumor network realizations (t = 600 h)
was evaluated for blood flow, hematocrit and oxygen concentration in blood and tissue. In the
following we discuss three different scenarios denoted BASE, CMPR and METAB. Cases BASE
and METAB use the same tumor vascular networks (t = 600 h), but differ in their assumptions
made to calculate tissue metabolic rate of oxygen consumption variables. CMPR, on the other hand,
augments the processes that cause remodeling of the tumor vasculature by accounting for vascular
compression by solid pressure, leading to tumor vascular networks at t = 600 h that differ from the
networks of the scenarios BASE and METAB.
Case BASE
This is our base case with parameters for growth of breast tumor vasculature listed in Table 3.
Blood flow, hematocrit distribution, blood and tissue oxygen concentrations were calculated using
each of the 90 realizations of tumor vasculature (t = 600 h) together with parameters related to
oxygen transport given in Table 1. It should be noted that Michaelis-Menten parameters for tumor
tissue were assumed to be M0(tumor) = 4 ·M0(normal) and PM50(tumor) = 0.5 · PM50(normal).
Compared to melanomas changes in the tumor growth parameters (s. Table 3) include l(spr),
governing the MVD near the tumor rim, f (coll) , and r(max) determining the central MVD and
rBV . Other parameters such as the sprouting time t
(sprout)
EC , and vessel wall degradation rate ∆w
are unaltered. Interestingly, our value for f (coll) falls within the order of magnitude of physiological
wall shear stress in human veins (ca. 1 Pa), which is about one order of magnitude lower than in
arteries [103]. Consistent with previous results, we obtain highly compartmentalized networks that
comprise a central core with low MVD and highly vascularized peripheral shell of a few hundred
micrometer thickness, see Fig. 8. The arterio- venous organization is lost, and the remaining high
caliber vessel protruding into and through the tumor are connected with a chaotic network of dilated
capillaries. The aforementioned processes causing vascular remodeling via cooption, angiogenesis,
and regression favor either growth of vessels up to the limit r(max) or complete regression. It turns
out that the tumor vasculature of scenario BASE is unsuited to explain some of the experimental
data, in particular the correlation plot Ytum versus Ynorm. Since average blood oxygen saturation Y
is the RBC-volume-weighted average of blood oxygen saturation taken over all vessel segments (s.
S2 Appendix), high caliber vessels predominantly contribute to Y . Likewise, because high caliber
vessels criss-cross the central tumor volume, oxygen supply exceeds oxygen demand and average
blood oxygen saturation values of tumors generally fall above those of corresponding normal breast
tissue.
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Table 3. List of parameters for tumor growth
Parameter Value Unit Description
Rtumor(t = 0) 250 µm Initial tumor radius
vtumor 2 µm/h Tumor radius expansion rate
Rg 200 µm Growth factor diffusion range
t
(switch)
EC 12 h Circumferential growth switch delay
t
(sprout)
EC 2 h Time between sprouting events
t
(migr)
EC 50 h Sprout activity duration
l(spr) 80 µm Sprout sites minimum separation
t
(prol)
EC 144 h Endothelial cell proliferation time
r(sprout) 2.6 µm Initial sprout vessel radius
r(max) 14 µm Maximum dilation radius
p(coll) 1 Vessel collapse probability
∆w 0.05 µm/h Vessel stability (w) decrease rate
f (coll) 0.25 Pa Critical wall shear stress
h(tumor) 10 µm Lattice constant of tumor growth simulation
h(gen) 130 µm Lattice constant of initial network generation
A B
CMPR
BASE
Figure 8. Radial distributions of the microvascular density, MVD , and the relative blood
volume, rBV . The simulation box was divided in 100 µm thick concentric shells over which the
regional MVD and rBV were determined to obtain radial profiles depending on the distance from
the center |x|. Plotted is the ensemble mean of these profiles, where the error bars display the
standard deviation (STD). As can be seen, a compartmentalization into varying degrees of
vascularization and vasodilation exist which is typical for Melanoma [104] and Glioma [105]. We
assume that these features are also present in breast tumors. The STD of MVD further shows that
the MVD of the tumor core is below normal in most realizations of the ensemble which conforms to
our expectations for tumors. For cases BASE and CMPR, both of which are shown, we require the
mean values to be similar since we want to study the effect of additional fluctuations alone (see case
CMPR). Oscillations are an artifact of the confinement of the vessels to a lattice.
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Case CMPR: Vascular compression
We explored the effect of compression of tumor vessels during tumor growth by extravascular stress
on simulated average blood oxygen saturation Ytum based on the final t = 600 h tumor vasculature.
Compression of tumor vessels will change the relation of Ytum and the blood oxygen saturation
of the surrounding normal breast tissue Ynorm obtained from the corresponding vascular network
at t = 0. Elevated interstitial fluid pressure (IFP) is known to be a hallmark of tumors [10],
primarily caused by the increased leakiness of tumor vessels and the lymph drain being impaired
in solid tumors. Yet the precise mechanisms by which extravascular pressure compresses tumor
vessels are still under debate [106, 107]. The uncontrolled proliferation and growth of tumor cells
within a restricted volume generates extravascular solid stress. Solid stress accumulates within
the tumor volume through an increase in tumor cell density and hyperproduction of interstitial
matrix molecules such as collagen and hyaluronan [9, 10, 11]. Collagen fibers are resistant to tensile
stress whereas hyaluronan resists compression thus transferring stress on tumor vessels. On the
other hand water-loaded hyaluronan can be considered to be part of the relative immobile fluid
phase of the interstitial fluid, contributing to IFP apart from contributions of the freely mobile
fluid phase. Furthermore, solid stress can be exerted on the tumor volume by the surrounding
normal tissue. It was estimated that solid stress becomes significant for tumor volumes larger than
0.065 mm3, corresponding to a sphere of Rtumor = 250 µm [108]. A detailed simulation of solid
stress during progression of the tumor is beyond the scope of the present paper. Therefore we
assume that all vessels of the tumor vasculature experience compression during the growth process,
i.e. a reduction of their radius by a constant factor. The fundamental difference to the case BASE is
that in this way high-caliber vessels experience a reduction in radius, which cannot be achieved by
the previous model that predicts either growth or complete removal of vessels. Hence we introduce a
new “compressed” vessel radius, denoted r˜ which enters the blood flow and oxygen computation. We
consider a function ψ(|x|) of the spatial coordinate x that represents the magnitude of compression
relative to the base radius, depending on the distance from the tumor center |x|. Therefore we
define r˜ = ψ · r. We let ψ describe a linear transition between full compression of magnitude 1− ξcpr,
in the tumor center and zero in normal tissue. Thus, vascular radii r˜ within the tumor, with the
exception of a small transition zone of width wcpr, are reduced relative to r by a factor of ξcpr.
ψ(x) =


ξcpr for x < R− wcpr
1 for x > R+ wcpr
ξcpr − x−R+wcpr2wcpr · (ξcpr − 1) else,
(44)
where R is the radius of the tumor and wcpr is 200 µm in our simulations. We assume that
varying degrees of compression are present in the tumors of the patient cohort due to phenotypical
differences from tumor to tumor or differences in the micro environment of the host. Therefore
a new ξcpr was drawn for each simulation from a uniform distribution over the interval between
0.5 and 1. The lower bound of 0.5 was deliberately chosen since it appears to be the lower bound
of what was reported for experiments, i.e. relief of stress resulted in two times increase of vessel
diameters [109].
Case METAB: Variation of tumor oxygen consumption rate
In contrast to case CMPR scenario, METAB uses the identical tumor vascular networks as case
BASE. However, rather than selecting the same maximal oxygen consumption rate M0 for all tumors
as in scenario BASE we consider variations of the maximal tumor oxygen consumption rate M0
among various tumors reflecting phenotypical differences. In this way we probe the impact of
tumor tissue oxygen consumption versus tumor vascular restructuring on intra-and extravascular
oxygen distributions. Therefore, M0 / (ml O2/ml/min) is drawn from a lognormal distribution with
mu = log(0.0149) and sigma = 0.3 on a tumor by tumor basis, yielding a median M0 identical to
case BASE (s. Table 2) and a standard deviation of 32% of the median. The oxygen consumption
rate of normal tissue is kept at its original value (Table 2). Furthermore oxygen partial pressures
PM50 were kept unchanged.
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Results of the computational model
We calculated various biophysical variables for the initial network at t = 0 and for the cases
BASE, CMPR and METAB at t = 600 h. Values listed in Table 4 represent averages (means) over
the results of all 90vascular networks, including standard deviations. Explicit formulas for these
parameters are given in S2 Appendix. It should be kept in mind that for most biophysical variables
results corresponding to a particular vascular network represent (weighted) averages taken over all
segments of the network (s. S2 Appendix). For comparison we list in Table 4 experimental and
some theoretical results taken from the literature.
The microvascular density MVD is measured microscopically by counting the number of mi-
crovessels per area of a tissue microscopic slide. It is a quantity not easy to simulate. Therefore we
take the simulated length density LD , i.e. the total length of the vascular network divided by the
tissue volume as measure for MVD (s. S2 Appendix). This definition yields at least the correct
dimension and is identical to the number of vessels per cross-sectional area in case of a Krogh-like
arrangement of parallel vessels. When comparing experimental MVD data and simulated length
densities LD it should be kept in mind that both parameters are not identical. In a large portion of
the experimental literature on breast tumors, the MVD is obtained from well vascularized areas,
so called hot-spots. Dhakal et al. [111] reported densities between 15-348 mm−2 with a mean of
88 mm−2. Hot-spots are predominantly found near the tumor rim, but apparently not exclusively.
Fernandez-Guinea et al. [112] reported MVD values from tumor centers which are somewhat lower
0-157 mm−2 with a median of 20 mm−2. We obtain a wholetumor average of 133± 18mm−2 (case
CMPR, s. Table 4) which includes a significant contribution of the rim. The prediction of the MVD
of the central part of the tumor agrees with this data. Microvessel density MVD of normal breast
tissue is reproduced accurately.
The regional vessel volume rBV denotes the volume fraction of tissue occupied by vessels.
Additionally, the relative venous volume vrBV , i.e. the total volume occupied by venules and
venes over the total blood volume is given in case of normal tissue. Because the classification of
vessel segments of the tumor vasculature into arterioles, capillaries and venules no longer applies,
the latter quantity is meaningless in case of tumors. Tissue hemoglobin concentration cHb is the
product of mean corpuscular hemoglobin concentration (MCHC ) and regional RBC volume rRBCV
(s. S2 Appendix). Assuming homogeneous hematocrit, tissue hemoglobin concentration is given
by cHb = MCHC · H · rBV . Thus, using experimentally measured hemoglobin concentrations
of normal breast tissue (cHb = 17.3 µmol/l [37]), and of tumors (cHb = 53 mol/Hb [37]), we
estimate the vascular volume fraction to be rBV = 0.008 (normal breast tissue) and rBV = 0.0244
(breast tumors) assuming a hemoglobin molar mass of 64.5 kg/mol and hemoglobin concentration
in blood cHb,blood = 14 g/dl (women, normal range: 12-16 g/dl) corresponding to MCHC = 311 g/l
hemoglobin per RBC volume and H = 0.45.
Results on hemoglobin concentration of normal breast tissue and breast tumors obtained by
a number of groups using optical mammography scatter by about a factor of two [37], resulting
in an upper limit of rBV = 0.016 for normal breast tissue and a range of rBV = 0.01–0.06 for
tumors. Beaney [21] obtained distinctly larger rBV estimates for normal breast tissue (rBV = 0.034)
and breast tumors (rBV = 0.043), derived from PET measurements using the steady state 15O2
inhalation technique. Note, however, that the rBV values reported by Beaney [21] for breast
tumors, have to be considered as unreliable since the compartment model used to analyze the PET
data is inaccurate for heterogeneous tissue [23]. For comparison, in normal human brain regional
blood volume was determined from PET measurements to be rBV = 0.038 ± 0.007 [19]. Using
MRI and a brain tumor animal model yielded rBV = 0.026 ± 0.003 (normal brain tissue) and
rBV = 0.053 ± 0.006 (brain tumor) [28]. Our simulated regional vessel volume of normal breast
tissue and breast tumors (case CMPR) are consistent with experimental breast data, simulated
rBV of breast tumors was found to be larger than rBV of normal breast tissue as observed
experimentally. For breast tissue, we deduce a venous fraction of the total blood volume fraction
vrBV /rBV = 68% (s. Table 4) in fair agreement with MRI data in normal human brain (77%)
[119]. Vessel segments contribute to the tissue hemoglobin concentration cHb according to their
blood hemoglobin concentration, weighted by their fractional volume. Likewise, vessel segments
contribute to the tissue oxy-hemoglobin concentration cHb,O (deoxy-hemoglobin concentration cHb,D)
according to their average blood oxy-hemoglobin concentration (average blood deoxy-hemoglobin
concentration), again weighted by their fractional volume. In order to simulate cHbO or cHbD average
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Table 4. Simulation results of the computational model and experimental data.
Symbol Unit Initial Exp/Lit. BASE CMPR METAB Exp/Lit.
MVD mm−2 111± 0 115± 8 [110] 112± 19 133± 18 112± 19 88 [111]
20 [112] (a)
rBV % 0.983± 0.105 - 1.94± 0.63 1.81± 0.86 1.94± 0.63 2.7± 1.6 [37]
4.3± 1.3 [21] (b)
f Pa 4.21± 1.12 0.1− 2 [103] 3.15± 0.95 2.63± 0.7 3.15± 0.95 -
r µm 4.07± 0.07 - 5.94± 0.4 5.21± 0.98 5.94± 0.4 -
Sρ mm−1 2.84± 0.04 - 4.21± 0.96 4.39± 1.14 4.21± 0.96 -
Sρ/rBV µm−1 0.292± 0.029 - 0.224± 0.026 0.266± 0.055 0.224± 0.026 0.165 [7] (c)
rBF ml g−1min−1 0.053± 0.0139 0.06 [24] 1.6± 1.27 1.24± 1.34 1.6± 1.27 0.32 [24]
0.056± 0.014 [25] 0.19± 0.1 [21]
0.04± 0.01 [21] 0.29± 0.17 [25]
0.028± 0.017 [113]
rBFscaled ml g
−1min−1 - - 0.123± 0.042 0.0911± 0.0507 0.123± 0.042 (d)
〈Sin〉q 0.958± 0.018 0.98 [114] (e) 0.888± 0.062 0.833± 0.1 0.888± 0.063 -
rJin µl O2ml
−1min−1 11.6± 3.2 - 331± 266 249± 282 331± 265 -
jtv nl O2 cm
−2min−1 122± 1 600 [115] (f) 238± 20 202± 17 242± 58 -
MRO2 µl O2ml
−1min−1 3.32± 0.07 4.5 [21] 12.5± 1.3 12.1± 1.6 12.7± 3.3 6.6 [21]
33± 5 [19] (g)
OEF 0.336± 0.098 0.65± 0.1 [21] 0.0678± 0.0497 0.109± 0.088 0.0677± 0.0515 0.23± 0.08 [21]
cHb µmol/l 23.6± 2.6 17.3± 6.2 [37] 47.4± 14.4 43.1± 19.5 47.4± 14.4 53± 32 [37]
16± 4 [38] 70± 35 [38]
Y 0.703± 0.098 0.74± 0.14 [37] 0.807± 0.096 0.733± 0.14 0.807± 0.097 0.72± 0.14 [37]
0.74± 0.09 [38] 0.71± 0.10 [38]
P mmHg 38.6± 6.1 - 44.9± 11.3 34.3± 12.6 44.9± 11.7 -
Pt mmHg 36.3± 6.1 30 [116] 34.8± 13.8 28.7± 13.5 34.9± 14.3 30 [14]
65 [14]
40− 50 [117] (h)
Shows averages and standard deviations taken over 90 initial networks (t = 0 h) and tumors (t = 600 h) for cases BASE, CMPR and METAB. We compiled
experimental literature data in the columns ‘Exp/Lit.‘ for normal (left) and tumor tissue (last col.), respectively. (a) The computed values are actually the
line density LD. The experimental values given are medians of histological MVD [111, 112]. (b) rBV estimated from cHb assuming 2.18 µmol/l hemoglobin
in blood [37]. Data from [21] was obtained by PET of human breasts. Note that PET data from [21] for tumor tissues are considered unreliable (see text).
(c) Obtained from digitized animal model tumor network obtained by µ-CT. (d) rBF scaled is the initial tissue rBF scaled by the ratio of the rBF values for
the iso-volumetric tumor sphere at t = 0 and t = 600 h (see text). (e) Oxygen saturation of human arterial blood at sea level. (f) Obtained by oxygen
micro-electrode measurement in rat brains [115]. (g) Ref. [19] refers to human brain MRO2 . See also Table 1. (h) Obtained from human skin tissue [118],
peritumoral skin tissue [116] and muscle tissue in breast tumor-bearing rats [117].
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for each vessel segment blood oxygenation has to be known. The simulated average blood oxygen
saturation Y = cHbO/cHb of normal breast tissue agrees well with experimental data. The same
holds true for tumor average blood oxygen saturation simulated within the compression model (case
CMPR).
Besides the vascular surface area per unit volume of tissue, i.e. vascular surface density Sρ = SD,
Table 4 lists the vessel surface to vessel volume ratio S/V = Sρ/rBV . For tumor vasculature (case
CMPR) we find S/V = 0.27 µm−1 close to the value for normal breast tissue (S/V = 0.29 µm−1).
This modest decrease is ultimately explained by the low maximal dilation radius r(max) = 14 µm,
leading to an average vascular diameter r only 2 µm above the average radius in initial networks.
Naturally, S/V is proportional to 1/r, i.e. for a single vessel, but in general the trend for lower
surface area to volume ratios for increasing radii still holds true. A contributing factor is the
peripheral plexus of thin and densely packed vessel (high S/V ), part of which is included in the
tumor volume. Stamatelos [7] reported a surface to volume ratio of S/V = 0.17 µm−1 for a breast
tumor model.
The regional blood flow, rBF , i.e. perfusion, is given by the total blood flow q entering a
selected tissue volume Ω per regional volume |Ω| (s. S2 Appendix). To obtain perfusion of the
entire system rBFnorm over all arterial root nodes and divide by the volume of the simulation box
|Ω| = L3. For a partial volume such as a small spherical tumor inside a tissue cuboid some caution
must be taken. For example, considering a Krogh-like arrangement of parallel vessels crossing the
entrance face A of a tissue cuboid corresponding to total blood flux qtot and surface flux density
qtot/A, the perfusion of a cross-sectional slice with volume Vslice = A ·∆x inside the tissue and
oriented parallel to the entrance face A is proportional to 1/∆x . Likewise, at constant surface flux
density the perfusion of a small spherical volume inside a tissue cuboid scales as tumor 1/R. In
order to compare simulated tumor regional blood flow with experimental perfusion data for breast
tumors with typical volumes of several cm3 we normalize total flux qsph,tum(t = 600 h) of the small
spherical (Rtumor ≈ 1.5mm) tumor to the total flux qsph,norm(t = 0) of the isovolumetric spherical
volume of normal tissue at the center of the simulation box. The scaled tumor perfusion is then
given by rBF scaled = rBFnorm · qsph,tum(t = 600 h)/qsph,norm(t = 0). The total flux qsph,tum, and
qsph,norm are obtained by summing blood flow q over those vessels that penetrate the surface of
the sphere and have a blood flow direction into the spherical tissue volume. In addition, Table
4 lists the regional blood flow of the small spherical tumor rBF = qsph,tum/|Ωsph|. Previously,
a general decrease of total tumor blood flow normalized to tumor weight was seen for human
breast cancer xenografts ranging from 0.5 m/g/min at mtumor = 0.4 g down to 0.025 ml/g/min at
mtumor = 8g [120]. On the other hand dynamical PET measurements (
15O2) on 37 breast cancer
patients yielded rBF = 0.06 ml/g/min (mean, normal tissue, range 0.03 − 0.17 ml/g/min) and
rBF = 0.32 ml/g/min (mean, tumor, range 0.08 − 0.9 ml/g/min) [24]. Nearly the same results
were obtained by [25]. Our results for normal breast tissue (range: 0.032− 0.064 ml/ml/min) agree
well with experimental data. The simulated mean perfusion (range: 0.13− 7.5 ml/g/min) of the
small (0.014 cm3) spherical tumors is higher by about a factor of 5 compared to the clinical results,
whereas the scaled perfusion (case CMPR) is lower by a factor 1/2.
The global ensemble average of simulated PO2 of normal tissue and tumor tissue amounts to
36±6 mmHg and 29±13 mmHg, respectively. Polarographic PO2 measurements at a large number
of sites in normal breast tissue and breast tumors of 15 patients yielded median PO2 values of
65 mmHg and 30 mmHg, respectively [14]. None of the measurements in normal breast tissue
fell below 12.5 mmHg, whereas in almost 40 tissue areas with partial oxygen pressures between
0 and 2.5 mmHg were detected. The simulated PO2 value of tumor tissue (case CMPR) exactly
reproduces the experimental result, the coincidence possibly being fortuitous, considering the skewed
histogram of measured partial oxygen pressures. Since the distribution of measured partial oxygen
pressures in normal breast tissue is rather broad, simulated and measured tissue partial oxygen
pressures in normal tissue can be considered to agree.
The computational model assumes tissue metabolic rate of oxygen consumption to follow a
Michaelis-Menten relation and takes the maximal rate M0 and half-pressure PM50 as input. In
particular, maximal rate M0 in tumor tissue was assumed to be four times larger than in normal
breast tissue, whereas half-pressure PM50 of normal breast tissue was adopted to be twice that
of breast cancers. Since (average) partial oxygen pressure in normal and tumorous breast tissue
were simulated to be considerably higher than the assumed half-pressures PM50, the simulated
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metabolic rates MRO2 = 3.25 µlO2/ml/min (normal tissue) and MRO2 = 12.1 µlO2/ml/min
(breast tumor, case CMPR) are essentially determined by the assumed parameters of the Michaelis-
Menten relation. From PET measurements based on the steady-state 15O2 inhalation technique,
Beaney [21] reported MRO2 = 4.5 µlO2/ml/min and MRO2 = 6.6 µlO2/ml/min for normal breast
tissue and breast tumors, respectively. The latter value had been challenged because of tumor
inhomogeneity [23]. Within the framework of the three compartment model (s. Table 1 in S3
Appendix) we estimate metabolic rate of oxygen consumption to range between MRO2 = 3.5-
5.2 µlO2/ml/min (normal tissue) and MRO2 = 8.9− 14.3 µlO2/ml/min (breast tumor), using for
the average blood oxygen saturation Yexp = 0.74 (normal) and Yexp = 0.72 (breast tumors) [37].
Sin = 0.958 and Sin = 0.833 of the average arterial saturation for normal and tumorous tissue,
respectively, given in Table 4. The quoted ranges of the metabolic rates of oxygen consumption
correspond to the range 0 ≤ Pt ≤ 37 mmHg of tissue partial oxygen pressures assumed by the
compartment model. Simulated and experimental metabolic rates agree well, For comparison we
note that for normal human brain PET measurements yielded CMRO = 33± 5 µlO2/ml/min [19].
It was discussed in Sec. ‘Predictions of Compartment Model and Comparison with Experimental
Data‘, that average blood oxygen saturation is (negatively) correlated with oxygen extraction fraction
OEF = Jtv/Jin = (Jin − Jout)/Jin, where Jtv is the total transvascular oxygen flux into tissue, in
J (Jout) the total vascular influx (efflux) into the vasculature (leaving the vasculature) of the tissue
volume considered. For the whole simulation box, Jin and Jout are determined by summing oxygen
flux qc over all root arteries or veins, respectively. For the tumor, we sum qc over vessels penetrating
the tumor surface with a flow direction into or out of the tumor. For normal breast tissue and breast
tumors (case CMPR) we obtain the result OEF = 0.34± 0.1 and OEF = 0.11± 0.09, respectively.
Within the framework of the compartment model we estimate oxygen extraction fraction both
of normal breast tissue and breast tumors to fall into the range OEF = 0.26 ± 0.41, depending
on partial oxygen pressure in tissue. Oxygen extraction data on normal breast tissue and breast
tumors are scarce. Beaney [21] reported the oxygen extraction fraction of normal breast tissue to
be OEF = 0.65 ± 0.1. This result seems to be rather high considering the oxygen extraction of
normal human brain measured by PET to be OEF = 0.44± 0.06 [19]. Using the steady state 15O2
inhalation technique almost the same oxygen extraction fractions were measured for breast tumors
(OEF = 0.23±0.08, [21]) and brain tumors (OEF = 0.22±0.04, [22]) , however the same reservations
remain concerning inadequate data analysis because of tissue heterogeneity. Our simulations predict
for breast tumors (case CMPR) oxygen extraction fractions of OEF = 0.11± 0.09, an estimate likely
to be too low. Since MRO2 = cHb,bloodSin · rBF ·OEF , where Sin is the arterial blood oxygenation
of the vessels penetrating the surface of the spherical tumor, overestimation of the tumor regional
blood flow will cause an underestimation of the oxygen extraction fraction OEF , since the metabolic
rate of oxygen consumption is essentially fixed by the input parameters of the model. In other words,
since tum in OEF = MRO2 · rJin overestimation of the oxygen influx into the tumor reduces the
estimated oxygen extraction fraction. In addition, Table 4 lists the oxygen influx Jin and average
transvascular oxygen flux density jtv, where we write jtv informally for the average over the network
length (s. S2 Appendix).
In the following we illustrate results obtained for selected root node geometries. Fig. 9 corresponds
to case CMPR, root node geometry RC9 and shows partial oxygen pressure (PO2) distributions of
blood vessels, P , and of tissue, Pt, as well as corresponding blood oxygen saturations S. Typical
features of tumor vasculatures are visible such as heterogeneity, compartmentalization, a highly
vascularized rim, a sparsely vascularized center and the loss of hierarchical organization. Other cases
(BASE, METAB) and root node geometries exhibit similar looking distributions of PO2 and blood
oxygen saturation of normal tissue and tumor periphery. On the other hand the vascularization of the
tumor center can be clearly visibly lower or higher than the example shown, which is accompanied
with varying degrees of oxygenation. The compartmentalization is also evident in the average radial
profile of the microvascular density, MVD , and regional blood volume, rBV , shown Fig. 8. We made
sure that in good approximation cases BASE and CMPR exhibited similar radial MVD and rBV
profiles. This requirement is critical since we aim to analyze the effect on blood oxygen saturation
Y by varying the compression factors ξcpr among the ensemble of 90 tumor vascular networks, while
retaining agreement with experimental data on MVD and rBV . Let us now consider details of the
oxygen distribution as for instance shown in Fig. 9C. Immediately obvious, we see severe hypoxia at
the tumor center due the sparse vasculature there. As one would expect, Pt is highest near vessels
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and falls off over a scale of 100 to 200 µm into non-vascularized spaces. Tumor vessels in the central
region of the tumor, significantly vary in their oxygen content. Some vessels, carry highly saturated
blood, in particular when connected to nearby arterioles. When isolated vessels thread the tumor
over distances of several hundred micrometers, blood oxygen saturation S visibly decreases to the
point where vessels are completely depleted of oxygen. The tissue PO2 near such vessels appears
to follow this trend, i.e. it also decreases. Remarkably, the (neo)vascular plexus around the tumor
rim is dominated by severe oxygen deprivation, too. Evidently, vessels that are underoxygenated
do not penetrate far into the tumor, but those vessels which advance towards the tumor center
carry normal amounts of oxygen. As Fig. 10 shows, underoxygenation of the rim results from the
accompanying low hematocrit, leading to reduced oxygen capacity and fast oxygen depletion. On
average, at the tumor center the hematocrit is elevated by 17%, whereas in the periphery hematocrit
amounts on average to 66% only of the baseline normal tissue (data not shown), according to radial
profiles analogous to Fig. 8.
We compare the results of our oxygen model with tumor growth models that assume for simplicity
constant intravascular oxygen concentration. To this end we modified our model, omitting the
propagation of oxygen through the vascular network. A map of the resulting oxygen distribution is
shown in Fig. 11, where we assumed a constant intravascular partial oxygen pressure P equal to the
ensemble mean of 39 mmHg as it is obtained from the full model. An obvious qualitative difference
is the absence of long ranged Pt variations in normal tissue. Instead, fine grained fluctuations
in-between neighboring vessels are much more apparent. Moreover, the Pt level along the surviving
tumor vessels is nearly constant so that the Pt distribution can approximately be described by a
function of the distance to the closest vessel alone. The neglect of varying hematocrit leads to
overestimation of Pt in the peripheral region (see above). Naturally, this simplified model implies
constant tissue oxygen saturation Y , and thus does not allow to analyze experimental data on blood
oxygen saturation in normal and tumorous tissue.
Furthermore our model predicts mean tissue concentrations of hemoglobin cHb, oxyhemoglobin
cHbO, deoxy-hemoglobin cHbD and, therefore, mean blood oxygen saturation Y in tissue at least
in qualitative agreement with optical mammography data [37, 38]. In analogy to the experimental
papers [37, Fig. 3a,b and 5a], [38, Fig. 3a,b], we produced Figs. 12, 13 and 14 for cases BASE,
CMPR, and METAB, respectively. In these figures, one data point shows the result of a single
simulation based on a selected root node configuration identified by colored symbols (s. Fig. 7). The
cHb(tumor)-cHb(normal) correlations simulated for cases BASE, CMPR and METAB (s. Fig. 12A,
Fig. 13A) qualitatively agree well with the experimentally observed ones [37, Fig. 3a] and [38, Fig.
3a]. One the other hand only for case CMPR the simulated Y (tumor)-Y (normal) correlations (s.
Fig. 13B) shows the blood oxygen saturation in tumor tissue to fall both above and below that of the
corresponding host tissue, whereas cases BASE and METAB yield tumor blood oxygen saturations
essentially to be always larger than host tissue. For the simulated Y (tumor)-Y (normal) plots it
makes virtually no difference choosing the initial tissue at time t = 0 or the tissue surrounding the
final tumor as reference. Since Y is the RBC-volume weighted average of blood oxygen saturation
taken over all vessel segments, dilated tumor vessel, prevailing in case BASE (s. discussion above)
will dominantly contribute to Y , in particular when high blood flow rates and hence high oxygen
input flux cause their blood oxygen saturation to be high.
Variation of M0 in case METAB affects transvascular oxygen flux Jtv and therefore oxygen
extraction fraction. Since average blood oxygen saturation Y is (negatively) correlated with OEF ,
blood oxygen saturation Y of tumors is lowered, provided oxygen extraction fraction is increased
by selecting a higher maximal metabolic rate M0 (s. Fig. 14A). However, since simulated Jtv/Jin
tumors is rather low, i.e. oxygen influx is rather large compared to transvascular oxygen flux and
the variations of M0 applied are not sufficient to lower Y (tumor) below Y (normal). Likewise,
compressing tumor vessels will reduce oxygen influx and hence increase oxygen extraction. Because
of the negative correlation of blood oxygen saturation Y with oxygen extraction fraction, average
blood oxygen saturation will decrease with increasing compression, i.e. at lower compression factors
ξcpr, as long as average blood oxygen saturation is sufficiently far from saturation. These conclusions
are immediately evident from Fig. 14D. Different initial vessel configurations give rise to a spread
among Y for a given ξcpr (or M0).
Figs. 12C, 13C and 14C illustrate the correlation between blood oxygen saturation Y and
total hemoglobin concentration. In each case (BASE, CMPR, METAB) good agreement with
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Figure 9. Blood oxygen saturation and oxygen partial pressure corresponding to case
CMPR, root node configuration RC9. The left column (A,C) shows the PO2 of vessels, P and of
tissue, Pt in a slice through the center of the simulation domain. The camera is looking vertically
onto the horizontal cutting plane so that the whole lateral extent of 8 mm is shown. The vessel
network is visualized as a collection of cylinders that have been truncated 100 µm above and below
the central plane. The resulting cross sectional areas are light grey. Otherwise the color code
indicates the PO2, P , of vessels and Pt of tissue, respectively. In the right column (B,D), only the
network is shown color coded by saturation S. The top row (A,B) shows the initial state at t=0.
The bottom row (C,D) shows the final state after t = 600 h.
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Figure 10. Hematocrit distribution corresponding to Fig. 9D, showing the same slice of the
vessel network, but color coded for H. Our blood flow model includes the phase separation effect
which leads to a severe reduction of the hematocrit in the peripheral tumor network and an elevated
hematocrit in the vessels at the tumor center.
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Figure 11. Tissue oxygen distribution at constant vascular PO2: This figure shows a
visualization of the network depicted in Fig. 9 but with blood PO2 held constant, and only the
tissue PO2 map was computed. The value of the blood PO2 was chosen to equal the prediction of
the ensemble mean of blood PO2 of normal tissue, amounting to 39 mmHg .
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Figure 12. Hemoglobin concentrations and tissue oxygen saturations (Case BASE):
Each data point corresponds to a different simulation run, where the color code indicates the type
of initial network configuration (see text). Figure A displays the hemoglobin concentration cHb of
tumor tissue versus cHb in normal tissue. The depiction in (B) shows analogously the tissue oxygen
saturation Y . (C) shows Y against cHb where tumor (colored) and normal tissue (black) are both
shown as different point sets. Black lines in (A) and (B) have slope 1 and serve as visual guides, i.e.
a symbol underneath them corresponds to a tumor where the quantity considered is less than in
normal tissue. Consistent with experimental results on hemoglobin concentration in normal breast
tissue and breast tumors [37, Fig.3a] hemoglobin concentration cHb and hence regional blood
volume rBV in tumors is predicted to be always larger than that of surrounding normal breast
tissue. However, contrary to experimental data [37, Fig.3b] average blood oxygen saturation Y in
tumors is predicted to be always larger than in normal breast tissue (base line).
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Figure 13. Hemoglobin concentrations and tissue oxygen saturations (Case CMPR):
This figure is the analog of Fig. 12, but for case CMPR. Each simulation was performed with a
different factor ξcpr according to which the radii of all tumor vessels were scaled so that the
variation across the ensemble is increased and blood flow through some of the high caliber tumor
vessels is impaired. In addition, panel (D) shows the Y dependence on ξcpr.
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Figure 14. Hemoglobin concentrations and tissue oxygen saturations (Case METAB):
This figure is the analog of Fig. 12 for case METAB. Here, each simulation was performed with a
different tumor oxygen consumption rate parameter M0, distributed according to a lognormal
distribution. In this case, cHb is identical to case BASE, therefore panel (A) shows instead the
dependence of Y on M0. Panels (B) and (C), show plots of cHb and Y as in the previous figures.
The impact on the tumor Y is more moderate compared to case CMPR.
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experimental results is obtained [37, Fig. 5a]. The figures show the limiting behavior of average
blood oxygen saturation, yet data above the lower limit of Y at selected hemoglobin concentration
cHb are missing. Fig. 15A,C illustrates that perfusion rates rBF correlate positively with tissue
hemoglobin concentration cHb in both tumor and normal tissue, and therefore with vessel volume
rBV . Indeed, the correlation of Y versus cHb and Y versus rBF look qualitatively similar (data not
shown). Configurations RC4 through RC8 yield particularly high perfusion rates. This must be
related to the number of arterial inlets (venous outlets) of which only two to four are involved for
these geometries
In contrast, root node geometries RC1, RC2, and RC3 contain root nodes on all sites on one or
several faces of the simulation cuboid (see Fig. 7). In order to obtain good agreement of Y versus
cHb correlations with Grosenick et al. [37], data points of all configurations RC1 through RC9 are
required. In particular RC4 through RC8 contribute high cHb and Y . Evidently these configurations
exhibit a large vessel volume rBV , hence high cHb. This apparent contradiction can be explained
by the network construction algorithm. Since vessel radii are governed by Murray’s law, the radii
of root vessels grow the larger, the more expansive the supplied (or drained) tree is. This is clear
because for 0 < Murray-α <∞ vessel radii become larger at each bifurcation from leafs to the top.
In S4 Appendix we show for perfect binary trees, that the regional blood volume rBV decreases
according to a power law with growing number of roots nodes, provided that the total number of
vessels is kept constant. Variation of the root radii and blood volume rBV causes increased perfusion
in two ways. First, the flow resistance of the entire vascular tree decreases with increasing rBV .
Thus, provided a fixed blood pressure difference, the perfusion rBF increases with rBV . Secondly,
the blood pressure differential between arterial and venous sides increases with root radii according
to the blood pressure-radius relation (Eq. (1) in S5 Appendix) for p(BC)(r). Since p(BC) is used
as pressure boundary-condition at root nodes, perfusion increases with the pressure differential
depending on r. Consequently, given other parameters such as permeabilities fixed, an increased
perfusion rBF leads to an increase in Y until saturation (s. Sec. ‘Predictions of Compartment Model
and Comparison with Experimental Data‘).
Fig. 15D and Fig. 15F correlate vascular surface to volume ratios for normal tissue and tumors
respectively. In either case, the ratio decreases with increasing regional blood volume rBV , probably
due to the presence of larger vessels at higher fractional blood volumes. As can be seen from
Fig. 15E vascular surface to volume ratios of tumors are mostly smaller than those of normal tissue.
In contrast, vascular surface density Sρ increases with increasing regional blood volume both for
normal breast tissue and tumors. Vascular surface density is seen to be higher than that of normal
breast tissue. Finally we compare oxygen extraction fractions for normal (Fig. 15J) and tumorous
(Fig. 15K) tissue. Since metabolic rate of oxygen consumption MRO2 is essentially an input in both
cases and intravascular oxygen concentration at input is nearly constant, OEF = MRO2/cin/rBF
plotted versus rBF follows a hyperbola, as can be seen from Fig. 15J (normal tissue) and Fig. 15L
(tumor).
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Figure 15. Other biophysical quantities (Case CMPR): Like in previous scatter plots, each
data point corresponds to a single simulation. The symbol code shows the root nodes configuration
according to the legend in (A). Correlations for initial tissue (t = 0) and tumor tissue (t = 600 h)
are shown in the left column (A,D,G,J) and right column (C,F,I,L), respectively. Correlations for
normal vs. tumor tissue are shown in the center column (B,E,H,K). Perfusion rates rBF increase
with hemoglobin concentration cHb due to increasing vascular volume. The correlation of rBF
(Tumor) vs. rBF (Initial) exhibits virtually the distribution of cHb correlations of Fig. 13A. In (D),
(F): Vascular surface to volume ratio decreases with increasing regional vascular volume due to
increasing vascular radii. E compares vascular surface to volume ratio of tumors with corresponding
normal tissue. In (G, H, I): Surface density increases with increasing regional blood volume. Tumor
surface density is seen to be higher than that of normal breast tissue. In (J, K, L): Oxygen
extraction of tumors is below that of normal tissue because of higher regional blood flow.
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Discussion
Discussion of Results of the Network Model
We simulated intravascular and extravascular distributions of partial oxygen pressure arising in
artificial, algorithmically generated, tumor blood vessel networks and networks of surrounding
normal tissue. The model takes the blood vessel network, tissue oxygen consumption rates and
the radius of the tumor as input besides biophysical parameters such as arterial blood pressure,
hematocrit, and arterial blood oxygen saturation and computes stationary oxygen partial pressure
maps (PO2) for the network and tissue. Our computational method the iteration of the solution
of sparse matrix equations, avoiding the costly inversion of dense equations which arise from the
Green’s functions method [68]. Our method also allows for under resolved numerical grids discretizing
the tissue domain, where PO2 gradient boundary conditions at vessel walls [41] cannot be used
since the diameter of vascular lumens can be smaller than the grid constant and thus completely
contained inside a grid cell. The present work uses a tissue cuboid of about 0.5cm3 and a tumor
radius of 1.5 mm, still significantly below tissue volumes probed experimentally. In particular, we
compared regional blood volume rBV or total hemoglobin concentration cHb and average blood
oxygen saturation Y = cHbO/cHb of tumors and associated normal networks. Furthermore the
dependence of average blood oxygen saturation Y on regional blood flow rBF and on rBV or cHb
was simulated separately for tumor and normal tissue. We focused on breast tumors and normal
breast tissue guided by metabolic and morphological experimental data. From optical mammography
studies [37, 38] taken on a large cohort (n=87, n=32) of breast cancer patients it was concluded that
tissue hemoglobin concentration cHb in tumors almost exclusively exceeds that in corresponding
normal breast tissue, whereas average blood oxygen saturation Y in tumors was seen to be higher or
lower than blood oxygen saturation in surrounding normal breast tissue. Besides such correlations
of biophysical or metabolic parameters between tumor and surrounding normal breast tissue it was
observed that in tumors high hemoglobin concentration was correlated with high average blood
oxygen saturation.
Our simulations of distributions of intravascular and extravascular partial oxygen pressures
aim at underpinning the experimental observations with artificially generated vascular networks
of tumors and associated normal tissue, i.e. we attempt to solve an illposed inverse problem. Our
previous model of tumor vessel remodeling (case BASE), developed to account for the vasculature of
growing melanomas, qualitatively explains all experimental observations of optical mammography,
apart from cases with tumor average blood oxygen saturation lower than that of normal breast
tissue. The higher hemoglobin concentration generally observed in tumors compared to surrounding
normal tissue is simply a consequence of circumferential growth of tumor blood vessels, outweighing
vascular regression. A moderate vasodilation is sufficient because vessel volume grows proportional
to r4. Furthermore, regional blood flow rBF was simulated to be well to moderately correlated with
hemoglobin concentration cHb and therefore with regional blood volume rBV , a result obtained
both for tumors and normal tissue. Thus the correlation of high hemoglobin concentration with
high average blood oxygen saturation observed experimentally reflects low oxygen extraction at high
blood flow rates.
However, cases with average blood oxygen saturation in tumors below normal breast tissue
require a modification of the tumor vascular growth process. Using our previous model of tumor
vessel remodeling (case BASE) the average blood oxygen saturation was calculated in tumors to be
exclusively higher than in surrounding normal tissue. Our method to simulate tumor vasculature
had been developed previously based on morphologic data (MVD) of melanomas. It is therefore not
too surprising that addition of data on average blood oxygen saturation Y depending on metabolic
characteristics of tumor tissue besides vascular structure and hemodynamics, i.e. on oxygen demand
and oxygen supply, may require modifications of the vascular growth model. In this paper we
tentatively assume for these cases that tumor blood vessels are compressed during growth by solid
pressure known to be elevated in solid tumors (case CMPR). Each of the 90 tumor vessel networks is
subject to a different, statistically selected degree of compression, mimicking phenotypical differences
among breast cancer patients, yet keeping the ensemble average of MVD , and rBV the same as for
case BASE. In this way average blood oxygen saturation Y of about half of the tumors fell below that
of surrounding normal tissue. However, there are some drawbacks with this extension of our vascular
growth model. The compression of tumor blood vessels by a randomly selected degree effectively
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amounts to reducing the maximal radius r(max) reached by circumferential growth on average. On
the one hand the value of r(max) = 14µm selected is already rather small considering that we expect
some degree of vasodilation to occur. On the other hand, reducing r(max) leads to skewed balance
between microvessel density MVD and regional blood volume rBV which we currently consider as
adequate. Alternatively using the original tumor vessel networks of case BASE we calculated blood
oxygen saturation in tumors assuming different (maximal) metabolic rates of oxygen consumption in
each case simulating phenotypical differences between cancer patients (case METAB). The ensemble
average of the metabolic rate of oxygen consumption MRO2 was kept the same as in case BASE.
Despite differences in metabolic rates of oxygen consumption among the 90 tumors, blood oxygen
saturation of all tumors were calculated to be higher than in surrounding normal tissue. Although
allowance for compression of tumor vessels by solid pressure enables us to qualitatively explain
experimental data on blood oxygen saturation in tumor and surrounding normal tissue, we cannot
exclude other modifications of growth processes leading to vascular remodeling in tumors.
All of our tumor networks exhibit typical features like chaotic connectivity, a sparsely vascularized
tumor center, a highly vascularized tumor rim and vasodilation. Variations of vessel networks from
tumor to tumor are introduced by the vascular microenvironments in which the tumors grow. To
this end we arbitrarily adopted nine root node geometries, differing in location and number of
arterial (venous) inlet (outlet) vessels. Starting from each root node geometry ten normal vascular
networks were grown which, too, differed among each other because of the statistical nature of the
growth process. Using the total of 90 normal vascular networks we demonstrated that the specific
arrangement of host vessels prior to tumor growth can play a significant role for the outcome of tumor
vascular remodeling. Depending on the root node geometry, drastic variations in microvascular
density MVD at the tumor center, regional blood volume rBV and perfusion rBF were observed.
The same parameters are subject to fluctuations over the initial networks, yet to a much lesser extent.
In earlier work [57, 58] such variations were explained by the interplay of shear stress controlled
vessel survival and the location of former arterioles and veins within the tumor. When arteries
(arterioles) and veins (venules) are coopted in close proximity by the tumor, angiogenesis is likely to
produce arterio-venous shunts that are very stable due to high shear stress caused by high blood
flow rate associated with large blood pressure gradients across the shunts. Such shunts can form
clusters with high transport capacity. Since the rate of change of the oxygen concentration along
the vessel axis is inversely proportional to blood flow rate q, it follows that tumors with many such
arterio-venous shunts will exhibit low oxygen extraction and therefore high average blood oxygen
saturation Y . Hence, tumors with clusters of high-caliber vessels threading the tumor are associated
with cases for which average blood oxygen saturation was found to exceed that of surrounding normal
breast tissue. Recently it was proposed that defective signaling along the tumor microvasculature to
avoid excessive flow through shunts is a primary cause of local hypoxia in tumors [121].
In our simulations we take the phase separation effect into account, i.e. RBCs at bifurcations
prefer to flow into the more strongly perfused branch [95, 122]. Accordingly our simulated hematocrit
distributions show a redirection of red blood cells (RBCs) into central tumor vessels. These redirected
RBCs are lacking in the peripheral capillary plexus, drastically decreasing its oxygen carrying capacity,
resulting in fast oxygen depletion to hypoxia inducing levels which could drive further invasive
behavior in real tumors.
When setting the intravascular PO2 constant our maps of PO2 in tissue obtained suggest that
the simplified model is suitable to produce qualitative results when features like necrotic regions, and
oxygen concentration at the outer rim are of interest but exact numbers on oxygen availability are
secondary. Many tumor growth models make this approximation for reasons of computational cost
and simplicity. A model variant of intermediate complexity might consider an oxygen source strength
proportional to the hematocrit which better captures the oxygen distribution in the periphery
but overestimates the oxygen concentration around central tumor vessels compared to the simple
constant source approximation. The latter variant has also found application e.g. in [50, 57].
Discussion of Results of the Compartment Model
The three-compartment model provides a complementary approach to simulate blood oxygen
saturation in tissue. The model considers a single vessel representing the total length of the vascular
network together with a homogeneous tissue compartment of constant partial oxygen pressure.
Hence no information on vascular structure and distribution of oxygen concentration in tissue
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can be obtained. In reality, biophysical and metabolic parameters entering the model represent
averages taken over the vessel network and tissue volume. Input parameters are hematocrit H and
arterial blood oxygen saturation S(0), regional blood flow rBF and hence oxygen flux Jin into the
vasculature per unit volume of tissue. Other relevant parameters are the extravasation rate constant
PO2Sρ, the transvascular oxygen flux Jtv/|Ω| = MRO2 per unit volume of tissue, i.e. the metabolic
rate of oxygen consumption, and (average) partial oxygen pressure Pt in tissue. Average blood
oxygen saturation Y plotted versus the ratio rBF/PO2Sρ for selected partial oxygen pressures Pt
immediately explains the experimentally observed dependence of average blood oxygenation Y in
tumor tissue versus hemoglobin concentration cHb. The computational model has shown regional
blood flow rBF to be correlated with hemoglobin concentration cHb, thus the experimental plot
Y versus cHb and the simulated dependence Y versus rBF/PO2Sρ can be compared, apart from a
scaling of the horizontal axis. The lower limit of average blood oxygen saturation Y at constant ratio
rBF/PO2Sρ or at constant hemoglobin concentration cHb corresponds to the maximal transvascular
oxygen flux into tissue, i.e. maximal oxygen loss at minimal partial oxygen pressure in tissue. Data
on average blood oxygen saturation Y appearing above the limiting curve Y = Y (rBF/PO2Sρ) are
interpreted as corresponding to higher oxygen partial pressures Pt in tissue. The computational
model likewise reproduces the limiting curve of average blood oxygenation versus hemoglobin
concentration in tumors, yet it fails to account for data with higher blood oxygen saturation
corresponding to lower oxygen losses from the vasculature to tissue, a fact presently not understood.
The compartment model allows to interpret the correlation between blood oxygen saturation Y
in tumors and surrounding normal breast tissue. Tumors with ratios PO2Sρ/rBF smaller (larger)
than that of surrounding normal tissue exhibit higher (lower) average blood oxygen saturation than
normal tissue, provided average oxygen partial pressures in tumor and normal surrounding tissue
are the same, otherwise shifts of blood oxygen saturation with partial oxygen pressure have to be
taken into account. Equivalently, average blood oxygen saturation in tumors is higher (lower) when
the ratio MRO2/Jin = OEF , i.e. the ratio of oxygen demand over oxygen supply is smaller (higher)
than in surrounding normal tissue, apart from shifts due to different partial oxygen pressures in
tissue.
The same argument explains why case METAB did not achieve blood oxygen saturation Y of
some tumors to fall below that of normal breast tissue despite higher (maximal) metabolic rates of
oxygen consumption. Because of high regional blood flow in tumors, i.e. high oxygen supply, the
increases in metabolic rates of oxygen consumption, i.e. oxygen demand, were not large enough to
increase oxygen extraction fraction sufficiently. Likewise, compression of tumor vasculature during
growth (case CMPR) was carried out keeping the ensemble average of regional blood volume rBV to
be the same as in case BASE. Therefore, a fraction of the tumor vascular networks of the ensemble
correspond to lower rBV while others are associated with higher regional blood volumes. Since
regional blood volume and regional blood flow are correlated, tumors with lower regional blood flow
and hence lower oxygen supply lead to lower blood oxygen saturation Y , provided Y is far enough
from saturation.
Limitations and Outlook
Although we explained salient features of the experimentally observed correlations of hemoglobin
concentration and blood oxygen saturation between tumorous and corresponding normal breast
tissue (inter-vascular-network correlations) as well as the dependence of average blood oxygenation on
hemoglobin concentration for normal breast tissue and tumors (intra-vascular-network correlations)
our computational and compartment models have significant limitations. The compartment model
used to calculate average blood oxygenation should be extended to include a distribution of vascular
segment transit times. Our computational model did not exploit all experimental information
available from optical mammography on a cohort of 87 patients. Hemoglobin (cHb), oxy- and deoxy-
hemoglobin (cHbO, cHbD) concentrations, exhibit log-normal distributions, with tumors generally
showing broader distributions compared with normal breast tissue. In future, such prior knowledge
should be included as input for simulations.
A significant limitation of the computational model is the small size of the spherical tumors
embedded in the simulation domain, making a comparison of simulated data with experimental
results to some extent uncertain, notably for regional blood flow. Also, the vascular structure of cm
sized tumors might be different from the mm-sized tumors that were simulated. In future, efforts
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should aim at simulating larger vascular networks of normal and tumorous tissue. Moreover, for the
sake of simplicity we considered vascular networks to be embedded into homogeneous tissues in our
present paper, a simplification being questionable in case of tumors.
Presently our computational method based on a uniform grid is inaccurate due to poor convergence
with lattice spacing h. As pointed out in [123], optimal convergence of the solution of elliptic partial
differential equations with Dirac source terms can be achieved by adaptive meshes, concentrating
discretization points near the source contributions. This insight should be taken into account in
future work in order to improve the accuracy the method.
Available anatomical information should be used to generate realistic geometries of feeding
arteries (arterioles) and draining veins (venules), rather than arbitrarily creating geometric patterns
of root nodes as in this paper. Alternatively, following [82] a possible remedy to this problem might
be to exclude root node geometries that result in unrealistic values of biophysical variables, e.g.
unreasonably low or high perfusion rates. Indeed network types RC1, RC2, RC3 and RC9 exhibit
regional blood flows rBF which agree much better with experimental data than other root node
geometries.
More fundamentally, although elevated interstitial fluid pressure is a hallmark of tumors, and
unhindered fluid communication between blood and interstitial space is supposed, [124] we neglected
the enhanced extravasation of liquid from the vascular network to the interstitial compartment.
Elevated interstitial fluid pressure affects blood flow by lowering the intravascular pressure gradient,
that may even lead to stasis. Due to the hyperpermeability of tumor vasculature towards e.g. plasma
proteins, hemoconcentration occurs resulting in an increase in apparent viscosity [125]. Presently,
this modification of tumor blood rheology is not taken into account in our paper . In addition, we
did not consider local disturbances, such as partial or complete (temporary) pinch-offs of tumor
vessels or local plasma leakage, causing high local blood viscosity, resulting in shunting away blood
flow from some parts of the vasculature. Only steady state solutions, e.g. of blood flow distribution
and average blood oxygen saturation were calculated, although blood flow in tumor vasculature is
known to be sluggish and chaotic, sometimes even reversing directions.
Overall compression of tumor blood vessels by tissue internal pressures was found to be one
mechanism to explain low average blood oxygen saturations in tumors. However, other biological
processes may cause tumor blood vessels to shrink and such processes cannot be excluded. No attempt
was made to simulate pressure of liquid and solid tissue components, other than an oversimplified
ad-hoc radius reduction by a constant factor (Case CMPR). Furthermore, pressure applied externally
to the breast during optical mammography should be included into such simulations.
Future efforts should clarify to what extent the various approximations made affect the simulation
of average blood oxygenation. To our knowledge our present paper is the first attempt to correlate
blood oxygen saturation of human tumors with artificial tumor vascular networks, blood flow and
transvascular oxygen flux, i.e. metabolic rate of oxygen consumption. We expect our computational
and compartment models to find applications to analyses of clinical data obtained by PET, MRI,
biomedical optics and hybrid techniques such as photoacoustics, probing tissue vascularization and
oxygenation.
Supporting Information
S1 Appendix
Oxygen Mass Transfer Coefficient In this supplemental material we will review simulation
results in comparison with literature references and our calibration procedure of the mass transfer
coefficient γ.
S2 Appendix
Explicit Formulas for Relevant Biophysical Quantities The simulation of tumor growth and
oxygen PO2 distributions in blood and tissue yields vascular flow rates qv, hematocrit Hv, oxygen
partial pressure P at discrete points on vessel axes, and tissue partial oxygen pressure Pt. In this
section explicit formulas of other derived biophysical quantities are provided.
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S3 Appendix
Compartment Model. Longitudinal oxygen saturation variation of single vessels obtained from
the compartment model at fixed average saturation level or fixed oxygen extraction.
S4 Appendix
Regional Blood Volume of Confined Perfect Binary Trees. In this section we derive an
approximative relation between the number of root nodes and the regional blood volume , provided
that the total number of vessels is held constant. Here we assume that all vascular trees are perfect
binary trees.
S5 Appendix
Blood Pressure Radius Relation. The formula for the boundary value of the blood pressure
p(BC) is provided.
References
1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971
Nov;285(21):1182–1186.
2. Nagy JA, Chang SH, Dvorak AM, Dvorak HF. Why are tumour blood vessels abnormal and
why is it important to know? Br J Cancer. 2009 Mar;100(6):865–869.
3. Carmeliet P, Jain R. Angiogenesis in cancer and other diseases. Nature. 2000;407:249–257.
4. Dewhirst MW, Cao Y, Moeller B. Cycling hypoxia and free radicals regulate angiogenesis
and radiotherapy response. Nat Rev Cancer. 2008 Jun;8(6):425–437.
5. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.
Science. 2005 Jan;307(5706):58–62.
6. Neri D, Bicknell R. Tumour vascular targeting. Nat Rev Cancer. 2005 Jun;5(6):436–446.
7. Stamatelos SK, Kim E, Pathak AP, Popel AS. A bioimage informatics based reconstruction
of breast tumor microvasculature with computational blood flow predictions. Microvasc Res.
2014 Jan;91:8–21.
8. Gillies RJ, Schornack PA, Secomb TW, Raghunand N. Causes and effects of heterogeneous
perfusion in tumors. Neoplasia. 1999 Aug;1(3):197–207.
9. Chauhan VP, Stylianopoulos T, Boucher Y, Jain RK. Delivery of molecular and nanoscale
medicine to tumors: transport barriers and strategies. Annu Rev Chem Biomol Eng.
2011;2:281–298.
10. Padera TP, Stoll BR, Tooredman JB, Capen D, di Tomaso E, Jain RK. Pathology: cancer
cells compress intratumour vessels. Nature. 2004 Feb;427(6976):695.
11. Stylianopoulos T, Martin JD, Chauhan VP, Jain SR, Diop-Frimpong B, Bardeesy N, et al.
Causes, consequences, and remedies for growth-induced solid stress in murine and human
tumors. Proc Natl Acad Sci USA. 2012 Sep;109(38):15101–15108.
12. Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer.
2004 Jun;4(6):437–447.
13. Harris AL. Hypoxia–a key regulatory factor in tumour growth. Nat Rev Cancer. 2002
Jan;2(1):38–47.
14. Vaupel P, Schienger K, Knoop C, Hockel M. Oxygenation of human tumors: Evaluation
of tissue oxygen distribution in breast cancers by computerized O2 tension measurements.
Cancer Research. 1991;51(12):3316–3322.
45
15. Padhani AR, Krohn KA, Lewis JS, Alber M. Imaging oxygenation of human tumours. Eur
Radiol. 2007 Apr;17(4):861–872.
16. Skeldon AC, Chaffey G, Lloyd DJ, Mohan V, Bradley DA, Nisbet A. Modelling and detecting
tumour oxygenation levels. PLoS ONE. 2012;7(6):e38597.
17. Kelly CJ, Brady M. A model to simulate tumour oxygenation and dynamic [18F]-Fmiso
PET data. Phys Med Biol. 2006 Nov;51(22):5859–5873.
18. Monnich D, Troost EG, Kaanders JH, Oyen WJ, Alber M, Thorwarth D. Modelling and
simulation of [18F]fluoromisonidazole dynamics based on histology-derived microvessel maps.
Phys Med Biol. 2011 Apr;56(7):2045–2057.
19. Ito H, Kanno I, Kato C, Sasaki T, Ishii K, Ouchi Y, et al. Database of normal human
cerebral blood flow, cerebral blood volume, cerebral oxygen extraction fraction and cerebral
metabolic rate of oxygen measured by positron emission tomography with 15O-labelled
carbon dioxide or water, carbon monoxide and oxygen: a multicentre study in Japan. Eur J
Nucl Med Mol Imaging. 2004 May;31(5):635–643.
20. Beaney RP, Lammertsma AA, Jones T, McKenzie CG, Halnan KE. Positron emission
tomography for in-vivo measurement of regional blood flow, oxygen utilisation, and blood
volume in patients with breast carcinoma. Lancet. 1984 Jan;1(8369):131–134.
21. Beaney RP. Positron emission tomography in the study of human tumors. Semin Nucl Med.
1984 Oct;14(4):324–341.
22. Leenders KL. PET: blood flow and oxygen consumption in brain tumors. J Neurooncol.
1994;22(3):269–273.
23. Lammertsma AA, Jones T. Low oxygen extraction fraction in tumours measured with the
oxygen-15 steady state technique: effect of tissue heterogeneity. The British Journal of
Radiology. 1992;65(776):697–700.
24. Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Charlop A, Lawton TJ, et al. Blood flow
and metabolism in locally advanced breast cancer: relationship to response to therapy. J
Nucl Med. 2002 Apr;43(4):500–509.
25. Wilson CB, Lammertsma AA, McKenzie CG, Sikora K, Jones T. Measurements of blood
flow and exchanging water space in breast tumors using positron emission tomography: a
rapid and noninvasive dynamic method. Cancer Res. 1992 Mar;52(6):1592–1597.
26. Christen T, Bolar DS, Zaharchuk G. Imaging brain oxygenation with MRI using blood
oxygenation approaches: methods, validation, and clinical applications. AJNR Am J
Neuroradiol. 2013;34(6):1113–1123.
27. An H, Liu Q, Eldeniz C, Lin W. Absolute oxygenation metabolism measurements using
magnetic resonance imaging. Open Neuroimag J. 2011;5:120–135. Suppl. 1-M8.
28. Christen T, Lemasson B, Pannetier N, Farion R, Remy C, Zaharchuk G, et al. Is T2* enough
to assess oxygenation? Quantitative blood oxygen level-dependent analysis in brain tumor.
Radiology. 2012 Feb;262(2):495–502.
29. Christen T, Ni W, Qiu D, Schmiedeskamp H, Bammer R, Moseley M, et al. High-resolution
cerebral blood volume imaging in humans using the blood pool contrast agent ferumoxytol.
Magn Reson Med. 2013 Sep;70(3):705–710.
30. Ostergaard L. Principles of cerebral perfusion imaging by bolus tracking. J Magn Reson
Imaging. 2005 Dec;22(6):710–717.
31. Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, Edelman RR. A general kinetic
model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med. 1998
Sep;40(3):383–396.
46
32. Wolf RL, Detre JA. Clinical neuroimaging using arterial spin-labeled perfusion magnetic
resonance imaging. Neurotherapeutics. 2007 Jul;4(3):346–359.
33. Taroni P. Diffuse optical imaging and spectroscopy of the breast: a brief outline of history
and perspectives. Photochem Photobiol Sci. 2012 Feb;11(2):241–250.
34. Grosenick D, Moesta KT, Moller M, Mucke J, Wabnitz H, Gebauer B, et al. Time-domain
scanning optical mammography: I. Recording and assessment of mammograms of 154 patients.
Phys Med Biol. 2005 Jun;50(11):2429–2449.
35. Taroni P, Torricelli A, Spinelli L, Pifferi A, Arpaia F, Danesini G, et al. Time-resolved optical
mammography between 637 and 985 nm: clinical study on the detection and identification
of breast lesions. Phys Med Biol. 2005 Jun;50(11):2469–2488.
36. Choe R, Konecky SD, Corlu A, Lee K, Durduran T, Busch DR, et al. Differentiation
of benign and malignant breast tumors by in-vivo three-dimensional parallel-plate diffuse
optical tomography. J Biomed Opt. 2009;14(2):024020.
37. Grosenick D, Wabnitz H, Moesta KT, Mucke J, Schlag PM, Rinneberg H. Time-domain
scanning optical mammography: II. Optical properties and tissue parameters of 87 carcinomas.
Phys Med Biol. 2005 Jun;50(11):2451–2468.
38. Spinelli L, Torricelli A, Pifferi A, Taroni P, Danesini G, Cubeddu R. Characterization of
female breast lesions from multi-wavelength time-resolved optical mammography. Phys Med
Biol. 2005 Jun;50(11):2489–2502.
39. Welter M, Rieger H. Interstitial fluid flow and drug delivery in vascularized tumors: a
computational model. PLoS ONE. 2013;8(8):e70395. Available from: http://dx.doi.org/
10.1371%2Fjournal.pone.0070395.
40. Krogh A. The number and distribution of capillaries in muscles with calculations of the oxygen
pressure head necessary for supplying the tissue. J Physiol (Lond). 1919 May;52(6):409–415.
41. Goldman D. Theoretical models of microvascular oxygen transport to tissue. Microcirculation.
2008 Nov;15(8):795–811.
42. Nair PK, Hellums JD, Olson JS. Prediction of oxygen transport rates in blood flowing in
large capillaries. Microvasc Res. 1989 Nov;38(3):269–285.
43. Nair PK, Huang NS, Hellums JD, Olson JS. A simple model for prediction of oxygen
transport rates by flowing blood in large capillaries. Microvasc Res. 1990 Mar;39(2):203–211.
44. Hellums JD, Nair PK, Huang NS, Ohshima N. Simulation of intraluminal gas transport
processes in the microcirculation. Ann Biomed Eng. 1996;24(1):1–24.
45. Moschandreou TE, Ellis CG, Goldman D. Influence of tissue metabolism and capillary
oxygen supply on arteriolar oxygen transport: a computational model. Math Biosci. 2011
Jul;232(1):1–10.
46. Safaeian, N . Computational Modelling of Capillaries in Neuro-vascular Coupling: A Thesis
Presented for the Degree of Doctor of Philosophy in Mechanical Engineering at the University
of Canterbury, Christchurch, New Zealand. University of Canterbury; 2012.
47. Alarcon T, Byrne HM, Maini PK. A cellular automaton model for tumour growth in
inhomogeneous environment. Journal of Theoretical Biology. 2003;225:257–274.
48. Byrne HM, Owen MR, Alarcon T, Murphy J, Maini PK. MODELLING THE RESPONSE
OF VASCULAR TUMOURS TO CHEMOTHERAPY: A MULTISCALE APPROACH.
Mathematical Models and Methods in Applied Sciences. 2006;16(supp01):1219–1241.
49. Byrne HM, Alarcon T, Owen MR, Webb SD, Maini PK. Modelling aspects of cancer
dynamics: a review. Phil Trans R Soc. 2006;364:1563–1578.
47
50. Owen MR, Alarcon T, Maini PK, Byrne HM. Angiogenesis and vascular remodelling in
normal and cancerous tissues. J Math Biol. 2009 Apr;58(4-5):689–721.
51. Bauer AL, Jackson TL, Jiang Y. A cell-based model exhibiting branching and anastomosis
during tumor-induced angiogenesis. Biophys J. 2007 May;92(9):3105–3121.
52. Zheng X, Wise SM, Cristini V. Nonlinear simulation of tumor necrosis, neo-vascularization
and tissue invasion via an adaptive finite-element/level-set method. Bull Math Biol.
2005;67:211–259.
53. Macklin P, McDougall S, Anderson AR, Chaplain MA, Cristini V, Lowengrub J. Multiscale
modelling and nonlinear simulation of vascular tumour growth. J Math Biol. 2009 Apr;58:765–
798.
54. Frieboes HB, Lowengrub JS, Wise S, Zheng X, Macklin P, Bearer EL, et al. Computer
simulation of glioma growth and morphology. Neuroimage. 2007;37 Suppl 1:59–70.
55. Bartha K, Rieger H. Vascular network remodeling via vessel cooption, regression and growth
in tumors. J Theor Biol. 2006;241:903–918. Available from: http://www.sciencedirect.
com/science/article/pii/S0022519306000373.
56. Lee DS, Rieger H, Bartha K. Flow correlated percolation during vascular remodeling
in growing tumors. Physical Review Letters. 2006;96:0581041–0581044. Available from:
http://link.aps.org/doi/10.1103/PhysRevLett.96.058104.
57. Welter M, Bartha K, Rieger H. Emergent vascular network inhomogeneities and resulting
blood flow patterns in a growing tumor. J Theor Biol. 2008 Jan;250(2):257–280. Available
from: http://www.sciencedirect.com/science/article/pii/S0022519307004584.
58. Welter M, Bartha K, Rieger H. Vascular remodelling of an arterio-venous blood vessel
network during solid tumour growth. J Theor Biol. 2009 Aug;259(3):405–422. Available
from: http://www.sciencedirect.com/science/article/pii/S0022519309001635.
59. Welter M, Rieger H. Physical determinants of vascular network remodeling during tumor
growth. Eur Phys J E Soft Matter. 2010 Oct;33(2):149–163. Available from: http://dx.
doi.org/10.1140/epje/i2010-10611-6.
60. Rieger H, Welter M. Integrative models of vascular remodeling during tumor growth. Wiley
Interdisciplinary Reviews: Systems Biology and Medicine. 2015;7(3):113–129. Available from:
http://dx.doi.org/10.1002/wsbm.1295.
61. Goldman D, Popel AS. Computational modeling of oxygen transport from complex capillary
networks. Relation to the microcirculation physiome. Adv Exp Med Biol. 1999;471:555–563.
62. Goldman D, Popel AS. A computational study of the effect of capillary network anastomoses
and tortuosity on oxygen transport. J Theor Biol. 2000 Sep;206(2):181–194.
63. Goldman D, Bateman RM, Ellis CG. Effect of sepsis on skeletal muscle oxygen consumption
and tissue oxygenation: interpreting capillary oxygen transport data using a mathematical
model. Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2535–2544.
64. Goldman D, Bateman RM, Ellis CG. Effect of decreased O2 supply on skeletal muscle
oxygenation and O2 consumption during sepsis: role of heterogeneous capillary spacing and
blood flow. Am J Physiol Heart Circ Physiol. 2006 Jun;290(6):H2277–2285.
65. Tsoukias NM, Goldman D, Vadapalli A, Pittman RN, Popel AS. A computational model
of oxygen delivery by hemoglobin-based oxygen carriers in three-dimensional microvascular
networks. J Theor Biol. 2007 Oct;248(4):657–674.
66. Fraser GM, Goldman D, Ellis CG. Comparison of generated parallel capillary arrays to
three-dimensional reconstructed capillary networks in modeling oxygen transport in discrete
microvascular volumes. Microcirculation. 2013 Nov;20(8):748–763.
48
67. Hsu R, Secomb TW. A Green’s function method for analysis of oxygen delivery to tissue by
microvascular networks. Mathematical Biosciences. 1989;96(1):61 – 78.
68. Secomb TW, Hsu R, Park EYH, Dewhirst MW. Green’s Function Methods for Analysis of
Oxygen Delivery to Tissue by Microvascular Networks. Annals of Biomedical Engineering.
2004;32(11):1519–1529.
69. Secomb TW, Hsu R, Dewhirst MW, Klitzman B, Gross JF. Analysis of oxygen transport to
tumor tissue by microvascular networks. Int J Radiat Oncol Biol Phys. 1993 Feb;25(3):481–
489.
70. Secomb TW; 2014. Available from: http://www.physiology.arizona.edu/people/
secomb/greens.
71. Safaeian N, Sellier M, David T. A computational model of hemodynamic parameters in
cortical capillary networks. J Theor Biol. 2011 Feb;271(1):145–156.
72. Safaeian N, David T. A computational model of oxygen transport in the cerebrocapillary levels
for normal and pathologic brain function. J Cereb Blood Flow Metab. 2013 Oct;33(10):1633–
1641.
73. Beard DA. Computational framework for generating transport models from databases of
microvascular anatomy. Ann Biomed Eng. 2001 Oct;29(10):837–843.
74. He Y, Shirazaki M, Liu H, Himeno R, Sun Z. A numerical coupling model to analyze the
blood flow, temperature, and oxygen transport in human breast tumor under laser irradiation.
Comput Biol Med. 2006 Dec;36(12):1336–1350.
75. Dasu A, Toma-Dasu I, Karlsson M. Theoretical simulation of tumour oxygenation and
results from acute and chronic hypoxia. Phys Med Biol. 2003 Sep;48(17):2829–2842.
76. Espinoza I, Peschke P, Karger CP. A model to simulate the oxygen distribution in hypoxic
tumors for different vascular architectures. Med Phys. 2013 Aug;40(8):081703.
77. Degond P, Mas-Gallic S. The Weighted Particle Method for Convection-Diffusion Equations.
Part 1: The Case of an Isotropic Viscosity. Mathematics of Computation. 1989;53(188):485–
507.
78. Lagerlo¨f JH, Kindblom J, Cortez E, Pietras K, Bernhardt P. Image-based 3D modeling study
of the influence of vessel density and blood hemoglobin concentration on tumor oxygenation
and response to irradiation. Med Phys. 2013 Feb;40(2):024101.
79. Lagerlo¨f JH, Kindblom J, Bernhardt P. The impact of including spatially longitudinal
heterogeneities of vessel oxygen content and vascular fraction in 3D tumor oxygenation
models on predicted radiation sensitivity. Med Phys. 2014 Apr;41(4):044101.
80. Kim E, Stamatelos S, Cebulla J, Bhujwalla ZM, Popel AS, Pathak AP. Multiscale imaging
and computational modeling of blood flow in the tumor vasculature. Ann Biomed Eng. 2012
Nov;40(11):2425–2441.
81. Kim E, Cebulla J, Ward BD, Rhie K, Zhang J, Pathak AP. Assessing breast cancer
angiogenesis in vivo: which susceptibility contrast MRI biomarkers are relevant? Magn
Reson Med. 2013 Oct;70(4):1106–1116.
82. Sourbron SP, Buckley DL. Tracer kinetic modelling in MRI: estimating perfusion and
capillary permeability. Phys Med Biol. 2012 Jan;57(2):1–33.
83. Valabregue R, Aubert A, Burger J, Bittoun J, Costalat R. Relation between cerebral blood
flow and metabolism explained by a model of oxygen exchange. J Cereb Blood Flow Metab.
2003 May;23(5):536–545.
49
84. Hayashi T, Watabe H, Kudomi N, Kim KM, Enmi J, Hayashida K, et al. A theoretical model
of oxygen delivery and metabolism for physiologic interpretation of quantitative cerebral blood
flow and metabolic rate of oxygen. J Cereb Blood Flow Metab. 2003 Nov;23(11):1314–1323.
85. Jespersen SN, Ostergaard L. The roles of cerebral blood flow, capillary transit time het-
erogeneity, and oxygen tension in brain oxygenation and metabolism. J Cereb Blood Flow
Metab. 2012 Feb;32(2):264–277.
86. Zubieta-Calleja G, Paulev PE. 15. In: New Human Physiology. Paulev-Zubieta; 2015. .
87. Pittman RN. Regulation of tissue oxygenation. In: Colloquium Series on Integrated Systems
Physiology: From Molecule to Function. vol. 3. Morgan & Claypool Life Sciences; 2011. p.
1–100.
88. Yaseen MA, Srinivasan VJ, Sakadzic S, Radhakrishnan H, Gorczynska I, Wu W, et al.
Microvascular oxygen tension and flow measurements in rodent cerebral cortex during
baseline conditions and functional activation. J Cereb Blood Flow Metab. 2011;31:1051–
1063.
89. Kirkpatrick JP, Brizel DM, Dewhirst MW. A mathematical model of tumor oxygen and
glucose mass transport and metabolism with complex reaction kinetics. Radiat Res. 2003
Mar;159(3):336–344.
90. Jain RK. Transport of molecules, particles, and cells in solid tumors. Annu Rev Biomed
Eng. 1999;1:241–263.
91. Leu AJ, Berk DA, Yuan F, Jain RK. Flow velocity in the superficial lymphatic network of
the mouse tail. Am J Physiol. 1994;267(4 Pt 2):H1507–1513.
92. Chary SR, Jain RK. Direct measurement of interstitial convection and diffusion of albumin
in normal and neoplastic tissues by fluorescence photobleaching. Proc Natl Acad Sci USA.
1989;86:5385–5389.
93. Dafni H, Israely T, Bhujwalla ZM, Benjamin LE, Neeman M. Overexpression of vascular
endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic
drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple-
labeled albumin. Cancer Res. 2002;62(22):6731–6739.
94. Coppola, G and Caro, C. Oxygen mass transfer in a model three-dimensional artery. Journal
of The Royal Society Interface. 2008;5(26):1067–1075.
95. Pries A, Secomb T, Gaehtgens P, Gross J. Blood flow in microvascular networks. Experiments
and simulation. Circulation Research. 1990;67:826–834.
96. Heroux MA, Bartlett RA, Howle VE, Hoekstra RJ, Hu JJ, Kolda TG, et al. An overview of
the Trilinos project. ACM Transactions on Mathematical Software. 2005;31(3):397–423.
97. Pries AR, Secomb TW, Gessner T, Sperandio MB, Gross JF, Gaehtgens P. Resistance to
blood flow in microvessels in vivo. Circ Res. 1994 Nov;75(5):904–915.
98. Thomas H Cormen RLR Charles E Leiserson, Stein C. 22.3. In: Introduction to Algorithms,
third edition. The MIT Press; 2009. .
99. LeVeque RJ. Finite difference methods for ordinary and partial differential equations -
steady-state and time-dependent problems. SIAM; 2007.
100. Knabner P, L A. Numerik partieller Differentialgleichungen. Springer Verlag; 2000.
101. Lorthois S, Duru P, Billanou I, Quintard M, Celsis P. Kinetic modeling in the context of
cerebral blood flow quantification by H152 O positron emission tomography: the meaning of
the permeability coefficient in Renkin-Crone’s model revisited at capillary scale. J Theor
Biol. 2014 Jul;353:157–169.
50
102. Go¨dde R, Kurz H. Structural and Biophysical Simulation of Angiogenesis and Vascular
Remodeling. Developmental Dynamics. 2001;220:387–401.
103. Ando J, Yamamoto K. Flow detection and calcium signalling in vascular endothelial cells.
Cardiovasc Res. 2013 Jul;99(2):260–268.
104. Do¨me B, Paku S, B S, T´ıma´r. Vascularization of cutaneous melanoma involves vessel
co-option and has clinical significance. The Journal of Pathology. 2002;197(3):355–362.
105. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, et al. Vessel
Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF. Science.
1999;284:1994–1998.
106. Chauhan VP, Boucher Y, Ferrone CR, Roberge S, Martin JD, Stylianopoulos T, et al.
Compression of pancreatic tumor blood vessels by hyaluronan is caused by solid stress and
not interstitial fluid pressure. Cancer Cell. 2014 Jul;26(1):14–15.
107. DelGiorno KE, Carlson MA, Osgood R, Provenzano PP, Brockenbough JS, Thompson CB,
et al. Response to Chauhan et Al.: interstitial pressure and vascular collapse in pancreas
cancer-fluids and solids, measurement and meaning. Cancer Cell. 2014 Jul;26(1):16–17.
108. Stylianopoulos T, Martin JD, Snuderl M, Mpekris F, Jain SR, Jain RK. Coevolution of solid
stress and interstitial fluid pressure in tumors during progression: implications for vascular
collapse. Cancer Res. 2013 Jul;73(13):3833–3841.
109. Griffon-Etienne G, Boucher Y, Brekken C, Suit HD, Jain RK. Taxane-induced apoptosis
decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical
implications. Cancer Res. 1999 Aug;59(15):3776–3782.
110. Viacava P, Naccarato AG, Bocci G, Fanelli G, Aretini P, Lonobile A, et al. Angiogenesis and
VEGF expression in pre-invasive lesions of the human breast. J Pathol. 2004 Oct;204(2):140–
146.
111. Dhakal HP, Bassarova A, Naume B, Synnestvedt M, Borgen E, Kaaresen R, et al. Breast
carcinoma vascularity: a comparison of manual microvessel count and Chalkley count. Histol
Histopathol. 2009 Aug;24(8):1049–1059.
112. Fernandez-Guinea O, Alvarez-Cofino A, Eiro N, Gonzalez LO, del Casar JM, Fernandez-
Garcia B, et al. Low microvascular density at the tumor center is related to the expression
of metalloproteases and their inhibitors and with the occurrence of distant metastasis in
breast carcinomas. Int J Clin Oncol. 2013 Aug;18(4):629–640.
113. Carp SA, Selb J, Fang Q, Moore R, Kopans DB, Rafferty E, et al. Dynamic functional and
mechanical response of breast tissue to compression. Opt Express. 2008 Sep;16(20):16064–
16078.
114. Marieb EN, Hoehn K. Human Anatomy & Physiology. Pearson; 2013.
115. Sharan M, Vovenko EP, Vadapalli A, Popel AS, Pittman RN. Experimental and theoretical
studies of oxygen gradients in rat pial microvessels. J Cereb Blood Flow Metab. 2008
Sep;28(9):1597–1604.
116. Hartmann P, Mirtolouei R, Untersberger S, Ziegler W, Hermann Z, Richtig E, et al. Non-
invasive imaging of tissue PO2 in malignant melanoma of the skin. Melanoma Res. 2006
Dec;16(6):479–486.
117. Ito M, Yang DJ, Mawlawi O, Mendez R, Oh CS, Azhdarinia A, et al. {PET} and Planar
Imaging of Tumor Hypoxia With Labeled Metronidazole. Academic Radiology. 2006;13(5):598
– 609.
118. Spence VA, Walker WF. Tissue oxygen tension in normal and ischaemic human skin.
Cardiovasc Res. 1984 Mar;18(3):140–144.
51
119. An H, Lin W. Cerebral venous and arterial blood volumes can be estimated separately in
humans using magnetic resonance imaging. Magn Reson Med. 2002 Oct;48(4):583–588.
120. Vaupel P, Fortmeyer HP, Runkel S, Kallinowski F. Blood flow, oxygen consumption, and
tissue oxygenation of human breast cancer xenografts in nude rats. Cancer Res. 1987
Jul;47(13):3496–3503.
121. Pries AR, Hopfner M, le Noble F, Dewhirst MW, Secomb TW. The shunt problem: control of
functional shunting in normal and tumour vasculature. Nat Rev Cancer. 2010 Aug;10(8):587–
593.
122. Pries AR, Ley K, Claassen M, Gaehtgens P. Red cell distribution at microvascular bifurcations.
Microvasc Res. 1989 Jul;38(1):81–101.
123. D’Angelo C. Finite Element Approximation of Elliptic Problems with Dirac Measure Terms
in Weighted Spaces: Applications to One- and Three-dimensional Coupled Problems. SIAM
Journal on Numerical Analysis. 2012;50(1):194–215.
124. Jain RK, Tong RT, Munn LL. Effect of vascular normalization by antiangiogenic therapy
on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a
mathematical model. Cancer Res. 2007;67(6):2729–2735.
125. Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol.
2010 Nov;7(11):653–664.
52
S1 Appendix
Oxygen Mass Transfer Coefficient
In this supplemental material we will review simulation results in comparison with literature
references and our calibration procedure of the mass transfer coefficient γ. In order to determine
γ we constructed the phenomenological formula
γ(r) =
Dpαp
r
p2(1− exp(−r/p1)), (1)
with free parameters p1 and p2 based on experimental and computed data for Nusselt numbers
nu [1, 2] of capillaries and arterioles (see Fig. 1). The Nusselt number is related to the mass
transfer coefficient by nu = 2rγ/D−1p α
−1
p , where r is the radius,Dp the oxygen diffusion constant in
plasma and αp the solubility constant, i.e. nu is a non-dimensional permeability coefficient. Using
aforementioned data we obtained initial guesses of parameters p1 and p2 of Eq. (1). However, we
also pursued the idea to fit the results of our model, i.e. the partial oxygen pressure in vascular
tubes, to experimental data and precise calculations [3, 2]. This way we also take systematic
discretization errors into account.
To this end, the common setting considered is a 4 mm long perfused vascular tube embedded
in a block of a medium through which oxygen can diffuse. In brief, some details are as follows,
The theoretical model [2] incorporates a multi-layered vascular tube as source of oxygen and a
surrounding infinite tissue with a homogeneous background representing oxygen release from the
capillary plexus. We augmented the tissue diffusion equation (15)accordingly by adding the source
term κ − Pt,iκ/P ∗, where κ = 0.625mmHg and κ/P ∗ = 30. Other parameter which are already
present in our model were readily adopted. The flow rate q poses an exception since it was not
provided directly. We determined it according to [2, (A6)] using the velocity profile coefficients in
the appendix. The simulation box was made large enough that the radial Pt profile can assume the
asymptotic value (42 mmHg) determined by κ and M0. Nair et al. [3] considered a configuration
where a vascular tube is surrounded by a block of rubber which is in contact with air with a specific
oxygen partial pressure. Two variants of this exist. One where oxygen rich blood releases oxygen
[3, Fig. 2] and another where oxygen depleted blood takes up oxygen [3, Fig. 3]. In the former
case the PO2 of the air is kept at 168 mmHg and the blood PO2 at the inlet is 0. Vice versa for
the latter case. In either case, gas exchange happens through the surrounding rubber block. We
realized this by Dirichlet boundary conditions and by setting the consumption rate M0 = 0. The
faces perpendicular to the longitudinal axis were imposed with no-flux conditions. The system size
was set according to the reported half-thickness of the block as 4mm× 80µm× 80µm. Our data
is produced with a spatial resolution of h = 20 µm. We compare the blood oxygen saturation S at
the end of the vascular tubes with the reference values from [3, 2] as shown in Fig. 2. It was not
possible to obtain good agreement in all the cases, in particular for vascular oxygen uptake (plus in
Fig. 2). In order to obtain the result shown, we used p2 = 4. The best fit to aforementioned Nusselt
numbers (p2 = 4.7) resulted in a worse fit for vascular oxygen uptake and little change else.
Secomb [4] recently published the software that produced the results for the theoretical studies
[5, 6] using a Green’s function method. We compared it against our results in several cases
for single vessels as well as vessel networks, although not to the size that we require (s. Sec.
‘Computational models allowing for oxygen diffusion in tissue‘). The deviations are generally of the
magnitude ±10 mmHg depending on the location on the network. An example of our results is
shown in Fig. 3.
Poor convergence of the solution with the grid constant his a significant source of error in our
method. Convergence tests with respect to the grid constant h show sublinear convergence as
shown in Fig. 4 where we plotted vascular and tissue oxygen partial pressures in a single vascular
tube for different grid constants. Extrapolating, we again expect an error of the order of 10 mmHg
by the end of the vessels, depending on q and S. The reason for poor convergence is the singular
nature of the oxygen source term (18)in the tissue oxygen diffusion equation , i.e. the use of the
Dirac-δ function. It was shown [7] that optimal convergence is obtained by using locally refined
meshes. In future work it will be mandatory to improve the accuracy.
It is possible to arrive at inconsistent solutions when the iteration of (20)and (21)has not suffi-
ciently converged. Then the amount of oxygen extracted from the network will not be the same as
1
the amount consumed by tissue. Hence, in order to check for conservation of mass we determined
the total transvascular oxygen flux Jtv, the total consumption Jcons =
∫
Ω
M(Pt) and consider the
error etv = (Jtv − Jcons)/Jtv. We also check the mass conservation error in the vasculature due
to the numerical integration of P and determine ev = (Jin − Jout − Jtv)/Jin, where Jin and Jout
are the influx and efflux through root nodes. We found both errors to be less than 1% at the point
where further iteration does not change the solution any more.
Figure 1. Nusselt numbers: The dimensionless Nusselt number nu describes the oxygen flux
through the vessel wall in proportion to difference between the average intravascular PO2 and the
PO2 at the wall. The designations of the legend are as follows: nu∗ denotes the Nusselt number
used in our simulations, whereas nu(hellums) and nu(moschandreou) denote experimental [1]
and theoretical data [2, Fig. 6]. In future a saturation dependence should be added, but here we
only included the radius dependence and assumed a constant saturation of S ≈ 0.9. The blue line
is a best fit to aforementioned data. For nu∗, the prefactor is 4 instead of 4.7 in the best fit.
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Figure 2. Result of mass transfer coefficient calibration: We considered a single 4 mm long
vascular tube embedded in a passive medium through which oxygen can diffuse. We computed
the blood oxygen saturation S at the end of the vascular tube x = 4 mm (red) under various
conditions (see text), in particular varying vascular radii r. Literature data of more sophisticated
capillary models for equivalent cases [2, Fig. 4] (◦), [3, Fig. 2] (×), and [3, Fig. 3] (+) are shown
as black symbols. We aimed to chose the mass transfer coefficient γ for good agreement with this
data.
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Figure 3. Comparison with Green’s function method: (A) shows the oxygen partial pressure
PO2 distribution produced by our program. (B) shows the distribution produced by the software
by Secomb [4]. The solution of vascular PO2 distribution P is layered on top of a slice through the
tissue oxygen PO2 distribution Pt. The same input, a small artificial network, was used in both
cases. Although the solutions appear qualitatively solutions similar, there are differences of ca.
10 mmHg.
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Figure 4. Convergence test w.r.t. grid constant h. We consider a small simulation volume with
a single vessel of length 1 mm inside. Vascular (P , crosses) and tissue (Pt, pluses) oxygen
partial pressure PO2 distributions are shown. The development of P and Pt (dotted line) along
the vessel center axis is displayed in (A). In (B) we plotted the transversal profile of Pt, i.e.
perpendicular to the vessel axis along the spatial coordinate y1 at a point half way between the
ends of the vessel. The horizontal lines indicate the vascular PO2 at this point. For smaller h the
curves lie somewhat further apart, indicating sub-linear convergence, i.e. if the error to the true
solution was linear in h we would observe a constant spacing between curves.
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S2 Appendix
Explicit Formulas for Relevant Biophysical Quantities
After vascular networks of normal tissue and tumor were constructed, distributions of hemat-
ocrit in vascular networks and oxygen concentrations in vascular networks and tissue are calcu-
lated, yielding for each vessel segment v ∈ V e.g. radius rv , length lv, hematocrit Hv, blood
flow qv, blood oxygen saturation Sv(0) and oxygen concentration at vessel entrance cv(0), aver-
age blood oxygen saturation Yv. Using this information, the following averages are calculated,
pertaining to the tissue volume Ω.
Length density :
LD =
1
|Ω|
∑
v∈V
lv, (1)
taken as measure for microvessel density MVD .
Regional blood volume :
rBV =
1
|Ω|
∑
v∈V
πr2vlv (2)
Vascular surface area per unit volume of tissue :
Sρ =
1
|Ω|
∑
v∈V
2πrvlv, (3)
where S is the vascular surface area per gram tissue and ρ tissue density.
Regional blood flow :
rBF =
1
|Ω|
∑
v∈I∩∂Ω
qv =
1
|Ω|
∑
v∈O∩∂Ω
qv, (4)
where I∩V (O∩V) denote set of all vessel segments penetrating surface ∂Ω with blood flow
pointing inwards (outwards).
Hemoglobin concentration :
cHb =MCHC · rRBCV = MCHC|Ω|
∑
v∈V
πr2vlvHv (5)
with mean corpuscular hemoglobin concentration MCHC, regional RBC volume rRBCV .
Oxyhemoglobin concentration :
cHbO2 =
MCHC
|Ω|
∑
v∈V
πr2vlvHv
1
lv
∫
v
Sv(x)dx (6)
and an analogous expression for the deoxyhemoglobin concentration cHbD, replacing
1
lv
∫
v
Sv(x)dx
by 1− 1lv
∫
v
Sv(x)dx.
Blood oxygen saturation :
Y =
cHbO
cHb
=
∑
v∈V
{
πr2vHvlv∑
u∈V πr
2
uluHu
1
lv
∫
v
Sv(x)dx
}
, (7)
where Y is the RBC-volume-weighted average of blood oxygen saturation taken over all
vessel segments.
1
Length-weighted average blood oxygen saturation :
〈S〉 =
∑
v∈V
lv∑
u∈V lu
1
lv
∫
v
Sv(x)dx (8)
Average partial oxygen pressure in blood :
〈P 〉 =
∑
v∈V
lv∑
u lu
1
lv
∫
v
P (x)dx, (9)
where the average concentration of dissolved oxygen in blood is given by c¯p = α〈P 〉.
Average tissue partial oxygen pressure :
Pt =
1
|Ω|
∫
Ω
Pt(x)d
3x, (10)
where the average oxygen concentration in tissue is given by c¯t = αt〈Pt〉.
Metabolic rate of oxygen consumption :
MRO2 =
1
|Ω|
∫
Ω
M(Pt(x))d
3x, (11)
where M is the Michaelis-Menten relation (17).
Total transvascular oxygen flux :
Jtv =
∑
v∈V
2πrvγ(rv)
∫
v
{P (x)− Pt(x)} dx, (12)
and corresponding regional transvascular oxygen flux rJtv = Jtv/|Ω|.
Average transvascular oxygen flux density :
〈jtv〉 = 1∑
u∈V lu
∑
v∈V
γ(rv)
∫
v
{P (x)− Pt(x)} dx, (13)
i.e. the average transvascular oxygen flux density is the length weighted average over the
mean oxygen flux density of all vessel segments; note that Sρ〈jtv〉 6= Jtv|Ω| = MRO2 .
Oxygen permeability : from Jtv/|Ω| = PO2Sρ {c¯p − c¯t} one obtains
PO2 =
MRO2
〈Sρ〉 {c¯p − c¯t} =
1
|Ω|
∑
v∈V 2πrvγ(rv)
∫
v
{P (x)− Pt(x)} dx
〈Sρ〉 {α〈P 〉 − αt〈Pt〉} (14)
Oxygen flux entering vascular network :
Jin =
∑
v∈I∩∂Ω
qv {c0HvSin,v + αPin,v} , (15)
with Pin,v = P
(BC)
v and Sin,v given by the Hill equation. The corresponding regional influx is
rJin = Jin/|Ω|.
Oxygen flux leaving vascular network :
Jout =
∑
v∈O∩∂Ω
qv {c0HvSout,v + αPout,v} (16)
Oxygen extraction fraction :
OEF =
Jin − Jout
Jin
. (17)
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S3 Appendix
Compartment Model
For comparison with results obtained by the computational model (s. Table 4 in the main paper)
we estimated metabolic rates of oxygen consumption MRO2 and oxygen extraction fraction OEF
within the framework of the computational model, using the following model (input) parameters:
• RBC oxygen carrying capacity: c0 = 0.50ml O2/ml RBC (s. Table 1)
• hematocrit: H = 0.45 (s. Table 1)
• Hill exponent: n = 2.7 (s. Table 1)
• blood oxygen partial pressure at half saturation: PS50 = 27 mmHg (s. Table 1)
• oxygen solubility (plasma): 3.1 · 10−5ml O2/ml/mmHg (s. Table 1)
• measured average blood oxygen saturation: Yexp = 0.74 (normal), Yexp = 0.72 (tumor) [1].
• arterial blood oxygen saturation:Sin = 0.958 (normal, s. Table 4), Sin = 0.833 (tumor, s. Table
4)
• perfusion: rBF = 0.06ml blood/ml/min (normal), rBF = 0.30ml blood/ml/min (tumor)
[2, 3]
Table 1. Metabolic rate of oxygen consumption and oxygen extraction fraction as function
of assumed tissue oxygen partial pressure
Pt
mmHg
MRO2 (normal)
µl O2/ml/min
OEF
(normal)
MRO2 (tumor)
µl O2/ml/min
OEF
(tumor)
0 5.15 0.398 14.30 0.254
5 5.08 0.393 14.18 0.252
10 4.99 0.386 14.02 0.249
15 4.88 0.377 13.81 0.246
20 4.74 0.366 13.51 0.240
25 4.54 0.351 13.04 0.232
30 4.25 0.328 12.24 0.218
35 3.76 0.291 10.44 0.186
37 3.45 0.267 8.91 0.159
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Figure 1. Vascular blood oxygen saturation S(ξ) along vessel axis (0 ≤ ξ ≤ 1) for fixed
average blood oxygenation Y = 0.73, assuming S(0) = 0.95 and tissue oxygen partial pressures
of Pt = 0, 10, 15, 20, 25, 30, 35 mmHg (from bottom to top at ξ = 1); intersection caused by
constraint Y = constant results in decrease of oxygen extraction fraction OEF with increasing
tissue oxygen pressure.
Figure 2. Vascular blood oxygen saturation S(ξ) along vessel axis (0 ≤ ξ ≤ 1) for fixed
oxygen extraction fraction OEF = 0.351, assuming S(0) = 0.95 and tissue oxygen partial
pressures of Pt = 0, 10, 15, 20, 25, 30 mmHg (from top to bottom).
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S4 Appendix
Regional Blood Volume of Confined Perfect Binary Trees
In this section we derive an approximative relation between the number of root nodes R and
the regional blood volume rBV , provided that the total number of vessels M is held constant,
i.e. all vascular trees are confined to the simulation box Ω and adhere to a fixed vascular density.
Naturally R is also the number of trees. We assume that all vascular trees are perfect binary trees,
i.e. tree levels from k = 0 at the top to k = n− 1 at capillary (leaf) level have the maximum number
of vessels 2k. Furthermore we assume that trees are equal in the number of vessels (connections)
N . HenceM = N ·R is split to equal parts between trees. There is no distinction between arterial
and venous tree, and capillaries are neglected. For given number of levels (depth) n, a tree has
N =
∑n−1
k=0 2
k connections. This is a geometric series for which holds in general
n−1∑
k=0
qk =
qn − 1
q − 1 , (1)
for some q. N can therefore be written as N = 2n − 1, from which we obtain the depth
n = log2(N + 1), (2)
Let further the radii at a bifurcation be given by Murray’s law, i.e. rαc = r
α
a + r
α
b . Since a and b are
the same, we have rc = 2
1/αra=b, or in relation to the tree level k, we have the radius at level k
rk = 2
(n−1−k)/αrn−1, (3)
where rn−1 is the capillary radius. Now let’s estimate the volume of the tree TV , provided equal
vessel lengths l. By summing over tree levels we obtain
TV = lπ
n−1∑
k=0
2kr2k, (4)
since each level has 2k vessels of radius rk. Replacing rk by Eq.(3) we obtain
TV = πr20l · 2(n−1)2/α
n−1∑
k=0
2k(1−2/α). (5)
This is again a geometric series which is rewritten with the help of Eq.(1) and q = 21−(2/α−1) to
remove the sum. Furthermore without loss of generality we set πr20l = 1. After some basic algebra,
the result is
TV =
2n − 2(2/α)n
2− 22/α (6)
=
(N + 1)− (N + 1)2/α
2− 22/α , (7)
where in the second line we further used that 2n = N + 1. Now to satisfy the constraint that the
total number of vessels taken over all trees is constant M , we substitute N = M/R, using the
number of trees R. For brevity we set the volume of the simulation box |Ω| = 1 without loss of
generality. Thus we obtain the total regional volume of all trees rBV
rBV =
TVR
|Ω| (8)
=M
1 + RM − RM (MR + 1)2/α
2− 22/α . (9)
The denominator 2 − 22/α is a positive increasing function of α that vanishes for α = 2 and which
asymptotically approaches 1 for α → ∞. It can be shown that the nominator is a decreasing
1
function in R, which is well approximated for small R/M ≪ 1 by 1 − (R/M)(1−2/α). In the edge
case where α = 2 we still obtain a decreasing function by calculating the limit of α → 2 for Eq.(6).
In that case it is logarithmic with rBV = 12 (R+M) log2(M/R+ 1).
Murrays α determines how much parent vessel radii grow at bifurcations. In the limit of α→∞,
Murrays law selects the radius of the thicker child vessel as the radius of the parent vessel. This
means all radii become equal, and indeed rBV (α→∞) =M is obtained from Eq.(9). As we would
intuitively expect, the dependence on R is eliminated. For realistic 2 ≤ α ≤ 3, the dependence on
R cannot be removed. Moreover we can consider the case where all vessels are root vessels, i.e.
R =M . Then again rBV =M is obtained, which is clear since then again all vessels have equal
radii. In actual simulations the assumption of perfect and equally sized trees does not hold, i.e.
frequently, small branches are generated. Moreover, even if all lattice boundary sites are occupied
with root nodes, only a small fraction of them grow to vascular trees of significant size. Most of
them regress to a single starting node without any connections. Despite that, we observe a clear
trend of decreasing rBV with increasing R.
2
S5 Appendix
Blood Pressure Radius Relation
We first fit a curve to blood pressure data of rat mesentery [1]. Then we scaled the curve
(adjusting A1 and A2) so that physiological blood pressures [2, Fig. 19.6] are obtain in venules
and arterioles, thus obtaining for the blood pressure boundary condition
p(BC)(r) = [A2 + (A1−A2)/(1 + exp((r′ − r0)/∆r))], (1)
where r′ = r for a vein, else −r, and A1 = 89mmHg, A2 = 18mmHg, r0 = −21µm, ∆r = 16µm.
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cation manuscripts, the Weiter delivered the presentation of results, comprising figures and tables 
and other data. The co-authors supplied an introduction and discussion for the earlier papers 
[WBR08; WBR09]. Weiter wrote drafts of other sections, or in case of the later papers [WR10; 
WR 13; Wel+] he wrote a complete draft. After that, the authors revised the manuscript for better 
readability and additional remarks. 
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